{"title": "vacuna cubana heberbiovac-hb: Topics by WorldWideScience.org", "author": null, "url": null, "hostname": null, "description": null, "sitename": null, "date": "2013-04-11", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "[Comportamiento reactog\u00e9nico de la vacuna cubana contra la hepatitis B en ni\u00f1os f\u00edsica y mentalmente discapacitados](https://www.openaire.eu/search/publication?articleId=doajarticles::cd2d869696f88a55899ab58f2ce979f2)\nPl\u00e1cido Pedroso Flaquet; Manuel D\u00edaz Gonz\u00e1lez\n2000-01-01\nSe estudi\u00f3 la reactogenicidad de la vacuna recombinante cubana contra el virus de la hepatitis B, derivada de c\u00e9lulas de levadura (Heberbiovac-HB), al aplicar dosis de 5 y 10 mg y emplear el esquema de inmunizaci\u00f3n 0, una segunda dosis al mes y la tercera a los 6 meses a 2 grupos de ni\u00f1os f\u00edsica y mentalmente discapacitados de 5 a 14 a\u00f1os de edad. Los s\u00edntomas observados en el total de la poblaci\u00f3n estudiada fueron de 5,1 %, mientras que en los grupos vacunados con 10 y 5 mg, la sintomatolog\u00ed...\n[Respuesta inmune para la vacuna heberbiovac-hb y factores de riesgo Consolaci\u00f3n del Sur, a\u00f1o 2004 Immnune response to the Heberbiovac-HB and risk factors, Consolaci\u00f3n del Sur 2004](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-31942009000200011) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nEmilia Rosa Rieumont\n2009-06-01\nFull Text Available Uno de los pilares fundamentales para el control, eliminaci\u00f3n de la hepatitis tipo B es la utilizaci\u00f3n de la vacunas que se aplica en Cuba, desde el a\u00f1o 1992. (Heberbiovac -HB. La inmunogenicidad, indicador que se obtiene mediante la cuantificaci\u00f3n de T\u00edtulos de Anticuerpos (Anti-HBs contra el ant\u00edgeno de superficie (HBsAg post vacunaci\u00f3n permite conocer la eficacia y calidad de la vacuna. En este estudio se utiliz\u00f3 el m\u00e9todo inmunoenzim\u00e1tico (ELISA tipo sandwich, llevado a cabo por el Departamento de Hepatitis B. del Laboratorio de Inmunolog\u00eda del Centro Nacional de Gen\u00e9tica M\u00e9dica, Ciudad Habana, consider\u00e1ndose protegidos los individuos cuyos resultados estaban entre \u00b310 UI/L y One of the mainstays to control and eliminate hepatitis-B is the use of the vaccines (Herberbiovac-HB applied in Cuba since 1992. The immunogenicity, an indicator obtained through the quantification of the Antibodies Titers (Anti-HBs against the surface antigens (HbsAg post-vaccination, allowing knowing the effectiveness and quality of the vaccine. The immunoenzymatic method was used in this study kind of sandwich (ELISA, carried out by the Department for the study of Hepatitis B of the Immunology Laboratory in the National Center of Medical Genetics, Havana City. The individuals which results were between =10 UI/L and < 100 UI/L, Hyperresponsers = 100 UI/L are considered protected and sero-unprotected when the titers were < 10 UI/L; in 498 children of 10 years old that were vaccinated in the early childhood having the schedule (0-16 months of negative mothers for HBsAg, belonging to Consolacion del Sur in Pinar del Rio province. Results showed that male sex, Hypersensibilities Type I and the boys and girls maintaining treatments with immunosupresor drugs were the risk factors that provided the association with the serum-unprotection; as for in the individuals having Titers of Ac < 10 UI/L; a buster of the vaccine was applied and after 15 days the 100% of\n[[The reactogenicity of Heberbiovac-HB vaccine at different doses].](https://www.ncbi.nlm.nih.gov/pubmed/9805071)\nD\u00edaz Gonz\u00e1lez, M; Navia Molina, O; Bravo Gonz\u00e1lez, J R; Pedroso Flaquet, P; Urbino L\u00f3pez, A\n1995-01-01\nReactogenicity was measured after applying the Heberbiovac-HB recombinant vaccine against hepatitis B virus to three groups of children aged 6-9 years. The vaccine was derived from yeast cells, administered at doses of 10, 5, and 2.5 g, with a schedule of 0, 1 and 6 months. The overall observed symptomatology was low (12.2%) in the three groups with 10.7%, 13.5%, and 12.3% for 10, 5, and 2.5 g, respectively. The predominant symptoms and signs were febricula (7.0%), local pain (3.1%), and erythema (1.2%). No significant differences were found when making a comparison between groups and sexes. An acceptable reactogenicity of the immunogen was confirmed, thus its use is recommended for the protection against hepatitis B virus.\n[Reactogenicidad de la vacuna cubana trivalente contra la leptospirosis humana en un ensayo cl\u00ednico de fase II](https://www.openaire.eu/search/publication?articleId=doajarticles::71daec30452063189f5b50ff40cbc04d)\nRaydel Mart\u00ednez,; Alberto P\u00e9rez; Alberto Baly; Morelia Bar\u00f3; Reynaldo Men\u00e9ndez; Aroldo Ru\u00edz; Amelia Urbino L\u00f3pez; Manuel D\u00edaz; Marlene Armesto\n2001-01-01\nCon el objetivo de evaluar la reactogenicidad de la vacuna cubana trivalente contra la leptospirosis humana (vax- SPIRAL) en grupos de voluntarios sanos utilizando diferentes dosis, se realiz\u00f3 un ensayo cl\u00ednico controlado, aleatorio y a doble ciego. Los voluntarios fueron distribuidos en dos grupos (vacunados y placebos) para evaluar las reacciones adversas en diferentes concentraciones de dosis (0,25 y 0,5 mL). Los s\u00edntomas y signos locales evaluados fueron: dolor, rubor, infiltraci\u00f3n local,...\n[Estudio de inmunogenicidad para dos vacunas recombinantes contra hepatitis B](http://www.revistabiomedica.org/index.php/biomedica/article/view/2011) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nO. Juliao\n1991-12-01\nFull Text Available Este estudio compara la inmunogenicidad (seroconversi\u00f3n, seroprotecci\u00f3n e Hiperrespuesta, producida por dos vacunas recombinantes contra la hepatitis B (Engerix-B de B\u00e9lgica y Cubana, en dos esquemas (012 y 016 meses, empleando los m\u00e9todos de cuantificaci\u00f3n para Anti-HBsAg (Abbott y Organ\u00f3n, los cuales fueron tambi\u00e9n comparados. En el estudio participaron 257 voluntarios, divididos al azar en 4 grupos (dos vacunas, dos esquemas. Resultados: los dos m\u00e9todos de Abbon y Organon, no presentan diferencias estad\u00edsticas significativas. La vacuna cubana muestra una mayor respuesta inmunog\u00e9nica para dos dosis de vacuna y para el esquema 012. No hay diferencia entre los esquemas 012 y 016 y en el esquema 016 no se ven diferencias estad\u00edsticamente significativas con la vacuna Engerix-B. En esta \u00daltima el esquema 016 muestra mejores resultados que el 012.\n[Eficacia y seguridad de una vacuna contra la leptospirosis humana en Cuba Efficacy and safety of a vaccine against human leptospirosis in Cuba](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892004000400005) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRaydel Mart\u00ednez\n2004-04-01\nFull Text Available OBJETIVOS: Evaluar la eficacia de la vacuna cubana contra la leptospirosis vax-SPIRAL y aportar informaci\u00f3n adicional acerca de la seguridad de esta vacuna. M\u00c9TODOS: Ensayo de eficacia (fase III controlado, aleatorizado y con doble enmascaramiento de la vacuna cubana contra la leptospirosis vax-SPIRAL (Instituto Finlay, Cuba. Como control se utiliz\u00f3 la vacuna recombinante contra la hepatitis B Heberbiovac-HB (Heber Biotec, Cuba. Como unidad de aleatorizaci\u00f3n para la asignaci\u00f3n al grupo de estudio o al grupo testigo se emplearon los 523 consultorios de los m\u00e9dicos de familia existentes en los municipios seleccionados. El estudio abarc\u00f3 a toda persona de 20 a 64 a\u00f1os de edad de uno u otro sexo que resid\u00eda en los municipios de Ranchuelo, Quemado, Santo Domingo, Encrucijada, Corralillo, Cifuentes y Camajuan\u00ed, en la provincia de Villa Clara, ubicada en la regi\u00f3n central de Cuba, que acept\u00f3 participar voluntariamente en el ensayo. La vacunaci\u00f3n se efectu\u00f3 en los consultorios de los m\u00e9dicos de familia entre febrero y julio de 1998, con un intervalo de 6 semanas entre las dos dosis. El per\u00edodo de seguimiento fue de 12 meses. Se consider\u00f3 positivo un caso si hab\u00eda recibido las dos dosis de la vacuna asignada y hab\u00eda enfermado de leptospirosis, con diagn\u00f3stico confirmado mediante m\u00e9todos serol\u00f3gicos y microbiol\u00f3gicos, despu\u00e9s de 21 d\u00edas de aplicada la segunda dosis. Se calcularon la eficacia de la vacuna y el riesgo relativo (RR de enfermar de leptospirosis despu\u00e9s de la vacunaci\u00f3n. Para el estudio de seguridad se escogi\u00f3 a dos personas al azar entre las personas vacunadas en cada uno de los consultorios que participaron en el estudio de eficacia. El seguimiento de las reacciones adversas locales y sist\u00e9micas lo realizaron los m\u00e9dicos de familia durante los siete d\u00edas posteriores a la aplicaci\u00f3n de cada dosis. El nivel de significaci\u00f3n se fij\u00f3 en 0,05. RESULTADOS: En total se vacun\u00f3 a 101 832 personas, de las cuales 50\n[Estudio de inmunogenicidad de la vacuna antitifo\u00eddica cubana de polisac\u00e1rido Vi vax-TyVi\u00ae en ratones](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200001&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJuan Carlos Ram\u00edrez\n2006-08-01\nFull Text Available Salmonella enterica serovar Typhi es un microorganismo que provoca m\u00e1s de 16 millones de casos de fiebre tifoidea con aproximadamente 600 000 muertes al a\u00f1o en todo el mundo. Dentro de las vacunas antitifo\u00eddicas la de polisac\u00e1rido capsular Vi ha encontrado, gracias a sus incuestionables ventajas, una gran aceptaci\u00f3n entre productores y consumidores. El presente trabajo aborda el estudio de inmunogenicidad de la vacuna antitifo\u00eddica cubana de polisac\u00e1rido Vi vax-TyVi\u00e2 en ratones. El estudio estuvo conformado por un grupo control no inoculado y un segundo grupo que recibi\u00f3 0,05 mL de la vacuna por v\u00eda intramuscular. Se tomaron muestras de sangre a los -3, 7, 14, 21, 28, 42, 56 y 84 d\u00edas. La actividad de anticuerpos IgG antipolisac\u00e1rido Vi de los sueros individuales fue determinada por ELISA. Los datos fueron analizados por grupo y por sexo y se calcul\u00f3 el porcentaje de seroconversi\u00f3n, consider\u00e1ndose respondedor aquel animal que al menos aumentara en cuatro veces su t\u00edtulo inicial. La respuesta de anticuerpos inducida por la vacuna mostr\u00f3 un aumento notable de los t\u00edtulos de IgG antipolisac\u00e1rido Vi en el grupo vacunado (100% de seroconversi\u00f3n, mientras que el grupo control no increment\u00f3 sus niveles m\u00ednimos iniciales (0% de respondedores. Aunque m\u00e1s dispersa, la respuesta de anticuerpos antiVi fue significativamente mayor en las hembras que en los machos.\n[Primary and booster vaccination with DTPw-HB/Hib pentavalent vaccine in Costa Rican children who had received a birth dose of hepatitis B vaccine Vacunaci\u00f3n primaria y de refuerzo con la vacuna pentavalente DTPw-HB/Hib en ni\u00f1os costarricenses vacunados al nacer contra la hepatitis B](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892002001000005) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nIdis Faingezicht\n2002-10-01\nprotective/seropositive titers for Hib, HB, and tetanus and about 50% for diphtheria and Bordetella pertussis. At 15 months of age, virtually all the toddlers responded with a strong boost response to all the vaccine antigens, whether they received the DTPw-HB/Hib pentavalent vaccine or the DTPw/Hib vaccine as a booster. Both booster regimens were equally well tolerated, indicating that up to five doses of the HB vaccine can be given without impact on safety. Conclusions. Our study confirms that the DTPw-HB/Hib pentavalent vaccine is highly immunogenic as a primary vaccination in children who received an HB vaccine at birth, with the pentavalent combination inducing both persisting immunity and boostable memory. The pentavalent vaccine was safe both for primary and booster vaccinations. Thus, this study in Costa Rican infants supports the routine use of the pentavalent DTPw-HB/Hib vaccine as part of childhood vaccination programs in Latin America and the Caribbean.Objetivos. La vacuna combinada pentavalente DTPw-HB/Hib ha sido creada siguiendo la recomendaci\u00f3n de la Organizaci\u00f3n Mundial de la Salud de a\u00f1adir las vacunas contra la hepatitis b (HB y el Haemophilus influenzae tipo b (Hib a los programas de vacunaci\u00f3n infantil. Los objetivos del presente estudio consistieron en: 1 analizar la inmunogenicidad y reactogenicidad de la vacuna combinada pentavalente DTPw-HB/Hib en comparaci\u00f3n con las inyecciones separadas de las vacunas DTPw-HB e Hib como vacunaci\u00f3n primaria en un grupo de ni\u00f1os que hab\u00edan recibido al nacer una dosis de vacuna contra la HB, y 2 evaluar la persistencia de anticuerpos en el segundo a\u00f1o de vida, as\u00ed como la respuesta a las dosis de recuerdo de DTPw-HB/Hib o DTPw/Hib. M\u00e9todos. En la primera parte del estudio (fase de vacunaci\u00f3n primaria, realizada en 1998-1999, se analiz\u00f3 la inmunogenicidad y reactogenicidad de la vacuna combinada DTPw-HB/Hib en comparaci\u00f3n con inyecciones separadas de las vacunas DTPw-HB e Hib como vacunaci\u00f3n primaria a\n[A new DTPw-HB/Hib combination vaccine for primary and booster vaccination of infants in Latin America Nueva vacuna combinada DTPw-HB/Hib para la vacunaci\u00f3n primaria y de refuerzo de menores de un a\u00f1o en Am\u00e9rica Latina](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892006000300006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMiguel Tregnaghi\n2006-03-01\n, la Organizaci\u00f3n Mundial de la Salud (OMS recomend\u00f3 que se incluyeran vacunas conjugadas contra Haemophilus influenzae tipo B (Hib en los programas de vacunaci\u00f3n de ni\u00f1os menores de un a\u00f1o, siempre que ello estuviera en consonancia con las prioridades nacionales. La compa\u00f1\u00eda GlaxoSmithKline Biologicals ha creado una nueva vacuna pentavalente que es una combinaci\u00f3n de la vacuna contra la difteria (D, el t\u00e9tanos (T y la tos ferina (P (con ant\u00edgeno tosfer\u00ednico a base de c\u00e9lulas completas y las vacunas contra la hepatitis B (HB y contra Haemophilus influenzae tipo B (Hib (DTPw-HB/Hib, con un total de 5 \u00b5g de fosfato de polirribosilrribitol (FPR. Hemos evaluado la inmunogenia y reactogenia observadas al aplicarse las dosis primaria y de refuerzo de esta nueva vacuna a ni\u00f1os sanos y las hemos comparado con las observadas al aplicar un r\u00e9gimen de referencia a base de las vacunas autorizadas DTPw-HB (Tritanrix y antiHib (Hiberix en forma de inyecciones simult\u00e1neas. M\u00c9TODOS: Llevamos a cabo un estudio aleatorizado y con doble enmascaramiento de septiembre de 1998 a agosto de 1999 para establecer la inmunogenia y reactogenia observadas al administrarles a ni\u00f1os sanos la nueva vacuna combinada pentavalente (DTPw-HB/Hib en una sola inyecci\u00f3n, y compararlas con las observadas con el r\u00e9gimen de referencia. RESULTADOS: Se obtuvieron excelentes respuestas inmunitarias con ambos reg\u00edmenes. Todos los ni\u00f1os vacunados en ambos grupos alcanzaron concentraciones s\u00e9ricas protectoras de anticuerpos antiFPR > 0,15 \u00b5g un mes despu\u00e9s de recibir la dosis primaria. La vacuna combinada DTPw-HB/Hib no dio resultados inferiores a los obtenidos con las vacunas autorizadas en t\u00e9rminos de los porcentajes de seroprotecci\u00f3n, seropositividad y respuesta frente a todos los componentes antig\u00e9nicos de la vacuna. La persistencia de anticuerpos contra todos los ant\u00edgenos contenidos en ella hasta el momento en que se administr\u00f3 la dosis de refuerzo fue parecida en ambos grupos, y\n[Seguimiento de la reactogenicidad de la vacuna DTP cubana, utilizando dos m\u00e9todos paralelos](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2005000100002&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMar\u00eda de los \u00c1ngeles Pe\u00f1a Machado\n2005-05-01\nFull Text Available Con el objetivo de caracterizar la reactogenicidad de la vacuna Antidift\u00e9rica-Antitet\u00e1nica- Antipertusis (DTP cubana, desarrollada por el Instituto Finlay, se realiz\u00f3 un estudio utilizando dos m\u00e9todos o fuentes de informaci\u00f3n diferentes y paralelos. La primera se obtuvo de un ensayo cl\u00ednico (EC Fase IV, abierto, no controlado, en el que se incluyeron 57 lactantes. La segunda fuente de informaci\u00f3n se obtuvo de los reportes de los eventos temporalmente asociados a la vacunaci\u00f3n (ETAV, recepcionados por la Unidad Coordinadora Nacional de Farmacovigilancia (UCNFv que incluyen a 86 lactantes que fueron atendidos por sospechas de ETAV. En el EC se aplicaron 167 dosis, los eventos adversos esperados e inesperados se observaron en un escaso n\u00famero de lactantes, fueron mayoritariamente ligeros y autolimitados en el tiempo y su frecuencia de aparici\u00f3n se redujo en la 2da y 3ra dosis. El dolor fue el evento local m\u00e1s frecuente y la fiebre fue el evento general que m\u00e1s se present\u00f3. No se reportaron v\u00f3mitos y la anorexia, la somnolencia, y el llanto persistente aparecieron en un n\u00famero limitado de sujetos vacunados.Se presentaron 12 eventos no esperados, solo en 2 de ellos se consider\u00f3 que exist\u00eda relaci\u00f3n causal con la vacunaci\u00f3n. Se report\u00f3 un evento adverso grave (ni\u00f1a hospitalizada por s\u00edndrome febril prolongado postvacunaci\u00f3n, que se estudi\u00f3 y demostr\u00f3 que fue causado por una sepsis urinaria persistente provocada por una malformaci\u00f3n vesico-ureteral. Los 86 reportes recepcionados por la UCNFv inclu\u00edan un total de 141 ETAV, dentro de los s\u00edntomas locales, el eritema alcanz\u00f3 un 9,30% y la induraci\u00f3n un 5,81%, la fiebre fue un s\u00edntoma frecuente aunque no se especifica la temperatura corporal alcanzada. Aunque existen varias diferencias con relaci\u00f3n a las condiciones en que se realiza la vigilancia de eventos adversos en un EC o en la pr\u00e1ctica cl\u00ednica habitual, los resultados aqu\u00ed analizados nos confirman que la\n[Detecci\u00f3n mediante RT-PCR en tiempo real del virus vacunal en cerdos inmunizados con la vacuna cubana contra la peste porcina cl\u00e1sica](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2016000200002&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nTania Campos-Cuello\n2016-08-01\nFull Text Available La peste porcina cl\u00e1sica (PPC es una enfermedad viral infectocontagiosa, producida por un virus ARN del g\u00e9nero Pestivirus, familia Flaviviridae. En la actualidad es una de las causas de p\u00e9rdidas econ\u00f3micas en la industria porcina a nivel mundial. En su prevenci\u00f3n se han utilizado vacunas vivas atenuadas, empleando la cepa China lapinizada. La Reacci\u00f3n en Cadena de la Polimerasa Reverso Transcriptasa (RT-PCR ha sido uno de los m\u00e9todos m\u00e1s sensibles aplicado en Medicina Veterinaria para la detecci\u00f3n de virus ARN. En el caso del virus de la PPC es muy \u00fatil porque el \u00e1cido nucleico se puede detectar desde muy temprano en la infecci\u00f3n y en periodos m\u00e1s largos en aquellos animales que se recuperan. El objetivo de este estudio fue aplicar la t\u00e9cnica de RT-PCR en tiempo real para la detecci\u00f3n de la cepa China lapinizada de la vacuna cubana contra la PPC. Las tonsilas de los cerdos vacunados fueron el \u00f3rgano m\u00e1s positivo en la detecci\u00f3n del ARN del virus vacunal. Los resultados obtenidos evidenciaron una interferencia del virus vacunal en el diagn\u00f3stico, siendo el d\u00eda 12 posvacunaci\u00f3n en el que se obtiene una emisi\u00f3n umbral de fluorescencia m\u00e1s bajo.\n[In vitro study of protein release from AFCo1 and implications in mucosal immunisation](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2012000200003&lng=es&nrm=iso) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJos\u00e9 Ra\u00fal Dopico\n2012-04-01\nFull Text Available Los anticuerpos aviares (IgY presentan algunas ventajas con relaci\u00f3n a los anticuerpos IgG de mam\u00edferos, debido a su f\u00e1cil obtenci\u00f3n y purificaci\u00f3n y su bajo costo de producci\u00f3n. El objetivo de este trabajo fue estudiar la factibilidad de acoplar anticuerpos IgY a part\u00edculas de poliestireno y evaluar su desempe\u00f1o en ensayos de l\u00e1tex-aglutinaci\u00f3n en l\u00e1mina. Para este prop\u00f3sito se utiliz\u00f3 como modelo la detecci\u00f3n del ant\u00edgeno de superficie de la hepatitis B (HBsAg. Gallinas Leghorn se inmunizaron con el ingrediente farmac\u00e9utico activo que se utiliza en la elaboraci\u00f3n de la vacuna recombinante cubana Heberbiovac-HB. Los anticuerpos obtenidos se purificaron y emplearon en la preparaci\u00f3n de reactivos de l\u00e1tex-aglutinaci\u00f3n (0,8 \u00b5m para la detecci\u00f3n del HBsAg, los cuales se evaluaron con 50 muestras de suero frente a un reactivo comercial similar. Los resultados se evaluaron de satisfactorios. Se demostr\u00f3 la factibilidad de acoplar anticuerpos aviares a part\u00edculas de l\u00e1tex y se abre una perspectiva al empleo de este tipo de ensayo para el diagn\u00f3stico r\u00e1pido de diversas enfermedades.\n[Perfil de seguridad de la vacuna antileptospir\u00f3sica trivalente vax-SPIRAL\u00ae](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2010000300001&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGiset Jim\u00e9nez\n2010-12-01\nFull Text Available Con el objetivo de mostrar el perfil de seguridad de la vacuna antileptospir\u00f3sica cubana, vax-SPIRAL\u00ae, se realiz\u00f3 un estudio observacional descriptivo y transversal, a partir de la base de datos de la red nacional de farmacovigilancia a medicamentos. Se estim\u00f3 la frecuencia de reportes por dosis de vacunas administradas, la valoraci\u00f3n de causalidad, severidad, localizaci\u00f3n y los eventos adversos con mayor asociaci\u00f3n estad\u00edstica, a partir del c\u00e1lculo de disproporcionalidad de las combinaciones de eventos adversos a vacunas de todos los diagn\u00f3sticos en los reportes de eventos del grupo farmacol\u00f3gico de vacunas y el c\u00e1lculo de la Raz\u00f3n de Riesgo Proporcional (PRR y la Raz\u00f3n Diferencial de Riesgo (ROR. Hubo 1,62 reportes por 100 000 dosis administradas y 1,9 diagn\u00f3sticos por reporte en personas entre 18 y 77 a\u00f1os de edad y una media \u00b1DE de 40 \u00b1 13 a\u00f1os, con predominio del sexo femenino (65,54%. No se reportaron casos graves; el 74,17% fueron con severidad leve y el 66,96% fueron manifestaciones adversas sist\u00e9micas. El 94,17% de los reportes estuvieron relacionados con la vacuna. Los eventos adversos m\u00e1s frecuentes fueron: fiebre/hipertermia (18,75%, cefalea (14,73%, dolor local (13,84%, enrojecimiento/eritema/rubor en el sitio de inyecci\u00f3n (12,05%, malestar general (8,48% y manifestaciones de hipersensibilidad m\u00ednimas, s\u00f3lo a nivel cut\u00e1neo. Entre los que mostraron mayor asociaci\u00f3n: cefalea, malestar general y rubor. Los resultados obtenidos son similares y con mejor perfil de seguridad que los de la vacuna francesa SPIROLEPT, por lo cual se recomienda para la protecci\u00f3n en grupos de riesgo de leptospirosis.\n[Identidad de la vacuna contra Streptococcus pneumoniae \u201cQuimi-Vio\u201d mediante la t\u00e9cnica Dot Blot empleando los anticuerpos monoclonales contra los polisac\u00e1ridos capsulares 1,5, 6B, 14 y 19F de la bacteria](http://revistabionatura.com/2017.02.01.7.html) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nElizabeth Gonz\u00e1lez Aznar\n2017-02-01\nFull Text Available Streptococcus pneumoniae (neumococo constituye una de las principales causas de enfermedades infecciosas bacterianas, particularmente en ni\u00f1os menores de 2 a\u00f1os de edad. Basadas en el polisac\u00e1rido capsular (PsC, su principal factor de virulencia, existen dos tipos de vacunas aprobadas para uso en humanos: las vacunas polisacar\u00eddicas planas y las vacunas polisacar\u00eddicas conjugadas. Quimi-Vio, la vacuna antineumoc\u00f3cica cubana, pertenece al segundo grupo y est\u00e1 compuesta por los PsC de los siete serotipos de mayor incidencia y circulaci\u00f3n en Cuba (1, 5, 6B, 14, 18C, 19F y 23F. El objetivo de este trabajo fue realizar el ensayo de identidad de la vacuna cubana Quimi-Vio empleando los AcM contra los PsC 1, 5, 6B, 14, y 19F de Sp obtenidos recientemente en el Instituto Finlay de Vacunas, teniendo en cuenta que los Ensayos de identidad de las vacunas son requisito indispensable para la liberaci\u00f3n final de los lotes. La t\u00e9cnica empleada para la realizaci\u00f3n del ensayo de identidad de Quimi-Vio fue el Dot Blot, donde empleando membrana de Nitrocelulosa se realiz\u00f3 la captura de tres lotes de vacuna Quimi-Vio y como control positivo de la t\u00e9cnica los respectivos PsC de los serotipos 1, 5, 6B, 14, y 19F sin conjugar y una vacuna comercial Prevenar-13. Para la identidad de los PsC de neumococo se emplearon los respectivos AcM a una concentraci\u00f3n de 10\u00b5g/mL y como segundo anticuerpo anti IgG de rat\u00f3n conjugado a peroxidasa teniendo en cuenta que los AcMs empleados son murinos. Cada AcM fue capaz de identificar de forma altamente especifica al PsC homologo (mismo serotipo, tanto en su forma no conjugada y monovalente como en el contexto de las vacunas Quimi-Vio y Prevenar 13V, donde adem\u00e1s de estar conjugado al TT se encuentra mezclado con otros PsC de forma multivalente. La t\u00e9cnica Dot Blot empleando los AcMs contra los PsC serotipos 1, 5,6B, 14 y 19F permite identificar de forma espec\u00edfica cada PsC en la formulaci\u00f3n multivalente, por lo\n[Validaci\u00f3n de un ELISA tipo inhibici\u00f3n para cuantificar polisac\u00e1rido Vi en la vacuna antitifo\u00eddica cubana vax-TyVi](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200002&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nEsther Mar\u00eda Fajardo\n2006-08-01\nFull Text Available Se describe la validaci\u00f3n de un ELISA tipo inhibici\u00f3n, reportado por primera vez en la literatura cient\u00edfica para cuantificar un ant\u00edgeno vacunal: el polisac\u00e1rido Vi de Salmonella Typhi, para ser empleado en el control de la calidad de la vacuna antitifo\u00eddica cubana vax- TyVi\u00e2. El ensayo consta de seis pasos: 1 Recubrimiento de placa de reacci\u00f3n con poli-L-lisina y posteriormente polisac\u00e1rido Vi; 2 Bloqueo con leche descremada; 3 Inhibici\u00f3n o neutralizaci\u00f3n en tubos de suero anti-Vi de conejo, respectivamente, con polisac\u00e1rido Vi de Curva de Calibraci\u00f3n (concentraciones desde 1\u201332 \u03bcg/mL, control positivo y muestras de vacuna (3 diluciones; 4 Neutralizaci\u00f3n de anticuerpos anti-Vi libres, presentes en las mezclas anteriores, por el Polisac\u00e1rido de Recubrimiento; 5 Reconocimiento de anticuerpos anti-Vi unidos a la placa (conjugado anti-IgG de conejo-fosfatasa alcalina y 6 Revelado por reacci\u00f3n enzima-sustrato. Los par\u00e1metros de validaci\u00f3n estudiados y sus resultados fueron: 1 Precisi\u00f3n, expresada como coeficiente de variaci\u00f3n a tres niveles de concentraci\u00f3n de polisac\u00e1rido, comprendidos en el rango de su especificaci\u00f3n (35, 50 y 70 \u03bcg/mL y evaluada en t\u00e9rminos de repetibilidad; precisi\u00f3n intraensayos (cuatro analistas y reproducibilidad (seis analistas: \u00a3 20%; 2 Linealidad (100*R2: 99,68 %; 3 L\u00edmite de detecci\u00f3n: 0,5 \u03bcg/mL; 4 Exactitud (recuperaci\u00f3n para las tres diluciones de la muestra: entre 100 y 118%, y 5 Robustez: no influye 1,5 h de bloqueo (p = 0,52 ni \u00b1 5 min para leer placa (p = 0,56; influye grandemente la calidad del agua (p = 0,026, a favor del agua para inyecci\u00f3n. El ensayo es adecuado para los fines propuestos y es una medida de la inmunogenicidad in vitro del polisac\u00e1rido Vi.\n[Validaci\u00f3n de un ELISA para la cuantificaci\u00f3n de las impurezas proteicas de la cepa hospedera en el principio activo de la vacuna recombinante cubana contra la hepatitis B](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2014000100003&lng=es&nrm=iso) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nEliana P\u00e9rez\n2014-04-01\nFull Text Available Se valid\u00f3 un inmunoensayo tipo sandwich de doble anticuerpo para cuantificar las impurezas proteicas de la cepa hospedera que pueden estar presentes en el principio activo de la vacuna cubana contra la hepatitis B. Se prepararon los reactivos biol\u00f3gicos empleados en el ELISA. Las prote\u00ednas de la cepa hospedera se obtuvieron bajo las mismas condiciones que el proceso de producci\u00f3n de la prote\u00edna recombinante hasta un paso de semipurificaci\u00f3n o purificaci\u00f3n primaria. Los antisueros dirigidos contra las prote\u00ednas de la cepa hospedera se generaron en conejos por un proceso de inmunizaci\u00f3n en cascada. Para la validaci\u00f3n se analizaron los siguientes par\u00e1metros: linealidad, l\u00edmite de detecci\u00f3n y cuantificaci\u00f3n, exactitud, rango y precisi\u00f3n. El ensayo establecido result\u00f3 espec\u00edfico, con una exactitud entre 89% y 109% para todos los tampones estudiados; se demostr\u00f3 un ajuste parab\u00f3lico y un rango de trabajo entre 0,63 y 1,25 ng/mL, la repetibilidad y la precisi\u00f3n intermedia mostraron coeficientes de variaci\u00f3n inferiores al 10 y 20% respectivamente.\n[Comparison of four recombinant hepatitis B vaccines applied on an accelerated schedule in healthy adults.](https://www.ncbi.nlm.nih.gov/pubmed/21941089)\nHern\u00e1ndez-Bernal, Francisco; Aguilar-Betancourt, Ar\u00edstides; Aljovin, Virginia; Arias, Gloria; Valenzuela, Carmen; de Alejo, Karen P\u00e9rez; Hern\u00e1ndez, Karina; Oquendo, Orcilia; Figueredo, Niurka; Figueroa, Nelvis; Musacchio, Alexis; V\u00e9liz, Gloria; Garc\u00eda, Elizeth; Mollineda, Alina D; Juvier, Ana Isabel; Trujillo, Janette; Delahanty, Aurora; Ortega, D; Cinza, Z; Gonz\u00e1lez, Verena L Muzio\n2011-10-01\nA post-marketing, double blind, randomised, controlled clinical trial to assess the immunogenicity and safety profiles of four commercially available recombinant hepatitis B vaccines was performed. The vaccines included in this study were Heberbiovac-HB (\u00ae) (Heber Biotec S.A., Havana, Cuba), Euvax-B (\u00ae) (LG Chemical Ltd., Seoul, Korea), Hepavax-Gene (\u00ae) (Greencross Vaccine Corp., Seoul, Korea), and Engerix-B (\u00ae) (GlaxoSmithKline Biologicals, Rixensart, Belgium). Vaccines were administered intramuscularly to healthy adults in three 20mg doses at monthly intervals (0 - 1 - 2 months). Four hundred volunteers aged 18 to 45 years (average age, 35 years) non-reactive for serological markers of hepatitis B virus infection were vaccinated. Volunteers were randomly assigned (ratio 1:1:1:1) to one of the four treatment groups. The antibody response (anti-HBs) was assessed at days 60, 90 and 365 post-vaccination using a commercial kit. The four vaccines showed to be safe and highly immunogenic. Similar seroprotection rates (anti-HBs \u226510 IU/L) about one month after application of the second and third dose were obtained for Engerix-B (\u00ae) , Hepavax-Gene (\u00ae) , Euvax-B (\u00ae) , and Heberbiovac-HB (\u00ae) vaccines 96.7%, 96.6%, 100%, 100% and 98.8%, 89.5%, 100%, 100%, respectively.. Heberbiovac-HB (\u00ae) vaccine achieved significantly higher geometric mean antibody titers (GMT) and rate of good and hyper-responders at all time-points post-vaccination. The GMT on day 365 after full vaccination was significantly reduced in all groups compared to day 90, although Heberbiovac-HB (\u00ae) showed the highest anti-HBs GMT and good-responders rate. The four vaccines were well tolerated and poorly reactogenic. No serious adverse events were observed. This study confirms an overall good immune response and rapid priming for the four vaccines in the course of an accelerated schedule, with higher anti-HBs geometric mean concentrations and better responses for Heberbiovac-HB (\u00ae) . [WHO\nLlor Vila, Carles\n2005-01-01\nLa vacunaci\u00f3n antigripal, con m\u00e1s de 50 a\u00f1os de existencia, tiene una eficacia, una efectividad y una seguridad contrastadas, pero la respuesta inmunitaria oscila entre el 60 y el 90%, siendo algo menor en la poblaci\u00f3n anciana. Cl\u00e1sicamente se han utilizado las vacunas inactivadas trivalentes en las campa\u00f1as de vacunaci\u00f3n antigripal pero se considera que su aceptabilidad no es \u00f3ptima. Desde hace unos a\u00f1os se est\u00e1n investigando otros tipos de vacunas antigripales con el objetivo de mejorar su ...\n[Los laboratorios p\u00fablicos productores de vacunas: el nuevo paradigma](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891998001000001&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAkira Homma\nFull Text Available Los laboratorios p\u00fablicos productores de vacunas de Am\u00e9rica Latina y el Caribe han contribuido en diferente grado al control y a la erradicaci\u00f3n de las enfermedades prevenibles por vacunaci\u00f3n y varios est\u00e1n produciendo las vacunas que se aplican rutinariamente en los programas nacionales de inmunizaci\u00f3n, como la vacuna antituberculosa (a base del bacilo de Calmette-Gu\u00e9rin, BCG, la vacuna contra difteria-t\u00e9tanos-pertussis (DTP, el toxoide tet\u00e1nico (TT, la vacuna antisarampionosa y la vacuna antipoliomiel\u00edtica oral. Gracias a los adelantos cient\u00edficos recientes, se prev\u00e9 un aumento importante del n\u00famero de vacunas seguras y eficaces que estar\u00e1n disponibles en un futuro cercano para uso en los programas normales de vacunaci\u00f3n. Sin embargo, los gastos asociados con el desarrollo de estas vacunas y con los derechos de propiedad intelectual que las protegen son cuantiosos. Adem\u00e1s, pocos laboratorios en Am\u00e9rica Latina poseen la capacidad t\u00e9cnica para investigar y elaborar estas vacunas. Tales factores tendr\u00e1n un impacto en la celeridad con que se incorporar\u00e1n en los esquemas de vacunaci\u00f3n de los pa\u00edses de la Regi\u00f3n. En la actualidad, los laboratorios p\u00fablicos productores de vacunas de la Regi\u00f3n no est\u00e1n capacitados para competir en este nuevo contexto y corren el riesgo de ser desplazados del mercado por completo. De ah\u00ed la necesidad de que cambien radicalmente su manejo gerencial y su capacidad cientificot\u00e9cnica, lo cual exige que los gobiernos se comprometan a mejorar y fortalecer aquellos aspectos pol\u00edticos y financieros que garanticen la participaci\u00f3n de los laboratorios nacionales en el suministro sostenible de vacunas a los programas de vacunaci\u00f3n, as\u00ed como en la investigaci\u00f3n, desarrollo y producci\u00f3n de vacunas nuevas\n[Registro de ensayos con vacunas del Programa Mundial de Vacunas e Inmunizaci\u00f3n de la OMS](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891998001000006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRobertson S. E.\n1998-01-01\nFull Text Available En 1995, el Programa Mundial de Vacunas e Inmunizaci\u00f3n de la OMS estableci\u00f3 un registro para ensayos con vacunas. En septiembre de 1996, este registro conten\u00eda 50 ensayos de vacunaci\u00f3n patrocinados por la OMS, de los cuales 25 (50% eran estudios ya terminados. Las vacunas que se hab\u00edan estudiado con mayor frecuencia fueron las de sarampi\u00f3n (9 ensayos, poliovirus (8 ensayos, c\u00f3lera (8 ensayos, Escherichia coli enterotox\u00edgena (4 ensayos y neumococo (4 ensayos. Casi 80% de estos ensayos se llevaron a cabo en pa\u00edses en desarrollo, principalmente en el \u00c1frica. En los 25 ensayos ya terminados, los resultados investigados fueron la respuesta inmunitaria (24 ensayos, las reacciones adversas (13 ensayos, la morbilidad (4 ensayos y la mortalidad (1 ensayo. La OMS contribuy\u00f3 a estos ensayos con el aporte indirecto de fondos, ayuda con el dise\u00f1o metodol\u00f3gico, visitas a las localidades, el an\u00e1lisis de los datos, la adquisici\u00f3n de vacunas y la investigaci\u00f3n de su potencia.\n[Vacuna contra el VPH (HPV Vaccine)](https://www2c.cdc.gov/podcasts/player.asp?f=8630175) [Centers for Disease Control (CDC) Podcasts](http://www2c.cdc.gov/podcasts/search.asp)\n2013-07-25\nDesde el 2006, hay una vacuna que protege contra los tipos de VPH que causan c\u00c3\u00a1ncer con mayor frecuencia. Este podcast habla sobre la importancia de que los padres hablen con los proveedores de atenci\u00c3\u00b3n m\u00c3\u00a9dica de sus hijos sobre ponerles la vacuna contra el VPH. Created: 7/25/2013 by MMWR. Date Released: 11/4/2013.\n[La vacuna contra el virus del papiloma humano](https://www.openaire.eu/search/publication?articleId=od______3040::cc271e44d67bb301b8673ae704eb1321)\nTobar Ruiz, Mar\u00eda\n2015-01-01\nLa carciog\u00e9nesis est\u00e1 condicionada por factores dependientes del virus como de los h\u00e1bitos del hu\u00e9sped. En cuanto a la vacunaci\u00f3n se han descubierto vacunas seguras y eficaces, siendo las dos vacunas destacadas la tetravalente o Gardasil y la bivalente o Cervarix. E nfermer\u00eda es la profesional que administra la vacuna y conoce los efectos adversos posibl es a causa de su administraci\u00f3n, y es por esa raz\u00f3n por la que mi inter\u00e9s se centr\u00f3 en la vacunaci\u00f3n.\n[Respuesta de anticuerpos inducidos por la vacuna antimeningoc\u00f3cica cubana VA-MENGOC-BC\u00ae frente a la cepa de Neisseria meningitidis B:4:P1.19,15 en adolescentes despu\u00e9s de 12 a\u00f1os de inmunizados](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000300001&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMar\u00eda A. Camaraza\n2006-12-01\nFull Text Available Se estudi\u00f3 la respuesta de anticuerpos inducida por la vacuna antimeningoc\u00f3cica cubana VA-MENGOC-BC\u00ae contra la cepa de Neisseria meningitidis B:4:P1.19,15 mediante el Ensayo Bactericida del Suero (EBS y ELISA de tipo indirecto, para medir anticuerpos contra ves\u00edculas de membrana externa (VME de N. meningitidis B a 184 adolescentes de un polit\u00e9cnico de Ciego de \u00c1vila que fueron inmunizados en campa\u00f1as masivas 12 a\u00f1os antes. Se realizaron extracciones de sangre antes de aplicar la primera dosis (T0, 4 semanas despu\u00e9s de \u00e9sta (T1 y 4 semanas despu\u00e9s de la segunda dosis (T2. Transcurridos 12 a\u00f1os de esta vacunaci\u00f3n el 42% de los adolescentes present\u00f3 t\u00edtulos bactericidas \u2265 1:4 frente a la cepa hom\u00f3loga (B:4:P1.19,15 y el 98% mostr\u00f3 anticuerpos detectables contra las VME. En el EBS; el porcentaje de seroconversi\u00f3n T1/T0 fue del 57% y T2/T0 del 60%. Mediante ELISA la seroconversi\u00f3n fue del 59% y 54%, respectivamente, por lo que se demostr\u00f3 que la aplicaci\u00f3n de una sola dosis despu\u00e9s de 12 a\u00f1os indujo una respuesta inmune importante que puede sugerir una respuesta anamn\u00e9sica.\n[Vaccines against dengue: a review of current candidate vaccines at advanced development stages Vacunas contra el dengue: una revisi\u00f3n de las vacunas candidatas en etapas avanzadas de desarrollo](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892007000300011) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJoachim Hombach\n2007-04-01\nFull Text Available Los esfuerzos sistem\u00e1ticos para desarrollar una vacuna contra el dengue comenzaron durante la Segunda Guerra Mundial, inspirados en el desarrollo exitoso de una vacuna contra la fiebre amarilla. Sin embargo, la falta de modelos adecuados de la enfermedad, la informaci\u00f3n incompleta acerca de los mecanismos patog\u00e9nicos y los insuficientes incentivos econ\u00f3micos han dificultado los avances. Debido al impacto actual del dengue en todo el mundo y su explosiva diseminaci\u00f3n, ha aumentado el inter\u00e9s en el desarrollo de vacunas contra el dengue y se ha avanzado considerablemente en el camino hacia la evaluaci\u00f3n cl\u00ednica de vacunas candidatas. La Iniciativa para la Investigaci\u00f3n en Vacunas, de la Organizaci\u00f3n Mundial de la Salud, est\u00e1 facilitando el desarrollo de y los ensayos con las vacunas candidatas. Las vacunas contra el dengue que se encuentran actualmente en etapas avanzadas de desarrollo son de tres tipos fundamentales: 1 vivas atenuadas; 2 vivas recombinantes; y 3 de subunidades e inactivadas. La mayor\u00eda de las vacunas en cartera son vivas atenuadas, siguiendo el camino exitoso de otras vacunas vivas contra flavivirus, especialmente de la desarrollada contra la fiebre amarilla. En general, las vacunas contra el dengue que se encuentran actualmente en desarrollo est\u00e1n bastante avanzadas y son muy diversas. Muy pronto comenzar\u00e1 la evaluaci\u00f3n de estas vacuna candidatas en ensayos de eficacia basados en poblaciones expuestas, lo que requerir\u00e1 resolver varios problemas t\u00e9cnicos, operacionales y regulatorios.\n[Vacunas de bacterias recombinantes vivas](https://www.openaire.eu/search/publication?articleId=od______3272::e04c2a8ca070b76a97f8c299cefc6434)\nBlanco Le\u00f3n, Marina\n2016-01-01\nLa vacunaci\u00f3n es uno de los logros m\u00e1s importantes en la historia de la medicina, que ha ido evolucionando a lo largo de los a\u00f1os permitiendo una reducci\u00f3n significativa de la mortalidad infantil, una disminuci\u00f3n de la incidencia de enfermedades e incluso la erradicaci\u00f3n de algunas de ellas en pa\u00edses enteros. Las vacunas de nueva generaci\u00f3n surgen para reducir o eliminar las carencias de las vacunas \u201ctradicionales\u201d. T\u00e9cnicas biotecnol\u00f3gicas basadas en el ADN recombinante han dado lugar, entre...\n[Respuesta inmune intratecal y caracter\u00edsticas cl\u00ednicas de la meningoencefalitis por Neisseria meningitidis en pacientes inmunizados con la vacuna cubana VA-MENGOC-BC\u00ae](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2008000200004&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nElena Noris-Garc\u00eda\n2008-08-01\nFull Text Available La morbimortalidad por la enfermedad meningoc\u00f3cica en Cuba disminuy\u00f3 notablemente despu\u00e9s de la introducci\u00f3n de la vacuna VA-MENGOC-BC\u00ae. Sin embargo, a\u00f1os despu\u00e9s de ser vacunados se han reportado algunos ni\u00f1os que enfermaron. En este trabajo nos propusimos describir el comportamiento neuroinmunol\u00f3gico y cl\u00ednico de esta enfermedad en 12 pacientes vacunados que fueron ingresados en el Hospital Pedi\u00e1trico de San Miguel del Padr\u00f3n con el diagn\u00f3stico de meningoencefalitis producida por Neisseria meningitidis. Se tomaron muestras de forma simult\u00e1nea de sangre y l\u00edquido cefalorraqu\u00eddeo para la cuantificaci\u00f3n de alb\u00famina e inmunoglobulinas mayores por inmunodifusi\u00f3n radial; para el an\u00e1lisis de los resultados se tom\u00f3 como referencia el registro hist\u00f3rico de los resultados de ocho pacientes no inmunizados que enfermaron antes de incluir esta vacuna en el Esquema Nacional de Vacunaci\u00f3n. La respuesta neuroinmunol\u00f3gica y las caracter\u00edsticas cl\u00ednicas de los pacientes vacunados resultaron diferentes a lo observado previamente en pacientes no vacunados. El grupo vacunado mostr\u00f3 un cuadro menos grave de la enfermedad. El patr\u00f3n de s\u00edntesis intratecal de inmunoglobulinas fue diferente entre los dos grupos. La media de la s\u00edntesis intratecal de IgG, IgM e IgA fue significativamente superior en el grupo de los pacientes no vacunados. Este estudio nos permiti\u00f3 concluir que en la muestra estudiada la vacuna modific\u00f3 la respuesta neuroinmunol\u00f3gica y el cuadro cl\u00ednico de la enfermedad.\n[Realidad y nuevos horizontes de la vacuna del virus del papiloma humano](https://www.openaire.eu/search/publication?articleId=od______1472::a09ac4cf255ae73a6b4363b1bbc0a6ad)\nGarc\u00eda G\u00f3mez, Nuria\n2014-01-01\nLa vacuna frente al VPH es la primera vacuna destinada a la prevenci\u00f3n del c\u00e1ncer inducido por un virus, el CCU (problema de salud p\u00fablica mundial), y de lesiones precursoras. Disponemos de 2 vacunas profil\u00e1cticas: Gardasil\u00ae (frente a VPH 6, 11, 16 y 18) y Cervarix\u00ae (frente a VPH 16 y 18). El trabajo consiste en una revisi\u00f3n bibliogr\u00e1fica que tiene como objetivo conocer la situaci\u00f3n que vive actualmente la vacuna del VPH en Espa\u00f1a, utilizando como palabras clave virus, vacun...\n[Los laboratorios p\u00fablicos productores de vacunas: el nuevo paradigma](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891998001000001) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAkira Homma\n1998-10-01\nFull Text Available Los laboratorios p\u00fablicos productores de vacunas de Am\u00e9rica Latina y el Caribe han contribuido en diferente grado al control y a la erradicaci\u00f3n de las enfermedades prevenibles por vacunaci\u00f3n y varios est\u00e1n produciendo las vacunas que se aplican rutinariamente en los programas nacionales de inmunizaci\u00f3n, como la vacuna antituberculosa (a base del bacilo de Calmette-Gu\u00e9rin, BCG, la vacuna contra difteria-t\u00e9tanos-pertussis (DTP, el toxoide tet\u00e1nico (TT, la vacuna antisarampionosa y la vacuna antipoliomiel\u00edtica oral. Gracias a los adelantos cient\u00edficos recientes, se prev\u00e9 un aumento importante del n\u00famero de vacunas seguras y eficaces que estar\u00e1n disponibles en un futuro cercano para uso en los programas normales de vacunaci\u00f3n. Sin embargo, los gastos asociados con el desarrollo de estas vacunas y con los derechos de propiedad intelectual que las protegen son cuantiosos. Adem\u00e1s, pocos laboratorios en Am\u00e9rica Latina poseen la capacidad t\u00e9cnica para investigar y elaborar estas vacunas. Tales factores tendr\u00e1n un impacto en la celeridad con que se incorporar\u00e1n en los esquemas de vacunaci\u00f3n de los pa\u00edses de la Regi\u00f3n. En la actualidad, los laboratorios p\u00fablicos productores de vacunas de la Regi\u00f3n no est\u00e1n capacitados para competir en este nuevo contexto y corren el riesgo de ser desplazados del mercado por completo. De ah\u00ed la necesidad de que cambien radicalmente su manejo gerencial y su capacidad cientificot\u00e9cnica, lo cual exige que los gobiernos se comprometan a mejorar y fortalecer aquellos aspectos pol\u00edticos y financieros que garanticen la participaci\u00f3n de los laboratorios nacionales en el suministro sostenible de vacunas a los programas de vacunaci\u00f3n, as\u00ed como en la investigaci\u00f3n, desarrollo y producci\u00f3n de vacunas nuevasIn Latin America and the Caribbean, public laboratories that produce vaccines have contributed in varying degrees to the control and eradication of vaccine-preventable diseases, and several of them\n[Vacunas, biotecnolog\u00eda y su relaci\u00f3n con el aborto provocado](https://www.openaire.eu/search/publication?articleId=doajarticles::4639710bd8874709386dd27339826e1d)\nJos\u00e9 Luis Redondo Calder\u00f3n\n2008-01-01\nLas vacunas de c\u00e9lulas diploides humanas (WI-38, MRC-5) tienen un origen \u00e9ticamente objetable, dado que dichas c\u00e9lulas proceden de abortos provocados. Entre ellas destacan vacunas empleadas contra rub\u00e9ola, sarampi\u00f3n, parotiditis, rabia, poliomielitis, viruela, hepatitis A, varicela y herpes z\u00f3ster. Actualmente se encuentran en desarrollo otras vacunas cultivadas en c\u00e9lulas (293, PER.C6) transformadas mediante virus, procedentes de abortos. Entre ellas hay vacunas contra la gripe, virus respi...\n[Efic\u00e1cia e seguran\u00e7a da vacina brasileira contra hepatite B em rec\u00e9m-nascidos Eficiencia y seguridad de la vacuna brasilera contra hepatitis B en reci\u00e9n-nacidos Efficacy and safety of the Brazilian vaccine against Hepatitis B in newborns](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102009000600013) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nExpedito Jos\u00e9 de Albuquerque Luna\n2009-12-01\nFull Text Available OBJETIVO: Analisar a efic\u00e1cia e seguran\u00e7a de vacina recombinante contra hepatite B em rec\u00e9m-nascidos. M\u00c9TODOS: O estudo foi conduzido em hospital geral do munic\u00edpio de Guarulhos, SP, entre 2002 e 2005. A vacina recombinante contra hepatite B do Instituto Butantan (VrHB-IB foi analisada em dois ensaios cl\u00ednicos. Em ambos os ensaios, os rec\u00e9m-nascidos foram alocados aleatoriamente ao grupo experimental ou controle (vacina de refer\u00eancia. Os rec\u00e9m-nascidos receberam tr\u00eas doses das vacinas, uma em at\u00e9 24 h ap\u00f3s o nascimento e as subseq\u00fcentes 30 e 180 dias ap\u00f3s. No primeiro ensaio 538 rec\u00e9m-nascidos completaram o protocolo e no segundo ensaio, 486. Considerou-se crit\u00e9rio de equival\u00eancia a diferen\u00e7a na soroprote\u00e7\u00e3o inferior a 5%. RESULTADOS: A soroprote\u00e7\u00e3o no primeiro ensaio (anti HBs > 10mUI/ml foi de 92,5% (247/267 no grupo experimental, comparada a 98,5% (267/271 no grupo controle (p = 0,001. Com este resultado, a VrHB-IB n\u00e3o atingiu o crit\u00e9rio de equival\u00eancia estabelecido. Ap\u00f3s o aumento da concentra\u00e7\u00e3o de ant\u00edgeno na vacina para 25\u00bcg, a soroprote\u00e7\u00e3o no segundo ensaio foi de 100% no grupo experimental e 99,2% no grupo controle. Nenhum evento adverso grave foi registrado. CONCLUS\u00d5ES: A vacina VrHB-IB modificada foi considerada equivalente \u00e0 vacina de refer\u00eancia e seu uso recomendado \u00e0 vacina\u00e7\u00e3o de rec\u00e9m-nascidos.OBJETIVO: Analizar la eficiencia y seguridad de vacuna recombinante contra hepatitis B en reci\u00e9n-nacidos. M\u00c9TODOS: El estudio fue conducido en hospital general del municipio de Guarulhos, Sureste de Brasil, entre 2002 y 2005. La vacuna recombinante contra hepatitis B del Instituto Butantan (VrHB-IB fue analizada en dos ensayos cl\u00ednicos. En ambos ensayos, los reci\u00e9n-nacidos fueron distribuidos aleatoriamente en el grupo experimental o control (vacuna de referencia. Los reci\u00e9n-nacidos recibieron tres dosis de las vacunas, una en m\u00e1ximo 24 h posterior al nacimiento y las subsecuentes 30 y 180 d\n[Susceptibility of Ceraeochrysa cubana larvae and adults to six insect growth-regulator insecticides.](https://www.ncbi.nlm.nih.gov/pubmed/27776238)\nOno, \u00c9ric Kodi; Zanardi, Odimar Zanuzo; Aguiar Santos, Kenia Fernanda; Yamamoto, Pedro Takao\n2017-02-01\nThe impacts of six insect growth-regulators were assessed on the predator Ceraeochrysa cubana (Hagen) larvae and adults. Our results showed that diflubenzuron, lufenuron and pyriproxyfen caused 100% larva mortality, whereas buprofezin, methoxyfenozide and tebufenozide were similar to control treatment. In comparison to the control, buprofezin prolonged the duration of larval stage, while methoxyfenozide and tebufenozide reduced the predator larva development time. Buprofezin, methoxyfenozide and tebufenozide did not affect the C. cubana duration and survival of pupal stage, fecundity and fertility. However, methoxyfenozide and tebufenozide reduced predator female and male longevities. Based on a reduction coefficient, diflubenzuron, lufenuron and pyriproxyfen were highly harmful to first instar larvae, while buprofezin, methoxyfenozide and tebufenozide were considered slightly harmful to the predator. Estimating the life table parameters, our results showed that buprofezin, methoxyfenozide and tebufenozide reduced the C. cubana R o , r and \u03bb. In comparison to the control, buprofezin prolonged the T and methoxyfenozide and tebufenozide shortened the predator T. In adults, our results showed that the insecticides did not cause significant mortality, but diflubenzuron, lufenuron and pyriproxyfen reduced the C. cubana fecundity and longevity. Diflubenzuron and lufenuron also reduced the C. cubana fertility. Based on a reduction coefficient, diflubenzuron and lufenuron were highly harmful to C. cubana adults, while pyriproxyfen was slightly harmful and buprofezin, methoxyfenozide and tebufenozide were considered harmless to the predator. Therefore, insect growth-regulators affect the C. cubana biological or populational parameters, and they can harm the integrated pest management programs that aim the predator conservation and/or augmentation in agroecosystems. Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.\n[Vacuna Sint\u00e9tica contra la Malaria](http://revistamedicina.net/ojsanm/index.php/Revistamedicina/article/view/903) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nManuel Elkin Patarroyo\n1993-12-01\nFull Text Available\nEl doctor Manuel Elkin Patarroyo hace un recuento de lo que fueron sus primeros a\u00f1os de estudio y los primeros pasos que se dieron para fundar el Instituto de Inmunolog\u00eda, ayudado por muchos de los Acad\u00e9micos. Siempre ha querido representar al pueblo colombiano en sus valores de trabajo, disciplina, estudio, pensamiento y generosidad, en aras de un pueblo que sufre, que en definitiva es el objetivo del M\u00e9dico, el paciente.\nPosteriormente comenta qu\u00e9 es lo que se ha hecho con toda la profundidad que se merece pero con simpleza de palabras y en t\u00e9rminos sencillos, c\u00f3mo se desarroll\u00f3 la Vacuna Sint\u00e9tica contra la malaria: \u00bfPor qu\u00e9 malaria?, porque esta es una enfermedad de gran trascendencia; aclara que \u00e9l no le teme ni le molesta el cuestionamiento cient\u00edfico sobre el desarrollo de esta investigaci\u00f3n, por el contrario lo acepta y lo goza porque es el ejercicio intelectual; lo que s\u00ed le molesta es el morbo alrededor de ello, por esto pidi\u00f3 al doctor Mu\u00f1oz que al final se adelante un debate al respecto.\nDice a continuaci\u00f3n que las vacunas tradicionales son biol\u00f3gicas como todo el mundo lo sabe, es el microorganismo causal mismo que se muta ose mata, pero que descomponiendo la estructura qu\u00edmica de sus mol\u00e9culas, con el concepto de la s\u00edntesis qu\u00edmica se podr\u00edan rehacer qu\u00edmicamente y ser utilizadas como vacuna.\nDecidieron entonces atacar el problema de la vacuna a trav\u00e9s de esta metodolog\u00eda creando la vacuna contra la malaria de la cual se conoce su estructura qu\u00edmica, y aclara que las vacunas qu\u00edmicas tienen otra ventaja, que son puras, con menos reacciones adversas que las tradicionales.\nDice el doctor Patarroyo que decidieron aislar, e identificar m\u00e1s de la mitad de las prote\u00ednas del par\u00e1sito y dividiendo la muestra en dos fracciones, una de ellas se seleccion\u00f3 para averiguar su composici\u00f3n qu\u00edmica y la otra para saber cu\u00e1l podr\u00eda ser \u00fatil como vacuna. As\u00ed, fueron al Amazonas y all\n[Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAlejandro Roque Vald\u00e9s\n2004-04-01\nFull Text Available El presente trabajo es un art\u00edculo de revisi\u00f3n que pretende abordar un tema tan controvertido como actual: la posible asociaci\u00f3n causal que se ha querido establecer entre el autismo y las vacunas infantiles. A partir de la \u00faltima d\u00e9cada del siglo XX se producen una serie de cambios en la clasificaci\u00f3n, nomenclatura y criterios diagn\u00f3sticos del autismo. Los hallazgos de estudios epidemiol\u00f3gicos llevados a cabo bajo estos nuevos ponderados han revelado que las tasas de prevalencia del autismo son en la actualidad muy superiores a las de hace 15 a\u00f1os. Entre los factores que se esgrimen para explicar este fen\u00f3meno est\u00e1n las vacunas, y entre los mecanismos que se invocan para tratar de inculpar a las vacunas en la etiolog\u00eda del autismo est\u00e1n el exceso de mercurio derivado del tiomersal que se emplea como conservante de las mismas y procesos autoinmunes que de forma directa o indirectamente act\u00faan sobre el SNC, induciendo lesiones a nivel de la mucosa intestinal, lo cual favorecer\u00e1 la absorci\u00f3n de macromol\u00e9culas, ant\u00edgenos y toxinas que una vez en el torrente sangu\u00edneo llegar\u00edan al SNC produciendo all\u00ed las lesiones responsables de la g\u00e9nesis del autismo.\n[Una vacuna contra la tuberculosi, provada en cabres](https://www.openaire.eu/search/publication?articleId=od______1404::6574285bd1662fef225103ab5f2fa6f1)\nP\u00e9rez del Val, Bernat\n2012-01-01\nInvestigadors del CReSA han dut a terme el primer estudi de vacunaci\u00f3 contra la tuberculosi utilitzant com a model experimental la cabra dom\u00e8stica, que reprodueix amb molta similitud la resposta a la tuberculosi en humans. La vacuna, anomenada AdAg85A, ha estat dissenyada per investigadors de McMaster University (Canad\u00e0) per prevenir la tuberculosi en humans, i actualment es troba en fase I d\u2019assajos cl\u00ednics. De moment, aquest estudi mostra que la inoculaci\u00f3 d\u2019aquesta nova vacuna, com a refor...\n[VACUNAS E INFECCIONES RESPIRATORIAS](http://www.sciencedirect.com/science/article/pii/S0716864017300160) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDr. Rodolfo Villena\n2017-01-01\nFull Text Available Las vacunas han demostrado ser una excelente estrategia para reducir la morbimortalidad en infecciones respiratorias, con un perfil de seguridad adecuado. Nuestro PNI incorpora varias de ellas con este objetivo, logrando resultados de alto impacto a nivel de salud p\u00fablica. Para que esto prosiga se requiere de nuestro compromiso y conocimiento para estimular, difundir y obtener altas tasas de cobertura, de manera de lograr efectos de protecci\u00f3n indirecta, conocidos como inmunidad comunitaria. Por otro lado, se debe mantener la vigilancia epidemiol\u00f3gica de los agentes inmunoprevenibles para conocer su oscilaci\u00f3n temporal, serogrupos, sero y/o genotipos, de manera de establecer directrices adecuadas de edad y esquemas de vacunaci\u00f3n para la poblaci\u00f3n. Debemos avanzar en estos temas y realizar estudios de efectividad de las vacunas que hemos introducido, para conocer su aporte en la prevenci\u00f3n de infecciones respiratorias, de manera de objetivar sus beneficios, conocer el impacto en poblaciones de riesgo y avanzar en la vacunaci\u00f3n de embarazadas, para otorgar mejores estrategias de prevenci\u00f3n a nuestra poblaci\u00f3n.\n[Efectividad comunitaria de las vacunas frente a la Parotiditis Infecciosa. Estudio de casos](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1135-57271999000400003) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLim\u00f3n Mora Juan\n1999-01-01\nFull Text Available FUNDAMENTO: En nuestro pa\u00eds existen dos tipos de vacunas disponibles frente a la parotiditis infecciosa. En los \u00faltimos tiempos se han planteado dudas sobre la eficacia global de estas vacunas y de la eficacia comparada entre ambas (cepa Rubini y cepa Jeryl Lynn. En el distrito sanitario de A.P. \"Sevilla Este\" se registraron 256 casos durante 1997 (90,1 casos por 100.000 habitantes. Con este estudio se pretende aprovechar la aparici\u00f3n de casos de parotiditis para evaluar poblaciones afectadas e incidencia comparada seg\u00fan tipo de vacuna recibida durante la infancia. M\u00c9TODOS: An\u00e1lisis descriptivo de los casos (edad, distribuci\u00f3n territorial, antecedentes vacunales,... y an\u00e1lisis evolutivo (tasas de incidencia anuales en el distrito sanitario y su entorno. Se eval\u00faa la efectividad global de las vacunas frente a la parotiditis. Igualmente se estiman las tasas de incidencia de casos entre los vacunados con cepa Rubini y Jeryl Lynn. RESULTADOS: Se observan las tasas de incidencias m\u00e1s elevadas en ni\u00f1os entre 1 y 4 a\u00f1os. Se han estimado niveles de efectividad global para estas vacunas. Adem\u00e1s se observa una incidencia de casos significativamente m\u00e1s elevada entre los ni\u00f1os vacunados con cepa Rubini que en los que lo hicieron con Jeryl Lynn (riesgo relativo de 6,5 con Intervalo de confianza 95% 3,6-11,8. CONCLUSIONES: La efectividad que se desprende de este estudio no parece ser tan buena como la eficacia te\u00f3rica preconizada para las vacunas frente a la parotiditis. Se plantea la conveniencia de realizar otros estudios de casos seg\u00fan tipos de vacunas utilizadas. Igualmente son de gran inter\u00e9s los datos a suministrar por estudios seroepidemiol\u00f3gicos.\n[Vacunas en situaciones especiales. Embarazo, inmunodepresi\u00f3n, transplante](https://www.openaire.eu/search/publication?articleId=od______1404::05502ca26081377cb9ac9b967d7e66d8)\nFarjas Abad\u00eda, M\u00aa Pilar\n2005-01-01\nEn las recomendaciones de vacunaci\u00f3n de grupos de poblaci\u00f3n que por su situaci\u00f3n de salud requieren medidas espec\u00edficas deben conjugarse: Las limitaciones en la aplicaci\u00f3n de determinadas vacunas por la mayor probabilidad de efectos secundarios en estos pacientes (por ejemplo la aplicaci\u00f3n de vacunas de virus vivos en pacientes inmunodeprimidos). El mayor riesgo de infecci\u00f3n frente a determinados agentes que genera la patolog\u00eda o situaci\u00f3n inmunitaria del paciente, y que determina un mayor in...\n[PRACTICAS MEDICAS, PRACTICAS POLITICAS. ROSAS Y LA \u00abVACUNA INDIGENA\u00bb](http://www.revistas.usach.cl/ojs/index.php/historiasocial/article/view/319) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMAR\u00cdA SILVIA DI LISCIA\n2011-10-01\nFull Text Available BUENOS AIRES, 1830. Se declara una epidemia de viruela entre los indios \u00abpampas\u00bb que est\u00e1n en la ciudad para honrar al Restaurador de las Leyes. Los caciques no disimulan su admiraci\u00f3n ante la valent\u00eda de Rosas, quien los visita sin alarma ante el contagio y los estimula a vacunarse para eliminar el temible mal. Un n\u00famero estimado en m\u00e1s de cien indios acepta, entonces, inmunizarse, coloc\u00e1ndose, seg\u00fan el testimonio de Parish, la \u00abvacuna a ind\u00edgenas \u00bb. Buenos Aires, 1833. Francisco X. Mu\u00f1iz, m\u00e9dico de la campa\u00f1a bonaerense, inicia las investigaciones con las que diez a\u00f1os despu\u00e9s se logra el redescubrimiento del cow pox, es decir, la viruela vacuna, llamada por Sarmiento \u00abla vacuna ind\u00edgena\u00bb.\n[VACUNAS E INFECCIONES RESPIRATORIAS](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::61ee14b25b56c72855596bb426219d56)\nDr. Rodolfo Villena\n2017-01-01\nLas vacunas han demostrado ser una excelente estrategia para reducir la morbimortalidad en infecciones respiratorias, con un perfil de seguridad adecuado. Nuestro PNI incorpora varias de ellas con este objetivo, logrando resultados de alto impacto a nivel de salud p\u00fablica. Para que esto prosiga se requiere de nuestro compromiso y conocimiento para estimular, difundir y obtener altas tasas de cobertura, de manera de lograr efectos de protecci\u00f3n indirecta, conocidos como inmunidad comunitaria. ...\n[La fidelidad cubana durante la edad de las revoluciones](http://estudiosamericanos.revistas.csic.es/index.php/estudiosamericanos/article/view/372/378) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nKuethe, Allan J.\n1998-06-01\nFull Text Available Not available.\nLa historiograf\u00eda cubana tradicional explica la fidelidad de la perla de las Antillas durante las revoluciones americanas por raz\u00f3n del miedo al intimidante ej\u00e9rcito espa\u00f1ol acuartelado en la isla y por miedo a que cualquier divisi\u00f3n pol\u00edtica diera aliento a una sublevaci\u00f3n de la masiva poblaci\u00f3n esclava. Este art\u00edculo plantea la tesis de que el asunto fue mucho m\u00e1s complicado que lo que estas explicaciones dan a entender. Por una parte, el ej\u00e9rcito de la isla lleg\u00f3 a estar esencialmente controlado por cubanos y, por otra, un movimiento revolucionario naci\u00f3 entre los elementos ilustrados; pero fall\u00f3 por la oposici\u00f3n abrumadora que surgi\u00f3 dentro de la propia clase criolla. La fidelidad cubana no se explica actualmente tanto por los temores como por las relaciones positivas que se crearon entre la corona espa\u00f1ola y las elites cubanas durante el siglo XVIII, sobre todo durante el reinado de Carlos III, relaciones que resultaron sumamente ventajosas para los azucareros que dominaban la vida econ\u00f3mica y pol\u00edtica de la isla.\n[El legado de la Real Expedici\u00f3n Filantr\u00f3pica de la Vacuna (1803-1810: las juntas de vacuna](http://asclepio.revistas.csic.es/index.php/asclepio/article/view/71/74) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRam\u00edrez Mart\u00edn, Susana Mar\u00eda\n2004-06-01\nFull Text Available The Royal Vaccination Expedition, directed by the physicians Francisco Xavier Balmis and Jos\u00e9 Salvany, was the most important scientific and medical achievement of the Spanish colonial era. It took place at a time of political restlessness, and its achievements were thus conditioned by each of the cultures into which the vaccine was introduced. As its legacy, the philantropic expedition left the Vaccination Boards, established in the Americas as centers of medical expertise to sustain the expedition\u00b4s principal objetive: the battle against the smallpox epidemics in pursuit of public health.\nLa Expedici\u00f3n de la Vacuna, dirigida por los m\u00e9dicos Francisco Xavier Balmis y Jos\u00e9 Salvany, es la gesta cient\u00edfica y sanitaria m\u00e1s importante de \u00e9poca colonial. Su desarrollo tuvo lugar en un momento pol\u00edtico convulso y los resultados estuvieron condicionados por las sociedades donde la vacuna se estableci\u00f3. El legado de esta expedici\u00f3n filantr\u00f3pica fue la creaci\u00f3n de las Juntas de Vacuna. Estas instituciones se erigieron como centros creadores de saber m\u00e9dico en Am\u00e9rica y consolidaron el objetivo primario de la expedici\u00f3n: la b\u00fasqueda de la salud p\u00fablica luchando contra las epidemias de viruela.\n[La vacuna en Cuba durante el gobierno de Someruelos](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::9c7220297c636745e06628ec37f2b47e)\nV\u00e1zquez Cienfuegos, Sigfrido\n2004-01-01\nLa Real Expedici\u00f3n Filantr\u00f3pica de la Vacuna (1803-1806), dirigida por Francisco Javier de Balmis, se dirigi\u00f3 al Nuevo Mundo para paliar las epidemias de viruelas que hab\u00edan venido asolando Am\u00e9rica desde casi el mismo momento del Descubrimiento. Para entonces en la isla de Cuba ya se hab\u00eda iniciado una labor con el mismo objetivo por el m\u00e9dico cubano Tom\u00e1s Romay, apoyado en el fomento de la introducci\u00f3n y aplicaci\u00f3n de la vacuna por el marqu\u00e9s de Someruelos gobernador y capit\u00e1n general de la ...\n[Aceptabilidad de la vacuna contra el virus papiloma humano en padres de adolescentes, en colombia](https://www.openaire.eu/search/publication?articleId=od______1326::8ba7ba7cedd44552d4d60ca52f50c9aa)\nWiesner, Carolina; Pi\u00f1eros, Marion; Cort\u00e9s, Claudia; Jaime Ardila, Jaime Ardila\n2012-01-01\nObjetivo La vacuna contra el VPH es una nueva tecnolog\u00eda disponible para el control del c\u00e1ncer de cuello uterino. Se espera, que en el menor tiempo posible esta vacuna pueda tener cobertura universal. Este art\u00edculo presenta la aceptabilidad que tiene los padres de adolescentes en Colombia hacia la vacuna contra el VPH y hace una aproximaci\u00f3n a sus determinantes. M\u00e9todos Estudio cualitativo en cuatro regiones en Colombia. Se realizaron 17 grupos focales con padres de ni\u00f1as y ni\u00f1os entre 11 a 1...\n[De la actualizaci\u00f3n del paradigma autobiogr\u00e1fico en la literatura cubana](http://www.romanischestudien.de/index.php/rst/article/view/127) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nReinier P\u00e9rez-Hern\u00e1ndez\n2016-03-01\nFull Text Available Adem\u00e1s de abordar la construcci\u00f3n de la figura del h\u00e9roe narrativo en autobiograf\u00edas y memorias cubanas de reciente publicaci\u00f3n, este ensayo refiere c\u00f3mo el testimonio marc\u00f3 desde fuera la autobiograf\u00eda cubana en los a\u00f1os setenta y ochenta y c\u00f3mo las memorias y las autobiograf\u00edas han vuelto a ocupar un espacio destacado, libre del \u201ctestimonio\u201d, en las letras cubanas. Entre las obras tratadas, figuran la del pintor Ra\u00fal Mart\u00ednez, la de la ensayista Graziella Pogolotti y la del m\u00fasico Paquito D\u2019Rivera, entre otras publicadas a finales del siglo XX y principios del XXI.\nPatarroyo, Manuel Elkin\n2017-01-01\nLa malaria es una enfermedad parasitaria producida por la picadura de un mosquito; una afecci\u00f3n que en el a\u00f1o 2015 registr\u00f3 212 millones de casos y 429.000 muertes. Cada dos minutos, la malaria provoc\u00f3 la muerte de un ni\u00f1o menor de cinco a\u00f1os en todo el mundo. Diferentes cient\u00edficos a lo largo de todo el mundo han hecho m\u00faltiples intentos para combatir esta enfermedad con una vacuna efectiva que pueda erradicarla de ra\u00edz.\n[Efectividad de la vacuna VA-MENGOC-BC\u00ae contra cepas heter\u00f3logas de meningococo B](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2016000200003&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRolando Ochoa-Azze\n2016-08-01\nFull Text Available La efectividad de las vacunas de ves\u00edculas de membrana externa de Neisseria meningitidis serogrupo B ha sido cuestionada por algunos investigadores, limit\u00e1ndola a la cepa vacunal. VA-MENGOC-BC\u00ae es una vacuna antimeningoc\u00f3cica basada en dicha tecnolog\u00eda. Presentamos un metaan\u00e1lisis de estudios realizados en diferentes contextos epidemiol\u00f3gicos, evaluando su efectividad contra cepas heter\u00f3logas de meningococo B en varios grupos de edades. Se demuestra que la vacuna es efectiva contra cepas hom\u00f3logas, heter\u00f3logas y de diferentes complejos clonales.\n[Enfermedad meningoc\u00f3cica: epidemiolog\u00eda y vacunas, un enfoque pr\u00e1ctico](http://www.sciencedirect.com/science/article/pii/S0716864014700689) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nC. Giannina Izquierdo, Dra.\n2014-05-01\nLas principales estrategias para la prevenci\u00f3n de la enfermedad son el uso de vacunas (prevenci\u00f3n primaria y el uso de quimioprofilaxis a los contactos de un caso \u00edndice (prevenci\u00f3n secundaria. A la fecha existen numerosas vacunas contra Nmen, todas ellas con adecuados perfiles de seguridad e inmunogenicidad, por lo que la elecci\u00f3n de la vacuna a utilizar depender\u00e1 del serogrupo prevalente en cada pa\u00eds; de las caracter\u00edsticas de la poblaci\u00f3n m\u00e1s afectada y de la factibilidad de disponer de ella e insertarla dentro de los programas nacionales o campa\u00f1as respectivas de vacunaci\u00f3n.\n[El estado actual de las vacunas contra las drogas](http://riiad.org/index.php/riiad/article/view/riiad.2017.2.05) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMaura Epifan\u00eda Matus Ortega\n2017-12-01\nFull Text Available Introducci\u00f3n: por lo com\u00fan, la adicci\u00f3n a las drogas se trata con psicoterapia y farmacolog\u00eda que evita la uni\u00f3n de las sustancias psicoactivas a receptores espec\u00edficos en el cerebro. El resultado de estos tratamientos no ha sido del todo satisfactorio, por lo que el desarrollo de terapias m\u00e1s eficaces representa un reto constante para tratar las adicciones. Una alternativa a la farmacolog\u00eda antiadictiva es la vacunaci\u00f3n activa dirigida contra las sustancias de abuso. Objetivo: esta revisi\u00f3n re\u00fane la informaci\u00f3n disponible sobre los fundamentos y avances cient\u00edficos en la generaci\u00f3n de una terapia inmunol\u00f3gica, que coadyuve al tratamiento de la adicci\u00f3n a sustancias como la hero\u00edna-morfina, la coca\u00edna, la nicotina y la anfetamina. M\u00e9todo: se consideraron los reportes cient\u00edficos disponibles en PubMed \u2013de 2005 a abril de 2017\u2013, sobre los fundamentos, la metodolog\u00eda empleada, los estudios precl\u00ednicos y cl\u00ednicos, y los resultados obtenidos en dichas investigaciones para generar vacunas contra las drogas. Resultados: las vacunas lograron mitigar los efectos producidos por las sustancias en los estudios precl\u00ednicos en modelos de estudio en animales; sin embargo, con pacientes humanos los resultados no han sido del todo satisfactorios. Discusi\u00f3n y conclusiones: a pesar de los esfuerzos realizados por diferentes grupos de investigaci\u00f3n y compa\u00f1\u00edas farmac\u00e9uticas para generar vacunas terap\u00e9uticas contra el uso de diferentes drogas, ninguna ha alcanzado la fase III de estudios cl\u00ednicos. En la actualidad, se contin\u00faa con los esfuerzos para lograr que las vacunas contra las adicciones alcancen su m\u00e1xima eficiencia y eficacia, y contribuyan al tratamiento de la adicci\u00f3n a las drogas.\n[Las vacunas nos protegen (Vaccines Help Protect Us)](https://www2c.cdc.gov/podcasts/player.asp?f=8630647) [Centers for Disease Control (CDC) Podcasts](http://www2c.cdc.gov/podcasts/search.asp)\n2013-04-23\nEn este podcast, los ni\u00c3\u00b1os de Kidtastics hablan sobre la importancia de las vacunas y c\u00c3\u00b3mo funcionan. Created: 4/23/2013 by Centers for Disease Control and Prevention (CDC). Date Released: 12/11/2013.\n[Eficacia de la vacuna meningoc\u00f3cica de polisac\u00e1rido capsular del grupo C](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1135-57271997000200003) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGonz\u00e1lez Enr\u00edquez Jes\u00fas\n1997-01-01\nFull Text Available FUNDAMENTO: Este trabajo consiste esencialmente en una revisi\u00f3n sistem\u00e1tica de la literatura cient\u00edfica sobre los efectos, intensidad y duraci\u00f3n de la respuesta serol\u00f3gica, as\u00ed como sobre la eficacia, efectividad y seguridad de la vacuna meningoc\u00f3cica de polisac\u00e1rido capsular del grupo C. M\u00c9TODOS: B\u00fasqueda en repertorio MEDLINE en el periodo 1970-1996. B\u00fasqueda espec\u00edfica de ensayos cl\u00ednicos aleatorizados y estudios de intervenci\u00f3n prospectivos en humanos con vacunas de polisac\u00e1ridos capsulares de meningococo en el mismo repertorio y periodo. An\u00e1lisis cr\u00edtico de literatura cient\u00edfica y s\u00edntesis de evidencia. RESULTADOS: La vacuna de polisac\u00e1rido capsular del serogrupo C es considerada segura y ha mostrado una eficacia superior al 85% en adultos y ni\u00f1os mayores, 70% (IC95%: 5-91% en ni\u00f1os menores de 5 a\u00f1os y 55% (IC90%: 14-76% en ni\u00f1os de 2-3 a\u00f1os. La vacuna no se ha mostrado eficaz en ni\u00f1os menores de 2 a\u00f1os. La duraci\u00f3n de niveles de anticuerpos protectores disminuye con la edad. La proporci\u00f3n de ni\u00f1os menores de 6 a\u00f1os efectivamente protegidos al a\u00f1o de la vacunaci\u00f3n es baja. La vacunaci\u00f3n no limita la respuesta serol\u00f3gica de vacunaciones ulteriores. CONCLUSIONES: La vacuna meningoc\u00f3cica de polisac\u00e1rido capsular del serogrupo C est\u00e1 indicada en adultos y ni\u00f1os mayores de 2 a\u00f1os como protecci\u00f3n contra la enfermedad meningoc\u00f3cica causada por este serogrupo en situaciones de alto riesgo de enfermedad. La escasa protecci\u00f3n que ofrece la vacuna en los menores de 2 a\u00f1os, la limitada eficacia en menores de 5 a\u00f1os y la corta duraci\u00f3n de la inmunidad que confiere a estas edades, hace que la vacunaci\u00f3n rutinaria no est\u00e9 recomendada y que la vacuna se use fundamentalmente en el control de brotes epid\u00e9micos causados por serogrupo C.\n[Estrategia y resultados de la farmacovigilancia de vacunas desde el Instituto Finlay, 2009](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2010000200006&lng=es&nrm=iso) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nIv\u00e1n E. Cuevas-Valdespino\n2010-08-01\nFull Text Available El objetivo de este trabajo fue mostrar la estrategia y los resultados de la farmacovigilancia desde el Instituto Finlay, como titular de registros sanitarios. Se concret\u00f3 la biograf\u00eda de los productos en la etapa de poscomercializaci\u00f3n y se examin\u00f3 el balance riesgo/beneficio. Esto fue posible gracias a convenios con instituciones que permitieron el acceso a bases de datos digitales y auditables, donde se encontr\u00f3 la notificaci\u00f3n espont\u00e1nea de eventos adversos y el cumplimiento de las buenas pr\u00e1cticas, reglamentos y regulaciones de la autoridad reguladora. La miner\u00eda de datos para la b\u00fasqueda de la agrupaci\u00f3n de eventos raros e inesperados para un mismo lote o de accidentes, la confecci\u00f3n de los informes peri\u00f3dicos de seguridad y la pr\u00e1ctica sistem\u00e1tica para completar la informaci\u00f3n de seguridad solicitada en subpoblaciones y grupos especiales permiti\u00f3 actualizar el perfil de seguridad de las vacunas. Se confirm\u00f3 que la vacuna antileptospir\u00f3sica trivalente, la antitifo\u00eddica Vi y el toxoide tet\u00e1nico, presentaron una frecuencia de eventos adversos menor de 0,1 reporte por cada 100.000 dosis administradas, mientras las dem\u00e1s vacunas tuvieron valores entre 1 y 10 por cada 10.000 vacunados. Entre el 80% y 95% de las notificaciones fueron relacionadas causalmente con la vacuna, y solo el 0,89% fueron de severidad grave, casi todas en ni\u00f1os menores de un a\u00f1o. Las manifestaciones generales fueron las que predominaron. Los resultados presentados muestran la importancia que tiene la farmacovigilancia desde la industria para obtener una valiosa informaci\u00f3n de la seguridad en la aplicaci\u00f3n de las vacunas.\n[Perspectivas para nuevas vacunas antituberculosas en la era posgen\u00f3mica.](http://www.revistabiomedica.org/index.php/biomedica/article/view/1320) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLuis F. Garc\u00eda\n2004-06-01\nFull Text Available A pesar de que la vacunaci\u00f3n con Mycobacterium bovis BCG es el procedimiento m\u00e1s utilizado a nivel mundial para prevenir la tuberculosis, su eficicacia es muy cuestionable, lo cual ha motivado la b\u00fasqueda de nuevas opciones inmunoprofil\u00e1cticas. El conocimiento generado con el secuenciamiento completo de una cepa de Mycobacterium tuberculosis H37Rv y la aplicaci\u00f3n de nuevas tecnolog\u00edas inmunol\u00f3gicas, bioqu\u00edmicas y gen\u00e9ticas han permitido realizar una disecci\u00f3n fina del transcriptoma y el proteoma de M. tuberculosis, lo cual ha generado una gran cantidad de conocimiento sobre la biolog\u00eda de este microorganismo. Dado que alrededor de una tercera parte de la poblaci\u00f3n mundial puede estar infectada con M. tuberculosis y que \u00e9ste s\u00f3lo se detecta cuando se inicia la enfermedad, la mayor parte de los esfuerzos se han dedicado al dise\u00f1o de vacunas posinfecci\u00f3n que induzcan un aumento selectivo de la inmunidad celular espec\u00edfica del hospedero a largo plazo, no generen reacciones adversas y sean de bajo costo. Dentro de las nuevas estrategias que est\u00e1n siendo utilizadas para el desarrollo de vacunas, se destaca la utilizaci\u00f3n de mezclas de prote\u00ednas con una alta inmunogenicidad, cepas de M. bovis BCG recombinantes y de M. tuberculosis gen\u00e9ticamente atenuadas o modificadas para inducir una mayor respuesta inmune, y las vacunas de ADN desnudo. Los candidatos con m\u00e1s potencial incluyen las vacunas de subunidades micobacterianas, las cuales expresan mol\u00e9culas ampliamente reconocidas por el sistema inmune y cuyo reconocimiento resulta en el incremento de la respuesta Th1 y aqu\u00e9llas que utilizan vectores virales dise\u00f1ados para expresar mol\u00e9culas micobacterianas antig\u00e9nicas. Aunque los modelos animales son de valor limitado, puesto que la patolog\u00eda observada en ellos s\u00f3lo reproduce parcialmente la observada en humanos, los resultados obtenidos con estas vacunas son muy prometedores y algunas est\u00e1n siendo actualmente evaluadas en\n[Toxicidade de acaricidas a ovos e adultos de Ceraeochrysa cubana (Hagen, 1861 (Neuroptera: Chrysopidae Toxicity of acaricides to eggs and adults of Ceraeochrysa cubana (Hagen, 1861 (Neuroptera: Chrysopidae](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-70542011000100021) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGeraldo Andrade Carvalho\n2011-02-01\nFull Text Available Objetivou-se, neste trabalho, avaliar o efeito de treze acaricidas sobre ovos e adultos de Ceraeochrysa cubana (Hagen, 1861. Os acaricidas foram pulverizados por meio de torre de Potter, nas concentra\u00e7\u00f5es recomendadas para o controle de \u00e1caros na cultura dos citros. Os ensaios foram conduzidos sob condi\u00e7\u00f5es controladas de 25 \u00b1 2\u00ba C, umidade relativa de 70 \u00b1 10% e fotofase de 12 horas. Os acaricidas n\u00e3o foram t\u00f3xicos ao predador em sua fase de ovo. Em rela\u00e7\u00e3o aos adultos, o carbosulfan e o triazophos foram altamente t\u00f3xicos (100% de mortalidade, enquanto que os piretr\u00f3ides bifenthrin e fenpropathrin causaram mortalidade aproximadamente de 60%. Os acaricidas dicofol, bromopropylate, tetradifon, clofentezine, abamectin, hexythiazox, cyhexatin e \u00f3xido de fenbutatin n\u00e3o provocaram mortalidade dos adultos de C. cubana. Flufenoxuron inibiu a capacidade de oviposi\u00e7\u00e3o e provocou a inviabiliza\u00e7\u00e3o dos ovos. Baseando-se na escala da IOBC, os acaricidas carbosulfan, triazophos e flufenoxuron foram enquadrados na classe 4 = nocivos; bifenthrin e fenpropathrin na classe 2 = levemente nocivos, e dicofol, bromopropylate, tetradifon, clofentezine, abamectin, hexythiazox, cyhexatin e \u00f3xido de fenbutatin na classe 1 = in\u00f3cuos a C. cubana. Os compostos enquadrados na classe 1 podem ser recomendados em programas de manejo integrado de pragas de citros objetivando a integra\u00e7\u00e3o entre os m\u00e9todos qu\u00edmico e biol\u00f3gico por meio dessa esp\u00e9cie de predador.The objective of this work was to evaluate the effects of thirteen acaricides on eggs and adults of the lacewing Ceraeochrysa cubana (Hagen, 1861. The acaricides were sprayed using a Potter's tower at the rate recommended for mite control in citrus orchard. The trials were performed in climatic chamber at 25 \u00b1 2\u00ba C, 70 \u00b1 10% RH and photophase of 12 hours. The egg stage showed high tolerance to the tested acaricides. Carbosulfan and triazophos caused 100% adult mortality, whereas bifenthrin and\n[Vaccines against dengue: a review of current candidate vaccines at advanced development stages Vacunas contra el dengue: una revisi\u00f3n de las vacunas candidatas en etapas avanzadas de desarrollo](https://www.openaire.eu/search/publication?articleId=doajarticles::d1c5d56abb3c55f6f0d140a1ec694442)\nJoachim Hombach\n2007-01-01\nLos esfuerzos sistem\u00e1ticos para desarrollar una vacuna contra el dengue comenzaron durante la Segunda Guerra Mundial, inspirados en el desarrollo exitoso de una vacuna contra la fiebre amarilla. Sin embargo, la falta de modelos adecuados de la enfermedad, la informaci\u00f3n incompleta acerca de los mecanismos patog\u00e9nicos y los insuficientes incentivos econ\u00f3micos han dificultado los avances. Debido al impacto actual del dengue en todo el mundo y su explosiva diseminaci\u00f3n, ha aumentado el inter\u00e9s e...\n[Vacuna contra la fiebre hemorr\u00e1gica argentina Candid#1 producida en la Argentina: Inmunogenicidad y seguridad](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802010000300002&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDelia A. Enria\n2010-06-01\nFull Text Available Se realiz\u00f3 un estudio cl\u00ednico en 946 voluntarios humanos sanos, donde se compar\u00f3 la vacuna Candid#1 producida en Argentina con la elaborada en EE.UU., que hab\u00eda sido utilizada en estudios previos. Como objetivo primario se evalu\u00f3 la equivalencia en la eficacia utilizando como marcador subrogante a la inmunogenicidad medida por detecci\u00f3n de anticuerpos neutralizantes. Como objetivo secundario se evalu\u00f3 la equivalencia en inocuidad comparando las tasas de reacciones adversas. Ambas vacunas mostraron una tasa equivalente de inmunogenicidad ligeramente superior al 95.5%, que es la eficacia estimada para Candid #1 en estudios previos. No se observaron eventos adversos graves relacionados con la vacuna. Los eventos adversos generales considerados relacionados fueron de escasa significaci\u00f3n cl\u00ednica y de resoluci\u00f3n espont\u00e1nea o con tratamiento sintom\u00e1tico; se presentaron en los receptores de ambas vacunas en tasas equivalentes (29.9% para la vacuna fabricada en la Argentina y 35.0% para la fabricada en EE.UU., e incluyeron: cefalea, decaimiento, mialgias, plaquetopenia leve (< 150 000 plaquetas/mm\u00b3, n\u00e1useas y/o v\u00f3mitos, leucopenia leve (< 4 000 blancos/mm\u00b3, fiebre, dolor retroocular, mareos, microhematuria, lumbalgia y exantema. Estos resultados indican que la vacuna Candid #1 elaborada en la Argentina es equivalente a la elaborada en los EE.UU. Este estudio permiti\u00f3 el registro del biol\u00f3gico producido en la Argentina ante la autoridad regulatoria del pa\u00eds (ANMAT.\n[Provada amb \u00e8xit en cabres una nova vacuna contra la tuberculosi](https://www.openaire.eu/search/publication?articleId=od______1404::4dfcdb9afa501d98d59e07e37c0dec1f)\nP\u00e9rez del Val, Bernat\n2014-01-01\nInvestigadors del CReSA proven per primer cop i amb \u00e8xit una nova vacuna contra la tuberculosi que millora la protecci\u00f3 de l\u2019\u00fanica vacuna existent en l\u2019actualitat, l\u2019efic\u00e0cia de la qual \u00e9s for\u00e7a limitada. Els estudis s\u2019han realitzat emprant cabres dom\u00e8stiques, que reprodueixen amb elevada similitud les caracter\u00edstiques patol\u00f2giques i la resposta immunol\u00f2gica a la infecci\u00f3 tuberculosa activa en humans i que, pel fet de ser hostes naturals de la tuberculosi, tamb\u00e9 permeten estudiar l\u2019\u00fas potenci...\n[Conocimientos de los pediatras de Salvador, Brasil, sobre la vacuna antisarampionosa](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891997001200001) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMoreira Luiza A. Cabus\n1997-01-01\nFull Text Available El \u00e9xito de las iniciativas internacionales para la erradicaci\u00f3n del sarampi\u00f3n depende en gran medida del grado de conocimiento sobre la vacunaci\u00f3n. En 1992 se evaluaron mediante un estudio transversal los conocimientos sobre la vacuna antisarampionosa de los pediatras de la ciudad brasile\u00f1a de Salvador, Bahia. Del total de 506 pediatras residentes en la ciudad, 299 (59% pudieron ser localizados y respondieron a un cuestionario de 15 preguntas en las que se planteaban situaciones hipot\u00e9ticas sobre indicaciones y contraindicaciones de esta vacuna. El promedio de aciertos fue de 9,3 preguntas de las 15, lo que muestra el poco conocimiento de los pediatras sobre la vacunaci\u00f3n antisarampiososa. Situaciones comunes en la pr\u00e1ctica pedi\u00e1trica brasile\u00f1a -desnutrici\u00f3n, infecci\u00f3n de v\u00edas respiratorias altas, diarrea y estado prematuro- fueron a menudo err\u00f3neamente consideradas como contraindicaciones para la inmunizaci\u00f3n. M\u00e1s de la mitad (62% de los pediatras no conoc\u00edan la v\u00eda correcta de administraci\u00f3n de la vacuna. Los conocimientos sobre la vacuna no variaron en funci\u00f3n del tiempo transcurrido desde la formaci\u00f3n universitaria del pediatra o de su trabajo en centros sanitarios de la Secretar\u00eda Estatal de Salud. Los profesores universitarios, los pediatras con maestr\u00eda y los que cursaban estudios de posgrado tuvieron una media de aciertos ligeramente superior a la del resto. Estos resultados indican la necesidad de reforzar la ense\u00f1anza sobre la vacunaci\u00f3n antisarampionosa en las facultades de medicina y en los programas de formaci\u00f3n continuada para pediatras.\n[Conocimientos de los pediatras de Salvador, Brasil, sobre la vacuna antisarampionosa](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891997001200001&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLuiza A. Cabus Moreira\n1997-12-01\nFull Text Available El \u00e9xito de las iniciativas internacionales para la erradicaci\u00f3n del sarampi\u00f3n depende en gran medida del grado de conocimiento sobre la vacunaci\u00f3n. En 1992 se evaluaron mediante un estudio transversal los conocimientos sobre la vacuna antisarampionosa de los pediatras de la ciudad brasile\u00f1a de Salvador, Bahia. Del total de 506 pediatras residentes en la ciudad, 299 (59% pudieron ser localizados y respondieron a un cuestionario de 15 preguntas en las que se planteaban situaciones hipot\u00e9ticas sobre indicaciones y contraindicaciones de esta vacuna. El promedio de aciertos fue de 9,3 preguntas de las 15, lo que muestra el poco conocimiento de los pediatras sobre la vacunaci\u00f3n antisarampiososa. Situaciones comunes en la pr\u00e1ctica pedi\u00e1trica brasile\u00f1a -desnutrici\u00f3n, infecci\u00f3n de v\u00edas respiratorias altas, diarrea y estado prematuro- fueron a menudo err\u00f3neamente consideradas como contraindicaciones para la inmunizaci\u00f3n. M\u00e1s de la mitad (62% de los pediatras no conoc\u00edan la v\u00eda correcta de administraci\u00f3n de la vacuna. Los conocimientos sobre la vacuna no variaron en funci\u00f3n del tiempo transcurrido desde la formaci\u00f3n universitaria del pediatra o de su trabajo en centros sanitarios de la Secretar\u00eda Estatal de Salud. Los profesores universitarios, los pediatras con maestr\u00eda y los que cursaban estudios de posgrado tuvieron una media de aciertos ligeramente superior a la del resto. Estos resultados indican la necesidad de reforzar la ense\u00f1anza sobre la vacunaci\u00f3n antisarampionosa en las facultades de medicina y en los programas de formaci\u00f3n continuada para pediatras.\n[A economia cubana: experi\u00eancias e perspectivas (1989-2010](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-40142011000200004) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJos\u00e9 Luis Rodr\u00edguez Garc\u00eda\n2011-01-01\nFull Text Available O presente trabalho aborda a evolu\u00e7\u00e3o da economia cubana ao longo dos \u00faltimos vinte anos, denominados \"per\u00edodo especial\" pelo governo cubano. A an\u00e1lise \u00e9 realizada detalhando as medidas empreendidas para enfrentar a crise, as medidas adotadas com o intuito de superar a crise, mas sem fazer concess\u00f5es de princ\u00edpios que coloquem em perigo a pr\u00f3pria exist\u00eancia da revolu\u00e7\u00e3o. Para fundamentar essa an\u00e1lise, s\u00e3o expostas abundantes cifras e bibliografia. Isso permite constatar tanto o impacto da crise como os resultados obtidos na recupera\u00e7\u00e3o econ\u00f4mica ainda em curso. Finalmente, \u00e9 oferecido um resumo macroecon\u00f4mico dos principais resultados globais obtidos pela economia cubana ao longo de 50 anos.El presente trabajo aborda la evoluci\u00f3n de la econom\u00eda cubana durante los \u00faltimos 20 a\u00f1os en lo que se ha denominado como per\u00edodo especial por el gobierno cubano. Se hace un an\u00e1lisis con cierto grado de detalle de las medidas emprendidas para enfrentar la crisis, las que se adoptaron con el objetivo de lograr rebasarla pero sin hacer concesiones de principio que pusieran en peligro la existencia misma de la revoluci\u00f3n. Para fundamentar este an\u00e1lisis se exponen abundantes cifras y bibliograf\u00eda, lo que permite constatar tanto el impacto de la crisis, como los resultados que se han obtenido en la recuperaci\u00f3n econ\u00f3mica a\u00fan en curso. Finalmente se ofrece un resumen macroecon\u00f3mico de los principales resultados globales obtenidos por la econom\u00eda cubana en 50 a\u00f1os.This essay discusses the evolution of the Cuban economy over the past 20 years, called \"special period\" by the Cuban government. The analysis details the measures taken to address the crisis and the measures taken to overcome the crisis without compromising principles and without endangering the very existence of the revolution. To support this analysis, abundant figures and bibliography are set forth, allowing us to grasp both the impact of the crisis and the results\n[VARIABILIDAD EN LA NOTIFICACI\u00d3N DE REACCIONES ADVERSAS A LAS VACUNAS DE LA GRIPE PAND\u00c9MICA Y ESTACIONAL. TEMPORADAS 2009-2010 Y 2010-2011, COMUNITAT VALENCIANA](http://www.redalyc.org/articulo.oa?id=17023106004) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAna Mar\u00eda Alguacil Ramos\n2012-01-01\nFull Text Available Fundamentos: La p\u00e9rdida de confianza en la seguridad de las vacunas derivada de situaciones de alarma, como en el caso de la gripe pand\u00e9mica, puede afectar tanto a las coberturas vacunales como a la sensibilidad frente a la notificaci\u00f3n de las sospechas de reacciones adversas asociadas a vacunas (SRAAV. El objetivo del trabajo es describir los efectos adversos a la vacuna frente a la gripe pand\u00e9mica notificados en la temporada 2009-2010 y comparar si existen diferencias con los descritos con la vacuna de la gripe estacional en las temporadas 2009-2010 y 2010-2011 en la Comunitat Valenciana (CV. M\u00e9todos: Se realiz\u00f3 un estudio descriptivo de los individuos vacunados frente a la gripe que presentaron alguna SRAAV a la vacuna antigripal y que fue notificada a trav\u00e9s del Sistema de Informaci\u00f3n Vacunal, durante las temporadas 2009-2010 (incluyendo la vacunaci\u00f3n pand\u00e9mica y 2010-2011 en CV. se calcularon las tasas de notificaci\u00f3n de sospechas de reacciones adversas asociadas a vacunas por cada mil dosis de vacunas administradas y sus intervalos de confianza al 95%. Resultados: Durante el periodo 2009-2010 la tasa de notificaci\u00f3n de SRAAV para la vacuna de la gripe estacional fue de 0,02 por mil dosis administradas, para la vacuna pand\u00e9mica de 0,95. En el periodo 2010-2011 la tasa para la vacuna de la gripe estacional fue de 0,04 por mil. Conclusiones: Durante las temporadas analizadas se increment\u00f3 el n\u00famero de notificaciones de SRAAV para las vacunas pand\u00e9micas en comparaci\u00f3n con el resto de vacunas antigripales. La mayor tasa de notificaci\u00f3n de SRAAV correspondi\u00f3 al grupo de profesionales sociosanitarios, tanto para las vacunas frente a la gripe estacional como pand\u00e9- mica.\n[An\u00e1lisis econ\u00f3mico de las vacunas 10-valente y 13-valente contra neumococo: revisi\u00f3n sistem\u00e1tica](https://www.openaire.eu/search/publication?articleId=od______1325::3699ed70c8821c924c79160abcf4fcaf)\nTorres Garrido, Alba Luz; Vargas-Zambrano, Juan-Camilo\n2014-01-01\nIntroducci\u00f3n: Las vacunas cl\u00e1sicamente han representado un m\u00e9todo econ\u00f3mico y eficaz para el control y prevenci\u00f3n de m\u00faltiples enfermedades infecciosas. En los \u00faltimos a\u00f1os se han introducido nuevas vacunas contra neumococo a precios elevados, y los diferentes an\u00e1lisis econ\u00f3micos a nivel mundial de estas vacunas no muestran tendencias. El objetivo de este trabajo era resumir la evidencia existente a trav\u00e9s de los diferentes estudios econ\u00f3micos evaluando las dos vacunas de segunda generaci\u00f3n c...\n[A A\u00e7\u00e3o Libertadora Nacional, a revolu\u00e7\u00e3o cubana e a luta armada no Brasil](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-77042009000200013&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJean Rodrigues Sales\n2009-01-01\nFull Text Available O objetivo do artigo \u00e9 analisar as rela\u00e7\u00f5es da A\u00e7\u00e3o Libertadora Nacional com a revolu\u00e7\u00e3o cubana na d\u00e9cada de 1960. Parte do pressuposto de que a revolu\u00e7\u00e3o cubana representou um marco na hist\u00f3ria do socialismo no continente latino-americano. Uma das marcas distintivas dessa hist\u00f3ria foi a profunda influ\u00eancia que teve sobre as organiza\u00e7\u00f5es que participaram da luta armada contra a ditadura brasileira implantada em 1964. Nesse caminho, discutiremos aqui o tipo de influ\u00eancia que a revolu\u00e7\u00e3o cubana teve sobre a ALN, principalmente no que diz respeito ao seu projeto de luta armada.\n[Estrat\u00e9gias de campo em ensaios cl\u00ednicos com novas vacinas produzidas no Brasil Estrategias de campo en ensayos cl\u00ednicos con nuevas vacunas producidas en Brasil Clinical trials field strategies with novel vaccines produced in Brazil](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-05822012000200008) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nEm\u00edlia de Faria Carniel\n2012-06-01\nFull Text Available OBJETIVO: Relatar as estrat\u00e9gias de campo utilizadas em dois ensaios cl\u00ednicos com vacinas desenvolvidas pelo Instituto Butantan, em 2004 e 2006. M\u00c9TODOS: Estudo do tipo relato de experi\u00eancia, em que se descreve o planejamento e a operacionaliza\u00e7\u00e3o dos ensaios cl\u00ednicos, que avaliaram a imunogenicidade e a seguran\u00e7a da vacina BCG combinada com a vacina da hepatite B (VrHB-IB e da tetravalente bacteriana modificada pela extra\u00e7\u00e3o do lipopolissacar\u00eddeo (LPS do componente pertussis (DTPm/Hib. RESULTADOS: As principais estrat\u00e9gias de campo utilizadas foram: a Parceria entre os pesquisadores e os gestores da Secretaria Municipal de Sa\u00fade e b Realiza\u00e7\u00e3o dos procedimentos da pesquisa nos domic\u00edlios ou nos Centros de Sa\u00fade frequentados pelos participantes. No primeiro estudo, foram vacinados 552 rec\u00e9m-nascidos na maternidade com a BCG/VrHB-IB (combinadas ou separadas e nos domic\u00edlios, com as duas doses subsequentes de VrHB-IB. O segundo estudo incluiu 241 lactentes em Centros de Sa\u00fade da rede municipal, vacinados com tetravalente bacteriana (com componente pertussis total ou modificado. Em ambos os estudos, amostras de sangue foram colhidas nas resid\u00eancias. N\u00e3o houve relatos de eventos adversos. A ades\u00e3o foi de 90,2% para o primeiro estudo e 93,8%, para o segundo. As vacinas foram administradas nas datas preconizadas pelo Programa Nacional de Imuniza\u00e7\u00f5es e as coletas de sangue, de acordo com o cronograma dos estudos. CONCLUS\u00d5ES: As estrat\u00e9gias utilizadas facilitaram o recrutamento das crian\u00e7as e garantiram cumprir o protocolo da pesquisa com alta ades\u00e3o, sem interferir no v\u00ednculo da fam\u00edlia com o Servi\u00e7o de Sa\u00fade, no calend\u00e1rio vacinal ou no seguimento pedi\u00e1trico dos participantes.OBJETIVO: Relatar las estrategias de campo utilizadas en dos ensayos cl\u00ednicos con vacunas desarrolladas por el Instituto Butantan, en 2004 y 2006. M\u00c9TODOS: Estudio de tipo relato de experiencia, en que se describe la planificaci\u00f3n y la\n[Prescripci\u00f3n de vacunas no incluidas en el calendario vacunal en la Comunitat Valenciana durante el per\u00edodo 2004-2009](http://www.redalyc.org/articulo.oa?id=17020115007) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAna Ruiz Palacio\n2011-01-01\nFull Text Available Fundamentos, En el marco de las pol\u00edticas de uso racional del medicamento, y al objeto de conseguir una gesti\u00f3n eficiente de los programas de vacunaciones, el objetivo de este trabajo es conocer el n\u00famero de envases de las vacunas prescritas no incluidas en los programas de vacunaci\u00f3n en la Comunitat Valenciana y en sus departamentos de salud, as\u00ed como el gasto que produjeron en 2009, y analizar la evoluci\u00f3n desde 2004, centrando el an\u00e1lisis en la vacuna heptavalente conjugada frente al Streptococcus pneumoniae en menores de dos a\u00f1os. M\u00e9todo, Estudio descriptivo retrospectivo de las vacunas prescritas mediante receta en la Comunitat Valenciana durante el a\u00f1o 2009 y su evoluci\u00f3n desde 2004. Variables, n\u00famero de envases, tipo de beneficiario (activo/pensionista, departamento y gasto generado. Fuentes, Gestor de Prestaci\u00f3n Farmac\u00e9utica (GAIA y Sistema Informaci\u00f3n Poblacional (SIP. Resultados: En 2009 la prescripci\u00f3n mediante receta de vacunas no incluidas en los programas de vacunaci\u00f3n gener\u00f3 un gasto de 683.445,71 ] correspondiente a 17.353 envases, lo que supuso el 87! del total del gasto en vacunas recetadas. La vacuna frente al S. pneumoniae gener\u00f3 el 72! del gasto total de las vacunas no incluidas en el calendario. La evoluci\u00f3n 2004-2009 muestra un aumento del gasto de 735.334 ] (24,66! en 2005 a partir del cual se produjo un descenso acusado y paulatino que alcanz\u00f3 los 1.562.650,67 ] (-228.64!. El gasto por departamentos para la vacuna del neumococo conjugada heptavalente por mil ni\u00f1os/as menores de dos a\u00f1os oscil\u00f3 entre 17.377 y 324 ]. Conclusiones: La tendencia descendente del gasto en recetas prescritas se mantuvo durante 2009, fundamentalmente de vacunas conjugadas frente a neumococo. No obstante, se observ\u00f3 gran variabilidad interdepartamental en las tasas de prescripci\u00f3n que debe ser corregida.\nAlejandro Roque Vald\u00e9s\n2004-01-01\nEl presente trabajo es un art\u00edculo de revisi\u00f3n que pretende abordar un tema tan controvertido como actual: la posible asociaci\u00f3n causal que se ha querido establecer entre el autismo y las vacunas infantiles. A partir de la \u00faltima d\u00e9cada del siglo XX se producen una serie de cambios en la clasificaci\u00f3n, nomenclatura y criterios diagn\u00f3sticos del autismo. Los hallazgos de estudios epidemiol\u00f3gicos llevados a cabo bajo estos nuevos ponderados han revelado que las tasas de prevalencia del autismo s...\n[Desarrollo de un m\u00e9todo de CLAR-IR para la determinaci\u00f3n de etanol residual en vacuna Development of a HPLC-IR method for determination of residual ethanol in vaccine](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75152009000200004) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMatilde Cuevas Valdespino\n2009-08-01\nFull Text Available Los ingredientes farmac\u00e9uticos activos de la vacuna antimeningoc\u00f3cica cubana VA-MENGOC-BC TM (ves\u00edculas de membrana externa purificadas de Neisseria meningitidis, serogrupo B y polisac\u00e1rido capsular purificado de Neisseria meningitidis, serogrupo C son conservados en etanol, de ah\u00ed que dicha vacuna posea un contenido de etanol residual, cuya concentraci\u00f3n real no se conoc\u00eda hasta el momento. Las regulaciones internacionales plantean que los productos biofarmac\u00e9uticos y sus ingredientes farmac\u00e9uticos activos deben tener bien caracterizadas todas sus impurezas, por lo que el objetivo de este trabajo fue el desarrollo de un m\u00e9todo de determinaci\u00f3n de etanol mediante cromatograf\u00eda l\u00edquida de alta resoluci\u00f3n-\u00edndice de refracci\u00f3n para estos fines y su comparaci\u00f3n con un m\u00e9todo utilizado frecuentemente para cuantificar este solvente, como es la cromatograf\u00eda gaseosa. El m\u00e9todo evaluado result\u00f3 ser \u00fatil y con una buena robustez para la determinaci\u00f3n de este solvente org\u00e1nico en esta vacuna antimenigoc\u00f3cica. No se detectaron diferencias estad\u00edsticamente significativas entre los resultados obtenidos al evaluar las mismas muestras de vacuna mediante ambos m\u00e9todos cromatogr\u00e1ficos (cromatograf\u00eda l\u00edquida de alta resoluci\u00f3n y cromatograf\u00eda gaseosa, lo que indica la posibilidad del uso de la cromatograf\u00eda l\u00edquida de alta resoluci\u00f3n en sustituci\u00f3n de la cromatograf\u00eda gaseosa para esta determinaci\u00f3n.Active pharmaceutical ingredients of Cuban anti-meningococcal vaccine VA-MENGOC-BC TM (vesicles of purified external membranes of Neisseria meningitidis, B serum-group, and purified capsular polysaccharide of Neisseria meningitidis, serum-group C are stored in ethanol, thus that such vaccine has residual ethanol content, of which real concentration is not known just now. International regulations propose that the biopharmaceutical products and its active pharmaceutical ingredients must to have well defined all impurities, thus\n[Dot Blot para determinar la identidad antig\u00e9nica en vacunas conjugadas contra Streptococcus pneumoniae serotipo 19F](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2017000100001&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nOsmir Cabrera-Blanco\n2017-04-01\nFull Text Available Las autoridades regulatorias recomiendan el uso de t\u00e9cnicas de Resonancia Magn\u00e9tica Nuclear o t\u00e9cnicas serol\u00f3gicas para la determinaci\u00f3n de la identidad de los ant\u00edgenos presentes en las vacunas conjugadas. Con la aparici\u00f3n de las vacunas conjugadas multivalentes, se ha hecho necesario recurrir a t\u00e9cnicas inmunoqu\u00edmicas con la utilizaci\u00f3n de anticuerpos monoclonales para aumentar la sensibilidad en la determinaci\u00f3n de la identidad de los ant\u00edgenos en dichas vacunas conjugadas. El objetivo del presente trabajo fue establecer las condiciones \u00f3ptimas de trabajo que permitieran utilizar la t\u00e9cnica del Dot Blot para determinar la identidad de los ant\u00edgenos en vacunas conjugadas de Streptococcus pneumoniae serotipo 19F. Para ello se estudiaron los tiempos de incubaci\u00f3n, la influencia del reactivo en la soluci\u00f3n de bloqueo; tambi\u00e9n las concentraciones \u00f3ptimas del anticuerpo monoclonal y de los ingredientes farmac\u00e9uticos activos, as\u00ed como los vol\u00famenes de aplicaci\u00f3n \u00f3ptimos para estos y vacunas. Se utiliz\u00f3 un anticuerpo monoclonal contra el polisac\u00e1rido capsular del serotipo 19F de neumococo. Las muestras empleadas en este trabajo fueron lotes de ingredientes farmac\u00e9uticos activos de conjugados de polisac\u00e1rido capsular 19F y lotes de un candidato vacunal cubano conjugado heptavalente contra neumococos. Los resultados mostraron que para la determinaci\u00f3n de la identidad antig\u00e9nica fueron suficientes 10 \u00b5L de muestras de los principios activos a una concentraci\u00f3n de 125 \u00b5g/mL e igual volumen para las vacunas heptavalentes. Qued\u00f3 demostrado que una concentraci\u00f3n de 1 \u00b5g/mL para el anticuerpo monoclonal y tiempos de incubaci\u00f3n de 30 min a 37 \u00b0C fueron suficientes para la determinaci\u00f3n. Estos resultados permiten concluir que quedaron establecidas las condiciones \u00f3ptimas de trabajo para determinar la identidad antig\u00e9nica por Dot Blot del polisac\u00e1rido capsular de S. pneumoniae serotipo 19F presente en las vacunas\n[La censura bienintencionada. Representaciones del peregrinaje pol\u00edtico hacia la Revoluci\u00f3n Cubana.](https://www.openaire.eu/search/publication?articleId=doajarticles::6b66ddb6469e571415699a6d6ab5c90f)\nHenry Eric Hern\u00e1ndez\n2014-01-01\nEste art\u00edculo analiza la censura de las buenas intenciones, es decir la censura pol\u00edticamente necesaria representada por los peregrinos pol\u00edticos desde, por y para la Revoluci\u00f3n Cubana, y que discutiremos como un modus operandi de la burocracia cubana. El \u2018Revuelo P.M.\u2019 en 1961, el engavetamiento de la pel\u00edcula de peregrinaje Soy Cuba en 1964, la condena a Pablo Neruda por participar en el Congreso del Pen Club en 1966 y el Caso Padilla en 1971 son modelos censorios inici\u00e1ticos cuya secuencia...\n[Effects of hemoglobin variants HbJ Bangkok, HbE, HbG Taipei, and HbH on analysis of glycated hemoglobin via ion-exchange high-performance liquid chromatography.](https://www.ncbi.nlm.nih.gov/pubmed/28407371)\nZhang, Xiu-Ming; Wen, Dong-Mei; Xu, Sheng-Nan; Suo, Ming-Huan; Chen, Ya-Qiong\n2018-01-01\nTo explore the effects of HbJ Bangkok, HbE, HbG Taipei, and \u03b1-thalassemia HbH on the results of HbA1c assessment using ion-exchange high-performance liquid chromatography (IE-HPLC). We enrolled five patients in which the results of the IE-HPLC HbA1c assay were inconsistent with the average levels of FBG. We performed hemoglobin capillary (Hb) electrophoresis using whole-blood samples. We also sequenced the genes encoding Hb using dideoxy-mediated chain termination and analyzed HbA1c using borate affinity HPLC (BA-HPLC) and turbidimetric inhibition immunoassay (TINIA). Two patients had the HbJ Bangkok variant. Hb genotypes of these patients were \u03b2 41-42 /\u03b2 J Bangkok and \u03b2 N /\u03b2 J Bangkok , and the content of HbJ Bangkok was 93.9% and 52.4%, respectively. The remaining three patients had the following: HbE (\u03b2 N /\u03b2 E Hb genotype, 23.6% HbE content), HbG Taipei (\u03b2 N /\u03b2 G Taipei Hb genotype, 39.4% HbG Taipei content), and \u03b1-thalassemia HbH (6.1% HbH content, 2.8% Hb Bart's content). In the patients with \u03b2-thalassemia and HbJ Bangkok variants, the presence of the variants interfered with the results of HbA1c analyses using IE-HPLC and TINIA; in the remaining four patients, there was interference with the results of HbA1c IE-HPLC but not with the TINIA assay. There was no interference with BA-HPLC HbA1c results. HbJ Bangkok, HbE, HbG Taipei Hb, and \u03b1-thalassemia HbH disease cause varying degrees of interference with the analysis of HbA1c using IE-HPLC. In these patients, we suggest using methods free from such interference for the analysis of HbA1c and other indicators to monitor blood glucose levels. \u00a9 2017 Wiley Periodicals, Inc.\n[Vacuna per escur\u00e7ar el tractament contra la tuberculosi](https://www.openaire.eu/search/publication?articleId=od______1404::024354d31010002918ddb339dc0408a6)\nCardona, Pere-Joan\n2006-01-01\nUn grup d'investigadors de la Unitat de Tuberculosi Experimental de la Fundaci\u00f3 Institut Germans Trias i Pujol ha creat una vacuna que permet reduir la durada del tractament de la infecci\u00f3 latent que provoca la tuberculosi de nou mesos a nom\u00e9s un.\n[Vacunas para la prevenci\u00f3n de la gripe en personas de edad avanzada](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::9f9342f04c4ecfc6206eb357ddd593ea)\nJefferson, Tom; Di Pietrantonj, Carlo; Al-Ansary, Lubna A.; Ferroni, Eliana; Thorning, Sarah; Thomas, Roger E.\n2010-01-01\nAntecedentes: Durante las \u00faltimas cuatro d\u00e9cadas, las vacunas han sido la principal arma global para disminuir la repercusi\u00f3n de la gripe en las personas de edad avanzada, y a nivel mundial se recomiendan para los individuos de 65 a\u00f1os o m\u00e1s de edad. El objetivo principal de la vacunaci\u00f3n contra la gripe en las personas de edad avanzada es reducir el riesgo de complicaciones en quienes son m\u00e1s vulnerables. Objetivos: Evaluar la efectividad de las vacunas sobre la prevenci\u00f3n de la gripe, la...\n[Eficacia de la vacuna meningoc\u00f3cica de polisac\u00e1rido capsular del grupo C](https://www.openaire.eu/search/publication?articleId=doajarticles::665616b0e79abcde2883f393f494e02c)\nGonz\u00e1lez Enr\u00edquez Jes\u00fas; Garc\u00eda Comas Luis; Alcaide Jim\u00e9nez Juan Francisco; S\u00e1enz Calvo Antonio; Conde Olasagasti Jos\u00e9\n1997-01-01\nFUNDAMENTO: Este trabajo consiste esencialmente en una revisi\u00f3n sistem\u00e1tica de la literatura cient\u00edfica sobre los efectos, intensidad y duraci\u00f3n de la respuesta serol\u00f3gica, as\u00ed como sobre la eficacia, efectividad y seguridad de la vacuna meningoc\u00f3cica de polisac\u00e1rido capsular del grupo C. M\u00c9TODOS: B\u00fasqueda en repertorio MEDLINE en el periodo 1970-1996. B\u00fasqueda espec\u00edfica de ensayos cl\u00ednicos aleatorizados y estudios de intervenci\u00f3n prospectivos en humanos con vacunas de polisac\u00e1ridos capsular...\n[Seguridad, reactogenicidad e inmunogenicidad de una nueva vacuna de polisac\u00e1ridos meningoc\u00f3cicos en adultos j\u00f3venes cubanos](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2017000100003&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRossana Estruch\u2013de la Guardia\n2017-04-01\nFull Text Available Se realiz\u00f3 un estudio aleatorizado, controlado y a doble ciegas, en 352 adultos j\u00f3venes cubanos entre 18 y 35 a\u00f1os de edad, con el objetivo de evaluar la seguridad, reactogenicidad y la inmunogenicidad de una nueva vacuna de polisac\u00e1ridos de Neisseria meningitidis serogrupos A, C y W135, producida por el Instituto Finlay de Vacunas (La Habana, Cuba, con respecto a su similar comercial Mencevax\u00ae ACW de Glaxo Smith Kline. Se tomaron muestras de suero antes y 28 d\u00edas despu\u00e9s de la vacunaci\u00f3n. La reactogenicidad de ambas vacunas fue similar. Los s\u00edntomas y signos, tanto locales como generales fueron leves y aparecieron principalmente durante las primeras 48 h despu\u00e9s de la vacunaci\u00f3n. Ning\u00fan sujeto present\u00f3 eventos adversos graves durante los 28 d\u00edas del per\u00edodo de vigilancia. La vacuna en estudio mostr\u00f3 ser segura y poco reactog\u00e9nica; sus porcentajes de seroconversi\u00f3n a los 28 d\u00edas posteriores a la vacunaci\u00f3n fueron de: 92,19 % para el serogrupo A, 88,89 % para C y 90,06 % para W135. No se detectaron diferencias con respecto a la seroconversi\u00f3n. La seroprotecci\u00f3n alcanzada con la vacuna en estudio fue de 98,44 %, 91,81 % y 95,32 % para los serogrupos A, C y W135 respectivamente y no fue inferior con respecto a la vacuna control para los tres serogrupos estudiados.\n[Molecular analysis of Hb Q-H disease and Hb Q-Hb E in a Singaporean family.](https://www.ncbi.nlm.nih.gov/pubmed/8629117)\nTan, J; Tay, J S; Wong, Y C; Kham, S K; Bte Abd Aziz, N; Teo, S H; Wong, H B\n1995-01-01\nHb Q (alpha 74Asp-His) results from a mutation in the alpha-gene such that abnormal alpha Q-chains are synthesized. The alpha Q-chains combine with the normal Beta A-chains to form abnormal Hb alpha 2Q beta 2A (Hb Q). Hb Q-H disease is rare, and has been reported only in the Chinese. We report here a Chinese family, were the mother diagnosed with Hb Q-H disease and the father with Hb E heterozygosity and a child with Hb Q-E-thalassemia. Thalassemia screening of the mother's blood revealed a Hb level of 6.8g/dl with low MCV and MCH. Her blood film was indicative of thalassemia. Cellulose acetate electrophoresis showed Hb H and Hb Q with the absence of Hb A. Globin chain biosynthesis was carried out and alpha Q- and beta-chains were detected. Normal alpha- chains were absent. Digestion of the mother's DNA with Bam HI and Bgl II followed by hybridization with the 1.5 kb alpha-Pst probe showed a two alpha-gene deletion on one chromosome and the -alpha Q chain mutant with the -alpha 4.2 defect on the other chromosome. DNA amplification studies indicated the two-gene deletion to be of the -SEA/ defect. The patient was concluded to possess Hb Q-H disease (--SEA/-alpha 4.2Q). Cellulose acetate electrophoresis of the father's blood showed the presence of Hb A, F and E. Molecular analysis of the father's DNA confirmed an intact set of alpha-genes (alpha alpha/alpha alpha). Globin chain biosynthesis of fetal blood of their child showed gamma, beta A, beta E, alpha A and alpha Q-chains. Molecular analysis of the child's DNA showed one alpha-gene deletion, thus giving a genotype of alpha alpha/-alpha 4.2Q beta beta E.\n[Estudios de inmunogenicidad, seguridad y eficacia de la Vacuna Q frente a la leishmaniosis canina](https://www.openaire.eu/search/publication?articleId=od_______296::4dfda7f2f3e4339756541268672e7022)\nFern\u00e1ndez Cotrina, Javier\n2016-01-01\nSe analizaron la seguridad, inmunogenicidad y eficacia protectiva de cuatro dosis de la vacuna Q de Leishmania infantum (VQ). Para ello, cincuenta perros beagle (10 por grupo) fueron vacunados con una dosis \u00fanica de 200, 100, 50 y 25 \u00b5g de VQ. A los perros del grupo control se les inyect\u00f3 el diluyente de la vacuna. Los datos muestran que la vacunaci\u00f3n con VQ indujo una respuesta humoral temprana y espec\u00edfica dependiente de la dosis. Adem\u00e1s, durante el per\u00edodo post-vacunaci\u00f3n no se detect\u00f3 rea...\n[Desarrollo de una vacuna profil\u00e1ctica de segunda generaci\u00f3n contra el papilomavirus humano](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802011000500015&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAlonso Leonardo\n2011-06-01\nFull Text Available Los papilomavirus humanos (HPV son el agente etiol\u00f3gico del c\u00e1ncer cervical (CC, la segunda causa de muerte por c\u00e1ncer en mujeres. Se estima que medio mill\u00f3n de nuevos c\u00e1nceres se diagnostica cada a\u00f1o, ocurriendo la mayor\u00eda de ellos en pa\u00edses en v\u00edas de desarrollo debido a la ausencia o ineficiencia de los programas masivos de detecci\u00f3n temprana. Recientemente se han introducido en el mercado dos vacunas profil\u00e1cticas contra las principales cepas oncog\u00e9nicas de HPV, la cepa 16 y 18, responsables por el 80% de todos los CC. Estas vacunas se obtienen en forma recombinante y han demostrado ser extremadamente seguras y eficaces. Sin embargo, su impacto inmediato en la incidencia de la infecci\u00f3n por HPV en pa\u00edses en v\u00edas de desarrollo ser\u00e1 m\u00ednimo, debido principalmente al alto costo de las mismas. Existe la necesidad de contar con vacunas de segunda generaci\u00f3n, de bajo costo y de aplicaci\u00f3n masiva que permitan disminuir sensiblemente el n\u00famero de CC en la poblaci\u00f3n. Con este objetivo hemos desarrollado una plataforma de expresi\u00f3n recombinante que permite obtener part\u00edculas tipo virus (VLPs con las cuales es posible formular vacunas efectivas y accesibles contra la infecci\u00f3n por HPV.\n[El valor patriotismo, a\\ttrav\u00e9s de obras pl\u00e1sticas cubanas](http://edusol.cug.co.cu/index.php/EduSol/editor/submission/262) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nYamil\u00e9 Montero Leyva\n2017-11-01\nFull Text Available La\\tinvestigaci\u00f3n aborda una tem\u00e1tica de gran vigencia y actualidad para la finalidad de la educaci\u00f3n cubana: el fortalecimiento del valor patriotismo a trav\u00e9s de obras pl\u00e1sticas cubanas en los estudiantes de la Secundaria B\u00e1sica. Se proponen actividades de apreciaci\u00f3n art\u00edstica estructuradas teniendo en cuenta cada unas de las variantes a trabajar, donde aborda la vida y obra de los artistas de la pl\u00e1stica cubanos, as\u00ed como un cuestionario para la realizaci\u00f3n de la apreciaci\u00f3n. Se brindan orientaciones metodol\u00f3gicas, y adem\u00e1s se puede establecer la relaci\u00f3n intermateria con las dem\u00e1s asignaturas del grado: Espa\u00f1ol. Historia de Cuba, Historia Antigua y Medieval.\n[Evaluaci\u00f3n de la toxicidad por dosis \u00fanica y tolerancia local de la vacuna vax-SPIRAL\u00ae en ratas Sprague Dawley](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2004000200002&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJuan F. Infante\n2004-04-01\nFull Text Available Las pruebas precl\u00ednicas de toxicidad en dosis \u00fanica y en dosis repetidas brindan una valiosa informaci\u00f3n sobre la seguridad del producto, al incluir el estudio macrosc\u00f3pico e histopatol\u00f3gico de \u00f3rganos importantes, as\u00ed como evaluaciones de las v\u00edas de administraci\u00f3n y el r\u00e9gimen de dosificaci\u00f3n. Cuba desarroll\u00f3 una vacuna polivalente de c\u00e9lulas inactivadas qu\u00edmicamente adyuvadas con hidr\u00f3xido de aluminio, vax-SPIRAL\u00ae. Esta vacuna presenta ventajas en relaci\u00f3n con otras vacunas como la procedente de la antigua URSS. El esquema de vacunaci\u00f3n para humanos consiste en dos dosis de 0,5 mL, separadas por un intervalo \u00f3ptimo de seis semanas. El objetivo de este estudio de toxicidad en ratas Sprague Dawley fue determinar la toxicidad potencial, letalidad, \u00f3rganos y sistemas susceptibles y otros eventos adversos, as\u00ed como la toxicidad en el sitio de inoculaci\u00f3n despu\u00e9s de la administraci\u00f3n de una dosis de la vacuna en estudio. Los resultados indicaron que, bajo las condiciones en estudio y seg\u00fan los criterios establecidos para evaluar los datos obtenidos, la vacuna antileptospir\u00f3sica trivalente no produce efectos t\u00f3xicos en el modelo animal usado. Las \u00fanicas alteraciones encontradas fueron formaciones granulomatosas a nivel del sitio de inoculaci\u00f3n. Estas formaciones han sido reportadas como pertenecientes al adyuvante de dep\u00f3sito (hidr\u00f3xido de aluminio, tambi\u00e9n usado en otras vacunas de aplicaci\u00f3n parenteral.\n[LA EDUCACI\u00d3N SUPERIOR CUBANA: LOGROS Y PERSPECTIVAS](http://www.redalyc.org/articulo.oa?id=129517775004) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAcela Cantero Zayas\n2004-01-01\nFull Text Available El impetuoso desarrollo de la ciencia y la t\u00e9cnica contempor\u00e1neo en general y muy espec\u00edficamente en la realidad cubana, est\u00e1 dirigido a satisfacer las necesidades creciente de nuestra sociedad, lo que conlleva a un continuo perfeccionamiento de todo el sistema educativo en correspondencia con las exigencias, demandas y necesidades de nuestro pueblo. En tal sentido, para comprender los resultados que exhibe la Educaci\u00f3n cubana y dentro de ella la Educaci\u00f3n Superior, se precisa de toda una reflexi\u00f3n hist\u00f3rica, como soporte l\u00f3gico y metodol\u00f3gico del hecho educativo cubano. En la actualidad, el mayor impacto de nuestra Educaci\u00f3n Superior, desde los puntos de vista social, pol\u00edtico, econ\u00f3mico y en especial formativo, lo constituye, el dise\u00f1o e implementaci\u00f3n del modelo de Universalizaci\u00f3n, el cual tiene como objetivo supremo la extensi\u00f3n de la Universidad a los distintos municipios del pa\u00eds, con la finalidad de irradiar cultura y saber, que son las \u00fanicas modalidades de garantizar un hombre libre y de hecho una sociedad independiente. En el presente trabajo se muestra una panor\u00e1mica de la Educaci\u00f3n Superior en Cuba, partiendo del elemento hist\u00f3rico hasta la contemporaneidad y en \u00e9sta, los nuevos retos impuestos por el contexto socio-pol\u00edtico a escala mundial.\n[La Real Expedici\u00f3n Filantr\u00f3pica de la vacuna (1803 - 1810](http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0465-546X2007000400010) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJorge Veiga de Cabo\n2007-12-01\nFull Text Available La Expedici\u00f3n Filantr\u00f3pica de la vacuna supuso una de las empresas sanitarias realizadas en el Siglo XVIII de mayor envergadura, por su complejidad, dificultad y sobre todo, por constituir una de las misiones de Salud P\u00fablica m\u00e1s importantes realizadas en la Historia. Supone el resultado de un proceso en el que una serie de acontecimientos hist\u00f3ricos, sanitarios y sociales confluyen para generar uno de los primeros programas de intervenci\u00f3n en salud p\u00fablica a escala internacional y de expansi\u00f3n de la vacuna de la viruela. Se crean Centros de producci\u00f3n, almacenamiento y distribuci\u00f3n de la vacuna, y programas de capacitaci\u00f3n t\u00e9cnica enfocados a mantener campa\u00f1as de vacunaci\u00f3n poblacional.One of the most important medical achievements made in the eighteenth century was the Philanthropic Expedition of the Vaccine. Due to its complexity and difficulty it was one of the most important Public Health undertakings in history. It was the outcome of a series of historical, social and health advances that converged in creating one of the earliest international programs for the expansion of the smallpox vaccine, creating centres for the production, storage and distribution of the vaccine together with technical training programs aimed at maintaining population vaccination campaigns.\n[Estudio de toxicidad por dosis \u00fanica y tolerancia local de una vacuna antimeningoc\u00f3cica tipo B en ratas Sprague Dawley](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200004&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJuan F. N\u00fa\u00f1ez\n2006-08-01\nFull Text Available La vacuna antimeningoc\u00f3cica tipo B, objetivo de este estudio, contiene ves\u00edculas purificadas de la membrana externa del meningococo del serogrupo B de la cepa (Cu- 385 - 83 B:4:P1.19,15. El esquema de vacunaci\u00f3n propuesto en humanos consiste en tres dosis de 0,5 mL, separadas por un intervalo \u00f3ptimo de ocho semanas. El objetivo de este estudio de toxicidad en ratas Sprague Dawley (SD fue determinar la toxicidad potencial, letalidad, \u00f3rganos, sistemas susceptibles y otros eventos adversos, as\u00ed como la toxicidad en el sitio de inoculaci\u00f3n despu\u00e9s de la administraci\u00f3n de una dosis de la vacuna en estudio. Los resultados indicaron que, bajo las condiciones del estudio y seg\u00fan los criterios establecidos para evaluar los resultados, la vacuna antimeningoc\u00f3cica tipo B, no produce efectos t\u00f3xicos en el modelo animal usado. Todo lo que se observ\u00f3 fueron formaciones granulomatosas a nivel del punto de inoculaci\u00f3n. Estas formaciones han sido reportadas como pertenecientes a los adyuvantes de dep\u00f3sito, como el hidr\u00f3xido de aluminio, usado en otras vacunas parenterales. Se concluye que la vacuna antimeningoc\u00f3cica tipo B result\u00f3 satisfactoria en las pruebas de toxicidad por dosis\u00fanica y tolerancia local realizadas en la especie rata.\n[Erroneous HbA1c results in a patient with elevated HbC and HbF.](https://www.ncbi.nlm.nih.gov/pubmed/27664335)\nAdekanmbi, Joy; Higgins, Trefor; Rodriguez-Capote, Karina; Thomas, Dylan; Winterstein, Jeffrey; Dixon, Tara; Gifford, Jessica L; Krause, Richard; Venner, Allison A; Clarke, Gwen; Estey, Mathew P\n2016-11-01\nHbA1c is used in the diagnosis and monitoring of diabetes mellitus (DM). Interference from hemoglobin variants is a well-described phenomenon, particularly with HPLC-based methods. While immunoassays may generate more reliable HbA1c results in the presence of some variants, these methods are susceptible to negative interference from high concentrations of HbF. We report a case where an accurate HbA1c result could not be obtained by any available method due to the presence of a compound hemoglobinopathy. HbA1c was measured by HPLC, immunoassay, and capillary electrophoresis. Hemoglobinopathy investigation consisted of a CBC, hemoglobin fractionation by HPLC and electrophoresis, and molecular analysis. HbA1c analysis by HPLC and capillary electrophoresis gave no result. Analysis by immunoassay yielded HbA1c results of 5.9% (Siemens DCA 2000+) and 5.1% (Roche Integra), which were inconsistent with other markers of glycemic control. Hemoglobinopathy investigation showed HbC with the hereditary persistence of fetal hemoglobin-2 Ghana deletion. Reliable HbA1c results may be unobtainable in the presence of some hemoglobinopathies. HPLC and capillary electrophoresis alerted the laboratory to the presence of an unusual hemoglobinopathy. Immunoassays generated falsely low results without warning, which could lead to missed diagnoses and under treatment of patients with DM. Copyright \u00a9 2016 Elsevier B.V. All rights reserved.\n[A novel double heterozygous Hb Fontainebleau/HbD Punjab hemoglobinopathy.](https://www.ncbi.nlm.nih.gov/pubmed/26036869)\nRodr\u00edguez-Capote, Karina; Estey, Mathew P; Barakauskas, Vilte; Bordeleau, Pierre; Christensen, Cathie-Lou; Zuberbuhler, Peter; Higgins, Trefor N\n2015-09-01\nTo report the finding of a novel double heterozygous hemoglobinopathy, the coinheritance of Hb Fontainebleau (\u03b1-chain variant) with HbD-Punjab (\u03b2-chain variant) discovered upon investigation of unexplained microcytosis in an infant. Hemoglobinopathy investigation was performed by high performance liquid chromatography (HPLC) using the \u03b2-thalassemia Short Program on the Bio-Rad Variant II(TM) followed by gel electrophoresis at alkaline and acid pH (Sebia Hydrasys 2 Electrophoresis System) and molecular diagnostic testing. This study complied with our institutional board ethics requirements. HPLC and electrophoresis suggested a complex \u03b1- and \u03b2-chain hemoglobinopathy with presumptive identification of the beta Hb variant as Hb D-Punjab. DNA sequencing analysis revealed the presence of a double heterozygous status for Hb Fontainebleau/Hb D-Punjab. In this paper we report the coinheritance of Hb Fontainebleau with Hb D-Punjab. Copyright \u00a9 2015 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.\n[Comparison of the characteristics of two hemoglobin variants, Hb D-Iran and Hb E, eluting in the Hb A2 window.](https://www.ncbi.nlm.nih.gov/pubmed/28698850)\nDass, Jasmita; Gupta, Aastha; Mittal, Suchi; Saraf, Amrita; Langer, Sabina; Bhargava, Manorama\n2017-06-01\nCation exchange-high performance liquid chromatography (CE-HPLC) is most commonly used to evaluate hemoglobin (Hb) variants, which elute in the Hb A2 window. This study aimed to assess prevalence of an uncommon Hb variant, Hb D-Iran, and compare its red cell parameters and peak characteristics with those of Hb E that commonly elutes in the Hb A2 window. Generally, we assess abnormal Hb using CE-HPLC as the primary technique along with alkaline and acid electrophoresis. All cases with Hb A2 window >9%, as assessed by CE-HPLCs during 2009-2013, were selected. Twenty-nine cases with Hb D-Iran variant were identified-25 heterozygous, 2 homozygous, 1 compound heterozygous Hb D-Iran/\u03b2-thalassemia, and 1 Hb D-Iran/Hb D-Punjab. Overall prevalence of Hb D-Iran was 0.23%. Compared to patients with Hb E, those with Hb D-Iran had significantly higher Hb (12.1 vs. 11.3 g/dL, P =0.03), MCV (82.4 vs. 76.4 fL, P =0.0044), MCH (27.9 vs. 25.45 pg, P =0.0006), and MCHC (33.9 vs. 33.3 g/dL, P =0.0005). Amount of abnormal Hb (40.7 vs. 26.4%, P =0.0001) was significantly higher while retention time (3.56 vs. 3.70 min, P =0.0001) was significantly lower in Hb D-Iran than in Hb E. Hb D-Iran peak can be easily missed if area and retention time of the Hb A2 window are not carefully analyzed. To distinguish between variants, careful analysis of peak area and retention time is sufficient in most cases and may be further confirmed by the second technique-alkaline electrophoresis.\n[Evaluaci\u00f3n de la informaci\u00f3n sanitaria disponible en internet sobre la vacuna antigripal](https://www.openaire.eu/search/publication?articleId=doajarticles::10bf287ae0007ca1c04dfbe102687a3b)\nI. Hern\u00e1ndez-Garc\u00eda; R. Gonz\u00e1lez Celador\n2014-01-01\nFundamento: La calidad de la informaci\u00f3n sanitaria en internet preocupa a gobiernos y usuarios. Nuestro objetivo fue determinar en qu\u00e9 medida la informaci\u00f3n sobre la vacuna antigripal se adhiere al gold est\u00e1ndar representado por lo establecido por el Ministerio de Sanidad espa\u00f1ol. Material y m\u00e9todos: Entre junio-julio 2014 se evalu\u00f3 la adhesi\u00f3n al gold est\u00e1ndar de la informaci\u00f3n sobre indicaciones, efectos adversos y contraindicaciones de la vacuna. Dicha informaci\u00f3n se obtuvo a trav\u00e9s de Goo...\n[Efectividad de la vacuna contra influenza: metan\u00e1lisis de literatura](http://www.revistabiomedica.org/index.php/biomedica/article/view/44) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJos\u00e9 Moreno\n2009-03-01\nConclusiones. Los an\u00e1lisis sugieren la vacunaci\u00f3n como medida masiva de control para influenza en adultos mayores de 65 a\u00f1os. Existe un importante vac\u00edo de conocimiento en la efectividad de la vacuna en ni\u00f1os menores de dos a\u00f1os y madres gestantes.\n[Dengue, zika, chikungunya y el desarrollo de vacunas](https://www.openaire.eu/search/publication?articleId=od_______617::72f63e3faddc26d37afb5bec15e160d2)\nKantor, Isabel N\n2018-01-01\nDengue (DENV), zika (ZIKV) y chikungunya (CHIKV), tres arbovirosis transmitidas por mosquitos Aedes, se han propagado en las \u00faltimas d\u00e9cadas en zonas tropicales y subtropicales h\u00famedas. El dengue es epid\u00e9mico en \u00e1reas subtropicales de la Argentina. Despu\u00e9s de la infecci\u00f3n por DENV hay inmunidad duradera contra el serotipo infectante, pero aumenta el riesgo de enfermedad grave por los otros tres. La vacuna recombinante tetravalente, Dengvaxia\u00ae previene el dengue grave y la hospitalizaci\u00f3n en s...\n[HbD Punjab/HbQ India compound heterozygosity: An unusual association.](http://www.mjhid.org/index.php/mjhid/article/view/2050) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nStacy Colaco\n2014-11-01\nFull Text Available Background: Haemoglobinopathies are the commonest hereditary disorders in India and pose a major health problem. Both beta thalassaemia and structural haemoglobin variants are relatively common in north western India. Here we report a 29 year old Sindhi female who was referred to us for a haemoglobinopathy work up and genetic counseling since her spouse was a classical beta thalassaemia carrier. Method: A complete blood count was done on an automated cell counter. Haemoglobin analysis was carried out using HPLC Variant Haemoglobin Testing System. The cellulose acetate electrophoresis was carried out [pH 8.9]. Confirmation of mutations was done by automated DNA sequencing. Results: HPLC analysis showed four major peaks, HbA0, a peak in the HbD window, an unknown peak [retention time 4.74 minutes] and a peak in the HbC window. The HbA2 level was 2.2% and the HbF level was 0.7%.Cellulose acetate electrophoresis at alkaline pH, a slow moving band was seen at the HbS/D position along with a prominent band at the HbA2 position. DNA sequencing of the \u03b2 and \u03b1 genes showed presence of the 2 hemoglobin variants :Hb D [b 121GAA \u00e0 CAA] and Hb Q [a 64 AAG \u00e0 GAG]. The \u03b4 globin gene was normal. The additional peak in the HbC window was due to the formation of a heterodimer hybrid. Conclusion: Both HbD Punjab and HbQ India are relatively common in India but their co-inheritance has not been described in the country. This is the second report of compound heterozygosity for HbQ India/HbD Punjab haemoglobinopathy globally, and the first one from India.\n[The Properties of Red Blood Cells from Patients Heterozygous for HbS and HbC (HbSC Genotype](http://dx.doi.org/10.1155/2011/248527) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nA. Hannemann\n2011-01-01\nFull Text Available Sickle cell disease (SCD is one of the commonest severe inherited disorders, but specific treatments are lacking and the pathophysiology remains unclear. Affected individuals account for well over 250,000 births yearly, mostly in the Tropics, the USA, and the Caribbean, also in Northern Europe as well. Incidence in the UK amounts to around 12\u201315,000 individuals and is increasing, with approximately 300 SCD babies born each year as well as with arrival of new immigrants. About two thirds of SCD patients are homozygous HbSS individuals. Patients heterozygous for HbS and HbC (HbSC constitute about a third of SCD cases, making this the second most common form of SCD, with approximately 80,000 births per year worldwide. Disease in these patients shows differences from that in homozygous HbSS individuals. Their red blood cells (RBCs, containing approximately equal amounts of HbS and HbC, are also likely to show differences in properties which may contribute to disease outcome. Nevertheless, little is known about the behaviour of RBCs from HbSC heterozygotes. This paper reviews what is known about SCD in HbSC individuals and will compare the properties of their RBCs with those from homozygous HbSS patients. Important areas of similarity and potential differences will be emphasised.\n[Inmunoterapia en melanoma: vacunas de c\u00e9lulas dendr\u00edticas](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1726-46342015000300021&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nIvan Lozada-Requena\nFull Text Available La presente es una revisi\u00f3n narrativa que muestra la informaci\u00f3n accesible a la comunidad cient\u00edfica sobre melanoma e inmunoterapia. Las c\u00e9lulas dendr\u00edticas tienen la capacidad de participar en la inmunidad innata y adaptativa, pero no son ajenas a la evasi\u00f3n inmune de los tumores. Conocer su biolog\u00eda y rol ha llevado a generar in vitro varios prospectos de vacunas celulares aut\u00f3logas contra diversos tipos de c\u00e1ncer en humanos y modelos animales; sin embargo, en vista de la poca eficiencia que han mostrado, se deben implementar estrategias para potenciar su capacidad natural ya sea a trav\u00e9s de la coexpresi\u00f3n de mol\u00e9culas clave para activar o reactivar al sistema inmune, en combinaci\u00f3n con biosimilares o drogas quimioterape\u00faticas y no se debe descartar la acci\u00f3n de productos naturales como alternativa inmunoestimulante o adyuvante. Todos los tipos de inmunoterap\u00eda deber\u00edan medir el impacto de las c\u00e9lulas supresoras de origen mieloide, las que pueden atacar al sistema inmune y ayudar a la progresi\u00f3n tumoral, respectivamente. Esto puede reducir la actividad de las vacunas celulares y/o sus combinaciones pudiendo ser la diferencia entre el \u00e9xito o no de la inmunoterapia. Aunque en melanoma existen biosimilares aprobados por la Food and Drug Administration (FDA no todos tienen el \u00e9xito esperado por lo que es necesario evaluar otras estrategias que incluyan vacunas celulares cargadas con p\u00e9ptidos antig\u00e9nicos tumorales expresados exclusivamente o ant\u00edgenos provenientes de extractos tumorales y sus respectivos adyuvantes.\n[Stability study for magnetic reagent assaying Hb and HbA1c](http://dx.doi.org/10.1016/j.jmmm.2012.08.029) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nHsieh, Wen-Pin; Chieh, J.J.; Yang, C.C.; Yang, S.Y.; Chen, Po-Yu; Huang, Yu-Hao; Hong, Y.W.; Horng, H.E.\n2013-01-01\nReagents for magnetically labeled immunoassay on human Hb and human HbA1c have been synthesized. The reagents consist of Fe 3 O 4 magnetic particles biofunctionalized with antibodies against Hb and HbA1c. It has been demonstrated that the reagents can be applied to quantitatively detect Hb and HbA1c by using immunomagnetic reduction assay. In addition to characterizing the assay properties, such as the standard curve and the low-detection limit, the stability of reagents is investigated. To do this, the temporal dependence of particle sizes and the bio-activity of reagents are monitored. The results show that the reagents are highly stable when stored at 2\u20138 \u00b0C. This means that the reagents synthesized in this work are promising for practical applications. - Highlights: \u25ba The properties of assaying Hb and HbA1c using immunomagnetic reduction are studied. \u25ba The magnetic nanoparticles with antibodies are highly stable in solutions. \u25ba No significant mutual interference between Hb and HbA1c in assays is observed. \u25ba High-sensitivity assays on Hb and HbA1c using immunomagnetic reduction are achieved.\n[Stability study for magnetic reagent assaying Hb and HbA1c](http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=22155474) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nHsieh, Wen-Pin [Actherm Inc., Hsinchu 200, Taiwan (China); Chieh, J.J.; Yang, C.C. [Institute of Electro-optical Science and Technology, National Taiwan Normal University, Taipei 116, Taiwan (China); Yang, S.Y. [Institute of Electro-optical Science and Technology, National Taiwan Normal University, Taipei 116, Taiwan (China); MagQu Co., Ltd., Sindian Dist., New Taipei City 231, Taiwan (China); Chen, Po-Yu; Huang, Yu-Hao [Actherm Inc., Hsinchu 200, Taiwan (China); Hong, Y.W. [Institute of Electro-optical Science and Technology, National Taiwan Normal University, Taipei 116, Taiwan (China); Horng, H.E., E-mail: phyfv001@ntnu.edu.tw [Institute of Electro-optical Science and Technology, National Taiwan Normal University, Taipei 116, Taiwan (China)\n2013-01-15\nReagents for magnetically labeled immunoassay on human Hb and human HbA1c have been synthesized. The reagents consist of Fe{sub 3}O{sub 4} magnetic particles biofunctionalized with antibodies against Hb and HbA1c. It has been demonstrated that the reagents can be applied to quantitatively detect Hb and HbA1c by using immunomagnetic reduction assay. In addition to characterizing the assay properties, such as the standard curve and the low-detection limit, the stability of reagents is investigated. To do this, the temporal dependence of particle sizes and the bio-activity of reagents are monitored. The results show that the reagents are highly stable when stored at 2-8 Degree-Sign C. This means that the reagents synthesized in this work are promising for practical applications. - Highlights: Black-Right-Pointing-Pointer The properties of assaying Hb and HbA1c using immunomagnetic reduction are studied. Black-Right-Pointing-Pointer The magnetic nanoparticles with antibodies are highly stable in solutions. Black-Right-Pointing-Pointer No significant mutual interference between Hb and HbA1c in assays is observed. Black-Right-Pointing-Pointer High-sensitivity assays on Hb and HbA1c using immunomagnetic reduction are achieved.\n[Streptococcus pneumoniae aislados durante 2002-2006: serotipos y resistencia antibi\u00f3tica. Correlaci\u00f3n con las vacunas existentes](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832008000100006&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJos\u00e9 Mar\u00eda Guevara-Duncan\n2008-03-01\nFull Text Available Objetivos: Identificar los serotipos de S. pneumoniae aislados, correlacion\u00e1ndolos con los incluidos en las vacunas existentes y su resistencia antimicrobiana. Dise\u00f1o: Estudio descriptivo, observacional y longitudinal. Lugar: Instituto de Medicina Tropical Daniel A. Carri\u00f3n, Facultad de Medicina, UNMSM. Material biol\u00f3gico: Cepas de Streptococcus pneumoniae. Intervenciones: Cuarenta Streptococcus pneumoniae de nuestro cepario, aislados entre el 2002 y 2006, fueron serotipificados en el Instituto de Salud Carlos III en Madrid -Espa\u00f1a; 15 fueron invasivos, 11 aislados de infecciones localizadas, 6 de portadores y 8 eran multiresistentes. Principales medidas de resultados: Protecci\u00f3n de las vacunas existentes en nuestro medio a las infecciones causadas por Streptococcus pneumoniae. Resultados: Hubo 14 serotipos diferentes y los serogrupos m\u00e1s identificados fueron 23, 19 y 6. El 28,6% estaba contenido en la vacuna 7-valente, 42,9% en la 9-valente, 50% en la 11-valente y el 71,4% en la 23-valente; 57,5% fue resistente a la penicilina y 30% a eritromicina. El grupo de Streptococcus invasivo result\u00f3 m\u00e1s sensible a los antibi\u00f3ticos que los otros grupos. Los serotipos asociados a multirresistencia fueron 19F y 23F. Conclusiones: Ninguna de las vacunas protege a todas las infecciones causadas por Streptococcus pneumoniae, en nuestro medio.\n[Desarrollo de una vacuna probi\u00f3tica para el tratamiento del c\u00e1ncer c\u00e9rvico-uterino](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::1ea3de1bdf059dfdef615fb2bb624b84)\nCort\u00e9s P\u00e9rez, Naima Gisela; Berm\u00fadez Humar\u00e1n, Luis Gilberto; Alcocer Gonz\u00e1lez, Juan Manuel; Gruss, Alexandra; Le Loir, Yves; Langella, Phillipe; Luna Leal, Roberto Montes de Oca\n2003-01-01\nDado que el virus del papiloma humano tipo 16 (HPV- 16) es la principal causa del c\u00e1ncer c\u00e9rvicouterino, hay una gran necesidad de desarrollar una vacuna profil\u00e1ctica y/o terap\u00e9utica. La oncoprote\u00edna E7 es constitutivamente producida por neoplasias cervicales y, por tanto, considerada como un blanco potencial para dirigir el desarrollo de una vacuna terap\u00e9utica contra el c\u00e1ncer c\u00e9rvico-uterino. En este trabajo desarrollamos un sistema inducible para expresar la prote\u00edn...\n[Diagnosis of Compound Heterozygous Hb Tak/\u03b2-Thalassemia and HbD-Punjab/\u03b2-Thalassemia by HbA2 Levels on Capillary Electrophoresis.](https://www.ncbi.nlm.nih.gov/pubmed/29398808)\nPanyasai, Sitthichai; Sakkhachornphop, Supachai; Pornprasert, Sakorn\n2018-01-01\nA misdiagnosis of \u03b2-thalassemia carrier in samples with Hb Tak and HbD-Punjab, the \u03b2-variants, can be a cause of inappropriate genetic counseling thus having a new case of \u03b2-thalassemia major. A capillary electrophoresis (CE) is very efficient in separating and quantifying HbA 2 . In this study, HbA 2 levels of samples which were doubted for compound heterozygous Hb Tak/\u03b2-thalassemia or heterozygous HbD-Punjab/\u03b2-thalassemia were measured and compared between CE and high performance liquid chromatography (HPLC). The molecular confirmation for Hb Tak, HbD-Punjab and \u03b2-thalassemia codons 17 (A > T), 41/42 (-TCTT), 71/72 (+A) and IVSI-nt1 (G > T) mutations and 3.4 kb deletion were also performed. Based on DNA analysis, 3 cases were diagnosed as compound heterozygous Hb Tak/\u03b2-thalassemia and one for HbD-Punjab/\u03b2-thalassemia. The elevated HbA 2 levels were found in all 4 samples with rages of 4.6-7.3% on CE while those were not found on HPLC. Thus, the elevated HbA 2 measured by CE can be used as a screening parameter for differentiating the homozygote of Hb Tak and HbD-Punjab from the compound heterozygote of these hemoglobinopathies and \u03b2-thalassemia.\n[A Revolu\u00e7\u00e3o Agr\u00e1ria Cubana: conquistas e desafios](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-40142011000200007) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJuan Vald\u00e9s Paz\n2011-01-01\nFull Text Available Ap\u00f3s o triunfo da Revolu\u00e7\u00e3o em 1959, iniciou-se uma profunda transforma\u00e7\u00e3o da sociedade cubana, primeiro pol\u00edtica, depois social e, desde muito cedo, agr\u00e1ria. A Revolu\u00e7\u00e3o Cubana foi a supera\u00e7\u00e3o da quest\u00e3o agr\u00e1ria originada na etapa republicana e uma op\u00e7\u00e3o socialista para o desenvolvimento socioecon\u00f4mico do pa\u00eds, do qual o desenvolvimento agr\u00e1rio tem sido um eixo fundamental. A supera\u00e7\u00e3o dessa \"quest\u00e3o agr\u00e1ria\" do socialismo cubano determina as estrat\u00e9gias em curso e suas metas imediatas. Como parte desse processo, examinamos seis aspectos que caracterizaram seu desenvolvimento; s\u00e3o eles: a estrutura da pose de terra; o uso do solo; a organiza\u00e7\u00e3o agr\u00e1ria; o modelo tecnol\u00f3gico; a economia agr\u00e1ria; e o desenvolvimento da sociedade rural.Con el triunfo de la Revoluci\u00f3n en 1959, se inici\u00f3 una profunda transformaci\u00f3n de la sociedad cubana, primero pol\u00edtica, despu\u00e9s social y desde muy tempranamente, agraria. La Revoluci\u00f3n Cubana fue la superaci\u00f3n de la cuesti\u00f3n agraria originada en la etapa republicana y una opci\u00f3n socialista para el desarrollo socioecon\u00f3mico del pa\u00eds, del cual el desarrollo agrario ha sido un eje fundamental. La superaci\u00f3n de esta \"cuesti\u00f3n agraria\" del socialismo cubano, determina las estrategias en curso y sus metas inmediatas. Como parte de ese proceso, se examinan seis de los aspectos que caracterizaron su desarrollo, a saber: la estructura de tenencia de la tierra; el uso del suelo; la organizaci\u00f3n agraria; el modelo tecnol\u00f3gico; la econom\u00eda agraria; y el desarrollo de la sociedad rural.After the triumph of the revolution in 1959, a profound transformation of Cuban society began - first political, then social and, very early on, agrarian. The Cuban Revolution surmounted the agrarian issue that had originated during the republican phase and embodied a socialist option for socioeconomic development (of which agricultural development was a fundamental part. Cuban socialism's efforts to\n[Avances en el desarrollo de vacunas contra la neosporosis bovina Advances in the development of vaccines for bovine neosporosis](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412012000300014) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nYanina P. Hecker\n2012-09-01\nFull Text Available La neosporosis es una enfermedad que ocasiona abortos en bovinos y est\u00e1 causada por un protozoo intracelular obligado denominado Neospora caninum. Las graves p\u00e9rdidas econ\u00f3micas que provoca en los sistemas de producci\u00f3n de bovinos justifica la necesidad de avanzar en el desarrollo de vacunas. La resistencia a par\u00e1sitos Apicomplexa est\u00e1 asociada a una respuesta inmune T helper 1 mediada por linfocitos T CD4 citot\u00f3xicos y a la producci\u00f3n de interfer\u00f3n-gamma, interleuquina-12, factor de necrosis tumoral e inmunoglobulina G2. La disminuci\u00f3n de la transmisi\u00f3n vertical en las sucesivas pre\u00f1eces y el bajo nivel de repetici\u00f3n de abortos en animales infectados sugieren la existencia de mecanismos inmunitarios de protecci\u00f3n. Hasta el momento se conoce que la inoculaci\u00f3n pre-servicio con taquizo\u00edtos vivos protege contra la infecci\u00f3n y el aborto. Los antecedentes de desarrollo de vacunas vivas contra otros protozoos estimulan a los investigadores a continuar en la b\u00fasqueda de una vacuna de este tipo contra N. caninum de buena eficacia. Por otra parte, una vacuna inactivada, aun con una baja eficacia, es \u00fatil en la prevenci\u00f3n del aborto en aquellos establecimientos donde la enfermedad es epizo\u00f3tica. Una vacuna contra la neosporosis deber\u00eda evitar el aborto, la transmisi\u00f3n transplacental y la persistencia de la infecci\u00f3n. Este trabajo menciona los diversos tipos de vacunas que han sido evaluados hasta el momento, incluyendo inmun\u00f3genos inactivos, taquizo\u00edtos vivos, ant\u00edgenos recombinantes y vacunas en vectores.Neosporosis, a disease caused by the obligate intracellular protozoan Neospora caninum, produces abortions in cattle. The severe economic losses in cattle industry justify the need to develop control measures for preventing bovine abortion. Apicomplexan parasitic resistance is associated with T helper 1 immune response mediated by CD4 cytotoxic T lymphocytes, the production of interferon-gamma, interleukin-12, tumor necrosis\n[VARIABILIDAD EN LA NOTIFICACI\u00d3N DE REACCIONES ADVERSAS A LAS VACUNAS DE LA GRIPE PAND\u00c9MICA Y ESTACIONAL. TEMPORADAS 2009-2010 Y 2010-2011, COMUNITAT VALENCIANA](https://www.openaire.eu/search/publication?articleId=doajarticles::6f322a77ce0bd5fd88c95f861a1a0782)\nAna Mar\u00eda Alguacil Ramos; Jos\u00e9 Antonio Lluch Rodrigo; Antonio Portero Alonso; Rosa Mart\u00edn Ivorra; Eliseo Pastor Villalba\n2012-01-01\nFundamentos: La p\u00e9rdida de confianza en la seguridad de las vacunas derivada de situaciones de alarma, como en el caso de la gripe pand\u00e9mica, puede afectar tanto a las coberturas vacunales como a la sensibilidad frente a la notificaci\u00f3n de las sospechas de reacciones adversas asociadas a vacunas (SRAAV). El objetivo del trabajo es describir los efectos adversos a la vacuna frente a la gripe pand\u00e9mica notificados en la temporada 2009-2010 y comparar si existen diferencias con los descritos con...\n[Perspectivas para el desarrollo de vacunas e inmunoterapia contra c\u00e1ncer cervicouterino](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0036-36341998000100006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGUZM\u00c1N-ROJAS LILIANA\n1998-01-01\nFull Text Available El c\u00e1ncer cervicouterino representa un grave problema de salud p\u00fablica, debido a la asociaci\u00f3n de la neoplasia con el virus del papiloma humano; actualmente se realizan estudios usando estrategias dirigidas a combatir este pat\u00f3geno, mediante vacunas, que podr\u00edan ser de gran utilidad para el control de la progresi\u00f3n de la enfermedad. El estudio tanto de la inmunolog\u00eda humoral como celular ha servido para el desarrollo de vacunas. As\u00ed, la utilizaci\u00f3n de part\u00edculas virales sint\u00e9ticas para el estudio de anticuerpos neutralizantes y el uso de prote\u00ednas tempranas virales, entre otras, para la inducci\u00f3n de inmunidad mediada por c\u00e9lulas, han sido la pauta para realizar estudios que dirijan la respuesta inmune para prevenir la infecci\u00f3n celular tanto hacia c\u00e9lulas infectadas no transformadas como hacia c\u00e9lulas transformadas viralmente con resultados favorables.\n[La matanza de los inocentes. Intelectuales cubanas en defensa del ni\u00f1o espa\u00f1ol](https://revistas.unal.edu.co/index.php/achsc/article/view/28085) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nNiall Binns\n2011-07-01\nFull Text Available El art\u00edculo estudia el impacto que tuvo en siete intelectuales cubanas la Guerra Civil Espa\u00f1ola y, concretamente, las im\u00e1genes de ni\u00f1os muertos en los bombardeos a\u00e9reos de Madrid y otras ciudades republicanas. Estas im\u00e1genes, divulgadas por la prensa y los noticiarios cinematogr\u00e1ficos, se reiteran obsesivamente en los escritos de Mariblanca Sabas Alom\u00e1, Serafina N\u00fa\u00f1ez, Berta Arocena, Mirta Aguirre, Fina Garc\u00eda Marruz, Emma P\u00e9rez y Tet\u00e9 Casuso. Estas intelectuales cubanas, arropadas por el prestigioso ejemplo de Gabriela Mistral, apelan a su sensibilidad \u201cmaternal\u201d para expresar su compasi\u00f3n y para justificar su indignaci\u00f3n y su activismo pol\u00edtico en defensa del ni\u00f1o espa\u00f1ol.\n[La evidencia acerca de la controversia de las vacunas que contienen timerosal y su asociaci\u00f3n con el autismo](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1726-46342013000200018&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLisset Garc\u00eda-Fern\u00e1ndez\n2013-06-01\nFull Text Available La vacunaci\u00f3n es una de las medidas de mayor impacto en la salud p\u00fablica para la reducci\u00f3n de la morbimortalidad infantil. El timerosal es un compuesto org\u00e1nico del mercurio utilizado como preservante de los frascos multidosis. Eventualmente, en el Per\u00fa, surgen olas de controversia acerca de la seguridad de estas vacunas, asoci\u00e1ndolas especialmente con el autismo. Como resultado de estas controversias, se han propuesto, incluso, leyes que proh\u00edben este tipo de vacunas, lo que tendr\u00eda un importante impacto en los costos y en los aspectos log\u00edsticos de la estrategia nacional de vacunaci\u00f3n. En este art\u00edculo se revisa la literatura sobre las principales controversias acerca de las vacunas que contienen timerosal y su supuesta asociaci\u00f3n con el autismo. Se realiza una aproximaci\u00f3n hist\u00f3rica sobre estas controversias, se hace una actualizaci\u00f3n de la evidencia cient\u00edfica disponible al momento, y se revisa la posici\u00f3n de los organismos internacionales m\u00e1s importantes con respecto a este tema. Se concluye que la evidencia cient\u00edfica no apoya la noci\u00f3n que exista una asociaci\u00f3n entre el uso del timerosal en las vacunas con los trastornos del espectro autista en ni\u00f1os.\n[Caracter\u00edsticas de los v\u00eddeos en espa\u00f1ol publicados en YouTube sobre la vacuna contra el virus del papiloma humano](http://www.redalyc.org/articulo.oa?id=17033372012) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJos\u00e9 Tuells\n2015-01-01\nFull Text Available Fundamentos: Internet constituye un recurso de b\u00fasqueda de informaci\u00f3n relacionada con la salud. El objetivo de este trabajo fue conocer las caracter\u00edsticas de los v\u00eddeos en idioma espa\u00f1ol de YouTube relacionados con la vacuna contra el virus del papiloma humano (VPH. M\u00e9todos: Se realiz\u00f3 un estudio observacional a partir de una b\u00fasqueda en YouTube el 26 de julio de 2013, con las palabras claves: \u201cvacuna virus papiloma humano\u201d, \u201cvacuna VPH\u201d, \u201cvacuna Gardasil\u201d, \u201cvacuna Cervarix\u201d. Se establecieron categor\u00edas por tipo, fuente de publicaci\u00f3n y predisposici\u00f3n favorable o no hacia la vacuna. Se registr\u00f3 el n\u00famero de visitas, tiempo de duraci\u00f3n de los videos y origen de los 20 v\u00eddeos m\u00e1s visitados. Resultados. Se encontraron 1.080 videos registrados, 170 fueron seleccionados y clasificados como: noticias locales (n=39; 37 favorables, 2 desfavorables; 2:06:29; 42972 visitas, noticias nacionales (n=32; 30/2; 1:49:27; 50138 visitas, creados por subscritores de YouTube (n=21; 13/8; 2:50:35; 144655 visitas, entrevistas (n=21; 20/1; 1:44:39; 10991 visitas, anuncios (n=21; 19/2; 0:27:05; 28435 visitas, conferencias (n=17; 15/2; 3:25:39; 27206 visitas, documentales (n=16; 12/4; 2:11:31; 30629 visitas, y noticias internacionales (n=3; 3/0; 0:11:33; 1667 visitas. De los 20 videos m\u00e1s reproducidos predominan los favorables a la vacunaci\u00f3n (n=12; 0:43:43; 161.789 visitas frente a los desfavorables (n=8; 2:44:14; 86.583 visitas. Conclusiones. Predominan los videos que tiene una opini\u00f3n favorable hacia la vacuna contra el VPH, aunque los videos de contenido negativo son los m\u00e1s extensos y reproducidos-\n[Cation Homeostasis in Red Cells From Patients With Sickle Cell Disease Heterologous for HbS and HbC (HbSC Genotype](http://www.sciencedirect.com/science/article/pii/S2352396415301432) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nA. Hannemann\n2015-11-01\nFull Text Available Sickle cell disease (SCD in patients of HbSC genotype is considered similar, albeit milder, to that in homozygous HbSS individuals \u2014 but with little justification. In SCD, elevated red cell cation permeability is critical as increased solute loss causes dehydration and encourages sickling. Recently, we showed that the KCl cotransporter (KCC activity in red cells from HbSC patients correlated significantly with disease severity, but that in HbSS patients did not. Two transporters involved in red cell dehydration, the conductive channels Psickle and the Gardos channel, behaved similarly in red cells from the two genotypes, but were significantly less active in HbSC patients. By contrast, KCC activity was quantitatively greater in HbSC red cells. Results suggest that KCC is likely to have greater involvement in red cell dehydration in HbSC patients, which could explain its association with disease severity in this genotype. This work supports the hypothesis that SCD in HbSC patients is a distinct disease entity to that in HbSS patients. Results suggest the possibility of designing specific treatments of particular benefit to HbSC patients and a rationale for the development of prognostic markers, to inform early treatment of children likely to develop more severe complications of the disease.\n[La fidelidad cubana durante la edad de las revoluciones](https://www.openaire.eu/search/publication?articleId=doajarticles::0d49daa6f3bda39c5d5eb8a5dc3c809d)\nKuethe, Allan J.\n1998-01-01\nNot available.\nLa historiograf\u00eda cubana tradicional explica la fidelidad de la perla de las Antillas durante las revoluciones americanas por raz\u00f3n del miedo al intimidante ej\u00e9rcito espa\u00f1ol acuartelado en la isla y por miedo a que cualquier divisi\u00f3n pol\u00edtica diera aliento a una sublevaci\u00f3n de la masiva poblaci\u00f3n esclava. Este art\u00edculo plantea la tesis de que el asunto fue mucho m\u00e1s complicado que lo que estas explicaciones dan a entender. Por una parte, el ej\u00e9rcito de la isl...\n[Hb variants in Korea: effect on HbA1c using five routine methods.](https://www.ncbi.nlm.nih.gov/pubmed/28107170)\nYun, Yeo-Min; Ji, Misuk; Ko, Dae-Hyun; Chun, Sail; Kwon, Gye Cheol; Lee, Kyunghoon; Song, Sang Hoon; Seong, Moon Woo; Park, Sung Sup; Song, Junghan\n2017-07-26\nQuantification of glycated hemoglobin (HbA1c) is a challenge in patients with hemoglobin (Hb) variants. We evaluated the impact of various Hb variants on five routine HbA1c assays by comparing with the IFCC reference measurement procedure (RMP). Whole blood samples showing warning flags or no results on routine HPLC HbA1c assays were confirmed for Hb variants and were submitted to HbA1c quantification using Sebia Capillarys 2 Flex Piercing, Roche Tina-quant HbA1c Gen. 2, Bio-Rad Variant II Turbo 2.0, ADAMS HA-8180, Tosoh G8 standard mode, and IFCC RMP using LC-MS. Among 114 samples, the most common variants were Hb G-Coushatta (n=47), Queens (n=41), Ube-4 (n=11), Chad (n=4), Yamagata (n=4), G-His-Tsou (n=2), G-Taipei (n=1), Fort de France (n=1), Hoshida (n=1), and two novel variants (Hb \u03b1-globin, HBA 52 Gly>Cys and Hb \u03b2-globin, HBB 146 His>Asn). In terms of control samples, all the result of HbA1c were \"acceptable\", within the criteria of \u00b17% compared to IFCC RMP target values. However, percentage of \"unacceptable\" results of samples with Hb variants were 16% for Capillarys 2, 7% for Tina-quant, 51% for Variant II Turbo 2.0, 95% for G8 standard mode, and 89% for HA-8180. The Capillarys 2 and HA-8180 assay did not provide the results in 5 and 40 samples with Hb variants, respectively. HbA1c results from five routine assays in patients with relatively common Hb variants in Korea showed various degrees of bias compared to those of IFCC RMP. Therefore, laboratories should be aware of the limitation of their methods with respect to interference from Hb variants found commonly in their local population and suggest an alternative HbA1c quantification method.\n[Vacunas de ADN: inducci\u00f3n de la respuesta inmunitaria DNA Vaccines: Induction of the immune response](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342009000900012) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJavier Mota-S\u00e1nchez\n2009-01-01\nFull Text Available La efectividad de las vacunas y la inmunizaci\u00f3n en la prevenci\u00f3n de las enfermedades infecciosas es uno de los grandes avances de la medicina. En la actualidad, el acceso a la tecnolog\u00eda de punta en el \u00e1rea de la gen\u00f3mica y la prote\u00f3mica ha hecho posible acelerar el desarrollo de nuevos modelos de vacunas con caracter\u00edsticas mejoradas en aspectos fundamentales, como la inmunogenicidad y la seguridad. A casi dos d\u00e9cadas del primer informe, en el cual se demostr\u00f3 que un gen puede expresarse mediante la inyecci\u00f3n directa de ADN desnudo, las vacunas de ADN han probado ser eficientes para inducir una respuesta inmunitaria protectora contra par\u00e1sitos, virus y bacterias en diversos modelos animales. Esta revisi\u00f3n tiene por objetivo presentar un panorama general de las vacunas de ADN y los mecanismos mediante los cuales la inmunizaci\u00f3n con ant\u00edgenos insertados en vectores de ADN (pl\u00e1smidos inducen una respuesta inmunitaria.The effectiveness of vaccines and immunization in the prevention of infectious diseases is one of the greatest successes in medicine. In recent years, with access to cutting edge genomic and proteomic technology, it is possible to accelerate the development of new and improved vaccines with better immunogenicity and safety characteristics. Since the first report almost two decades ago, where it was demonstrated that gene expression is possible by directed injection of naked DNA, DNA vaccines have been proven to induce protective immune responses against parasites, virus and bacterium in diverse animal disease models. This review aims to present an overview about DNA vaccines and the mechanisms by which immune responses are induced after immunization with plasmid DNA-encoded antigens.\n[Evaluaci\u00f3n del impacto de la vacuna contra rotavirus en Colombia usando m\u00e9todos r\u00e1pidos de evaluaci\u00f3n](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892013001000002&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nKarol Cotes\n2013-10-01\nFull Text Available OBJETIVO: Estimar la efectividad de la vacuna monovalente antirrotav\u00edrica para prevenir la hospitalizaci\u00f3n por enfermedad diarreica aguda en ni\u00f1os menores de 2 a\u00f1os en cinco ciudades de Colombia. M\u00c9TODOS: Se realiz\u00f3 una encuesta poblacional sobre una muestra probabil\u00edstica de ni\u00f1os mayores de 2 meses y menores de 24 meses de edad en cinco ciudades de Colombia (Barranquilla, Bogot\u00e1, Cali, Cartagena y Riohacha en el per\u00edodo de agosto a octubre de 2010. La vacuna fue introducida en el Programa Ampliado de Inmunizaciones en enero de 2009. Se estimaron las coberturas de vacunaci\u00f3n contra rotavirus por grupos de edad y la incidencia acumulada de hospitalizaci\u00f3n por diarrea severa, y se evalu\u00f3 la magnitud de la asociaci\u00f3n entre la vacunaci\u00f3n con una o dos dosis de vacuna antirrotav\u00edrica y la hospitalizaci\u00f3n por diarrea, utilizando la raz\u00f3n de probabilidades (RP ajustada por edad y otros factores de importancia epidemiol\u00f3gica. La efectividad de la vacunaci\u00f3n se estim\u00f3 usando la expresi\u00f3n 1 - RP. RESULTADOS: La cobertura de vacunaci\u00f3n con una dosis de vacuna fue de 87,3%. En los 12 meses previos a la encuesta 43,2% (1 453 ni\u00f1os de menores de 24 meses presentaron diarrea, y de ellos, 5,2% (174 ni\u00f1os fueron hospitalizados por esta causa. La efectividad de dos dosis de vacuna antirrotav\u00edrica para prevenir la hospitalizaci\u00f3n por diarrea severa fue de 68% (intervalo de confianza de 95%: 55%-77%. CONCLUSIONES: La vacunaci\u00f3n contra rotavirus en Colombia protege contra la hospitalizaci\u00f3n por diarrea por cualquier causa. El uso de encuestas transversales se mostr\u00f3 adecuado para evaluar r\u00e1pidamente la efectividad de un programa de vacunaci\u00f3n con una nueva vacuna.\n[Reflexiones En Torno A La Adopci\u00f3n De Acuerdos Sociales En La Sociedad An\u00f3nima Cubana. Especial Referencia A Las Empresas Mixtas](http://revistas.uexternado.edu.co/index.php?journal=emerca&page=article&op=view&path%5B%5D=2625) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nNatacha T. Mesa Tejeda\n2010-12-01\nFull Text Available La empresa mixta cubana posee una estructura org\u00e1nica que responde a la estructura tradicional de las sociedades an\u00f3nimas: un \u00f3rgano deliberante y un \u00f3rgano ejecutivo. En el presente art\u00edculo titulado: Reflexiones en torno a la adopci\u00f3n de acuerdos en las empresas mixtas cubanas, se realiza un breve an\u00e1lisis, desde un punto de vista te\u00f3rico doctrinal, de la adopci\u00f3n de acuerdos en la junta de accionistas: \u00f3rgano deliberante; as\u00ed como una valoraci\u00f3n de la regulaci\u00f3n de este particular en la legislaci\u00f3n y en la realidad pr\u00e1ctica cubana. La regulaci\u00f3n del tema en cuesti\u00f3n en la legislaci\u00f3n cubana es insuficiente. Esto trae consigo, una regulaci\u00f3n deficitaria del tema en los estatutos sociales, el robustecimiento de dichos documentos y en ocasiones, falta de correspondencia del contenido de los estatutos con la realidad de nuestras empresas mixtas. Por otro lado se deja sentado en el cuerpo del art\u00edculo como las caracter\u00edsticas que poseen nuestras empresas mixtas inciden directamente en la adopci\u00f3n de acuerdos.\n[Hb Melusine and Hb Athens-Georgia: potentially underreported in the Belgian population? Four cases demonstrating the lack of detection using common CE-HPLC methods either for glycated hemoglobin (HbA1C) analysis or Hb variant screening.](https://www.ncbi.nlm.nih.gov/pubmed/27368113)\nPeeters, Bart; Brandt, Inger; Desmet, Koenraad; Harteveld, Cornelis L; Kieffer, Davy\n2016-12-01\nSuspected hemoglobin (Hb) variants, detected during HbA 1C measurements should be further investigated, determining the extent of the interference with each method. This is the first report of Hb Melusine and Hb Athens-Georgia in Caucasian Belgian patients. Intervention & Technique: Since common CE-HPLC methods for HbA 1C analysis or Hb variant screening are apparently unable to detect these Hb variants, their presence might be underestimated. HbA 1C analysis using CZE, however, alerted for their presence. Moreover, in case of Hb Melusine, even Hb variant screening using CZE was unsuccessful in its detection. Fortunately, carriage of Hb Melusine or Hb Athens-Georgia variants has no clinical implications and, as shown in this report, no apparent difference in HbA 1C should be expected.\n[La evidencia acerca de la controversia de las vacunas que contienen timerosal y su asociaci\u00f3n con el autismo](https://www.openaire.eu/search/publication?articleId=doajarticles::9f083d9cb2b9e06dbceeb1cf2c0fabe3)\nLisset Garc\u00eda-Fern\u00e1ndez; Adri\u00e1n V Hern\u00e1ndez; V\u00edctor Su\u00e1rez Moreno; Fabi\u00e1n Fiestas\n2013-01-01\nLa vacunaci\u00f3n es una de las medidas de mayor impacto en la salud p\u00fablica para la reducci\u00f3n de la morbimortalidad infantil. El timerosal es un compuesto org\u00e1nico del mercurio utilizado como preservante de los frascos multidosis. Eventualmente, en el Per\u00fa, surgen olas de controversia acerca de la seguridad de estas vacunas, asoci\u00e1ndolas especialmente con el autismo. Como resultado de estas controversias, se han propuesto, incluso, leyes que proh\u00edben este tipo de vacunas, lo que tendr\u00eda un impor...\n[CULTURA CUBANA Y MEDIOS DE COMUNICACI\u00d3N EN M\u00c9XICO, 1920-1950](http://revistas.unicartagena.edu.co/index.php/palobra/article/view/73) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRicardo P\u00e9rez Montfort\n2012-08-01\nFull Text Available En este art\u00edculo estudiamos las huellas que la cultura popular cubana, durante la primera mitad del siglo XX, imprimi\u00f3 en la cultura popular mexicana, a trav\u00e9s de los medios de comunicaci\u00f3n; estamos hablando de la prensa, el radio y el cine, en particular. Este proceso muestra c\u00f3mo las caracter\u00edsticas de los estereotipos culturales identificados con lo cubano, resultaron un producto de exportaci\u00f3n que los medios mexicanos supieron aprovechar de maneras muy creativas. Esto puede rastrearse, en particular, en la m\u00fasica y el cine producidos en los a\u00f1os treinta y cuarenta. Los teatros, salones de baile y cabarets fueron otros espacios en los que este imaginario cobr\u00f3 forma. Detr\u00e1s de esto hubo una nutrida migraci\u00f3n de artistas cubanos que contribuyeron a la manufactura de una vertiente de la cultura popular mexicana asociada a lo tropical. La relaci\u00f3n personal entre estos cubanos y cubanas, y sus comparsas mexicanos, as\u00ed como los v\u00ednculos que muchos de los oriundos de la Gran Antilla tuvieron con empresarios del espect\u00e1culo y, productores y directores de cine en M\u00e9xico, fueron pieza clave en esta historia.\n[Estudio de tolerancia local de la vacuna vax-TyVi\u00ae en ratas Sprague Dawley](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2005000100003&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nEligio Sosa Roble\n2005-05-01\nFull Text Available La vacuna antitifo\u00eddica vax-TyVi\u00ae consiste en una preparaci\u00f3n de polisac\u00e1rido capsular Vi de Salmonella typhi, el cual es diluido en una soluci\u00f3n buffer isot\u00f3nica soluci\u00f3n amortiguador, a la que se le a\u00f1ade fenol como preservo. Cada dosis de 0,5 mL contiene 25 \u03bcg de polisac\u00e1rido como sustancia activa. En nuestro pa\u00eds el esquema de vacunaci\u00f3n contra la fiebre tifoidea con vax- TyVi\u00ae se aplica a los alumnos de 9-10 a\u00f1os (5to grado, una 2da dosis a la edad de 12-13 a\u00f1os (8vo grado y una 3ra dosis a la edad de 16-17 a\u00f1os (11no grado. Adem\u00e1s, es vacunado el personal de riesgo de Salud P\u00fablica y el personal que manipula alimentos. En el presente trabajo se describe el ensayo de tolerancia local llevado a cabo con la vacuna vax-TyVi\u00ae durante su fase de estudios precl\u00ednicos, actualmente utilizada en la vacunaci\u00f3n contra la fiebre tifoidea en Cuba. Se emple\u00f3 un total de 170 ratas que fueron tratadas con la vacuna, su placebo (todos los componentes, excepto la materia prima activa, o que no recibieron tratamiento alguno (controles. Se realizaron observaciones cl\u00ednicas diarias durante todo el ensayo, se determin\u00f3 el consumo de agua y alimentos y se realizaron investigaciones anatomopatol\u00f3gicas a animales sacrificados 3, 7, 14, 21, 28, 35 y 42 d\u00edas despu\u00e9s de la inoculaci\u00f3n. No se observaron muertes ni s\u00edntomas de toxicidad; no se encontraron diferencias estad\u00edsticamente significativas entre los pesos vivos, el consumo de agua ni el de alimentos entre los grupos del ensayo. Tampoco se observaron lesiones anatomopatol\u00f3gicas que indicaran toxicidad por parte del producto inoculado. Los resultados permitieron concluir que la potencialidad de la vacuna vax-TyVi\u00ae para producir efectos adversos locales es baja.\n[ESTRUCTURA MOLECULAR Y ANTIG\u00c9NICA DE LA VACUNA](https://revistas.unal.edu.co/index.php/actabiol/article/view/11338) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nV\u00cdCTOR ANDR\u00c9S VANEGAS\n2008-09-01\nFull Text Available La prote\u00edna L1 del Virus del Papiloma Humano (VPH constituye el 80% de la c\u00e1pside viral. Las vacunas profil\u00e1cticas contra el VPH son sintetizadas a partir de la prote\u00edna L1 ensamblada en Part\u00edculas similares al Virus (del ingl\u00e9s VLP, las cuales son altamente inmunog\u00e9nicas generando anticuerpos espec\u00edficos de tipo y en algunos casos pueden presentar reacci\u00f3n cruzada entre tipos de VPH filogen\u00e9ticamente pr\u00f3ximos. La estructura de la prote\u00edna L1 del VPH es importante porque confiere estabilidad a la c\u00e1pside mediante el establecimiento de interacciones intra e intercapsom\u00e9ricas lo que asegura la integridad viral y antig\u00e9nicamente porque contiene los ep\u00edtopes que inducen la respuesta inmune protectora. En estudios en los que se evalu\u00f3 la antigenicidad de la prote\u00edna L1 se determin\u00f3 que los ep\u00edtopes inmunodominantes de la c\u00e1pside viral se encuentran en los bucles B-C, D-E, F-G, H-I y en el extremo C-terminal. Estos bucles son poco conservados entre los diferentes genotipos y se encuentran en segmentos de la prote\u00edna expuestos en la superficie de la c\u00e1pside. Los amino\u00e1cidos situados en los bucles B-C, F-G y H-I son primordiales para el reconocimiento por los anticuerpos neutralizantes. Los diferentes subtipos y variantes presentan cambios en estos amino\u00e1cidos o en residuos que conforman otros ep\u00edtopes. En esta revisi\u00f3n se presentar\u00e1 un estado del arte de la prote\u00edna L1 del VPH genotipo 16, la estructura y su importancia en el desarrollo de vacunas contra la infecci\u00f3n producida por este virus.\n[Vacuna atenuada de Salmonella como vector de ant\u00edgenos heter\u00f3logos](http://www.revistabiomedica.org/index.php/biomedica/article/view/1056) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nOscar G. G\u00f3mez\n2000-06-01\nFull Text Available Salmonella enterica, serotipo Typhi, es el agente etiol\u00f3gico de la fiebre tifoidea de los habitantes de las regiones m\u00e1s pobres del mundo y es, adem\u00e1s. el centro de atenci\u00f3n de muchos investigadores dados sus fascinantes mecanismos de invasi\u00f3n, multiplicaci\u00f3n intracelular y diseminaci\u00f3n intercelular que expresa in vivo e in vitro. Aunque estos mecanismos se asocian directamente con la patogenicidad y la severidad de la enfermedad, las mutaciones definidas en el cromosoma de Salmonella han permitido que estos mecanismos de virulencia se puedan utilizar en beneficio del hospedero. Las mutantes atenuadas de Salmonella son capaces de invadir las c\u00e9lulas M de la mucosa intestinal y de migrar a las c\u00e9lulas linfoides del sistema reticuloendotelial donde, en lugar de causar enfermedad, activan eficazmente las respuestas inmunes humoral y celular no s\u00f3lo contra el microorganismo mismo sino tambi\u00e9n contra aquellos antigenos heter\u00f3logos recombinantes que la bacteria pueda expresar y transportar. En la presente revisi\u00f3n, se discutir\u00e1n los avances m\u00e1s recientes en el campo de las vacunas vivas atenuadas de Salmonella, su evaluaci\u00f3n preclinica y clinica y, tambi\u00e9n, su aplicaci\u00f3n como vector de antigenos. Se dar\u00e1n a conocer las t\u00e9cnicas biomoleculares de clonaci\u00f3n y expresi\u00f3n procari\u00f3tica de las toxinas dift\u00e9rica, tet\u00e1nica y de pertusis. as\u00ed como de los ant\u00edgenos de Helicobacterpylori y de Plasmodium falciparum. Finalmente, se propone el uso de Salmonella atenuada como vector de vacunas de ADN para expresi\u00f3n eucari\u00f3tica de los ant\u00edgenos recombinantes. Los continuos esfuerzos cientificos y tecnol\u00f3gicos en el campo de la vacunaci\u00f3n con vectores vivos atenuados sugieren que Salmonella es una herramienta potencialmente \u00fatil para enfrentar el constante reto de la fiebre tifoidea. Igualmente, los estudios precl\u00ednicos y cl\u00ednicos de fase I demuestran la eficacia de la vacuna de Salmonella viva atenuada como vector de ant\u00edgenos heter\n[Plantas cubanas con efecto antiinflamatorio](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75152015000100015&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAda Ivis Regalado Veloz\nFull Text Available La actividad antiinflamatoria suscita gran inter\u00e9s cient\u00edfico en el \u00e1rea farmacol\u00f3gica, debido a que muchas enfermedades en su evoluci\u00f3n cursan por procesos inflamatorios (artritis reumatoide, ateroesclerosis, c\u00e1ncer, diabetes, gota, asma, dermatitis, trastornos neurodegenerativos y diversas dolencias menores. Las enfermedades inflamatorias constituyen un problema de salud importante, debido a la falta de medicamentos eficaces y seguros para su uso por periodos prolongados. Hoy en d\u00eda se trabaja en la b\u00fasqueda de alternativas de antiinflamatorios m\u00e1s seguros, en el que las plantas medicinales, una de las formas m\u00e1s antiguas de tratamiento, constituyen una elecci\u00f3n a considerar. En este trabajo se realiz\u00f3 una revisi\u00f3n bibliogr\u00e1fica, sobre especies de plantas que crecen en Cuba que le reportan propiedades farmacol\u00f3gicas como antinflamatorios. En la revisi\u00f3n de la literatura se utiliz\u00f3 la base de datos Medline (v\u00eda PubMed, as\u00ed como revistas nacionales desde el periodo de 2000 hasta el presente, con las palabras claves \"inflamaci\u00f3n\" y \"plantas cubanas antiinflamatorias\" o \"actividad antiinflamatoria\" y \"plantas medicinales\".\n[Effect of Hepatitis B Vaccination in Patients with Chronic Hepatitis C](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=45076028) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nKhokhar, N; Niazi, T. K.; Qureshi, M. O.\n2014-01-01\nObjective: To assess the effects of hepatitis B vaccination on the antibody titer in patients with chronic hepatitis C and to compare it with response in normal healthy subjects. Study Design: Interventional study. Place and Duration of Study: Shifa International Hospital, Islamabad, Pakistan, from January 2007 to January 2012. Methodology: Hepatitis vaccination (Heberbiovac-HB 20) was given intramuscularly to the patients of chronic hepatitis C (HCV group) and normal healthy subjects (control group) at 0, 1 and 6 months intervals. Anti-HBs titer was determined after second and third injection to assess the antibody response. Results: There were 46 patients in the HCV group and 45 patients in the control group. Mean age was 40.9 A +- 9.8 years in the HCV group and 33.18 A +- 8.35 years in the control group. Weight was 67.04 A +- 13.5 kg in the HCV group and 71.78 A +- 14.63 kg in the control group. Height was 162.45 A +- 9.06 cm in the HCV group and 167.03 A +- 7.83 cm in the control group. Anti-HBs antibody levels after the second injection were 253.89 A +- 76.76 mlU/mL in the HCV group and 245.81 A +- 72.65 mlU/mL in the control group (p=0.172). After third injection, the antibody levels were slightly higher in both groups. Conclusion: In patients with chronic hepatitis C and normal healthy subjects, Heberbiovac HB in standard dosage gave sero-protective levels in both groups and antibody titers were not significantly different in control and HCV group. (author)\n[Uso de la estreptoquinasa recombinante cubana: Atenci\u00f3n de enfermer\u00eda](https://www.openaire.eu/search/publication?articleId=od_______623::6cb0e6090b3a2b34b24cec7568c14ca8)\nArcia Lumpuy, Sof\u00eda; L\u00f3pez Pedrosa, Gloria L\n1995-01-01\nSe realizan estudios y aplicaci\u00f3n de agentes trombol\u00edticos en las primeras horas de diagnosticado e instalado el infarto, con el objetivo de recuperar la reperfusi\u00f3n coronaria y preservar el m\u00fasculo cardiaco. Se analiza el empleo de la estreptoquinasa recombinante cubana (heberkinasa) en \u00e9sta, que es la cuarta investigaci\u00f3n sobre ella y su aplicaci\u00f3n en los pacientes infartados.\n[Co-inheritance of \u03b10 -thalassemia elevates Hb A2 level in homozygous Hb E: Diagnostic implications.](https://www.ncbi.nlm.nih.gov/pubmed/28497611)\nSingha, K; Srivorakun, H; Fucharoen, G; Fucharoen, S\n2017-10-01\nDifferentiation of homozygous hemoglobin (Hb) E with and without \u03b1 0 -thalassemia is subtle on routine hematological ground. We examined in a large cohort of homozygous Hb E if the level of Hb A 2 is helpful. A total of 592 subjects with homozygous Hb E were recruited from ongoing thalassemia screening program. Additionally, five couples at risk of having fetuses with Hb Bart's hydrops fetalis who were homozygous Hb E were also investigated. Hb analysis was performed using capillary electrophoresis system. Globin genotypes were defined by DNA analysis. Subjects were classified into four groups including pure homozygous Hb E (n=532), homozygous Hb E/\u03b1 0 -thalassemia (n=48), Hb Constant Spring EE Bart's disease (n=8), and Hb EE Bart's disease (n=4). The levels of Hb A 2 were found, respectively, to be 4.97\u00b10.69, 6.64\u00b11.02, 4.86\u00b10.87, and 7.60\u00b11.04%. Among five couples at risk, \u03b1 0 -thalassemia was identified in three subjects with Hb A 2 >6.0%. Increased Hb A 2 level is a useful marker for differentiation of homozygous Hb E with and without \u03b1 0 -thalassemia. This should lead to a significant reduction in number of referral cases of homozygous Hb E for molecular testing of \u03b1 0 -thalassemia in routine practice. \u00a9 2017 John Wiley & Sons Ltd.\n[Evaluaci\u00f3n de los programas de vacunaci\u00f3n mediante estudios serol\u00f3gicos y vacunas distribuidas Evaluation of vaccination programs through serological studies and distributed vaccines](http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0213-91112005000600006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nPedro Plans\n2005-12-01\nFull Text Available Antecedentes: El objetivo del estudio fue comparar las coberturas vacunales en escolares para la vacuna triple v\u00edrica (sarampi\u00f3n-rub\u00e9ola-parotiditis, DTP (difteria-t\u00e9tanos-tos ferina y poliomielitis, obtenidas a partir de las vacunas distribuidas a los centros de vacunaci\u00f3n, las vacunaciones declaradas y el an\u00e1lisis serol\u00f3gico de anticuerpos. M\u00e9todos: La cobertura vacunal se obtuvo a partir de los antecedentes de vacunaci\u00f3n recogidos en un cuestionario y mediante el an\u00e1lisis serol\u00f3gico de anticuerpos frente al sarampi\u00f3n para la vacuna triple v\u00edrica, y el t\u00e9tanos para la vacuna DTP en una muestra representativa de escolares en 2001. La cobertura vacunal por registros se obtuvo dividiendo el n\u00famero de individuos que pod\u00edan haber completado la vacunaci\u00f3n por la poblaci\u00f3n objetivo. Se evalu\u00f3 la concordancia entre los antecedentes de vacunaci\u00f3n y los resultados serol\u00f3gicos mediante el \u00edndice kappa. Resultados: En los escolares de 6-8 y 9-11 a\u00f1os de edad se obtuvo una cobertura vacunal por cuestionario del 85,5 y el 87,6% para la vacuna DTP, del 89,9 y el 89,6% para la vacuna triple v\u00edrica, y del 90,4 y el 89,4% para la vacuna poliomiel\u00edtica, respectivamente, mientras la cobertura vacunal por an\u00e1lisis serol\u00f3gico fue del 100 y el 99,6% para la vacuna DTP, y del 85,5 y el 93,3% para la vacuna triple v\u00edrica, respectivamente. La cobertura vacunal por registros fue significativamente mayor que la obtenida mediante estos 2 m\u00e9todos: un 93,5 y un 100% para la vacuna DTP, un 96,3 y un 98,8% para la vacuna triple v\u00edrica, y un 100% para la vacuna poliomiel\u00edtica. La concordancia obtenida entre los antecedentes de vacunaci\u00f3n y los resultados serol\u00f3gicos fue muy baja (\u03ba Background: The objective of this study was to compare vaccination coverage in schoolchildren for the measles-mumps-rubella (MMR and diphtheria-tetanus-pertussis (DTP triple vaccines, and the poliomyelitis vaccine based on: a vaccines distributed to vaccination\n[Desarrollo de vacunas contra el virus de la inmunodeficiencia humana tipo 1: Relevancia de la inmunidad celular contra subtipos](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802010000600014&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAna Mar\u00eda Rodr\u00edguez\n2010-12-01\nFull Text Available Han pasado casi 30 a\u00f1os de la detecci\u00f3n de los primeros casos de infecci\u00f3n con HIV-1 y a\u00fan no se ha conseguido desarrollar una vacuna efectiva y segura. A pesar del impacto positivo sobre la pandemia que se ha conseguido gracias a los avances en la terapia antirretroviral (TARV, el HIV/sida sigue constituyendo un grave problema para la salud p\u00fablica, especialmente en los pa\u00edses en desarrollo, donde es dif\u00edcil el acceso al tratamiento. En el mundo, 33 millones de personas viven con el virus del sida, mientras que en la Argentina se calcula que habr\u00eda unos 120 000 infectados. Uno de los desaf\u00edos para lograr una vacuna contra el HIV es la variabilidad viral. El grupo M, responsable de la pandemia, se encuentra dividido en 10 subtipos y varios sub-subtipos, adem\u00e1s de las 48 formas recombinantes circulantes y m\u00e1s de cien formas recombinantes \u00fanicas. La epidemia de HIV en nuestro pa\u00eds es tan compleja como en el resto del mundo, con la co-circulaci\u00f3n principalmente de virus pertenecientes al subtipo B y recombinantes BF (CRF12_BF y derivadas. A pesar de la cantidad de trabajos dedicados a la caracterizaci\u00f3n de la respuesta inmune y al desarrollo de vacunas, no queda claro cu\u00e1l es el impacto de la variabilidad en la elecci\u00f3n del ant\u00edgeno. Trabajos realizados en nuestro laboratorio demuestran el papel que juega la inmunidad celular con respecto a las variantes recombinantes BF, tanto en humanos como en modelos animales. Estos resultados son de importancia en el desarrollo de futuras vacunas para nuestra regi\u00f3n.\n[Evaluaci\u00f3n de la toxicidad por dosis \u00fanica de la vacuna antitet\u00e1nica vax-TET en ratas Sprague Dawley](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2007000300004&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nYulie\u00e9 L\u00f3pez.\n2007-12-01\nFull Text Available La vacuna vax-TET\u00ae est\u00e1 indicada en la prevenci\u00f3n del t\u00e9tanos y es efectiva si se logra un completo y apropiado esquema de inmunizaci\u00f3n. Para investigar el potencial t\u00f3xico de este producto se realiz\u00f3 una prueba toxicol\u00f3gica con una dosis \u00fanica, por v\u00eda intramuscular, en un volumen de 0,2 mL en ratas Sprague Dawley. La composici\u00f3n de la vacuna de ensayo probada fue la misma de la vacuna comercial. Los animales fueron observados diariamente en busca de s\u00edntomas locales y sist\u00e9micos de toxicidad. Se realizaron mediciones del consumo de agua y alimento, as\u00ed como del peso corporal. Dos semanas despu\u00e9s de la inoculaci\u00f3n las ratas fueron sacrificadas por m\u00e9todos de eutanasia sin dolor y sometidas a necropsia. No se observaron muertes ni s\u00edntomas de toxicidad en los animales estudiados. Tampoco se encontraron diferencias de inter\u00e9s toxicol\u00f3gico entre los grupos experimentales en cuanto a las variables medidas. El estudio anatomopatol\u00f3gico revel\u00f3 la presencia de formaciones granulomatosas de tipo macrof\u00e1gico asociadas, fundamentalmente, al hidr\u00f3xido de aluminio. Estos resultados permitieron concluir que, bajo las condiciones del estudio y seg\u00fan los criterios establecidos, esta vacuna no produce efectos adversos en el modelo animal usado, por lo que se considera potencialmente no t\u00f3xica para humanos.\n[Diagnosis of a rare double heterozygous Hb D Punjab/Hb Q India hemoglobinopathy using Sebia capillary zone electrophoresis](http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2014;volume=57;issue=4;spage=626;epage=628;aulast=Parab) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSushama Parab\n2014-01-01\nFull Text Available In India, hemoglobinopathies constitute a major genetic disorder and hemoglobin variants such as Hb S, Hb D Punjab, and Hb E are the most common ones. Other variants include Hb Q India, Hb Lepore, Hb J Meerut, Hb D Iran, etc. These variants show heterozygous state along with beta thalassemia. However, compound heterozygosities among these variants are very rare. Ethylenediaminetetraacetic acid whole blood sample received for routine thalassemia screening was subjected to alkaline electrophoresis using automated capillary zone electrophoresis. Suspecting the presence of rare variants, further analysis was carried out using Bio-Rad D10 and Tosoh G8 high-performance liquid chromatography (HPLC systems. Capillary zone electrophoretograms showed the presence of peaks in zone Hb A, Hb D, a fused peak in Hb A2, and a small peak in Z1 zone. Bio-Rad and Tosoh chromatograms also indicated the presence of four peaks which are identified as Hb A, Hb D Punjab, Hb Q India, and hybrid of Hb D Punjab/Hb Q India. A peak in Hb D zone of capillary was due to co-migration of Hb D Punjab and Hb Q India variants. Small peak in Z1 zone indicated the presence of alpha chain variant Hb Q India. The findings were further confirmed by HPLC results and molecular genetic studies. The present study reports for the 1 st time a rare hemoglobinopathy of double heterozygosity for Hb D Punjab, Hb Q India on Capillarys 2 Flex Piercing analyzer and is forth reported case for this rare hemoglobinopathy.\n[Detection of Co-inheritance of Hb Hope and Hb Constant Spring in Three Thai Samples by Capillary Electrophoresis.](https://www.ncbi.nlm.nih.gov/pubmed/27408410)\nPanyasai, Sitthichai; Pornprasert, Sakorn\n2016-06-01\nThe diagnosis of co-inheritance of Hb Hope [\u03b2136(H14)Gly \u2192 Asp, GGT > GAT] and Hb constant spring [Hb CS; \u03b1142, Term \u2192 Gln (TAA > CAA IN \u03b12)] by high performance liquid chromatography (HPLC) is difficult because Hb Hope has a HPLC elution pattern similar to that of Hb Pyrgos, Hb New York, Hb Kodaira, and Hb Phimai. Moreover, the Hb CS mRNA, as well as the gene product, are unstable and present at a low level in peripheral blood. We report the use of a capillary electrophoresis (CE) for diagnosis of co-inheritance of Hb Hope and Hb CS in 3 Thai females who had mild anemia with Hb and Hct varying from 91-114 g/L to 0.28-0.36 L/L, respectively. Hb Hope eluted with a retention time of 125-140 s (Zone 10) of CE electrophoregram. Furthermore, the peak of Hb CS at the retention time of 245-250 s (Zone 2) was observed in these samples. In addition, the manual analysis by taking the non-black area under both peaks of HbA and Hb Hope (inverted V) into account provided the corrected Hb CS levels which are useful in screening of heterozygote or homozygote for Hb CS. Thus, the CE method provides an accurate diagnosis of Hb Hope and Hb CS which is useful in genetic counseling, prevention and control programs for these hemoglobinopathies.\n[La influencia del marxismo en el pensamiento y los debates de la campa\u00f1a por la escuela cubana en Cuba Libre en 1941](https://www.openaire.eu/search/publication?articleId=issn07193092::9380935891261c89d8ba9bef474961c5)\nAlgramonte Rosell, Regina de la Caridad\n2014-01-01\nResumen: El presente trabajo es resultado de una investigaci\u00f3n sobre un hecho de importancia trascendental en la Cuba de 1941: la campa\u00f1a Por la escuela cubana en Cuba Libre, luego de las sesiones de debate de la Asamblea Constituyente de 1940. Se determin\u00f3 como objetivo central analizar el lugar del marxismo en la atm\u00f3sfera intelectual-cultural cubana en los a\u00f1os 40, para lo cual result\u00f3 necesario un acercamiento a los principales debates sobre la educaci\u00f3n propiciados por el Partido Comunis...\n[Measurement of HbA1c and HbA2 by Capillarys 2 Flex Piercing HbA1c programme for simultaneous management of diabetes and screening for thalassemia.](https://www.ncbi.nlm.nih.gov/pubmed/28900367)\nKe, Peifeng; Liu, Jiawei; Chao, Yan; Wu, Xiaobin; Xiong, Yujuan; Lin, Li; Wan, Zemin; Wu, Xinzhong; Xu, Jianhua; Zhuang, Junhua; Huang, Xianzhang\n2017-10-01\nThalassemia could interfere with some assays for haemoglobin A 1c (HbA 1c ) measurement, therefore, it is useful to be able to screen for thalassemia while measuring HbA 1c . We used Capillarys 2 Flex Piercing (Capillarys 2FP) HbA 1c programme to simultaneously measure HbA 1c and screen for thalassemia. Samples from 498 normal controls and 175 thalassemia patients were analysed by Capillarys 2FP HbA 1c programme (Sebia, France). For method comparison, HbA 1c was quantified by Premier Hb9210 (Trinity Biotech, Ireland) in 98 thalassaemia patients samples. For verification, HbA 1c from eight thalassaemia patients was confirmed by IFCC reference method. Among 98 thalassaemia samples, Capillarys 2FP did not provide an HbA 1c result in three samples with HbH due to the overlapping of HbBart's with HbA 1c fraction; for the remaining 95 thalassaemia samples, Bland-Altman plot showed 0.00 \u00b1 0.35% absolute bias between two systems, and a significant positive bias above 7% was observed only in two HbH samples. The HbA 1c values obtained by Capillarys 2FP were consistent with the IFCC targets (relative bias below \u00b1 6%) in all of the eight samples tested by both methods. For screening samples with alpha (\u03b1-) thalassaemia silent/trait or beta (\u03b2-) thalassemia trait, the optimal HbA 2 cut-off values were \u2264 2.2% and > 2.8%, respectively. Our results demonstrated the Capillarys 2FP HbA 1c system could report an accurate HbA 1c value in thalassemia silent/trait, and HbA 2 value (\u2264 2.2% for \u03b1-thalassaemia silent/trait and > 2.8% for \u03b2-thalassemia trait) and abnormal bands (HbH and/or HbBart's for HbH disease, HbF for \u03b2-thalassemia) may provide valuable information for screening.\n[Probing the diphosphoglycerate binding pocket of HbA and HbPresbyterian (beta 108Asn --> Lys).](https://www.ncbi.nlm.nih.gov/pubmed/10471280)\nGottfried, D S; Manjula, B N; Malavalli, A; Acharya, A S; Friedman, J M\n1999-08-31\nHbPresbyterian (beta 108Asn --> Lys, HbP) contains an additional positive charge (per alpha beta dimer) in the middle of the central cavity and exhibits a lower oxygen affinity than wild-type HbA in the presence of chloride. However, very little is known about the molecular origins of its altered functional properties. In this study, we have focused on the beta beta cleft of the Hb tetramer. Recently, we developed an approach for quantifying the ligand binding affinity to the beta-end of the Hb central cavity using fluorescent analogues of the natural allosteric effector 2, 3-diphosphoglycerate (DPG) [Gottfried, D. S., et al. (1997) J. Biol. Chem. 272, 1571-1578]. Time-correlated single-photon counting fluorescence lifetime studies were used to assess the binding of pyrenetetrasulfonate to both HbA and HbP in the deoxy and CO ligation states under acidic and neutral pH conditions. Both the native and mutant proteins bind the probe at a weak binding site and a strong binding site; in all cases, the binding to HbP was stronger than to HbA. The most striking finding was that for HbA the binding affinity varies as follows: deoxy (pH 6.35) > deoxy (pH 7.20) > CO (pH 6.35); however, the binding to HbP is independent of ligation or pH. The mutant oxy protein also hydrolyzes p-nitrophenyl acetate, through a reversible acyl-imidazole pathway linked to the His residues of the beta beta cleft, at a considerably higher rate than does HbA. This implies a perturbation of the microenvironment of these residues at the DPG binding pocket. Structural consequences due to the presence of the new positive charge in the middle of the central cavity have been transmitted to the beta beta cleft of the protein, even in its liganded conformation. This is consistent with a newly described quaternary state (B) for liganded HbPresbyterian and an associated change in the allosteric control mechanism.\n[A pol\u00edtica externa cubana nos anos 90: condicionantes internos e inser\u00e7\u00e3o internacional](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-44782014000100006&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMarcos Antonio da Silva\n2014-03-01\nFull Text Available O presente trabalho analisa a pol\u00edtica externa cubana nos anos 90, depois do colapso do bloco sovi\u00e9tico, que conduziu o pa\u00eds a mais grave crise econ\u00f4mica de sua hist\u00f3ria recente e a um relativo isolamento internacional, elementos que foram determinantes para sua reinser\u00e7\u00e3o internacional. A partir disto aponta que sua reinser\u00e7\u00e3o internacional se fundamenta na afirma\u00e7\u00e3o da soberania nacional, na amplia\u00e7\u00e3o dos atores envolvidos na formula\u00e7\u00e3o e execu\u00e7\u00e3o de tal pol\u00edtica, na busca de novos parceiros que conduziu a uma inser\u00e7\u00e3o pendular no cen\u00e1rio internacional e no desenvolvimento da diplomacia social. A pesquisa foi realizada atrav\u00e9s de levantamento e an\u00e1lise bibliogr\u00e1fica, bem como de dados indicativos da situa\u00e7\u00e3o econ\u00f4mica do pa\u00eds e de sua inser\u00e7\u00e3o internacional, combinando elementos de an\u00e1lise quantitaviva com a qualitativa. A hip\u00f3tese inicial fundamenta-se na reorienta\u00e7\u00e3o da pol\u00edtica externa cubana, com o fim do bloco sovi\u00e9tico, e na sua reinser\u00e7\u00e3o, embora tensa, no cen\u00e1rio internacional determinadas pela crise interna e pelo novo contexto internacional. O levantamento de dados foi poss\u00edvel atrav\u00e9s de pesquisas in loco e em portais e publica\u00e7\u00f5es de organismos como a CEPAL (Comiss\u00e3o Econ\u00f4mica para a Am\u00e9rica Latina e ONEI (Oficina Nacional de Estadistica y Informaciones, assim como de autores dedicados ao tema. Atrav\u00e9s de an\u00e1lise cr\u00edtica e comparativa de tais dados e informa\u00e7\u00f5es estabelece as vari\u00e1veis fundamentais e os elementos que permitem a compreens\u00e3o da pol\u00edtica externa cubana no per\u00edodo mencionado. Tal trabalho demonstra que a pol\u00edtica externa cubana foi resultado da intera\u00e7\u00e3o entre os fatores dom\u00e9sticos, a crise econ\u00f4mica e social que o pa\u00eds enfrentou, e de fatores internacionais. Al\u00e9m disto, aponta que ocorreu uma reorienta\u00e7\u00e3o da pol\u00edtica externa cubana com o desenvolvimento de novas estrat\u00e9gias e parcerias para sua reinser\u00e7\u00e3o internacional. Finalmente, demonstra que tal\n[Dietary determinants for Hb-acrylamide and Hb-glycidamide adducts in Danish non-smoking women](https://pure.au.dk/ws/files/36381690/Dietary_determinants_for_Hb_acrylamide_and_Hb_glycidamide_adducts_in_Danish_non_smoking_women.pdf) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nOutzen, Malene; Egeberg, Rikke; Dragsted, Lars\n2011-01-01\nin erythrocytes were analysed by liquid chromatography/MS/MS. Dietary determinants were evaluated by multiple linear regression analyses adjusted for age and smoking behaviour among ex-smokers. The median for Hb-AA was 35 pmol/g globin (5th percentile 17, 95th percentile 89) and for Hb-GA 21 pmol/g globin (5th......Acrylamide (AA) is a probable human carcinogen that is formed in heat-treated carbohydrate-rich foods. The validity of FFQ to assess AA exposure has been questioned. The aim of the present cross-sectional study was to investigate dietary determinants of Hb-AA and Hb-glycidamide (GA) adducts....... The study included 537 non-smoking women aged 50\u201365 years who participated in the Diet, Cancer and Health cohort (1993\u201397). At study baseline, blood samples and information on dietary and lifestyle variables obtained from self-administered questionnaires were collected. From blood samples, Hb-AA and Hb-GA...\n[A Novel Double Heterozygous Hb D-Punjab/Hb J-Meerut Hemoglobinopathy.](https://www.ncbi.nlm.nih.gov/pubmed/29075078)\nChandra, Dinesh; Tyagi, Seema; Deka, Roopam; Chauhan, Richa; Seth, Tulika; Saxena, Renu; Pati, H P\n2017-12-01\nA comprehensive laboratory diagnosis of hemoglobinopathies forms an integral part in workup of disorders of globin chain synthesis. Clinical findings, complete blood counts, peripheral smear examination along with hemoglobin (Hb) electrophoresis and/or cation exchange high performance liquid chromatography findings and parental study helps to clinch a final diagnosis. Compound heterozygous hemoglobinopathy presents with variable clinical findings and some of them are picked up on screening tests done as part of routine antenatal workup. Here we report a rare double heterozygous hemoglobinopathy of Hb D-Punjab and Hb J-Meerut in a 35 year antenatal female.\n[Presencia de las ge\u00f3logas en revistas cient\u00edficas cubanas a partir del estudio de su producci\u00f3n cient\u00edfica](https://www.openaire.eu/search/publication?articleId=od______3056::82b64147f5ee52a084b87646ddedd8d4)\nFigueredo Figueredo, M.Sc Ana Luisa; Corona Rodr\u00edguez, M.Sc Aliana; Figueredo Matos, Lic. Maritza de la Caridad\n2017-01-01\nEn la investigaci\u00f3n se muestran los resultados de un estudio realizado sobre la presencia de las ge\u00f3logas en las revistas cient\u00edficas cubanas durante el per\u00edodo 1968 hasta abril de 2016, a partir de un an\u00e1lisis de su producci\u00f3n cient\u00edfica relacionada con la Geolog\u00eda. Se tomaron los datos del Registro Nacional de Publicaciones Seriadas de Cuba, seleccionando las revistas cient\u00edficas cubanas cuyas l\u00edneas de investigaci\u00f3n guardan relaci\u00f3n con esta ciencia. Se identificaron las ge\u00f3logas a partir ...\n[Reflexiones En Torno A La Adopci\u00f3n De Acuerdos Sociales En La Sociedad An\u00f3nima Cubana. Especial Referencia A Las Empresas Mixtas](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::75a9e32286355fccc441602108255ca3)\nNatacha T. Mesa Tejeda\n2010-01-01\nLa empresa mixta cubana posee una estructura org\u00e1nica que responde a la estructura tradicional de las sociedades an\u00f3nimas: un \u00f3rgano deliberante y un \u00f3rgano ejecutivo. En el presente art\u00edculo titulado: Reflexiones en torno a la adopci\u00f3n de acuerdos en las empresas mixtas cubanas, se realiza un breve an\u00e1lisis, desde un punto de vista te\u00f3rico doctrinal, de la adopci\u00f3n de acuerdos en la junta de accionistas: \u00f3rgano deliberante; as\u00ed como una valoraci\u00f3n de la regulaci\u00f3n de este particular en la le...\n[Influenza. Vacunas cl\u00e1sicas y novedosas a las puertas de otra pandemia](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200005&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRaiza Mart\u00ednez\n2006-08-01\nFull Text Available Los virus de la influenza A, adem\u00e1s del hombre, infectan otros mam\u00edferos y una gran variedad de especies de aves. Desde 1997 se sabe que cepas aviares son capaces de infectar al hombre provocando una enfermedad generalmente leve. El brote actual de gripe aviar H5N1 en humanos ha puesto en alerta a la comunidad cient\u00edfica internacional, no solo por su elevada mortalidad sino por su potencialidad en la generaci\u00f3n de una nueva pandemia. Las autoridades sanitarias han puesto en marcha un amplio programa para la preparaci\u00f3n ante esta contingencia, que abarca diferentes campos, desde el diagn\u00f3stico y la detecci\u00f3n precoz de los brotes tanto en animales como en humanos, la caracterizaci\u00f3n sistem\u00e1tica de las cepas circulantes, el sacrificio de aves infectadas, la producci\u00f3n masiva de antivirales y por supuesto el desarrollo y producci\u00f3n a gran escala de vacunas eficaces. En este \u00faltimo tema se trabaja intensamente tanto en el mejoramiento de las vacunas ya existentes como en la b\u00fasqueda de alternativas basadas en tecnolog\u00edas de nueva generaci\u00f3n.\n[INTRODUCCI\u00d3N DE NUEVAS VACUNAS: PROCESOS POL\u00cdTICOS, ADMINISTRATIVOS Y FINANCIEROS EN LA TOMA DE DECISIONES DEL PAI-BRASIL](http://revistamedicina.net/ojsanm/index.php/Revistamedicina/article/view/92) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nCarla Magda A.S. Domingues\n2012-07-01\nFull Text Available Se presentan los antecedentes del PAI en el Brasil remont\u00e1ndose al a\u00f1o de 1804 en que se inicia el programa de vacunaci\u00f3n en Brasil aplicando la vacuna contra la viruela hasta llegar a 1973 cuando se crea el Programa Nacional de Inmunizaciones en Brasil, y a partir de ah\u00ed se mantiene un esquema b\u00e1sico de vacunaci\u00f3n hasta llegar al 2012 cuando se introducen las vacunas VIP y pentavalentes. Muestra las alteraciones sufridas en el Calendario de Vacunaci\u00f3n del 2012, para llegar a la reformulaci\u00f3n de un Nuevo Calendario de Vacunaci\u00f3n a partir del 2012. Se\u00f1ala las estrategias nacionales de vacunaci\u00f3n enmarcadas en acciones de rutina, campa\u00f1as y control de brotes. Hace referencia a los criterios de inclusi\u00f3n de nuevas vacunas referidos a aspectos: epidemiol\u00f3gicos, inmunol\u00f3gicos, tecnol\u00f3gicos, log\u00edstica, socio-econ\u00f3micos, aprobaci\u00f3n por los Comit\u00e9s y presupuesto. Registra las novedades ocurridas en el Sistema de Informaciones del Programa Nacional de Inmunizaciones, relacionadas con la situaci\u00f3n actual, propuesta y Resoluci\u00f3n Ministerial. Por \u00faltimo se\u00f1ala los desaf\u00edos que debe enfrentar el Sistema enmarcados principalmente en la capacidad para mantener altas coberturas de vacunaci\u00f3n.\n[Quantitative Trait Loci Influencing Hb F Levels in Southern Thai Hb E (HBB: c.79G>A) Heterozygotes.](https://www.ncbi.nlm.nih.gov/pubmed/29457528)\nKesornsit, Aumpika; Jeenduang, Nutjaree; Horpet, Dararat; Plyduang, Thunyaluk; Nuinoon, Manit\n2018-01-01\nVariation of fetal hemoglobin (Hb F) expression in heterozygous Hb E (HBB: c.79G>A) individuals is associated with several genetic modifiers and not well understood. This study was undertaken in order to determine the effect of single nucleotide polymorphisms (SNPs), including XmnI G \u03b3 (rs7482144), rs766432 on the BCL11A gene and rs9376074 on the HBS1L gene, on Hb F levels in Southern Thai heterozygous Hb E individuals. A total of 97 Southern Thai subjects carrying heterozygous Hb E were selected for the hematological study. After excluding the samples with \u03b1-thalassemia (\u03b1-thal) interaction or moderate anemia, because both conditions can affect the hematological parameters, the remaining 74 samples were submitted to SNP analysis. Hematological parameters were measured using an automated hematology analyzer and high performance liquid chromatography (HPLC). The results show that rs766432 was strongly associated with increased Hb F levels and rs7482144 was associated with Hb F levels in each subgroup (genotype) of rs766432. This study suggested that the BCL11A locus has a major effect on Hb F levels compared with the XmnI polymorphism in Hb E heterozygotes. This association of Hb F levels with SNPs is useful for the interpretation of hemoglobin (Hb) typing in heterozygous Hb E samples with high Hb F levels. Future research will need to address the better understanding of the mechanisms of the SNPs that regulate Hb F production without stress erythropoiesis in Hb E heterozygotes.\n[Un caso de osteocondritis costal t\u00edfica tratado con vacunas y antivirus](https://www.openaire.eu/search/publication?articleId=od______1326::8fd162326a4cf806bef07884700a3945)\nLleras Acosta, F.; Rueda H., Alfonso\n2011-01-01\nPor considerala de importancia pr\u00e1ctica, presentamos la historiacl\u00ednica de una enferma afectada de osteocondritis costal de origen Eberthiano, tratada con \u00e9xito completo por las autovacunas y antivirus, Debemos esta interesante observaci\u00f3n al Dr. Juan N. Carpas y al interno de su servicio de mujeres, Sr. Azuero, quienes galantemente nos suministraron los datos cl\u00ednicos y las observaciones relativas a los efectos producidos por las vacunas.\n[VIGILANCIA DE LA GRIPE PAND\u00c9MICA EN LA COMUNIDAD VALENCIANA Y VACUNA ANTIGRIPAL ESTACIONAL](http://www.redalyc.org/articulo.oa?id=17015304012) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRosa Mar\u00eda Carb\u00f3 Malonda\n2010-01-01\nFull Text Available Fundamento: En la Comunidad Valenciana se ha llevado a cabo la vigilancia de la Gripe pand\u00e9mica. Algunos estudios sobre efectividad de la vacuna estacional para Gripe AnH1N1 han presentado resultados no consistentes. El objetivo del trabajo es describir los resultados de la vigilancia epidemiol\u00f3gica y la efectividad de la vacuna estacional para Gripe pand\u00e9mica en las semanas 28 a 51 de 2009. M\u00e9todos: Se estudiaron los casos en atenci\u00f3n primaria, hospitalizados confirmados, aislamientos virales y prote\u00edna C reactiva (PCR y coberturas vacunales. Se calcul\u00f3 la efectividad vacunal por el m\u00e9todo de screening de Farrington, en tres grupos de edad y dos periodos: vacunados de las temporadas 2008-9 y 2009-10. Resultados: En el primer periodo (semanas 28 a 40 los casos se concentraron en el grupo de 15 a 64 a\u00f1os (7.207 casos, seguido de los menores de 15 a\u00f1os (1.596 casos. En el segundo periodo (semanas 45 a 47 afect\u00f3 m\u00e1s a menores de 15 a\u00f1os (28.218 casos. En ambos periodos las tasas de incidencia en mayores de 65 a\u00f1os fue de 56,3 y 125,1 respectivamente. En el periodo estudiado (semanas 28 a 51 se confirmaron 5.481 casos de los que 1.746 (31,8% fueron hospitalizados. La curva de personas hospitalizadas presentaba un perfil similar al de atenci\u00f3n primaria, y tambi\u00e9n el seguimiento microbiol\u00f3gico del virus. La efectividad vacunal en el segundo periodo fue del 25% en adultos entre 15 y 64 a\u00f1os y del 51% en mayores de 64 a\u00f1os. Conclusiones: Se observ\u00f3 una protecci\u00f3n edad dependiente con efectividad vacunal positiva en los mayores de 64 a\u00f1os, aunque puede estar confundida por exposici\u00f3n natural al virus, vacunas previas y o respuesta inmunitaria.\n[Obtenci\u00f3n y evaluaci\u00f3n preliminar de un virus canarypox recombinante como candidato a vacuna antirr\u00e1bica Development and preliminary assessment of a recombinant canarypox virus as an antirabic vaccine candidate](https://www.openaire.eu/search/publication?articleId=doajarticles::0f1a7e9d964b5b4dd7e2026d0f5f7623)\nFlavia Zanetti; Liliana Rudak; Mat\u00edas Micucci; Daniela Conte Grand; Andrea Luque; Susana Russo; Oscar Taboga; Oscar P\u00e9rez; Gabriela Calamante\n2012-01-01\nEn la Argentina, la rabia est\u00e1 circunscripta a algunas provincias del norte. La disponibilidad de nuevas vacunas que eliminen la manipulaci\u00f3n del virus r\u00e1bico y que permitan el control de la enfermedad es de importancia estrat\u00e9gica nacional y regional. Las vacunas basadas en poxvirus recombinantes se han utilizado con \u00e9xito como vacunas antirr\u00e1bicas a nivel mundial. SI bien estos sistemas no est\u00e1n disponibles comercialmente, la plataforma de obtenci\u00f3n de virus canarypox (CNPV) recombinantes y...\n[Hemoglobin Constant Spring (Hb CS) Missed by HPLC in an Hb E Trait Pregnancy Resulting in Hb H-CS Disease in a Thai Girl: Utility of Capillary Electrophoresis.](https://www.ncbi.nlm.nih.gov/pubmed/27408407)\nPornprasert, Sakorn; Saoboontan, Supansa; Wiengkum, Thanatcha\n2016-06-01\nHemoglobin Constant Spring [Hb CS; \u03b1142, Term\u2192Gln (TAA>CAA IN \u03b12)] is often missed by routine laboratory testing, especially in subjects with co-inheritance of \u03b2-thalassemia or \u03b2-variants. We reported the case of a 1-year-old female with Hb H-CS disease who was born from a father with heterozygous of \u03b1-thalassemia-1 Southeast Asian type deletion and a mother with the combination of Hb CS and Hb E [\u03b226 (B8) Glu\u2192Lys, GAG>AAG] trait. A very tiny peak of Hb CS of the mother was easily ignored on the high performance liquid chromatography chromatogram while it was clearly seen on the capillary electrophoresis (CE) electrophoregram. Therefore, the CE is useful in screening for heterozygous Hb CS in a person with Hb E trait. This is of potential benefit for prevention of new cases of Hb H-CS disease.\n[Aproximaci\u00f3n al uso de hongos entomopat\u00f3genos y vacunas para el control sostenible de garrapatas en sistemas ganaderos: revisi\u00f3n](http://www.redalyc.org/articulo.oa?id=83743886006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAna Carolina Moncada Gonz\u00e1lez\n2015-01-01\nFull Text Available La resistencia desarrollada por las garrapatas frente a los acaricidas de s\u00edntesis, hace necesario replantear las estrategias utilizadas actualmen - te para su control. Los programas de manejo integrado de par\u00e1sitos se presentan como una alternativa que, al promover estrategias de con - trol basadas en la ecolog\u00eda y la epidemiolog\u00eda de cada especie de par\u00e1sito, reducen el riesgo de desarrollo de resistencia. Dichas estrategias incluyen la aplicaci\u00f3n de vacunas antigarrapata y hongos entomopat\u00f3genos que afectan la viabi - lidad y la reproducci\u00f3n en las garrapatas. Sin embargo, la informaci\u00f3n obtenida entre estudios sobre hongos y vacunas ha sido inconsistente, por lo que hoy en d\u00eda ambas representan \u00e1reas de investigaci\u00f3n bastante activas. El prop\u00f3sito de este trabajo consisti\u00f3 en realizar una revisi\u00f3n descriptiva sobre los mecanismos de acci\u00f3n de la vacuna antigarrapata y los hongos entomopat\u00f3genos, en la b\u00fasqueda de una po - sible complementariedad que permita el dise\u00f1o de planes de aplicaci\u00f3n conjunta, con miras a mejorar los resultados de control en sistemas ganaderos. En la primera parte del documento se revisa la actual problem\u00e1tica asociada al uso y abuso de los acaricidas de s\u00edntesis, haciendo un \u00e9nfasis particular en el tema de resistencia; posteriormente, se describen los mecanismos de acci\u00f3n de hongos y vacunas que afectan la re - producci\u00f3n y supervivencia en garrapatas, y se incluye informaci\u00f3n relevante sobre su eficacia. Se espera que la informaci\u00f3n aqu\u00ed recolectada, sirva como base para elaborar estudios que permitan identificar la utilidad de los hongos entomopat\u00f3genos y las vacunas antigarrapata al interior de los programas de manejo integrado de par\u00e1sitos en ganader\u00eda.\n[The super sickling haemoglobin HbS-Oman: a study of red cell sickling, K+ permeability and associations with disease severity in patients heterozygous for HbA and HbS-Oman (HbA/S-Oman genotype).](https://www.ncbi.nlm.nih.gov/pubmed/28699687)\nAl Balushi, Halima W M; Wali, Yasser; Al Awadi, Maha; Al-Subhi, Taimoora; Rees, David C; Brewin, John N; Hannemann, Anke; Gibson, John S\n2017-10-01\nStudying different sickle cell genotypes may throw light on the pathogenesis of sickle cell disease (SCD). Here, the clinical profile, red cell sickling and K + permeability in 29 SCD patients (15 patients with severe disease and 14 with a milder form) of HbA/S-Oman genotype were analysed. The super sickling nature of this Hb variant was confirmed. The red cell membrane permeability to K + was markedly abnormal with elevated activities of P sickle , Gardos channel and KCl cotransporter (KCC). Results were consistent with Ca 2+ entry and Mg 2+ loss via P sickle stimulating Gardos channel and KCC activities. The abnormal red cell behaviour was similar to that in the commonest genotype of SCD, HbSS, in which the level of mutated Hb is considerably higher. Although activities of all three K + transporters also correlated with the level of HbS-Oman, there was no association between transport phenotype and disease severity. The super sickling behaviour of HbS-Oman may obviate the need for solute loss and red cell dehydration to encourage Hb polymerisation, required in other SCD genotypes. Disease severity was reduced by concurrent \u03b1 thalassaemia, as observed in other SCD genotypes, and represents an obvious genetic marker for prognostic tests of severity in young SCD patients of the HbA/S-Oman genotype. \u00a9 2017 John Wiley & Sons Ltd.\n[Incidence of hemoglobinopathies and thalassemias in Northern Alberta. Establishment of reference intervals for HbF and HbA2.](https://www.ncbi.nlm.nih.gov/pubmed/25869492)\nRodriguez-Capote, Karina; Higgins, Trefor N\n2015-07-01\nThe aims of this study were to identify the incidence of hemoglobinopathies and thalassemias in Northern Alberta and calculate the reference intervals (RI) for hemoglobin (Hb) HbF and HbA2. A retrospective ad-hoc analysis of the structural Hb variants and thalassemias identified on patients who had a hemoglobinopathy/thalassemia investigation performed between February 1 to December 31, 2013. Results were extracted from the Laboratory Information System. Statistical analysis was performed using MedCalc\u00ae version 11.4.2.0 for Windows software. 6616 hemoglobinopathy/thalassemia investigations and HbS screens were physician requested and 602 Hb variants were fortuitously found during HbA1c analysis. 3438 were interpreted as \"normal\" and 532 were classified as iron deficient. 3306 individuals, with age ranging from 3 to 92 years were included in the RI calculation. HbA2 RI was 2.3% to 3.4% and HbF 0.0% to 1.8%. 524 and 423 \u03b1 and \u03b2 thalassemia traits respectively were identified. Additionally ten \u03b4\u03b2 thalassemia traits and twelve cases of HbH disease were identified. Regarding hemoglobinopathies, 7% were classified as \u03b1-chain variants and 93% as \u03b2-chain variants with HbS (46%), HbE (16%), HbD Punjab (8%) and HbC (7%) traits being the most prevalent. We also documented 20 homozygous hemoglobinopathies and 36 compound/double heterozygous hemoglobinopathies. A wide diversity of hemoglobinopathies is found in the Northern Alberta population, 80% of the hemoglobinopathies were found as a reflex to HbA1c testing. Reference intervals for HbF and HbA2 were established. Copyright \u00a9 2015 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.\n[Un caso de Osteocondritis costal t\u00edfica tratado con vacunas y antivirus](https://revistas.unal.edu.co/index.php/revfacmed/article/view/22140) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nF. Lleras Acosta\n1932-05-01\nFull Text Available Por considerala de importancia pr\u00e1ctica, presentamos la historia cl\u00ednica de una enferma afectada de osteocondritis costal de origen Eberthiano, tratada con \u00e9xito completo por las autovacunas y antivirus, Debemos esta interesante observaci\u00f3n al Dr. Juan N. Carpas y al interno de su servicio de mujeres, Sr. Azuero, quienes galantemente nos suministraron los datos cl\u00ednicos y las observaciones relativas a los efectos producidos por las vacunas.\n[Detection of compound heterozygous of hb constant spring and hb q-Thailand by capillary electrophoresis and high performance liquid chromatography.](https://www.ncbi.nlm.nih.gov/pubmed/25825563)\nPornprasert, Sakorn; Punyamung, Manoo\n2015-06-01\nA capillary electrophoresis (CE) has proven to be superior to a high performance liquid chromatography (HPLC) in the detection of hemoglobin Constant Spring (Hb CS). Thus the aim of this study was to analyze the efficacy of CE and HPLC for the detection of Hb CS in samples with compound heterozygous of Hb CS and Hb Q-Thailand. Hemoglobin analysis was performed in blood samples of 2 patients with compound heterozygous of Hb CS and Hb Q-Thailand by using HPLC and CE. The HPLC chromatogram and CE electrophoregram of the two techniques were compared. Hb CS was not found on HPLC chromatogram while Hb QA2 (\u03b12 (QT)\u03b42), a derivative of Hb Q-Thailand, was presented at the retention time of 4.70-4.80 min and it was close to the retention time of Hb CS. On CE electrophoregram, Hb CS was presented at zone 2 (Z2) and it was distinctly separated from Hb QA2 which was presented at Z1. Therefore, CE was more efficient to the HPLC for diagnosis of compound heterozygous of Hb CS and Hb Q-Thailand.\n[HB Puerta del Sol [HBA1:c.148A>C], HB Valdecilla [HBA2:c.3G>T], HB Gran V\u00eda [HBA2:c.98T>G], HB Macarena [HBA2:c.358C>T] and HB El Retiro [HBA2:c.364_366dupGTG]: description of five new hemoglobinopathies.](https://www.ncbi.nlm.nih.gov/pubmed/26485748)\nde la Fuente-Gonzalo, F\u00e9lix; Nieto, Jorge M; Velasco, Diego; Cela, Elena; P\u00e9rez, Germ\u00e1n; Fern\u00e1ndez-Teijeiro, Ana; Escudero, Antonio; Villegas, Ana; Gonz\u00e1lez-Fern\u00e1ndez, Fernando A; Ropero, Paloma\n2016-04-01\nStructural hemoglobinopathies do not usually have a clinical impact, but they can interfere with the analytical determination of some parameters, such as the glycated hemoglobin in diabetic patients. Thalassemias represent a serious health problem in areas where their incidence is high. The defects in the post-translational modifications produce hyper-unstable hemoglobin that is not detected by most of electrophoretic or chromatographic methods that are available so far. We studied seven patients who belong to six unrelated families. The first two families were studied because they had peak abnormal hemoglobin (Hb) during routine analytical assays. The other four families were studied because they had microcytosis and hypochromia with normal HbA2 and HbF without iron deficiency. HbA2 and F quantification and abnormal Hb separation were performed by chromatographic and electrophoretic methods. The molecular characterization was performed using specific sequencing. The Hb Puerta del Sol presents electrophoretic mobility and elution in HPLC that is different from HbA and similar to HbS. The electrophoretic and chromatographic profiles of the four other variants are normal and do not show any anomalies, and their identification was only possible with sequencing. Some variants, such as Hb Valdecilla, Hb Gran V\u00eda, Hb Macarena and Hb El Retiro, have significant clinical impact when they are associated with other forms of \u03b1-thalassemia, which could lead to more serious forms of this group of pathologies as for HbH disease. Therefore, it is important to maintain an adequate program for screening these diseases in countries where the prevalence is high to prevent the occurrence of severe forms.\n[Iron deficiency anemia interfering the diagnosis of compound heterozygosity for Hb constant spring and Hb Paks\u00e9: The first case report.](https://www.ncbi.nlm.nih.gov/pubmed/28244614)\nChiasakul, Thita; Uaprasert, Noppacharn\n2018-01-01\nDiagnosis of thalassemia or hemoglobinopathy concomitant with iron deficiency anemia (IDA) is challenging. We report a case of 43-year-old female whose diagnosis of compound heterozygosity for hemoglobin Constant Spring (HbCS) and Hb Paks\u00e9 became apparent after the treatment of IDA. Prior to treatment, Hb analysis using isoelectric focusing (IEF) showed HbA 95.6%, HbA 2 2.7%, and HbCS 1.7% compatible with heterozygous HbCS. After 4 months of oral iron therapy resulting in an improved Hb level, her HbCS level was substantially increased to 8.7% on IEF suggesting homozygous HbCS. Subsequent DNA analysis using multiplex amplification refractory mutation system analysis revealed compound heterozygosity for HbCS and Hb Paks\u00e9. This case demonstrated that IDA can significantly reduce HbCS/Hb Paks\u00e9 levels and probably mask the diagnosis of homozygous HbCS, homozygous Hb Paks\u00e9 or the compound heterozygosity for both hemoglobinopathies by hemoblogin analysis. The test should be repeated after resolution of IDA, or molecular testing should be performed to confirm the diagnosis. \u00a9 2017 Wiley Periodicals, Inc.\n[Vacunas para la prevenci\u00f3n de la gripe en personas de edad avanzada](http://www.sciencedirect.com/science/article/pii/S0716864010706088) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nTom Jefferson\n2010-09-01\nConclusiones de los autores: Las pruebas disponibles son de calidad deficiente y no proporcionan orientaci\u00f3n con respecto a la seguridad, la eficacia o la efectividad de las vacunas contra la gripe en las personas de 65 a\u00f1os de edad o m\u00e1s. Para resolver la incertidumbre se debe realizar un ensayo aleatorio controlado con placebo, con financiamiento p\u00fablico y con poder estad\u00edstico adecuado, durante varias estaciones.\n[Metodolog\u00eda de Gesti\u00f3n por Competencias Asumiendo la Norma Cubana sobre Gesti\u00f3n de Capital HumanoMetodologia de Gest\u00e3o por Compet\u00eancias Assumindo a Norma Cubana sobre Gest\u00e3o de Capital HumanoMethodology of Competences Management Assuming the Cuban Norm about Management of Human Capital](http://200.169.97.104/seer/index.php/RBGN/article/view/720/779) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSANTOS, Armando Ram\u00f3n Cuesta\n2011-09-01\nFull Text Available RESUMOO presente estudo se consiste em uma pesquisa realizada em oito empresas cubanas que seguiam o enfoque de compet\u00eancias na gest\u00e3o estrat\u00e9gica de recursos humanos segundo a norma cubana NC:3000-3002:2007 sobre gest\u00e3o do capital humano visando um desempenho de maior produtividade. O objetivo do estudo \u00e9 apresentar um modelo de gest\u00e3o de desempenho por compet\u00eancias com base nas normas citas e nos casos analisados. Para o desenvolvimento do modelo procurou-se relacionar o desempenho individual por compet\u00eancias com o desempenho organizacional. Como resultado pode-se apresentar um modelo de gest\u00e3o de desempenho por compet\u00eancias dos diversos n\u00edveis organizacionais com base nas Normas Cubanas mencionadas.ABSTRACTAn applied research conducted in eight Cuban companies which follow the approach of skills in strategic management of human resources according to the standard Cuban CN: 3000-3002:2007 on human capital management, seeking a superior performance to higher productivity. It sought to manage the connection of individual work with the responsibilities for the strategic organizational performance. As a result we have obtained a metodology to manage the various skill levels expressed in this companies, which acceptance of the competence concept in the position is fundamental in the NC mentioned. Presenting this methodology for performance management competence is the mais purpose of this article.RESUMENUna investigaci\u00f3n aplicada realizada en ocho empresas cubanas que estaban siguiendo el enfoque de competencias en gesti\u00f3n estrat\u00e9gica de recursos humanos, asumiendo la norma cubana NC: 3000-3002: 2007 sobre gesti\u00f3n de capital humano, en aras de un desempe\u00f1o superior o de mayor productividad, busc\u00f3 gestionar el v\u00ednculo del desempe\u00f1o individual por competencias con el desempe\u00f1o organizacional o estrat\u00e9gico. Como resultado se obtuvo una metodolog\u00eda de gesti\u00f3n de los distintos niveles de competencias que se expresan en esas\n[Reactogenicidad e inmunogenicidad de una nueva vacuna de toxoide tet\u00e1nico y dift\u00e9rico con concentraci\u00f3n reducida en adolescentes cubanos](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200003&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRolando Felipe Ochoa.\n2006-08-01\nFull Text Available Se realiz\u00f3 un estudio aleatorizado, controlado y a doble ciegas en 225 adolescentes cubanos entre 13 y 16 a\u00f1os de edad, con el objetivo de evaluar la reactogenicidad y la inmunogenicidad de una nueva vacuna de toxoide tet\u00e1nico y toxoide dift\u00e9rico con concentraci\u00f3n reducida, producida en el Instituto Finlay, con respecto a su similar comercial IMOVAX dT adult de Aventis Pasteur. Se tomaron muestras de suero antes y 21 d\u00edas despu\u00e9s de la vacunaci\u00f3n. La reactogenicidad de ambas vacunas fue similar. Los s\u00edntomas y signos, tanto locales como generales fueron moderados y aparecieron principalmente durante las primeras 72 h despu\u00e9s de la vacunaci\u00f3n. Todos los voluntarios vacunados alcanzaron niveles protectores (\u00b30,1 UI/mL de antitoxina contra el t\u00e9tanos y la difteria. El 99,25% de los inmunizados con la vacuna experimental y el 98,36% de los voluntarios del grupo control presentaron niveles de antitoxina tet\u00e1nica correspondientes a una protecci\u00f3n de larga duraci\u00f3n (\u00b31,0 UI/mL; para la antitoxina dift\u00e9rica se alcanzaron estos niveles en el 81,20% y 80,33% de los voluntarios en cada grupo. Los t\u00edtulos medios geom\u00e9tricos de antitoxina tet\u00e1nica (21,73 UI/mL y antitoxina dift\u00e9rica (2,55 UI/mL inducidos por la nueva vacuna fueron superiores (p<0,05 a los del grupo control: 15,55 UI/mL y 1,84 UI/Ml respectivamente(p<0.05.\n[La construcci\u00f3 de fets cient\u00edfics : La vacuna SPf66](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::69504224a67a1db5cf7f4eafc85160f1)\nNaspleda Pardo, Joan\n2015-01-01\nEn aquest treball, a partir de la teoria de l'actor-xarxa i la Sociologia del Coneixement Cient\u00edfic (SCC), analitzem la creaci\u00f3 i evoluci\u00f3 de la vacuna contra la mal\u00e0ria de l'equip del Dr. Manuel Elkin Patarroyo, durant els anys 80 i 90 del passat segle, per mostrar com les interaccions socials participen de manera decisiva en l'acceptaci\u00f3 o rebuig d'una proposta cient\u00edfica. En este trabajo, a partir de la teor\u00eda del actor-red y la Sociolog\u00eda del Conocimiento Cient\u00edfico (SCC), analizamos l...\n[La segunda expedici\u00f3n de Balmis, revoluci\u00f3n y vacuna](https://www.openaire.eu/search/publication?articleId=od_______935::d513a40dc09e50440853f4ad3258003a)\nTuells Hern\u00e1ndez, Jos\u00e9; Duro Torrijos, Jos\u00e9 Luis\n2013-01-01\nCuatro a\u00f1os despu\u00e9s de concluir la Real Expedici\u00f3n Filantr\u00f3pica de la Vacuna (REFV) (1803-1806) en calidad de director, Francisco Xavier Balmis emprendi\u00f3 una nueva comisi\u00f3n con destino a M\u00e9xico que le mantuvo all\u00ed desde 1810 a 1813. El objetivo inicial para el que fue comisionado pasaba por verificar si la estrategia de vacunaci\u00f3n implantada a trav\u00e9s de las Juntas era eficaz y, asimismo, encontrar una fuente de fluido vacuno aut\u00f3ctona que permitiera continuar la acci\u00f3n vacunadora. Balmis ejer...\n[Relationship between Hb and HbA1c in Japanese adults: an analysis of the 2009 Japan Society of Ningen Dock database.](https://www.ncbi.nlm.nih.gov/pubmed/24746101)\nTakahashi, Eiko; Moriyama, Kengo; Yamakado, Minoru\n2014-06-01\nWe investigated the effect of Hb on HbA1c levels in 265,427 Japanese individuals. The divergence between fasting plasma glucose (FPG) and HbA1c levels increased with lower Hb, resulting in HbA1c levels that were higher in relation to than the FPG levels. Similarly, the correlation between FPG and HbA1c levels, stratified by Hb, weakened as Hb decreased. Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.\n[Phenotypic Diversity of Sickle Cell Disease in Patients with a Double Heterozygosity for Hb S and Hb D-Punjab.](https://www.ncbi.nlm.nih.gov/pubmed/27535451)\nTorres, Lidiane S; Okumura, J\u00e9ssika V; Belini-J\u00fanior, \u00c9dis; Oliveira, Renan G; Nascimento, Patr\u00edcia P; Silva, Danilo G H; Lobo, Clarisse L C; Oliani, Sonia M; Bonini-Domingos, Claudia R\n2016-09-01\nPhenotypic heterogeneity for sickle cell disease is associated to several genetic factors such as genotype for sickle cell disease, \u03b2-globin gene cluster haplotypes and Hb F levels. The coinheritance of Hb S (HBB: c.20A > T) and Hb D-Punjab (HBB: c.364G > C) results in a double heterozygosity, which constitutes one of the genotypic causes of sickle cell disease. This study aimed to assess the phenotypic diversity of sickle cell disease presented by carriers of the Hb S/Hb D-Punjab genotype and the Bantu [- + - - - -] haplotype. We evaluated medical records from 12 patients with sickle cell disease whose Hb S/Hb D-Punjab genotype and Bantu haplotype were confirmed by molecular analysis. Hb S and Hb D-Punjab levels were quantified by chromatographic analysis. Mean concentrations of Hb S and Hb D-Punjab were 44.8 \u00b1 2.3% and 43.3 \u00b1 1.8%, respectively. Painful crises were present in eight (66.7%) patients evaluated, representing the most common clinical event. Acute chest syndrome (ACS) was the second most prevalent manifestation, occurring in two individuals (16.7%). Three patients were asymptomatic, while another two exhibited greater diversity of severe clinical manifestations. Medical records here analyzed reported a significant clinical diversity in sickle cell disease ranging from the absence of symptoms to wide phenotypic variety. The sickle cell disease genotype, Bantu haplotype and hemoglobin (Hb) levels did not influence the clinical diversity. Thus, we concluded that the phenotypic variation in sickle cell disease was present within a specific genotype for disease regardless of the \u03b2-globin gene cluster haplotypes.\n[First Case of a Compound Heterozygosity for Two Nondeletional \u03b1-Thalassemia mutations, Hb Constant Spring and Hb Quong Sze.](https://www.ncbi.nlm.nih.gov/pubmed/26956449)\nZhou, Jian-Ying; Yan, Jin-Mei; Li, Jian; Li, Dong-Zhi\n2016-06-01\nNondeletional \u03b1-thalassemia (\u03b1-thal) is the result of point mutations in critical regions of the \u03b1-globin genes, affecting mRNA processing, mRNA translation, or \u03b1-globin stability. Hb Constant Spring (Hb CS, HBA2: c.427T > C) is the most common nondeletional \u03b1-thal that results from a nucleotide substitution at the termination codon of the \u03b12-globin gene. Hb Quong Sze (Hb QS, HBA2: c.377T > C) is another nondeletional \u03b1-thal in South China with the missense mutation at codon 125 of the \u03b12-globin gene making this hemoglobin (Hb) variant highly unstable. Although homozygosity for Hb CS (\u03b1(CS)\u03b1/\u03b1(CS)\u03b1) or Hb QS (\u03b1(QS)\u03b1/\u03b1(QS)\u03b1) has been reported, clinical pictures vary from severe hemolysis that developed early in life to only mild anemia, no clinical phenotypic data of compound heterozygosity for Hb CS/Hb QS (\u03b1(CS)\u03b1/\u03b1(QS)\u03b1) has been described. In this report we describe an adult case with such a compound heterozygosity who presented with a mild \u03b1-thal.\n[Comparative haematological parameters of HbAA and HbAS genotype children infected with Plasmodium falciparum malaria in Yemen.](https://www.ncbi.nlm.nih.gov/pubmed/24074341)\nAlbiti, Anisa H; Nsiah, Kwabena\n2014-04-01\nSickle haemoglobin (HbS) is known to offer considerable protection against falciparum malaria. However, the mechanism of protection is not yet completely understood. In this study, we investigate how the presence of the sickle cell trait affects the haematological profile of AS persons with malaria, in comparison with similarly infected persons with HbAA. This study is based on the hypothesis that the sickle cell trait plays a protective role against malaria. Children from an endemic malaria transmission area in Yemen were enrolled in this study. Hematological parameters were estimated using manual methods, the percentage of parasite density on stained thin smear was calculated, haemoglobin genotypes were determined on paper electrophoresis, ferritin was measured using enzyme-linked immunosorbent assay, serum iron and TIBC were assayed using spectrophotometer, transferrin saturation index was calculated by dividing serum iron by TIBC and expressing the result as a percentage. Haematological parameters were compared in HbAA- and HbAS-infected children. Falciparum malaria parasitaemia was confirmed in the blood smears of 62 children, 44 (55.7%) of AA and 18 (37.5%) AS, so there was higher prevalence in HbAA children (P = 0.047). Parasite density was lower in HbAS- than HbAA-infected children (P = 0.003). Anaemia was prominent in malaria-infected children, with high proportions of moderate and severe forms in HbAA (P = 0.001). The mean levels of haemoglobin, packed cell volume, reticulocyte count, platelets count, lymphocytes, eosinophils, and serum iron were significantly lower while total leukocytes, immature granulocytes, monocytes, erythrocyte sedimentation rate, transferrin saturation, and serum ferritin were significantly higher in HbAA-infected children than HbAS-infected children. Infection with Plasmodium falciparum malaria caused more significant haematological alterations of HbAA children than HbAS. This study supports the observation that sickle cell trait\n[Que hay en el horizonte sobre el virus del papiloma humano, vacunas y el control del c\u00e1ncer](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342007000300011&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nPatricia J. Garc\u00eda\n2007-07-01\nFull Text Available Esta revisi\u00f3n provee una visi\u00f3n general sobre las infecciones genitales producidas por el virus del papiloma humano (VPH y de las neoplasias relacionadas con \u00e9ste y la informaci\u00f3n sobre las expectativas crecientes de la vacunaci\u00f3n como medio de prevenci\u00f3n. Se explora como se han desarrollado las vacunas contra el VPH y que aspectos hay que tener en cuenta para una posible implementaci\u00f3n de un programa de vacunaci\u00f3n para prevenir el c\u00e1ncer cervical, como los costos, el p\u00fablico objetivo (varones, mujeres o ambos, grupos de riesgo, a que edad vacunarlos, consideraciones que debemos tener en cuenta en la promoci\u00f3n de la vacuna, que pasar\u00eda con los programas de detecci\u00f3n precoz de c\u00e1ncer cervical y cuales son los potenciales problemas que tendr\u00eda en pa\u00edses en desarrollo.\n[Administraci\u00f3n de vacunas y casos de muerte s\u00fabita del lactante en el Per\u00fa, 2001: \u00bfasociaci\u00f3n o coincidencia temporal?](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342006000100007&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJavier Vargas H\nFull Text Available Objetivos: Describir las caracter\u00edsticas cl\u00ednicas, socioecon\u00f3micas, y patol\u00f3gicas de nueve casos de lactantes que fallecieron horas despu\u00e9s de administr\u00e1rseles vacunas antipolio y DPT junto con anti Haemophilus influenzae b o asociada con antihepatitis B o BCG. Materiales y m\u00e9todos: Revisi\u00f3n de la historia cl\u00ednica, entrevista con el equipo de salud a cargo de la vacunaci\u00f3n y con los padres del lactante fallecido. Revisi\u00f3n de los informes del protocolo de autopsia e informes de anatom\u00eda patol\u00f3gica y entrevista con los m\u00e9dicos legistas y pat\u00f3logos. Evaluaci\u00f3n de control de calidad de las vacunas administradas. Realizaci\u00f3n de ex\u00e1menes de inmunohistoqu\u00edmica de tejidos pulmonares para el diagn\u00f3stico de virus. Resultados: Entre agosto y diciembre de 2001 se notificaron en el Per\u00fa, nueve casos de fallecimiento de lactantes entre ocho horas y tres d\u00edas despu\u00e9s de la aplicaci\u00f3n de vacunas DPT y antipolio. Despu\u00e9s de la vacunaci\u00f3n, los s\u00edntomas iniciaron entre 30 minutos a tres horas y la muerte se produjo entre ocho a 78 horas. Los s\u00edntomas m\u00e1s frecuentes fueron irritabilidad 8/9, llanto persistente 6/9, somnolencia 5/9, sangrado por nariz y boca 5/9. Todos los casos procedieron de familias pobres o muy pobres. El control de calidad se corrobor\u00f3 que las vacunas cumplieron con los est\u00e1ndares establecidos por la OMS. Las causas de la muerte reportadas en las necropsias fueron neumon\u00eda en dos casos y edema pulmonar en cinco casos, los informes de anatom\u00eda patol\u00f3gica mostraron una neumonitis intersticial y meningitis linfocitaria. No se observaron efectos citop\u00e1ticos virales en los tejidos pulmonares y los estudios toxicol\u00f3gicos fueron negativos. Conclusiones: No existe evidencia de una asociaci\u00f3n causal entre los eventos fatales y la administraci\u00f3n de las vacunas.\n[Hydroxyurea decreases hospitalizations in pediatric patients with Hb SC and Hb SB+ thalassemia](https://www.dovepress.com/hydroxyurea-decreases-hospitalizations-in-pediatric-patients-with-hb-s-peer-reviewed-article-JBM) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLebensburger JD\n2015-12-01\nFull Text Available Jeffrey D Lebensburger, Rakeshkumar J Patel, Prasannalaxmi Palabindela, Christina J Bemrich-Stolz, Thomas H Howard, Lee M HilliardDivision of Pediatric Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USAPurpose: Patients with hemoglobin SC (Hb SC and hemoglobin SB+ (Hb SB+ thalassemia suffer from frequent hospitalizations yet strong evidence of a clinical benefit of hydroxyurea (HU in this population is lacking. Patients with recurrent hospitalizations for pain crisis are offered HU at our institution based on small cohort data and anecdotal benefit. This study identifies outcomes from a large cohort of patients with Hb SC and SB+ thalassemia who were treated with HU for 2 years.Materials and methods: A retrospective review was conducted of 32 patients with Hb SC and SB+ thalassemia who were treated with HU. We reviewed the number, and reasons for hospitalization in the 2 years prior to, and 2 years post-HU treatment as well as laboratory changes from baseline, over 1 year.Results: Patients with Hb SC and SB+ thalassemia started on HU for frequent pain, had a significant reduction in hospitalizations over 2 years as compared to the 2 years prior to HU initiation (mean total hospitalizations/year: pre-HU: 1.6 vs post-HU 0.4 hospitalizations, P<0.001; mean pain hospitalizations/year: pre-HU 1.5 vs post-HU 0.3 hospitalizations, P<0.001. Patients demonstrated hematologic changes including an increase in percent fetal hemoglobin (%HbF pre\u2013post HU (4.5% to 7.7%, P=0.002, mean corpuscular volume (74 to 86 fL, P<0,0001, and decrease in absolute neutrophil count (5.0 to 3.2\u00d7109/L, P=0.007. Patients with higher doses of HU demonstrated the greatest reduction in hospitalizations but this was unrelated to absolute neutrophil count.Conclusion: This cohort of patients with Hb SC and SB+ thalassemia provides additional support for using HU in patients with recurrent hospitalizations for pain. A large randomized multicenter trial of\n[Vacunaci\u00f3n de la poblaci\u00f3n de 65 a\u00f1os en Castilla-La Mancha con la vacuna antineumoc\u00f3cica conjugada 13valente (VNC13](http://www.revista-socampar.com/images/articulos/ArticulosSeparadosNum6/Articulo%20especial.pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSOCAMPAR\n2018-03-01\nFull Text Available La estrategia de vacunaci\u00f3n antineumoc\u00f3cica en adultos a partir de los 65 a\u00f1os de edad ha ido modific\u00e1ndose, tras la aprobaci\u00f3n de la vacuna 13valente conjugada (VNC13 para adultos y la recomendaci\u00f3n de los Centros de Control y Prevenci\u00f3n de enfermedad de EEUU (CDC en el a\u00f1o 2014 de incluir la vacuna VNC13 a la poblaci\u00f3n a partir de 65 a\u00f1os de edad, a partir de los resultados del estudio CAPiTA. Diversos pa\u00edses, y en Espa\u00f1a varias Comunidades Auto- n\u00f3micas, ya han incluido la vacuna VNC13 en los calendarios vacunales de adultos a partir de los 65 a\u00f1os. En este documento, las sociedades: Sociedad de M\u00e9dicos Generales y de Familia de Castilla-La Mancha, Sociedad Castellano Manchega de Patolog\u00eda Respiratoria, Sociedad Castellano Manchega de M\u00e9dicos Preventivistas, Sociedad Castellano Manchega de Geriatr\u00eda, Sociedad Castellano Manchega de M\u00e9dicos Internistas (Secci\u00f3n Infecciosas, Socie- dad Castellano Manchega de Farmacia Familiar y Comunitaria presentamos a la Direcci\u00f3n General de Salud P\u00fablica de la Junta de Comunidades de Castilla-La Mancha nuestra propuesta y justificaci\u00f3n para la inclusi\u00f3n de la vacuna VNC13 en cohorte de 65 a\u00f1os de edad de Castilla-La Mancha\n[El registro electoral en la historia constitucional cubana (1901-1958](http://www.tse.go.cr/revista/art/18/pena_barrios.pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRaudiel Pe\u00f1a Barrios\n2014-07-01\nFull Text Available Este art\u00edculo pretende analizar la regulaci\u00f3n existente en los textos constitucionales cubanos de 1901, 1940 y en los Estatutos Constitucionales del Gobierno de Fulgencio Batista de 1952, as\u00ed como en sus leyes complementarias, sobre la inscripci\u00f3n en el registro electoral. En vista de esto, analizaremos los diferentes sistemas empleados para la inscripci\u00f3n de los electores, mientras que veremos c\u00f3mo se va desarrollando la instituci\u00f3n del registro a causa del fortalecimiento de todo el marco legal e institucional que sobre este se va configurando, paulatinamente, durante esta etapa. Adem\u00e1s, podremos apreciar c\u00f3mo en determinado momento de la historia cubana esta instituci\u00f3n fue comprometida en su cometido pol\u00edtico-social lo que puede ser interpretado como una herramienta de fraude electoral.\n[Vacunas y autoinmunidad: una rara asociaci\u00f3n bajo debate Vaccines and autoimmunity: a strange association under debate](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1726-46342012000200017) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAlexander Batista-Duharte\n2012-06-01\nFull Text Available La posible asociaci\u00f3n entre vacunas y enfermedades autoinmunes es un tema controversial. Existen elementos a favor de esta relaci\u00f3n basados en modelos te\u00f3ricos, ensayos de laboratorio y varios casos cl\u00ednicos publicados. En cambio, los estudios epidemiol\u00f3gicos no han confirmado esta asociaci\u00f3n y, de ellos, puede inferirse que las vacunas no constituyen una causa demostrada de enfermedades autoinmunes. En este trabajo se analizan las evidencias a favor y en contra de esta controversial asociaci\u00f3n, adem\u00e1s, se aborda un nuevo s\u00edndrome asociado con la administraci\u00f3n continuada de adyuvantes vacunales. Se concluye que debido al gran impacto en beneficio de la salud logrado con las vacunas, es necesario continuar desarrollando esta tecnolog\u00eda, pero tambi\u00e9n se debe seguir perfeccionando los dise\u00f1os de las nuevas formulaciones y profundizando estudios b\u00e1sicos, precl\u00ednicos, ensayos cl\u00ednicos y farmacovigilancia de los nuevos candidatos vacunales para establecer el riesgo real de desarrollo de un evento autoinmune posvacunaci\u00f3n.The occurrence and significance of autoimmune manifestations after administration of vaccines remain controversial. Evidence for immunization triggered autoimmunity come from several sources including theoretical models, animal studies, single and multiple case reports. In contrast, several epidemiological studies don\u2019t report this association, which is reassuring and at least indicates that vaccines are not a major cause of autoimmune diseases. We analyzed current scientific data concluded that vaccines bring a positive impact on public health, so it is necessary to continue developing this technology. Evaluation methods should be improved to avoid or anticipate the possible autoimmune side effects that can be presented.\n[IMPLICACIONES \u00c9TICAS Y SOCIALES DE LA INTRODUCCI\u00d3N DE LA VACUNA CONTRA EL VIRUS DEL PAPILOMA HUMANO EN M\u00c9XICO: REFLEXIONES SOBRE UNA PROPUESTA DE INTERVENCI\u00d3N](https://www.openaire.eu/search/publication?articleId=od______3056::d4191acb1173d7dbea934cb8c961809f)\nPrieto de la Rosa,Alejandra; Guti\u00e9rrez Delgado,Cristina; Feinholz Klip,Dafna; Morales Gonz\u00e1lez,Gisela; Witlen,Renee\n2008-01-01\nEl objetivo de este trabajo es identificar aspectos \u00e9ticos y sociales relacionados con la introducci\u00f3n de la vacuna contra el virus del papiloma humano (VPH) en M\u00e9xico para una decisi\u00f3n informada y justa que considere no s\u00f3lo los aspectos financieros. De acuerdo con la informaci\u00f3n sobre eficiencia y costo de la vacuna, su introducci\u00f3n al sistema p\u00fablico mexicano puede acarrear consecuencias no previstas para las participantes y para toda la sociedad, por lo que debe examinarse en el contexto ...\n[Informaci\u00f3n sobre las vacunas y el tiomersal en la internet](https://www.openaire.eu/search/publication?articleId=od______3056::90581237738de503aa4b6681ae4c01e3)\nVargas, Javier\n2005-01-01\nLa informaci\u00f3n inexacta sobre la asociaci\u00f3n entre las vacunas y el autismo propagada en las \u00faltimas semanas por los medios de comunicaci\u00f3n, impacta de manera desfavorable en la salud p\u00fablica del pa\u00eds, restando m\u00e9rito a los logros alcanzados por la inmunizaci\u00f3n en la erradicaci\u00f3n de la viruela en el mundo y la erradicaci\u00f3n de la viruela en el mundo y la erradicaci\u00f3n en marcha de la poliomelitis y la eliminaci\u00f3n del sarampi\u00f3n en el Per\u00fa; confundiendo con la poblaci\u00f3n sobre los beneficios holgad...\n[Movimiento de alumnos ayudantes: experiencia de una instituci\u00f3n cubana](http://www.sciencedirect.com/science/article/pii/S1575181316301450) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nHalbert Hern\u00e1ndez-Negr\u00edn\n2018-03-01\nFull Text Available Resumen: El movimiento de alumnos ayudantes surge como una necesidad ante el \u00e9xodo masivo de profesionales al comienzo de la revoluci\u00f3n cubana. A m\u00e1s de 5 d\u00e9cadas de creado conserva total vigencia al perfeccionarse y adecuarse continuamente a los din\u00e1micos requerimientos sociales del pa\u00eds. En este art\u00edculo se describe la experiencia del Hospital Universitario Arnaldo Mili\u00e1n Castro en el trabajo con los alumnos ayudantes en el per\u00edodo entre 2011 y 2016, enfatizando sus logros y desaf\u00edos en el cumplimiento de sus principales objetivos en la educaci\u00f3n m\u00e9dica superior cubana: apoyar el desarrollo del proceso docente educativo, dirigir la orientaci\u00f3n profesional hacia especialidades que se encuentran en d\u00e9ficit y adquirir de forma acelerada habilidades como docente, investigativas y propias de la especialidad. Abstract: The teaching-support student movement arose out of the necessity to cover the lack of teachers caused by the massive exodus of professionals at the beginning of the Cuban Revolution. Five decades later it is still alive and continuously perfects and adjusts itself according to the dynamic social requirements of the country. This article intends to describe the experience acquired at the University Hospital \u201cArnaldo Mili\u00e1n Castro\u201d based on the work of teaching-support students in the period from 2011 to 2016, emphasising its achievements and challenges in the fulfilment of its main objectives in Cuban higher medical education such as: to support the development of the instructional and educational process, to address the professional orientation towards specialities deficient in professionals and to quickly acquire skills for teaching, research, and those related to specialities. Palabras clave: Educaci\u00f3n m\u00e9dica, Recursos humanos en salud, Internado y residencia, Especializaci\u00f3n, Cuba, Keywords: Medical education, Health manpower, Internship and residency, Specialisation, Cuba\n[A Revolu\u00e7\u00e3o Cubana nos document\u00e1rios de Chris Marker](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-21862013000100003&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nCarolina Amaral de Aguiar\n2013-06-01\nFull Text Available Nos anos 1960 a Revolu\u00e7\u00e3o Cubana ocupou o centro do debate entre os intelectuais de esquerda na Fran\u00e7a. Por outro lado, o governo revolucion\u00e1rio convidou europeus para colaborar com o desenvolvimento de novas institui\u00e7\u00f5es, caso do ICAIC. Chris Marker, um dos convidados desse instituto, estabeleceu trocas com realizadores cubanos e montou dois document\u00e1rios analisados neste artigo: Cuba si (1961 e La bataille des dix millions (1970. O primeiro visava a combater as cr\u00edticas da imprensa conservadora a Fidel, enquanto o segundo se voltou para a pr\u00f3pria esquerda que abandonava Cuba como um modelo.\n[[DESAUTORIZADO] La Revoluci\u00f3n cubana y la historiograf\u00eda](http://estudiosamericanos.revistas.csic.es/index.php/estudiosamericanos/article/view/106) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJos\u00e9 Mar\u00eda Aguilera Manzano\n2008-06-01\nFull Text Available Desautorizaci\u00f3n / Retraction El Consejo de Redacci\u00f3n del Anuario de Estudios Americanos, en aplicaci\u00f3n de las directrices marcadas por la Gu\u00eda de Buenas Pr\u00e1cticas de la Editorial CSIC y las recomendaciones de los comit\u00e9s internacionales de \u00e9tica editorial, ha decidido proceder a la desautorizaci\u00f3n formal del siguiente art\u00edculo: Aguilera Manzano, Jos\u00e9 Mar\u00eda: \u201cLa Revoluci\u00f3n cubana y la historiograf\u00eda\u201d, Anuario de Estudios Americanos, vol. 65, n\u00fam. 1, Sevilla, enero-junio 2008, pp. 297-320, DOI: http://doi.org/10.3989/aeamer.2008.v65.i1.106 Dicho art\u00edculo contiene numerosos p\u00e1rrafos que son reproducci\u00f3n literal (con leves cambios de redacci\u00f3n en algunas pocas ocasiones, sin entrecomillar ni citar, del siguiente texto: Piqueras Arenas, Jos\u00e9 Antonio: \u201cIntroducci\u00f3n: Ensayo de contextualizaci\u00f3n de la \u00faltima historiograf\u00eda cubana\u201d, en Piqueras Arenas, Jos\u00e9 A. (ed., Diez nuevas miradas de Historia de Cuba, Castell\u00f3 de la Plana, Publicaciones de la Universitat Jaume I, 1998, pp. 9-39. (Los p\u00e1rrafos reproducidos, que suman no menos de catorce p\u00e1ginas del art\u00edculo desautorizado, corresponden a pp. 10-24 y 28-32 de este texto. Asimismo, se ha detectado la existencia de p\u00e1rrafos que son reproducci\u00f3n literal, sin entrecomillar ni citar, de otros autores. Entre ellos (sin descartar que pueda haber m\u00e1s casos los siguientes: Hern\u00e1n Venegas (\u201cAm\u00e9rica en la historiograf\u00eda cubana, 1832-1940\u201d, Islas, 132, 2002, 69-79; textos de p\u00e1ginas 74-75 reproducidos en p. 297-298 del art\u00edculo desautorizado; El\u00edades Acosta (\u201c\u00bfQu\u00e9 aportan los estudios biogr\u00e1ficos a la historiograf\u00eda cubana actual?\u201d, en Hibay, Denise A. (ed., Trends and Traditions in Latin American and Caribbean History, Papers of the Forty-Seventh Annual Meeting of the Seminar on the Acquisition of Latin American Library Materials, SALALM Secretariat, USA, 2005, 77-84; textos de p. 81-82 reproducidos en p. 317-318 y Mildred de la Torre Molina (\u201cLa nueva\n[Tiempo libre de enfermedad en infecciones urinarias recurrentes seg\u00fan profilaxis con antibi\u00f3tico o con vacuna bacteriana](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::f118b21a924c80aa9ffde3c6916975f2)\nSanto Bueno, Pedro Jos\u00e9\n2014-01-01\n[ES]Estudio comparativo de dos tipos de tratamientos profilacticos, antibioterapia supresiva y vacuna bacteriana, en infecciones urinarias de repetici\u00f3n, para determinar el tiempo libre de enfermedad, entendida como el tiempo transcurrido entre la finalizaci\u00f3n de la profilaxis y la aparici\u00f3n de un episodio de infeccion urinario.\n[First Report of a Chinese Family Carrying a Double Heterozygosity for Hb Q-Thailand and Hb J-Bangkok.](https://www.ncbi.nlm.nih.gov/pubmed/28361593)\nJiang, Fan; Zhou, Jian-Ying; Yan, Jin-Mei; Lu, Yue-Cheng; Li, Dong-Zhi\n2016-11-01\nThe double heterozygosity for \u03b1 and \u03b2 chain variants leads to the formation of abnormal heterodimer hybrids, which could render laboratory diagnostics in a routine setting difficult. The following is the first report of a double heterozygosity for Hb Q-Thailand [\u03b174(EF3)Asp\u2192His; HBA1: c.223G>C] with \u03b1 + -thalassemia (\u03b1 + -thal) and Hb J-Bangkok [\u03b256(D7)Gly\u2192Asp; HBB: c.170G>A] found in a Chinese family. Both subjects were healthy with normal or borderline hematological parameters. Hemoglobin (Hb) analyses showed a novel variant, Hb Q-Thailand and Hb J-Bangkok. Family studies helped in the initial recognition and in making presumptive diagnoses, but definitive diagnoses of these cases with complex \u03b1 and \u03b2 chain variants could only be obtained after DNA analysis.\n[Stress analysis of the HFIR HB-2 and HB-3 beam tube nozzles](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=30013890) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nWilliams, P.T.\n1998-08-01\nThe results of three-dimensional linear elastic stress analyses of the HFIR HB-2 and HB-3 nozzles are presented in this report. Finite element models were developed using the PATRAN pre-processing code and translated into ABAQUS input file format. A scoping analysis using simple geometries with internal pressure loading was carried out to assess the capabilities of the ABAQUS/Standard code to calculate maximum principal stress distributions within cylinders with and without holes. These scoping calculations were also used to provide estimates for the variation in tangential stress around the rim of a nozzle using the superposition of published closed-form solutions for the stress around a hole in an infinite flat plate under uniaxial tension. From the results of the detailed finite element models, peak stress concentration factors (based on the maximum principal stresses in tension) were calculated to be 3.0 for the HB-2 nozzle and 2.8 for the HB-3 nozzle. Submodels for each nozzle were built to calculate the maximum principal stress distribution in the weldment region around the nozzle, where displacement boundary conditions for the submodels were automatically calculated by ABAQUS using the results of the global nozzle models. Maximum principal stresses are plotted and tabulated for eight positions around each nozzle and nozzle weldment\n[Formative research to shape HPV vaccine introduction strategies in Peru Investigaci\u00f3n formativa relacionada con el dise\u00f1o de estrategias para introducir la vacuna contra el VPH en Per\u00fa](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342010000300007) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRosario M Bartolini\n2010-06-01\nFull Text Available OBJECTIVE: To understand the sociocultural environment, health systems' capacities, and policy processes related to cervical cancer and HPV vaccines in order to inform HPV vaccine introduction. MATERIAL AND METHODS: Mixed-method formative research using qualitative and quantitative data collection techniques. Participants included girls, parents, community leaders, health and education officials, and policymakers. RESULTS: Respondents, including policymakers, generally supported HPV vaccine introduction, due partly to appreciation for the benefits of vaccination and the desire to prevent cancer. Community-level concerns regarding safety and quality of services will need to be addressed. The immunization system in Peru is strong and has capacity for including the HPV vaccine. CONCLUSION: Formative research provides key insights to help shape an effective program for HPV vaccine introduction.OBJETIVO: Comprender el contexto sociocultural, las capacidades del sistema de salud y las condiciones pol\u00edticas vinculadas al c\u00e1ncer cervical y a la vacuna contra el VPH para dise\u00f1ar una estrategia apropiada de introducci\u00f3n de la vacuna contra el VPH. MATERIAL Y M\u00c9TODOS: Investigaci\u00f3n formativa usando t\u00e9cnicas cualitativas y cuantitativas. Los participantes incluyeron ni\u00f1os, padres, l\u00edderes, funcionarios del sector salud y educaci\u00f3n, y dise\u00f1adores de pol\u00edticas. RESULTADOS: Generalmente se apoya la introducci\u00f3n de la vacuna contra el VPH, dado que se aprecian los beneficios de la vacunaci\u00f3n y se desea prevenir el c\u00e1ncer. En la comunidad se encontraron preocupaciones sobre seguridad, confianza y calidad de atenci\u00f3n. El sistema de inmunizaciones en el Per\u00fa es eficiente y tiene la capacidad para incluir la vacuna contra el VPH. CONCLUSIONES: La investigaci\u00f3n formativa permite comprender elementos clave que ayudan a dise\u00f1ar un programa efectivo para la introducci\u00f3n de la vacuna contra el VPH.\n[Coinheritance of High Oxygen Affinity Hb Helsinki [HBB: c.248A>T; \u03b282(EF6)Lys\u2192Met] with Hb H Disease.](https://www.ncbi.nlm.nih.gov/pubmed/28791912)\nLee, Shir-Ying; Goh, Jia-Hui; Tan, Karen M L; Liu, Te-Chih\n2017-05-01\nHb Helsinki [HBB: c.248A>T; \u03b282(EF6)Lys\u2192Met] is a high oxygen affinity hemoglobin (Hb) causing polycythemia, whereas Hb H (\u03b24) disease causes mild to severe chronic hemolytic anemia. The clinical characteristics, gel electrophoresis, capillary electrophoresis (CE) and molecular genotyping of a case of Hb Helsinki coinherited with Hb H disease in an ethnic Malay is described, illustrating the interaction between the \u03b2-globin variant and coinheritance of three \u03b1 gene deletions. The proband was asymptomatic, exhibited microcytosis and a normal with Hb value.\n[Characterization of a Novel Anti-Human HB-EGF Monoclonal Antibody Applicable for Paraffin-Embedded Tissues and Diagnosis of HB-EGF-Related Cancers.](https://www.ncbi.nlm.nih.gov/pubmed/26974561)\nIwamoto, Ryo; Takagi, Mika; Akatsuka, Jun-Ichi; Ono, Ken-Ichiro; Kishi, Yoshiro; Mekada, Eisuke\n2016-04-01\nHeparin-binding EGF-like growth factor (HB-EGF) is a member of the EGF family of growth factors that bind to and activate the EGF receptor (EGFR/ErbB1) and ErbB4. HB-EGF plays pivotal roles in pathophysiological processes, including cancer. Thus, monoclonal antibodies (mAbs) for HB-EGF detection could be an important tool in the therapeutic diagnosis of HB-EGF-related cancers and other diseases. However, few mAbs, especially those applicable for immunohistochemistry (IHC), have been established to date. In this study, we generated a clone of hybridoma-derived mAb 2-108 by immunizing mice with recombinant human HB-EGF protein expressed by human cells. The mAb 2-108 specifically bound to human HB-EGF but not to mouse HB-EGF and was successful in immunoblotting, even under reducing conditions, immunoprecipitation, and immunofluorescence for unfixed as well as paraformaldehyde-fixed cells. Notably, this mAb was effective in IHC of paraffin-embedded tumor specimens. Epitope mapping analysis showed that mAb 2-108 recognized the N-terminal prodomain in HB-EGF. These results indicate that this new anti-HB-EGF mAb 2-108 would be useful in the diagnosis of HB-EGF-related cancers and would be a strong tool in both basic and clinical research on HB-EGF.\nBloomgarden, Zachary\n2017-12-01\nIt can scarcely be denied that the supreme goal of all theory is to make the irreducible basic elements as simple and as few as possible without having to surrender the adequate representation of a single datum of experience. The diaTribe Foundation convened a meeting on the topic of glycemic outcomes beyond HbA1c on 21 July 2017, in Bethesda (MD, USA), focusing on potential uses of continuous glucose monitoring (CGM). Understanding patterns of glycemia in people with diabetes has long been a focus of approaches to improving treatment, and over the past few years this has become an available modality for clinical practice. Glucose levels are not the only biologic parameters affecting HbA1c levels; HbA1c changes with anemia or, more subtly, with changes in rates of erythrocyte turnover not reflected in hemoglobin levels outside the normal range. Renal disease often is associated with lower HbA1c than would be predicted based on an individual's glycemic levels. Furthermore, HbA1c levels tend to increase with age and are higher in some ethnic groups; for example, people of African ethnicity have higher HbA1c levels than people of Northern European descent. Indeed, we have argued that even as a measure of mean glycemia HbA1c is inherently imprecise. Overall, for some 20% of people with diabetes, HbA1c levels are substantially higher, or substantially lower, than those that would be predicted from mean blood glucose levels. If one recognizes that HbA1c is, at best, a partial measure of mean glycemic exposure, one must surely accept that HbA1c does not reflect variability within a day, from day to day, and from period to period. Many glucose-lowering medicines, particularly the sulfonylureas and insulin, cause hypoglycemia, with consequent negative effects on quality of life and patient-reported outcomes, as well as association with weight gain and adverse macrovascular outcome; hypoglycemia will, of course, not be captured by HbA1c measurement. Based on these\n[Hb Tianshui (HBB: C.119A > G) in Compound Heterozygosity with Hb S (HBB: C.20A > T) from Odisha, India.](https://www.ncbi.nlm.nih.gov/pubmed/27254408)\nMeher, Satyabrata; Dehury, Snehadhini; Mohanty, Pradeep Kumar; Patel, Siris; Pattanayak, Chinmayee; Bhattacharya, Subhra; Das, Kishalaya; Sarkar, Biswanath\n2016-08-01\nWe describe here a rare \u03b2-globin gene variant, Hb Tianshui [\u03b239(C5)Glu\u2192Arg; HBB: c.119A > G], detected during routine screening in Odisha, India. This is the second report of Hb Tianshui and the first to describe the cation exchange high performance liquid chromatography (HPLC) and DNA studies of two cases of this variant. Both cases had coinherited Hb S (HBB: c.20A > T) but none presented with typical symptoms of sickle cell disease. One of the cases was heterozygous for a common \u03b1-thalassemia (\u03b1-thal) allele (-\u03b1(3.7)) (rightward) (NG_000006.1: g.34164_37967del3804) and marginally raised Hb F percentage, while the other Hb S/Hb Tianshui case was completely benign and healthy. An atypical Asian Indian haplotype [+ - + - +] could be assigned to the Hb Tianshui variant. Hb Tianshui seems to mimic a few other Hb variants in cation exchange HPLC. However, we report two specific patterns in the chromatograms that are characteristic to Hb Tianshui. Combining an alkaline electrophoresis result with cation exchange HPLC at screening would be preferred to detect this rare variant, especially in regions with considerable frequency of Hb E [\u03b226(B8)Glu\u2192Lys; HBB: c.79G > A] or Hb S.\n[Simultaneous dual syringe electrospinning system using benign solvent to fabricate nanofibrous P(3HB-co-4HB)/collagen peptides construct as potential leave-on wound dressing](http://dx.doi.org/10.1016/j.msec.2016.03.102) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nVigneswari, S.; Murugaiyah, V.; Kaur, G.; Abdul Khalil, H.P.S.; Amirul, A.A.\n2016-01-01\nThe main focus of this study is the incorporation of collagen peptides to fabricate P(3-hydroxybutyrate-co-4-hydroxybutyrate) [P(3HB-co-4HB)] nano-fiber construct to further enhance surface wettability and support cell growth while harbouring desired properties for biodegradable wound dressing. Simultaneous electrospinning of nanofiber P(3HB-co-4HB)/collagen peptides construct was carried out using dual syringe system. The wettability of the constructs increased with the increase in 4HB molar fraction from 20 mol% 4HB [53.2\u00b0], P(3HB-co-35 mol%4HB)[48.9\u00b0], P(3HB-co-50 mol%4HB)[44.5\u00b0] and P(3HB-co-82 mol%4HB) [37.7\u00b0]. In vitro study carried out using mouse fibroblast cells (L929) grown on nanofiber P(3HB-co-4HB)/collagen peptides construct showed an increase in cell proliferation. In vivo study using animal model (Sprague Dawley rats) showed that nanofibrous P(3HB-co-4HB)/collagen peptides construct had a significant effect on wound contractions with the highest percentage of wound closure of 79%. Hence, P(3HB-co-4HB)/collagen peptides construct suitable for wound dressing have been developed using nano-fabrication technique. - Highlights: \u2022 Nano-fiber construct to enhance surface wettability and cell growth, harbouring desired properties as biodegradable wound dressing. \u2022 Simultaneous electrospinning of nanofiber P(3HB-co-4HB)/collagen construct using dual syringe system. \u2022 Nanofibrous construct accelerated wound healing with efficient cellular organization.\n[Simultaneous dual syringe electrospinning system using benign solvent to fabricate nanofibrous P(3HB-co-4HB)/collagen peptides construct as potential leave-on wound dressing](http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=22579736) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nVigneswari, S. [Malaysian Institute of Pharmaceuticals and Nutraceuticals, NIBM, MOSTI, 11700 Penang (Malaysia); Institute of Marine Biotechnology, Universiti Malaysia Terengganu, 21030 Kuala Terengganu (Malaysia); Murugaiyah, V. [School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11700 Penang (Malaysia); Kaur, G. [Institute of Research in Molecular Medicine, Universiti Sains Malaysia, 11700 Penang (Malaysia); Abdul Khalil, H.P.S. [School of Industrial Technology, Universiti Sains Malaysia, 11700 Penang (Malaysia); Amirul, A.A., E-mail: amirul@usm.my [Malaysian Institute of Pharmaceuticals and Nutraceuticals, NIBM, MOSTI, 11700 Penang (Malaysia); School of Biological Sciences, Universiti Sains Malaysia, 11800 Penang (Malaysia); Centre of Chemical Biology, Universiti Sains Malaysia, 11900 Penang (Malaysia)\n2016-09-01\nThe main focus of this study is the incorporation of collagen peptides to fabricate P(3-hydroxybutyrate-co-4-hydroxybutyrate) [P(3HB-co-4HB)] nano-fiber construct to further enhance surface wettability and support cell growth while harbouring desired properties for biodegradable wound dressing. Simultaneous electrospinning of nanofiber P(3HB-co-4HB)/collagen peptides construct was carried out using dual syringe system. The wettability of the constructs increased with the increase in 4HB molar fraction from 20 mol% 4HB [53.2\u00b0], P(3HB-co-35 mol%4HB)[48.9\u00b0], P(3HB-co-50 mol%4HB)[44.5\u00b0] and P(3HB-co-82 mol%4HB) [37.7\u00b0]. In vitro study carried out using mouse fibroblast cells (L929) grown on nanofiber P(3HB-co-4HB)/collagen peptides construct showed an increase in cell proliferation. In vivo study using animal model (Sprague Dawley rats) showed that nanofibrous P(3HB-co-4HB)/collagen peptides construct had a significant effect on wound contractions with the highest percentage of wound closure of 79%. Hence, P(3HB-co-4HB)/collagen peptides construct suitable for wound dressing have been developed using nano-fabrication technique. - Highlights: \u2022 Nano-fiber construct to enhance surface wettability and cell growth, harbouring desired properties as biodegradable wound dressing. \u2022 Simultaneous electrospinning of nanofiber P(3HB-co-4HB)/collagen construct using dual syringe system. \u2022 Nanofibrous construct accelerated wound healing with efficient cellular organization.\n[Measurements of red cell deformability and hydration reflect HbF and HbA2 in blood from patients with sickle cell anemia.](https://www.ncbi.nlm.nih.gov/pubmed/28472705)\nParrow, Nermi L; Tu, Hongbin; Nichols, James; Violet, Pierre-Christian; Pittman, Corinne A; Fitzhugh, Courtney; Fleming, Robert E; Mohandas, Narla; Tisdale, John F; Levine, Mark\n2017-06-01\nDecreased erythrocyte deformability, as measured by ektacytometry, may be associated with disease severity in sickle cell anemia (SCA). Heterogeneous populations of rigid and deformable cells in SCA blood result in distortions of diffraction pattern measurements that correlate with the concentration of hemoglobin S (HbS) and the percentage of irreversibly sickled cells. We hypothesize that red cell heterogeneity, as well as deformability, will also be influenced by the concentration of alternative hemoglobins such as fetal hemoglobin (HbF) and the adult variant, HbA 2 . To test this hypothesis, we investigate the relationship between diffraction pattern distortion, osmotic gradient ektacytometry parameters, and the hemoglobin composition of SCA blood. We observe a correlation between the extent of diffraction pattern distortions and percentage of HbF and HbA 2 . Osmotic gradient ektacytometry data indicate that minimum elongation in the hypotonic region is positively correlated with HbF, as is the osmolality at which it occurs. The osmolality at both minimum and maximum elongation is inversely correlated with HbS and HbA 2 . These data suggest that HbF may effectively improve surface-to-volume ratio and osmotic fragility in SCA erythrocytes. HbA 2 may be relatively ineffective in improving these characteristics or cellular hydration at the levels found in this patient cohort. Copyright \u00a9 2017. Published by Elsevier Inc.\n[La emigraci\u00f3n cubana a Estados Unidos desde una perspectiva econom\u00e9trica](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::b02a57661d19008e458fea569a4b230a)\nCobas Vald\u00e9s, Aleida\n2017-01-01\n220 p. Se estima que cerca de 244 millones de personas, en el a\u00f1o 2015, viv\u00edan en un pa\u00eds diferente al que les vio nacer. Dentro de este flujo migratorio creciente, han estado presentes, desde los a\u00f1os 30 del siglo pasado, los cubanos. La migraci\u00f3n desde Cuba ha estado orientada hist\u00f3ricamente hacia Estados Unidos, pa\u00eds donde viven m\u00e1s de 2 millones de personas de origen cubano.Para lograr entender la emigraci\u00f3n cubana, desde el momento de la toma de la decisi\u00f3n de emigrar hasta la integra...\n[Economic impact of pneumococcal conjugate vaccination in Brazil, Chile, and Uruguay Impacto econ\u00f3mico de la vacuna antineumoc\u00f3cica conjugada en Brasil, Chile y Uruguay](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892008000800004) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDagna O. Constenla\n2008-08-01\nFull Text Available OBJECTIVES: To evaluate the economic impact of vaccination with the pneumococcal 7-valent conjugate vaccine (PCV7 in Brazil, Chile, and Uruguay. METHODS: A decision analytic model was constructed to compare pneumococcal vaccination of children 0-5 years old with no vaccination in Brazil, Chile, and Uruguay. Costs and health outcomes were analyzed from the societal perspective. Vaccine, demographic, epidemiologic, and cost data were incorporated into this economic analysis. RESULTS: At the rate of diphtheria-tetanus-pertussis (DTP vaccine coverage and a vaccine price of US$ 53 per dose, PCV7 was projected to prevent 23 474 deaths per year in children under 5 years old in the three countries studied, thus averting 884 841 disability-adjusted life years (DALYs yearly. To vaccinate the entire birth cohort of the three countries, total vaccine costs would be US$ 613.9 million. At US$ 53 per dose, the cost per DALY averted from a societal perspective would range from US$ 664 (Brazil to US$ 2 019 (Chile. At a cost of US$ 10 per dose, vaccine cost is lower than the overall cost of illness averted (US$ 125 050 497 versus US$ 153 965 333, making it cost effective and cost-saving. CONCLUSIONS: The results of this study demonstrate that the incorporation of PCV7 vaccine at US$ 53 per dose confers health benefits at extra costs. It is unclear whether vaccination at the current price is affordable to these countries.OBJETIVOS: Evaluar el impacto econ\u00f3mico de la aplicaci\u00f3n de la vacuna antineumoc\u00f3cica conjugada heptavalente (PCV7 en Brasil, Chile y Uruguay. M\u00c9TODOS: Se elabor\u00f3 un modelo anal\u00edtico de decisiones para comparar la vacunaci\u00f3n antineumoc\u00f3cica de los ni\u00f1os de 0-5 a\u00f1os de edad con la no vacunaci\u00f3n, en Brasil, Chile y Uruguay. Los costos y los desenlaces para la salud se analizaron desde el punto de vista de la sociedad. Al an\u00e1lisis econ\u00f3mico se incorporaron los costos y los datos demogr\u00e1ficos, epidemiol\u00f3gicos y de la vacuna. RESULTADOS\n[Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRanjit Unnikrishnan\n2012-01-01\nFull Text Available Glycated hemoglobin (HbA1c is an important indicator of glycemic control in diabetes mellitus, based on which important diagnostic and therapeutic decisions are routinely made. However, there are several situations in which the level of HbA1c may not faithfully reflect the glycemic control in a given patient. Important among these is the use of certain non-diabetic medications, which can affect the HbA1c levels in different ways. This review focuses on the non-diabetic medications which can inappropriately raise or lower the HbA1c levels, and the postulated mechanisms for the same.\n[[About the HbA1c in the elderly].](https://www.ncbi.nlm.nih.gov/pubmed/27005335)\nFarcet, Ana\u00efs; Delalande, G\u00e9raldine; Oliver, Charles; Retornaz, Fr\u00e9d\u00e9rique\n2016-03-01\nHbA1c product of non enzymatic glycation of HbA increases in relation with the mean blood glucose level during the former 2-3 months. HbA1c levels are correlated with the development of diabetic complications and HbA1c assessment is now the gold standard for evaluation of diabetes control. HbA1c level should not be higher than 7% to avoid these complications. However, in aged peoples, the objectives of diabetes control vary according to their health status. It must be good with HbA1c lower than 7-7.5% in healthy subjects and more relax in subjects with symptoms of frailty and risks of non perceived and self corrected hypoglycemia. Under these conditions, HbA1c values lower than 8 to 9% are advised. Nevertheless, hypoglycemia episodes may occur in patients with high HbA1c and capillary glucose follow-up is necessary for detection of such complications.\n[Recomendaci\u00c3\u00b3n sobre la vacuna contra la tosferina para los preadolescentes y adolescentes(Whooping Cough Vaccine Recommendation for Preteens and Teens)](https://tools.cdc.gov/medialibrary/index.aspx#/media/id/303181) [Centers for Disease Control (CDC) Podcasts](http://www2c.cdc.gov/podcasts/search.asp)\nEste podcast proporciona informaci\u00c3\u00b3n acerca de la tosferina y la recomendaci\u00c3\u00b3n de que todos los preadolescentes reciban la vacuna Tdap a los 11 o 12 a\u00c3\u00b1os para ayudar a protegerlos contra esta grave enfermedad.\n[Detection of Hb Constant Spring (HBA2: c.427T>C) Heterozygotes in Combination with \u03b2-Thalassemia or Hb E Trait by Capillary Electrophoresis.](https://www.ncbi.nlm.nih.gov/pubmed/25884994)\nPornprasert, Sakorn; Saoboontan, Supansa; Punyamung, Manoo\n2015-01-01\nHb Constant Spring (Hb CS; HBA2: c.427T>C) is often missed by routine laboratory testing as its mRNA as well as gene product are unstable and presented at a low level in peripheral blood. This study aimed to analyze the efficacy of capillary electrophoresis (CE) for detecting and quantifying of Hb CS in \u03b2-thalassemia (\u03b2-thal) trait or Hb E (HBB: c.79G>A) trait samples with reduced \u03b2-globin chain expression. Thalassemia diagnostic data were reviewed in 2524 blood samples that were submitted to the laboratory of the Associated Medical Sciences Clinical Service Center, Chiang Mai, Thailand for hemoglobinopathy and thalassemia diagnosis. DNA analysis for Hb CS was performed in 322 \u03b2-thal trait and 397 Hb E trait samples using the amplification refractory mutation system (ARMS). The CE electropherogram of Hb CS at zone 2 was observed in all five samples with \u03b2-thal trait and nine samples with Hb E trait with levels varying from 0.1-2.8 and 0.1-2.3%, respectively. Thus, the CE method proved useful for screening of Hb CS in samples with \u03b2-thal trait or Hb E trait, which is essential for providing accurate diagnosis, genetic counseling, prevention and control programs of Hb H-CS disease.\n[Inhibition of Hb Binding to GP1b\u03b1 Abrogates Hb-Mediated Thrombus Formation on Immobilized VWF and Collagen under Physiological Shear Stress.](https://www.ncbi.nlm.nih.gov/pubmed/27105433)\nAnnarapu, Gowtham K; Singhal, Rashi; Peng, Yuandong; Guchhait, Prasenjit\n2016-01-01\nReports including our own describe that intravascular hemolysis increases the risk of thrombosis in hemolytic disorders. Our recent study shows that plasma Hb concentrations correlate directly with platelet activation in patients with paroxysmal nocturnal hemoglobinuria (PNH). The binding of Hb to glycoprotein1b\u03b1 (GP1b\u03b1) increases platelet activation. A peptide AA1-50, designed from N-terminal amino acid sequence of GP1b\u03b1 significantly inhibits the Hb binding to GP1b\u03b1 as well as Hb-induced platelet activation. This study further examined if the Hb-mediated platelet activation plays any significant role in thrombus formation on subendothelium matrix under physiological flow shear stresses and the inhibition of Hb-platelet interaction can abrogate the above effects of Hb. Study performed thrombus formation assay in vitro by perfusing whole blood over immobilized VWF or collagen type I in presence of Hb under shear stresses simulating arterial or venous flow. The Hb concentrations ranging from 5 to 10 \u03bcM, commonly observed level in plasma of the hemolytic patients including PNH, dose-dependently increased thrombus formation on immobilized VWF under higher shear stress of 25 dyne/cm2, but not at 5 dyne/cm2. The above Hb concentrations also increased thrombus formation on immobilized collagen under both shear stresses of 5 and 25 dyne/cm2. The peptide AA1-50 abrogated invariably the above effects of Hb on thrombus formation. This study therefore indicates that the Hb-induced platelet activation plays a crucial role in thrombus formation on immobilized VWF or collagen under physiological flow shear stresses. Thus suggesting a probable role of this mechanism in facilitating thrombosis under hemolytic conditions.\n[Alcaloides en la especie cubana Croton micradenus Urb](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75152001000100011) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nArmando Payo Hill\n2001-04-01\nFull Text Available Se emprendi\u00f3 el estudio del contenido de alcaloides en las hojas y tallos de la especie end\u00e9mica cubana, potencialmente medicinal, Crot\u00f3n micradenus Urb. Para la extracci\u00f3n y purificaci\u00f3n de dichos metabolitos se utilizaron solventes org\u00e1nicos y m\u00e9todos cromatogr\u00e1ficos de separaci\u00f3n por columna y placa. Mediante m\u00e9todos espectrosc\u00f3picos de UV, IR, Masa y RMN \u00b9H y 13C, as\u00ed como por la medici\u00f3n de sus constantes f\u00edsicas, se caracterizaron 4 de los 6 alcaloides aislados, de ellos 3 morfinandienonas: ocobotrina, sinoacutina y 8,14 dihidrosalutaridina y una aporfina: isoboldina.The study of the content of alkaloids in the leaves and stems of the Croton micradenus Urb Cuban endemic species, which is potentially medicinal, was conducted. Organic solvents and chromatographic methods of separation by column and plate were used for the extraction and purification of these metabolites. 4 of the 6 isolated alkaloids, 3 of them morphinandienones: ocobotrine, sinoacutine and 8,14-dihydrosalutaridine and an aporphine (Isobol-dine were characterized by spectroscopic methods of UV, IR, Mass and NMR \u00b9H and 13C, as well as by the measurement of their physical constants.\n[Farmacovigilancia en la literatura m\u00e9dica cubana](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75151996000100006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMar\u00eda de los Angeles Pe\u00f1a Machado\n1996-04-01\nFull Text Available Se aborda el tema de la vigilancia farmacol\u00f3gica, para lo cual se seleccionaron las publicaciones que aparec\u00edan en 5 revistas m\u00e9dicas cubanas, que suger\u00edan alguna relaci\u00f3n con las reacciones adversas de los medicamentos. Se describen las caracter\u00edsticas comunes y diferenciales de dichos art\u00edculos, haciendo \u00e9nfasis en las posibilidades de desarrollo de la farmacovigilancia, que es una necesidad en nuestro pa\u00eds, donde la producci\u00f3n y comercializaci\u00f3n de los f\u00e1rmacos es una realidad objetiva. Se sugieren m\u00e9todos para estimular al personal m\u00e9dico en la pesquisa de reacciones adversas de los medicamentos.The theme of drug surveillance is approached, and for this purpose, publications appeared in five Cuban medical journals were selected; these articles suggested a certain relation with drugs adverse reactions. The common characteristics, and the differences of such articles, are described, emphasizing in the development possibilities of drug surveillance, an item that is a necessity in our country, where drug production and marketing is an objective reality. Methods for the stimulation of the medical staff in search for drugs adverse reactions, are suggested.\n[Preventive vaccines for cervical cancer Vacunas para prevenir el c\u00e1ncer cervical](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36341997000400006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nCOSETTE M WHEELER\n1997-07-01\nFull Text Available The potential use of vaccines for the human papillomavirus (HPV in the prevention and treatment of cervical cancer is a possibility in the near future. Close to 20 genotypes of HPV, of the 75 that have been identified, infect the femine genital tract, but four subtypes (16, 18, 31 and 45 have been associated in close to 80% of cervical cancers. this article proposes that in order to design an effective prophylactic vaccine against HPV infection, an adequate immune response should be guaranteed through four goals; a activation of antigens present in the cell; b overcoming the host response and viral genetic variability in the T cell response; c generation of high levels of T and B memory cells; and d persistence of antigens.El potencial uso de vacunas de virus del papiloma humano (VPH en la prevenci\u00f3n y tratamiento del c\u00e1ncer cervical posiblemente ser\u00e1 implementado durante los pr\u00f3ximos a\u00f1os. Cerca de los 20 genotipos de VPH de los 75 que se encuentran identificados infectan el tracto genital femenino, pero son cuatro subtipos: 16, 18, 31 y 45 los que se han asociado en cerca de 80% a c\u00e1ncer cervical. En este ensayo se plantea que para poder dise\u00f1ar una vacuna profil\u00e1ctica contra la infecci\u00f3n de VPH, efectiva, se debe garantizar una adecuada respuesta inmune a trav\u00e9s de cuatro metas: a activaci\u00f3n de ant\u00edgenos presentes en la c\u00e9lula; b superar la respuesta del hu\u00e9sped y la variabilidad gen\u00e9tica viral en la respuesta de c\u00e9lulas T; c generaci\u00f3n de altos niveles de c\u00e9lulas T y B de memoria, y d persistencia de ant\u00edgenos.\n[Cadena del fr\u00edo para la conservaci\u00f3n de las vacunas en los centros de atenci\u00f3n primaria de un \u00e1rea de Madrid: mantenimiento y nivel de conocimientos](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1135-57272002000400008) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nOrtega Molina Paloma\n2002-01-01\nFull Text Available Fundamento. Las vacunas son medicamentos termol\u00e1biles y para garantizar su inmunogenicidad y eficacia protectora, dentro de los programas de inmunizaci\u00f3n, es imprescindible mantener la cadena de fr\u00edo. El elemento fundamental en esta cadena es el personal responsable de las vacunas, que debe conocer las caracter\u00edsticas de estabilidad de cada preparado con el fin de evitar errores durante su manipulaci\u00f3n. El objetivo de este trabajo fue conocer c\u00f3mo se realiza el mantenimiento de la cadena del fr\u00edo en equipos de atenci\u00f3n primaria de un \u00e1rea sanitaria de la Comunidad Aut\u00f3noma de Madrid, as\u00ed como establecer el grado de informaci\u00f3n que poseen los responsables de las vacunas con respecto a la termoestabilidad de las mismas. M\u00e9todos. Se ha realizado un estudio transversal en 46 puntos de vacunaci\u00f3n en atenci\u00f3n primaria. La recogida de los datos se realiz\u00f3 mediante entrevista personal por un \u00fanico investigador. Resultados. La tasa de participaci\u00f3n fue del 93,5% (43/46. En todos los casos exist\u00eda term\u00f3metro de m\u00e1xima y m\u00ednima y registro mensual de la temperatura. Se observ\u00f3 una temperatura inadecuada en tres ocasiones (6,97%. El porcentaje de profesionales que conoc\u00eda el efecto que la congelaci\u00f3n produc\u00eda sobre las vacunas fue muy diverso: 53.5%, 51.2%, 44.2% y 53.5% para difteria-t\u00e9tanos-pertussis (DTP, hepatitis B (VHB, polio oral (VPO y rub\u00e9ola-sarampi\u00f3n-paperas (RSP respectivamente. Y s\u00f3lo el 32% conoc\u00eda el test de agitaci\u00f3n. Conclusi\u00f3n. La formaci\u00f3n de los profesionales sobre el efecto que las altas temperaturas ocasionan en las vacunas era correcta, pero es necesario reforzar su formaci\u00f3n sobre la inestabilidad que presentan los preparados adsorbidos cuando se someten a congelaci\u00f3n.\n[El tr\u00e1nsito de migrantes por Costa Rica: el caso de las personas cubanas que persiguen el \u00absue\u00f1o americano\u00bb](http://investiga.uned.ac.cr/revistas/index.php/espiga/article/view/1800) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGabriela Villalobos-Torres\n2018-03-01\nFull Text Available La migraci\u00f3n de personas cubanas por Costa Rica en b\u00fasqueda de alcanzar el sue\u00f1o americano, hace que se aventuren en una traves\u00eda de grandes riesgos, en ella se ven envueltos en el pago de \u00abcoyotes\u00bb para cruzar pasos fronterizos o para que les eviten complicaciones con polic\u00edas de migraci\u00f3n, con el ej\u00e9rcito o con las guerrillas. El estudio permiti\u00f3 conocer las motivaciones para que las personas cubanas arriesguen sus vidas, conocer el camino recorrido, determinar la presencia de \u00abcoyotes\u00bb y redes de tr\u00e1fico de personas y el pago que les brindan; as\u00ed como conocer qu\u00e9 entienden por trata de personas y tr\u00e1fico il\u00edcito de migrantes. Los resultados obtenidos permiten contar con un panorama de las implicaciones de la migraci\u00f3n para Costa Rica.\n[Vectores recombinantes basados en el virus Vaccinia modificado de Ankara (MVA) como vacunas contra la leishmaniasis](https://www.openaire.eu/search/publication?articleId=od______1106::2d0994ebc04aca806f25b6ad7129d7d2)\nP\u00e9rez Jim\u00e9nez, Eva; Larraga, Vicente; Esteban, Mariano\n2005-01-01\nVectores recombinantes basados en el virus vaccinia modificado de Ankara (MVA) como vacunas contra la leishmaniasis. Los vectores de la invenci\u00f3n contienen secuencias codificantes de la prote\u00edna LACK, preferentemente insertadas en el locus de hemaglutinina del virus y bajo el control de un promotor que permite su expresi\u00f3n a lo largo del ciclo de infecci\u00f3n del virus. Son vectores seguros, estables, que dan lugar a una potente respuesta inmune que confiere protecci\u00f3n frente a la leishmaniasis,...\n[Activaci\u00f3n del polisac\u00e1rido capsular de Streptococcus pneumoniae serotipo 23F para la obtenci\u00f3n de vacunas conjugadas](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2017000100002&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJanoi Chang-Calder\u00f3n\n2017-04-01\nFull Text Available En la actualidad, las vacunas conjugadas constituyen un gran hito en el desarrollo de f\u00e1rmacos que protegen contra las enfermedades infecciosas. Estas vacunas no solo disminuyen dr\u00e1sticamente la mortalidad y morbilidad de diferentes enfermedades causadas por bacterias en la poblaci\u00f3n infantil; sino que tambi\u00e9n repercuten sobre la poblaci\u00f3n no vacunada. Las vacunas conjugadas se basan en establecer una uni\u00f3n covalente entre un polisac\u00e1rido y una prote\u00edna portadora para lo cual existen diferentes procedimientos qu\u00edmicos. Todos los procedimientos de conjugaci\u00f3n requieren la presencia de grupos reactivos complementarios que muchas veces son generados en ambas macromol\u00e9culas. Este trabajo se enfoca en el estudio de la reacci\u00f3n de fragmentaci\u00f3n y de la oxidaci\u00f3n pery\u00f3dica sobre el polisac\u00e1rido capsular serotipo 23F de Streptococcus pneumoniae para su uso como ant\u00edgeno vacunal. Se estableci\u00f3 la fragmentaci\u00f3n del polisac\u00e1rido mediante hidr\u00f3lisis con \u00e1cido ac\u00e9tico y trifluoro\u00e1cetico. En el caso de la reacci\u00f3n de oxidaci\u00f3n se encontr\u00f3 que la cantidad de moles de peryodato de sodio y la temperatura influyen de manera directamente proporcional sobre la generaci\u00f3n de grupos carbonilos. Adicionalmente se demostr\u00f3 que el sustituyente glicerol-fosfatos presente en la estructura del serotipo 23F es relevante para conservar la antigenicidad. El procedimiento descrito permite obtener conjugados inmunog\u00e9nicos a partir del polisac\u00e1rido capsular de Streptococcus pneumoniae serotipo 23F en el modelo de conejos.\n[Pregnancy outcome in patients with sickle cell disease in the UK--a national cohort study comparing sickle cell anaemia (HbSS) with HbSC disease.](https://www.ncbi.nlm.nih.gov/pubmed/25522142)\nOteng-Ntim, Eugene; Ayensah, Benjamin; Knight, Marian; Howard, Jo\n2015-04-01\nWe describe the findings from a national study of maternal and fetal outcomes of pregnancy in women with sickle cell disease (SCD). Data were collected via the United Kingdom Obstetric Surveillance System between 1 February 2010 and 31 January 2011 from 109 women, of whom 51 (46\u00b78%) had HbSS and 44 (40\u00b74%) had HbSC. Data included antenatal, maternal and fetal outcomes. Comparisons were made between women with HbSS and HbSC. Incidence of complications were acute pain (57%), blood transfusion (26%), urinary tract infection (UTI; 12%) and critical care unit admission (23%) and these were all more common in women with HbSS than HbSC. There was no difference in the incidence of acute chest syndrome, hypertension and venous thromboembolism between HbSS and HbSC. Women with HbSS were more likely to deliver at pregnancy. \u00a9 2014 John Wiley & Sons Ltd.\n[Characterization of Hb Lepore variants in the UK population.](https://www.ncbi.nlm.nih.gov/pubmed/25490067)\nGuo, Lina; Kausar, Anika; Old, John M; Henderson, Shirley J; Gallienne, Alice E\n2015-01-01\nA molecular study of Hb Lepore heterozygotes identified by the UK population screening program has revealed four out of the five known Lepore variants. The region of homologous \u03b4- and \u03b2-globin gene sequence was determined in 58 unrelated Hb Lepore heterozygotes referred for confirmation of their carrier status by DNA analysis through the national thalassemia and sickle cell screening program over a period of 10 years. The most common variant found was Hb Lepore-Boston-Washington (Hb LBW, HBD: c.265 C > c.315 + 7 C) observed in 46 carriers (79.0%). Hb Lepore-Hollandia (HBD: c.69 A > c.92 + 16 A) was found in nine cases (16.0%); Hb Lepore-Baltimore (HBD: c.208 G > c.254 C) in two cases (4.0%) and Hb Lepore-ARUP (HBD: c.97 C > c.150 C) in one carrier (2.0%). Analysis of the hematological findings showed no significant differences between the four groups. The wide range of Hb Lepore variants observed in this study confirms the very diverse range of \u03b1- and \u03b2-globin gene mutations observed in the UK population by previous studies.\n[Hb D/Talassemia beta associada \u00e0 anemia cr\u00f4nica Hb D/ Beta thalassaemia associated with chronic anaemia](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842002000100010) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nPaulo C. Naoum\n2002-03-01\nFull Text Available We describe a case of Hb D/Beta thalassemia associated with chronic anemia. Hematological analyses performed in a patient with chronic anemia demonstrating microcytosis and hypochromic in his erythrocytes. Specific laboratory diagnosis performed by alkaline and acid electrophoresis, and fetal determination by alkali resistance, indicated it to be Hb D associated with beta thalassemia. Analyses carried out on his family (father, mother and brother confirmed the suspected diagnosis. Hb D/Beta thalassemia is a very rare interaction in the Brazilian population, and its determination required specific laboratorial techniques and hematological analyses.\n[Influ\u00eancia da alimenta\u00e7\u00e3o de Anagasta kuehniella Zeller(Lepidoptera: Pyralidae no desenvolvimento de Ceraeochrysa cubana Hagen (Neuroptera: Chrysopidae](http://www.periodico.ebras.bio.br/ojs/index.php/ebras/article/view/ebrasilis.v10i1.641) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGilmar Nunes\n2017-04-01\nAbstract. Aimed to evaluate the biological development of Ceraeochrysa cubana Hagen immature stages fed on eggs of the mothsubmitted to different food substrates with ingredients on different concentrations (%: Corn flour (50% + Wheat flour (50% + Brewer\u00e2\u20ac\u2122s yeast (3%; Transgenic corn flour (50% + Wheat flour (50% + Brewer\u00e2\u20ac\u2122s yeast (3%; Breadcrumbs (97% + Brewer\u00e2\u20ac\u2122s yeast (3%; Breadcrumbs (48.5% + Wheat flour (48.5% + Brewer\u00e2\u20ac\u2122s yeast (3%; Rice flour (97% + Brewer\u00e2\u20ac\u2122s yeast (3%; Rice flour (48.5% + Wheat flour (48.5 % + Brewer\u00e2\u20ac\u2122s yeast (3%; Oatmeal (97% + Brewer\u00e2\u20ac\u2122s yeast (3%; Oatmeal (48.5% + Wheat flour (48.5% + Brewer\u00e2\u20ac\u2122s yeast (3%. We evaluated the period of each larval stage, complete larval period, pre pupal+pupal period, and larva to adulthood period, larval and pupal feasibility. Diets with oatmeal provided for moth promote greater time for the predator reach adulthood, with rice flour low sex ratio and with breadcrumbs low pupal feasibility. Diets formulated with corn flours + brewer\u00e2\u20ac\u2122s yeast are most recommended for Ephestia kuehniella Zeller, aiming C. cubana mass rearing.\n[Can the Afinion HbA1c Point-of-Care instrument be an alternative method for the Tosoh G8 in the case of Hb-Tacoma?](https://www.ncbi.nlm.nih.gov/pubmed/27191339)\nLenters-Westra, Erna; Strunk, Annuska; Campbell, Paul; Slingerland, Robbert J\n2017-02-01\nHb-variant interference when reporting HbA1c has been an ongoing challenge since HbA1c was introduced to monitor patients with diabetes mellitus. Most Hb-variants show an abnormal chromatogram when cation-exchange HPLC is used for the determination of HbA1c. Unfortunately, the Tosoh G8 generates what appears to be normal chromatogram in the presence of Hb-Tacoma, yielding a falsely high HbA1c value. The primary aim of the study was to investigate if the Afinion HbA1c point-of-care (POC) instrument could be used as an alternative method for the Tosoh G8 when testing for HbA1c in the presence of Hb-Tacoma. Whole blood samples were collected in K 2 EDTA tubes from individuals homozygous for HbA (n = 40) and heterozygous for Hb-Tacoma (n = 20). Samples were then immediately analyzed with the Afinion POC instrument. After analysis, aliquots of each sample were frozen at -80 \u00b0C. The frozen samples were shipped on dry ice to the European Reference Laboratory for Glycohemoglobin (ERL) and analyzed with three International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and National Glycohemoglobin Standardization Program (NGSP) Secondary Reference Measurement Procedures (SRMPs). The Premier Hb9210 was used as the reference method. When compared to the reference method, samples with Hb-Tacoma yielded mean relative differences of 31.8% on the Tosoh G8, 21.5% on the Roche Tina-quant Gen. 2 and 16.8% on the Afinion. The Afinion cannot be used as an alternative method for the Tosoh G8 when testing for HbA1c in the presence of Hb-Tacoma.\n[EMPRESAS DE DISE\u00d1O E INGENIER\u00cdA CUBANAS EN SU TR\u00c1NSITO HACIA EMPRESAS DE CLASE MUNDIAL](http://rii.cujae.edu.cu/index.php/revistaind/article/view/224) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJos\u00e9 Alfonso Mac\u00edas Mesa\n2002-10-01\nFull Text Available Las empresas de dise\u00f1o e ingenier\u00eda cubanas tienen ante s\u00ed el reto de la competitividad, siendo empresas estatales socialistas que aplican el perfeccionamiento empresarial. Deben lograr estar posicionadas adecuadamente y transitar hacia empresas de clase mundial. En este art\u00edculo los autores presentan sus consideraciones, de c\u00f3mo, en el entorno cubano y dadas las experiencias pret\u00e9ritas de este sector, debe ser el tr\u00e1nsito.\nLas empresas de dise\u00f1o e ingenier\u00eda cubanas tienen ante s\u00ed el reto de la competitividad, siendo empresas estatales socialistas que aplican el perfeccionamiento empresarial. Deben lograr estar posicionadas adecuadamente y transitar hacia empresas de clase mundial. En este art\u00edculo los autores presentan sus consideraciones, de c\u00f3mo, en el entorno cubano y dadas las experiencias pret\u00e9ritas de este sector, debe ser el tr\u00e1nsito.\n[HB-Line Plutonium Oxide Data Collection Strategy](http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=1204359) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nWatkins, R. [Savannah River Nuclear Solutions; Varble, J. [Savannah River Nuclear Solutions; Jordan, J. [Savannah River Nuclear Solutions\n2015-05-26\nHB-Line and H-Canyon will handle and process plutonium material to produce plutonium oxide for feed to the Mixed Oxide Fuel Fabrication Facility (MFFF). However, the plutonium oxide product will not be transferred to the MFFF directly from HB-Line until it is packaged into a qualified DOE-STD-3013-2012 container. In the interim, HB-Line will load plutonium oxide into an inner, filtered can. The inner can will be placed in a filtered bag, which will be loaded into a filtered outer can. The outer can will be loaded into a certified 9975 with getter assembly in compliance with onsite transportation requirement, for subsequent storage and transfer to the K-Area Complex (KAC). After DOE-STD-3013-2012 container packaging capabilities are established, the product will be returned to HB-Line to be packaged into a qualified DOE-STD-3013-2012 container. To support the transfer of plutonium oxide to KAC and then eventually to MFFF, various material and packaging data will have to be collected and retained. In addition, data from initial HB-Line processing operations will be needed to support future DOE-STD-3013-2012 qualification as amended by the HB-Line DOE Standard equivalency. As production increases, the volume of data to collect will increase. The HB-Line data collected will be in the form of paper copies and electronic media. Paper copy data will, at a minimum, consist of facility procedures, nonconformance reports (NCRs), and DCS print outs. Electronic data will be in the form of Adobe portable document formats (PDFs). Collecting all the required data for each plutonium oxide can will be no small effort for HB-Line, and will become more challenging once the maximum annual oxide production throughput is achieved due to the sheer volume of data to be collected. The majority of the data collected will be in the form of facility procedures, DCS print outs, and laboratory results. To facilitate complete collection of this data, a traveler form will be developed which\n[Low oxygen saturation and severe anemia in compound heterozygous Hb Louisville [\u03b242(CD1)Phe\u2192Leu] and Hb La Desirade [\u03b2129(H7)Ala\u2192Val].](https://www.ncbi.nlm.nih.gov/pubmed/27670359)\nKamseng, Parin; Trakulsrichai, Satariya; Trachoo, Objoon; Yimniam, Walaiporn; Panthan, Bhakbhoom; Jittorntam, Paisan; Niparuck, Pimjai; Sanguanwit, Pitsucha; Wananukul, Winai; Jindadamrongwech, Sumalee\n2017-03-01\nTo investigate the cause(s) of a Thai male proband presenting low oxygen saturation by pulse oximetry (SpO 2 ) and severe anemia. As Hb variant was suspected, Hb typing was determined by high-performance liquid chromatography and capillary electrophoresis, and subsequently Hb variant was identified by DNA sequencing. Complete blood counts were performed using automated blood cell counter and oxygen saturation was measured by pulse oximetry. Proband was compound heterozygous for Hb Louisville [\u03b242(CD1)Phe\u2192Leu] and Hb La Desirade [\u03b2129(H7)Ala\u2192Val]. Of the proband's two sons, one was compound heterozygous for Hb Louisville and Hb E and the other for Hb La Desirade and Hb E. The former son had similar clinical features and laboratory findings with those of the proband while the latter showed had no abnormal clinical manifestations. This the first report of compound heterozygosity of Hb Louisville and Hb La Desirade in an individual of Southeast Asian ethnicity. Hb variant identification is crucial for genetic counseling and appropriate treatment in regions where hemoglobinopathies are common.\n[Hb Dartmouth (HBA2: c.200T>C): An \u03b12-Globin Gene Associated with Hb H Disease in One Homozygous Patient.](https://www.ncbi.nlm.nih.gov/pubmed/25976777)\nFarashi, Samaneh; Faramarzi Garous, Negin; Ashki, Mehri; Vakili, Shadi; Zeinali, Fatemah; Imanian, Hashem; Azarkeivan, Azita; Najmabadi, Hossein\n2015-01-01\nHb H (\u03b24) disease is caused by deletion or inactivation of three out of four \u03b1-globin genes. A high incidence of Hb H disease has been reported all over the world. There is a wide spectrum of phenotypic presentations, from clinically asymptomatic to having significant hepatosplenomegaly and requiring occasional or even regular blood transfusions, even more severe anemia, Hb Bart's (\u03b34) hydrops fetalis syndrome that can cause death in the affected fetuses late in gestation. We here present a case who was diagnosed with Hb H disease that represents a new genotype for this hereditary disorder. Hb Dartmouth is a variant caused by a missense mutation at codon 66 of the \u03b12-globin gene (HBA2: c.200T>C), resulting in the substitution of leucine by proline. We here emphasize the importance of this point mutation involving Hb H disease and also the necessity for prenatal diagnosis (PND) for those who carry this point mutation in the heterozygous state.\n[Evaluation of experimental vaccines for bovine viral diarrhea in bovines, ovines and guinea pigs Evaluaci\u00f3n de vacunas experimentales para la diarrea viral bovina en bovinos, ovinos y cobayos](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412009000200005) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nF. Fern\u00e1ndez\n2009-06-01\nFull Text Available The bovine viral diarrhea virus (BVDV infection control should be based on elimination of persistently infected animals and on immunization through vaccination, to prevent fetal infection. However, the efficacy of inactivated BVDV vaccines is variable due to its low immunogenicity. This study evaluated the humoral immune response against homologous and heterologous strains of 7 inactivated BVDV vaccines, in bovines and two experimental models (ovine and guinea pig which might be used to test candidate vaccines. Vaccines formulated with BVDV Singer, Oregon, NADL, and multivalent, induced seroconversion in the three animal models studied, reaching antibody titres higher than 2. Vaccine containing 125C -genotype 2- only induced a low antibody response in ovine, while VS-115 NCP vaccine was not immunogenic. Furthermore, bovine sera at 60 dpv presented homologous as well as heterologous antibody response, indicating a high degree of cross-reactivity among the strains studied. However, when bovine sera were tested against the Argentine field strain 00-693, they showed the lowest levels of cross-reactivity, suggesting the need of continued surveillance to identify and characterize emerging field BVDV strains. Finally, optimal correlations between bovine-ovine and bovine-guinea pig models were observed, indicating that two alternative species could replace bovines when testing the immunogenicity of BVDV candidate vaccines.El control del virus de la diarrea viral bovina (VDVB se basa en la eliminaci\u00f3n de animales persistentemente infectados, y la inmunizaci\u00f3n de hembras para prevenir infecciones fetales. La eficiencia de estas vacunas es variable por su baja inmunogenicidad. Se evalu\u00f3 la respuesta inmune humoral contra virus hom\u00f3logos y heter\u00f3logos de 7 vacunas experimentales inactivadas del VDVB en bovinos y en dos modelos experimentales (ovinos y cobayos. Las vacunas conteniendo VDVB Singer, Oregon, NADL y polivalentes indujeron seroconversi\u00f3n en\n[Secondary polycythaemia in a Malay girl with homozygous Hb Tak.](https://www.ncbi.nlm.nih.gov/pubmed/29279598)\nAmran, H S; Aziz, M A; George, E; Mahmud, N; Lee, T Y; Md Noor, S\n2017-12-01\nHb Tak is one of more than 200 high affinity haemoglobin variants reported worldwide. It results from the insertion of two nucleotides (AC) at the termination codon, between codon 146 and codon 147 of the beta-globin gene [Beta 147 (+AC)]. Polycythaemia is the main clinical feature although affected carriers are usually asymptomatic and do not require intervention. Several case studies in this region have reported the co-inheritance of Hb Tak with Hb E, delta beta and beta thalassaemia with one case of homozygous Hb Tak in a Thai boy. In this case report, a cluster of haemoglobin Tak was found in a family of Malay ethnic origin. Cascade family screening was conducted while investigating a 4-year old girl who presented with symptomatic polycythaemia. She had 2 previous Hb analysis done, at 7-month and 2-year-old with the diagnosis of possible Hb Q Thailand and Homozygous Hb D, respectively. Both diagnosis did not fit her clinical presentations. She was plethoric, had reduced exercise tolerance as well as cardiomyopathy. Her parents were consanguineously married and later diagnosed as asymptomatic carriers of Hb Tak. Consequently, re-analysis of the girl's blood sample revealed a homozygous state of Hb Tak. In conclusion, high oxygen affinity haemoglobin like Hb Tak should be considered in the investigation of polycythaemic patients with abnormal Hb analyses. In this case, DNA analysis was crucial in determining the correct diagnosis.\n[Um olhar para a sa\u00fade p\u00fablica cubana](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-40142011000200008) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJos\u00e9 A. de la Osa\n2011-01-01\nFull Text Available Nas \u00faltimas cinco d\u00e9cadas, ap\u00f3s o triunfo da Revolu\u00e7\u00e3o em 1959, a medicina cubana atingiu avan\u00e7os not\u00e1veis em v\u00e1rias \u00e1reas. Este artigo prop\u00f5e um resumo cronol\u00f3gico, separado por temas, desses avan\u00e7os. O desenvolvimento de novos f\u00e1rmacos, a educa\u00e7\u00e3o sanit\u00e1ria da popula\u00e7\u00e3o, a cria\u00e7\u00e3o de hospitais e policl\u00ednicas e o acesso gratuito ao atendimento m\u00e9dico para toda a popula\u00e7\u00e3o s\u00e3o alguns dos fatores centrais analisados. O aumento do n\u00famero de profissionais na \u00e1rea m\u00e9dica tamb\u00e9m possibilitou a aproxima\u00e7\u00e3o dos servi\u00e7os b\u00e1sicos e preventivos (vacina\u00e7\u00e3o para todos os setores da popula\u00e7\u00e3o. Na mesma linha, e respondendo aos valores humanit\u00e1rios da Revolu\u00e7\u00e3o, as campanhas solid\u00e1rias realizadas pelos m\u00e9dicos cubanos s\u00e3o exemplo mundial de solidariedade.En las \u00faltimas cinco d\u00e9cadas, despu\u00e9s del triunfo de la Revoluci\u00f3n en 1959, la medicina cubana ha obtenido avances notables en varias \u00e1reas. Este art\u00edculo propone un recorrido cronol\u00f3gico, separado por temas, de esos avances. El desarrollo de nuevos f\u00e1rmacos, la educaci\u00f3n sanitaria, la creaci\u00f3n de hospitales y el acceso gratuito al atendimiento m\u00e9dico para toda la poblaci\u00f3n, son algunos de los factores centrales. Asimismo, el aumento del n\u00famero de profesionales en el \u00e1rea m\u00e9dica posibilit\u00f3 la aproximaci\u00f3n de los servicios b\u00e1sicos y preventivos (vacunaci\u00f3n para todos los sectores de la poblaci\u00f3n. En la misma l\u00ednea, y respondiendo a los valores humanitarios de la Revoluci\u00f3n, las campa\u00f1as solidarias realizadas por los m\u00e9dicos cubanos son ejemplo mundial de solidaridad.Over the last five decades, after the triumph of the Revolution in 1959, Cuban medicine made remarkable advances in several areas. This article provides a thematic timeline of those advances. The development of new drugs, hygiene and sanitary education for the people, the building of hospitals and polyclinics, and free access to medical care for the entire population are some of the\n[Aproximaci\u00f3n al tratamiento de los personajes femeninos en la narrativa cubana del per\u00edodo republicano](http://revistas.uo.edu.cu/index.php/stgo/article/view/140) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLic. Ronald Antonio Ram\u00edrez-Castellanos\n2015-10-01\nFull Text Available El presente art\u00edculo realiza un estudio preliminar del tratamiento de los personajes femeninos en la novel\u00edstica cubana del per\u00edodo republicano durante la etapa 1900-1940, teniendo en cuenta las principales obras y autores que integran el universo literario nacional. Desde esta perspectiva, el estudio perfila las bases para ulteriores investigaciones desde un enfoque de g\u00e9nero, y a su vez, contribuye a subsanar las carencias epistemol\u00f3gicas relacionadas con esta tem\u00e1tica.\n[Evaluaci\u00f3n de la actividad antimal\u00e1rica de algunas plantas utilizadas en la medicina tradicional cubana](https://www.openaire.eu/search/publication?articleId=doajarticles::a9d6493ca919442f461e731f2a8a6c9c)\nM. RODR\u00edGUEZ-P\u00e9REZ; J. M. MART\u00edNEZ; L. R. RIVERO; H. M.H. \u00c1LVAREZ; A. F.C. VALDEZ; D. A. RODR\u00edGUEZ; R. S. LIZAMA; J. A. PAYROL\n2009-01-01\nLa b\u00fasqueda de nuevas alternativas terap\u00e9uticas es una alta prioridad en la lucha por el control de la malaria. El objetivo del presente estudio fue evaluar extractos preparados a partir de plantas seleccionadas en base a informaci\u00f3n etnobot\u00e1nica obtenida de la Medicina Tradicional Cubana. Extractos de seis plantas (Bambusa vulgaris, Parth...\n[Producci\u00f3n cient\u00edfica cubana en Medicina y Salud P\u00fablica: Scopus 2003-2011](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-37862014000300281&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGrisel Zacca-Gonz\u00e1lez\nFull Text Available El objetivo de este trabajo fue analizar la evoluci\u00f3n del volumen y la visibilidad de la producci\u00f3n cient\u00edfica cubana en Salud P\u00fablica y en Medicina para determinar si siguen los mismos patrones de comunicaci\u00f3n, y recomendar buenas pr\u00e1cticas de publicaci\u00f3n. Se aplicaron indicadores bibliom\u00e9tricos de volumen, visibilidad y colaboraci\u00f3n extra\u00eddos del portal SCImago Institutions Rankings a partir de datos de Scopus, para el \u00e1rea tem\u00e1tica Medicine y la categor\u00eda Public Health, Environmental and Occupational Health, per\u00edodo 2003-2011. Cuba tiene una posici\u00f3n relativamente alta en los rankings de volumen de producci\u00f3n cient\u00edfica tanto en Medicina como en Salud P\u00fablica en los contextos internacionales y regionales, mientras que en impacto est\u00e1 entre los \u00faltimos pa\u00edses. La tendencia de la producci\u00f3n es al crecimiento, aunque en Salud P\u00fablica es m\u00e1s acelerado. El liderazgo es alto, pero la colaboraci\u00f3n internacional est\u00e1 por debajo de lo esperado. La publicaci\u00f3n en revistas de alto impacto (primer cuartil y los art\u00edculos en el 10% m\u00e1s citado (excelencia son escasos. Se concluye que el volumen y el impacto de la publicaci\u00f3n no est\u00e1n acorde al potencial cient\u00edfico de salud cubana. Se recomienda incrementar la colaboraci\u00f3n cient\u00edfica, la publicaci\u00f3n de art\u00edculos en revistas de alto impacto, la preparaci\u00f3n de los recursos humanos y seguir las recomendaciones internacionales sobre las buenas pr\u00e1cticas de edici\u00f3n y publicaci\u00f3n cient\u00edfica.\n[A method comparison study between two hemoglobinometer models (Hemocue Hb 301 and Hb 201+) to measure hemoglobin concentrations and estimate anemia prevalence among women in Preah Vihear, Cambodia.](https://www.ncbi.nlm.nih.gov/pubmed/27997764)\nRappaport, A I; Karakochuk, C D; Whitfield, K C; Kheang, K M; Green, T J\n2017-02-01\nHemoglobin (Hb) concentration is often measured in global health and nutrition surveys to determine anemia prevalence using a portable hemoglobinometer such as the Hemocue\u00ae Hb 201+. More recently, a newer model was released (Hemocue Hb 301) utilizing slightly different methods to measure Hb as compared to the older model. The objective was to measure bias and concordance between Hb concentrations using the Hemocue Hb 301 and Hb 201+ models in a rural field setting. Hemoglobin (Hb) concentration was measured using one finger prick of blood (approximately 10 \u03bcL) from 175 Cambodian women (18-49 years) using three Hemocue Hb 201+ and three Hb 301 machines. Bias and concordance were measured and plotted. Overall, mean \u00b1 SD Hb concentration was 116 \u00b1 13 g/L using the Hb 201+ and 118 \u00b1 12 g/L using the Hb 301; and anemia prevalence (Hb < 120 g/L) was 58% (n = 102) and 58% (n = 101), respectively. Overall bias \u00b1 SD was 2.0 \u00b1 10.5 g/L and concordance (95% CI) was 0.63 (0.54, 0.72). Despite the 2 g/L bias detected between models, anemia prevalence was very similar in both models. The two models measured anemia prevalence comparably in this population of women in rural Cambodia. \u00a9 2016 John Wiley & Sons Ltd.\n[Current Status of HbA1c Biosensors](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5579747)\nLin, Hua; Yi, Jun\n2017-01-01\nGlycated hemoglobin (HbA1c) is formed via non-enzymatic glycosylation reactions at the \u03b1\u2013amino group of \u03b2Val1 residues in the tetrameric Hb, and it can reflect the ambient glycemic level over the past two to three months. A variety of HbA1c detection methods, including chromatography, immunoassay, enzymatic measurement, electrochemical sensor and capillary electrophoresis have been developed and used in research laboratories and in clinics as well. In this review, we summarize the current status of HbA1c biosensors based on the recognition of the sugar moiety on the protein and also their applications in the whole blood sample measurements. PMID:28777351\n[Impact of Haemophilus influenzae type b conjugate vaccine on bacterial meningitis in the Dominican Republic Impacto de la vacuna conjugada contra Haemophilus influenzae tipo b sobre la meningitis bacteriana en la Rep\u00fablica Dominicana](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892008000900002) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nEllen H. Lee\n2008-09-01\nFull Text Available OBJECTIVES: Widespread use of Haemophilus influenzae type b (Hib vaccines has dramatically reduced the burden of Hib disease throughout the Americas. Few studies have evaluated the impact of Hib vaccination on non-culture-confirmed disease. This study analyzed trends in probable bacterial meningitis before and after the introduction of Hib vaccine in the Dominican Republic and estimated vaccine effectiveness against Hib meningitis. METHODS: Meningitis cases among children OBJETIVOS: El uso generalizado de la vacuna contra Haemophilus influenzae tipo b (Hib ha permitido reducir radicalmente la carga de enfermedad por Hib en las Am\u00e9ricas. Pocos estudios han evaluado el impacto de la vacunaci\u00f3n contra Hib sobre los casos no confirmados mediante cultivo. En este estudio se analizaron las tendencias en el n\u00famero de casos probables de meningitis bacteriana antes y despu\u00e9s de la introducci\u00f3n de la vacuna contra Hib en la Rep\u00fablica Dominicana y se estim\u00f3 la eficacia de la vacuna contra la meningitis. M\u00c9TODOS: Se identificaron los casos de meningitis en ni\u00f1os menores de 5 a\u00f1os a partir de los registros de ingreso del principal hospital pedi\u00e1trico de Santo Domingo entre 1998 y 2004. Los casos de meningitis con probable etiolog\u00eda bacteriana se clasificaron seg\u00fan criterios de laboratorio; los casos confirmados contaban con cultivo bacteriano positivo o detecci\u00f3n de ant\u00edgenos espec\u00edficos en el l\u00edquido cefalorraqu\u00eddeo. Se calcularon las tasas de incidencia acumulada de casos confirmados y probables de meningitis en los ni\u00f1os que viv\u00edan en el Distrito Nacional. Los casos confirmados de meningitis por Hib se incorporaron a un estudio de casos y controles -pareados seg\u00fan la edad y el barrio de residencia- para calcular la eficacia de la vacuna. RESULTADOS: Antes de la introducci\u00f3n de la vacuna, la tasa anual de meningitis de posible etiolog\u00eda bacteriana era de 49 casos por 100 000 ni\u00f1os menores de 5 a\u00f1os; de los casos confirmados de\n[La Pol\u00edtica de formaci\u00f3n de valores en la Nueva Universidad Cubana](http://www.redalyc.org/articulo.oa?id=181517990006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMagdiel P\u00e9rez Bauta\n2009-01-01\nFull Text Available Se aborda el proceso de formaci\u00f3n de valores en la Nueva Universidad Cubana, su importancia y papel del docente en el mismo. Se analizan algunas variables que intervienen en el desarrollo de valores como responsabilidad, honestidad, independencia, creatividad, etc. Se resalta la importancia del componente educativo como parte del proceso de formaci\u00f3n del futuro profesional. Se hace referencia a algunos requerimientos y t\u00e9cnicas que puede aplicar el profesor en el aula universitaria, haciendo \u00e9nfasis en el enfoque personol\u00f3gico. Por \u00faltimo se brindan algunas consideraciones en relaci\u00f3n al impacto del proceso de formaci\u00f3n de valores en el desempe\u00f1o profesional de los egresados.\n[No se ha demostrado asociaci\u00f3n entre la presencia del timerosal en las vacunas y el autismo](https://www.openaire.eu/search/publication?articleId=od______3056::5d7a8a9d35638166a4e7ccabd8678667)\nCabezas S\u00e1nchez, C\u00e9sar\n2007-01-01\nEl timerosal es un compuesto org\u00e1nico que contiene etilmercurio, el cual ha sido usado como preservante de algunas vacunas, sobre todo en la presentaci\u00f3n de multidosis desde los a\u00f1os 30. El etilmercurio es diferente del metilmercurio, este \u00faltimo s\u00ed se conoce que es neurot\u00f3xico; sin embargo, el metabolismo del etilmercurio es diferente del metilmercurio. En realidad se quiso inferir que la toxicidad del metilmercurio era similar al etilmercurio presente en el timerosal.\n[HB D Los Angeles in a Brazilian family Hb D Los Angeles em fam\u00edlia brasileira](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842001000300004) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGuilherme G. Leoneli\n2001-09-01\nFull Text Available Inherited disorders of hemoglobin, the most common monogenic disease, are now well understood at the molecular level, knowledge, which has led to considerable improvements in their control and management. The Brazilian population is multiethnic, and the correct characterization of the Hb D is important, mainly because the method available for detection of abnormal hemoglobins, present a migration in the same zone at alkaline pH, for Hb S, D, and G for example. In this paper we studied a family with an abnormal hemoglobin like S in alkaline electrophoresis, by appropriated methods including HPLC and molecular analysis, characterized as hemoglobin D Los Angeles.As doen\u00e7as heredit\u00e1ria da hemoglobina s\u00e3o as mais comuns doen\u00e7as monog\u00eanicas e atualmente bem conhecidas do ponto de vista molecular, fato este que propiciou um avan\u00e7o no seu controle e manuseio. A popula\u00e7\u00e3o brasileira caracteriza-se pela multiplicidade \u00e9tnica e a caracteriza\u00e7\u00e3o da Hb D torna-se importante por este dado, associado ao fato de que os m\u00e9todos de detec\u00e7\u00e3o das hemoglobinopatias comumente n\u00e3o identificam esta fra\u00e7\u00e3o anormal que apresenta a peculiaridade de migra\u00e7\u00e3o eletrofor\u00e9ticia em pH alcalino na mesma zona observada nas Hb S e G. Neste relato \u00e9 apresentado um estudo familiar no qual \u00e9 empregada metodologia adequada, o HLPC, que permite a identifica\u00e7\u00e3o da Hb D.\n[De Mart\u00ed a Fidel: a revolu\u00e7\u00e3o cubana e a Am\u00e9rica Latina](http://periodicos.uem.br/ojs/index.php/EspacoAcademico/article/view/10587) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLuiz Bernardo Peric\u00e1s\n2010-07-01\nFull Text Available Livro que j\u00e1 se tornou refer\u00eancia nos meios diplom\u00e1tico e acad\u00eamico, De Mart\u00ed a Fidel: a revolu\u00e7\u00e3o cubana e a Am\u00e9rica Latina, do historiador e cientista pol\u00edtico Luiz Alberto Moniz Bandeira, ganha agora uma nova edi\u00e7\u00e3o, revisada e ampliada.\n[Vacuna contra la fiebre hemorr\u00e1gica argentina Candid#1 producida en la Argentina: Inmunogenicidad y seguridad Candid#1 vaccine against Argentine Hemorrhagic Fever produced in Argentina: Immunogenicity and safety](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802010000300002) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDelia A. Enria\n2010-06-01\nFull Text Available Se realiz\u00f3 un estudio cl\u00ednico en 946 voluntarios humanos sanos, donde se compar\u00f3 la vacuna Candid#1 producida en Argentina con la elaborada en EE.UU., que hab\u00eda sido utilizada en estudios previos. Como objetivo primario se evalu\u00f3 la equivalencia en la eficacia utilizando como marcador subrogante a la inmunogenicidad medida por detecci\u00f3n de anticuerpos neutralizantes. Como objetivo secundario se evalu\u00f3 la equivalencia en inocuidad comparando las tasas de reacciones adversas. Ambas vacunas mostraron una tasa equivalente de inmunogenicidad ligeramente superior al 95.5%, que es la eficacia estimada para Candid #1 en estudios previos. No se observaron eventos adversos graves relacionados con la vacuna. Los eventos adversos generales considerados relacionados fueron de escasa significaci\u00f3n cl\u00ednica y de resoluci\u00f3n espont\u00e1nea o con tratamiento sintom\u00e1tico; se presentaron en los receptores de ambas vacunas en tasas equivalentes (29.9% para la vacuna fabricada en la Argentina y 35.0% para la fabricada en EE.UU., e incluyeron: cefalea, decaimiento, mialgias, plaquetopenia leve (A clinical study in 946 human volunteers was done to compare Candid #1 vaccine manufactured in Argentina with the vaccine produced in USA that had been previously used. The efficacy was evaluated using immunogenicity measured by the detection of neutralizing antibodies as a subrogate marker. Safety was evaluated comparing the rate of adverse events. Both vaccines showed a comparable rate of seroconversion, slighty higher than the efficacy estimated from previous studies (95.5%. There were no severe adverse events related to the vaccines. The general events considered related to the vaccines were not clinically relevant and disappeared either spontaneously or with symptomatic treatment. Similar rates of adverse events (29.9% for the Argentine vaccine and 35.0% for the USA vaccine were found for both vaccines. These included: headache, weakness, myalgias, mild low blood\n[Interaction of Hb Grey Lynn (Vientiane) [\u03b191(FG3)Leu>Phe (\u03b11)] with Hb E [\u03b226(B8) Glu>Lys] and \u03b1(+)-thalassemia: Molecular and Hematological Analysis.](https://www.ncbi.nlm.nih.gov/pubmed/26118199)\nSingha, Kritsada; Fucharoen, Goonnapa; Fucharoen, Supan\n2015-01-01\nHemoglobin (Hb) Grey Lynn is a Hb variant caused by a mutation at codon 91 of \u03b11-globin gene whereas Hb E is a common \u03b2-globin chain variant among Southeast Asian population. We report two hitherto undescribed conditions of Hb Grey Lynn found in Thai individuals. The study was done on two unrelated Thai subjects. Hematological parameters were recorded and Hb analysis was carried out using automated Hb analyzers. Mutations were identified by DNA analysis. Hematological features of the patients were compared with those of various forms of Hb Grey Lynn documented previously. Hb and DNA analyses identified a heterozygous Hb Grey Lynn in one patient and a double heterozygous Hb Grey Lynn and Hb E with \u03b1(+)-thalassemia in another. Interaction of \u03b1(Grey Lynn) with \u03b2(E) chains leads to the formation of a new Hb variant, namely the Hb Grey Lynn E (\u03b1(GL)2\u03b2(E)2), detectable by liquid chromatography (10.3%) but masked by Hb E on capillary electrophoresis. Interaction of these multiple globin gene defects could lead to complex hemoglobinopathies requiring combined analysis with multiple Hb analyzers followed by DNA testing to provide accurate diagnosis of the cases.\n[Transfusion Associated Peak in Hb HPLC Chromatogram \u2013 a Case Report](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3279321)\nJain, Sonal; Dass, Jasmita; Pati, Hara Prasad\n2012-01-01\nHigh performance liquid chromatography (HPLC) and electrophoresis are commonly used to diagnose various hemoglobinopathies. However, insufficient information about the transfusion history can lead to unexpected and confusing results. We are reporting a case of Juvenile myelomonocytic leukemia (JMML) in which HbHPLC was done to quantify fetal hemoglobin (HbF). The chromatogram showed elevated HbF along with a peak in the HbD window. A transfusion acquired peak was suspected based on the unexpectedly low percentage of HbD and was subsequently confirmed using parental HbHPLC. PMID:22348188\n[Pseudomonas aeruginosa. Vacunas: un reto a la investigaci\u00f3n](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2004000100001&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSara C. Esnard\n2004-04-01\nFull Text Available Pseudomonas aeruginosa, pat\u00f3geno gramnegativo vers\u00e1til y oportunista debido a su gran adaptabilidad fisiol\u00f3gica, potencial metab\u00f3lico y mecanismos de virulencia, es causa frecuente a escala mundial de severas o letales infecciones en pacientes hospitalizados. El empe\u00f1o por lograr terapias alternativas para prevenir o combatir las infecciones producidas por P. aeruginosa ha ocupado a investigadores de todo el mundo desde la segunda mitad del pasado siglo y actualmente se contin\u00faan reportando trabajos que respaldan los ensayos de candidatos vacunales, fundamentalmente a partir de ant\u00edgenos proteicos, mayoritariamente basados en la construcci\u00f3n de vacunas recombinantes. En este art\u00edculo se presenta una revisi\u00f3n de trabajos publicados sobre las investigaciones desarrolladas en diferentes pa\u00edses, con el objetivo de obtener candidatos vacunales para la prevenci\u00f3n o tratamiento de las infecciones causadas por Pseudomonas aeruginosa, a partir de la d\u00e9cada de los a\u00f1os 50 del siglo XX hasta el 2003.\n[Hb H Hydrops Fetalis Syndrome Caused by Association of the - -(SEA) Deletion and Hb Constant Spring (HBA2: c.427T > C) Mutation in a Chinese Family.](https://www.ncbi.nlm.nih.gov/pubmed/25897478)\nHe, Sheng; Zheng, Chenguang; Meng, Dahua; Chen, Rongyu; Zhang, Qiang; Tian, Xiaoxian; Chen, Shaoke\n2015-01-01\nHb Constant Spring (Hb CS; HBA2: c.427T > C) is an unstable hemoglobin (Hb) variant that results from a nucleotide substitution at the termination codon of the \u03b12-globin gene. Compound heterozygosity for \u03b1(0)-thalassemia (\u03b1(0)-thal) and Hb CS (- -(SEA)/\u03b1(CS)\u03b1) results in Hb H/Hb CS disease, which is generally characterized with mild hemolytic anemia, jaundice, and splenomegaly. Here, we describe one case with Hb H/Hb CS disease that presented with fetal anemia and fetal hydrops, known as Hb H (\u03b24) hydrops fetalis. This is the first report of fetal hydrops caused by association of the - -(SEA) deletion and the \u03b1(CS)\u03b1 mutation. Our study highlights the significance of watchful observation using a serial ultrasound method and care of pregnant women who have fetuses found to carry Hb H/Hb CS disease during pregnancy, to guard against the occurrence of fetal hydrops.\n[Nuclear translocation of the cytoplasmic domain of HB-EGF induces gastric cancer invasion.](https://www.ncbi.nlm.nih.gov/pubmed/22646534)\nShimura, Takaya; Yoshida, Michihiro; Fukuda, Shinji; Ebi, Masahide; Hirata, Yoshikazu; Mizoshita, Tsutomu; Tanida, Satoshi; Kataoka, Hiromi; Kamiya, Takeshi; Higashiyama, Shigeki; Joh, Takashi\n2012-05-30\nMembrane-anchored heparin-binding epidermal growth factor-like growth factor (proHB-EGF) yields soluble HB-EGF, which is an epidermal growth factor receptor (EGFR) ligand, and a carboxy-terminal fragment of HB-EGF (HB-EGF-CTF) after ectodomain shedding. We previously reported that HB-EGF-CTF and unshed proHB-EGF which has the cytoplasmic domain of proHB-EGF (HB-EGF-C), translocate from the plasma membrane to the nucleus and regulate cell cycle after shedding stimuli. However, the significance of nuclear exported HB-EGF-C in human gastric cancer is unclear. We investigated the relationship between intracellular localization of HB-EGF-C and clinical outcome in 96 gastric cancer patients treated with gastrectomy. Moreover, we established stable gastric cancer cell lines overexpressing wild-type HB-EGF (wt-HB-EGF) and mutated HB-EGF (HB-EGF-mC), which prevented HB-EGF-C nuclear translocation after shedding. Cell motility between these 2 gastric cancer cell lines was investigated using a transwell invasion assay and a wound healing assay. Of the 96 gastric cancer cases, HB-EGF-C immunoreactivity was detected in both the nucleus and cytoplasm in 19 cases (19.8 %) and in the cytoplasm only in 25 cases (26.0 %). The nuclear immunoreactivity of HB-EGF-C was significantly increased in stage pT3/4 tumors compared with pT1/2 tumors (T1/2 vs. T3/4: 11.1 % vs. 36.4 %, P Gastric cancer cell invasion obviously increased in wt-HB-EGF-expressing cells, but invasion in HB-EGF-mC-expressing cells showed a slight increase compared with control cells. Moreover, wt-HB-EGF overexpression increased the effectiveness of wound healing, but had no significant effect in HB-EGF-mC-expressing cells. Both the function of HB-EGF as an EGFR ligand and a novel signal for HB-EGF-C nuclear translocation induce gastric cancer growth, whereas HB-EGF-C nuclear translocation independently plays a critical role in gastric cancer invasion. The present study demonstrated that HB-EGF-C nuclear translocation\n[La real expedici\u00f3n filantr\u00f3pica de la vacuna en Canarias (9 de diciembre de 1803 - 6 de enero de 1804](http://asclepio.revistas.csic.es/index.php/asclepio/article/view/62/64) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGarc\u00eda Nieto, V\u00edctor\n2005-12-01\nFull Text Available The conditions, circumstances and aftermath of the stay of the Balmis\u2019 Royal Vaccinal Expedition (1803-1806 in the Canary Islands have been studied in this paper. We have focused on reports from canary witnesses rather than official and administrative data. We have records of the spreading of the vaccine out to the isles. Finally, the decisive and determinant part played by the Roman Catholic Church to achieve the objectives of the Royal Expedition has been remarked.\nSe han estudiado las circunstancias y consecuencias de la escala de la Real Expedici\u00f3n Filantr\u00f3pica de la Vacuna (1803-1806 en el Archipi\u00e9lago Canario. Nos hemos centrado en los relatos de testigos canarios m\u00e1s que en los datos burocr\u00e1ticos y administrativos. Tenemos constancia de la difusi\u00f3n de la vacuna en las islas. Finalmente, hemos puesto de relieve el papel determinante y decisivo de la Iglesia en la consecuci\u00f3n de los objetivos de la Real Expedici\u00f3n.\n[Nuclear translocation of the cytoplasmic domain of HB-EGF induces gastric cancer invasion](http://dx.doi.org/10.1186/1471-2407-12-205) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nShimura, Takaya; Higashiyama, Shigeki; Joh, Takashi; Yoshida, Michihiro; Fukuda, Shinji; Ebi, Masahide; Hirata, Yoshikazu; Mizoshita, Tsutomu; Tanida, Satoshi; Kataoka, Hiromi; Kamiya, Takeshi\n2012-01-01\nMembrane-anchored heparin-binding epidermal growth factor-like growth factor (proHB-EGF) yields soluble HB-EGF, which is an epidermal growth factor receptor (EGFR) ligand, and a carboxy-terminal fragment of HB-EGF (HB-EGF-CTF) after ectodomain shedding. We previously reported that HB-EGF-CTF and unshed proHB-EGF which has the cytoplasmic domain of proHB-EGF (HB-EGF-C), translocate from the plasma membrane to the nucleus and regulate cell cycle after shedding stimuli. However, the significance of nuclear exported HB-EGF-C in human gastric cancer is unclear. We investigated the relationship between intracellular localization of HB-EGF-C and clinical outcome in 96 gastric cancer patients treated with gastrectomy. Moreover, we established stable gastric cancer cell lines overexpressing wild-type HB-EGF (wt-HB-EGF) and mutated HB-EGF (HB-EGF-mC), which prevented HB-EGF-C nuclear translocation after shedding. Cell motility between these 2 gastric cancer cell lines was investigated using a transwell invasion assay and a wound healing assay. Of the 96 gastric cancer cases, HB-EGF-C immunoreactivity was detected in both the nucleus and cytoplasm in 19 cases (19.8 %) and in the cytoplasm only in 25 cases (26.0 %). The nuclear immunoreactivity of HB-EGF-C was significantly increased in stage pT3/4 tumors compared with pT1/2 tumors (T1/2 vs. T3/4: 11.1 % vs. 36.4 %, P < 0.01). The growth of wt-HB-EGF- and HB-EGF-mC-expressing cells significantly increased compared with control cells, but the growth of HB-EGF-mC-expressing cells was significantly decreased compared with wt-HB-EGF-expressing cells. Gastric cancer cell invasion obviously increased in wt-HB-EGF-expressing cells, but invasion in HB-EGF-mC-expressing cells showed a slight increase compared with control cells. Moreover, wt-HB-EGF overexpression increased the effectiveness of wound healing, but had no significant effect in HB-EGF-mC-expressing cells. Both the function of HB-EGF as an EGFR ligand and a novel signal for\n[Nuclear translocation of the cytoplasmic domain of HB-EGF induces gastric cancer invasion](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3414754)\n2012-01-01\nBackground Membrane-anchored heparin-binding epidermal growth factor-like growth factor (proHB-EGF) yields soluble HB-EGF, which is an epidermal growth factor receptor (EGFR) ligand, and a carboxy-terminal fragment of HB-EGF (HB-EGF-CTF) after ectodomain shedding. We previously reported that HB-EGF-CTF and unshed proHB-EGF which has the cytoplasmic domain of proHB-EGF (HB-EGF-C), translocate from the plasma membrane to the nucleus and regulate cell cycle after shedding stimuli. However, the significance of nuclear exported HB-EGF-C in human gastric cancer is unclear. Methods We investigated the relationship between intracellular localization of HB-EGF-C and clinical outcome in 96 gastric cancer patients treated with gastrectomy. Moreover, we established stable gastric cancer cell lines overexpressing wild-type HB-EGF (wt-HB-EGF) and mutated HB-EGF (HB-EGF-mC), which prevented HB-EGF-C nuclear translocation after shedding. Cell motility between these 2 gastric cancer cell lines was investigated using a transwell invasion assay and a wound healing assay. Results Of the 96 gastric cancer cases, HB-EGF-C immunoreactivity was detected in both the nucleus and cytoplasm in 19 cases (19.8 %) and in the cytoplasm only in 25 cases (26.0 %). The nuclear immunoreactivity of HB-EGF-C was significantly increased in stage pT3/4 tumors compared with pT1/2 tumors (T1/2 vs. T3/4: 11.1 % vs. 36.4 %, P HB-EGF- and HB-EGF-mC-expressing cells significantly increased compared with control cells, but the growth of HB-EGF-mC-expressing cells was significantly decreased compared with wt-HB-EGF-expressing cells. Gastric cancer cell invasion obviously increased in wt-HB-EGF-expressing cells, but invasion in HB-EGF-mC-expressing cells showed a slight increase compared with control cells. Moreover, wt-HB-EGF overexpression increased the effectiveness of wound healing, but had no significant effect in HB-EGF-mC-expressing cells. Conclusions Both the function of HB-EGF as an EGFR ligand\nBloomgarden, Zachary; Handelsman, Yehuda\n2018-04-01\nHOW DOES CHRONIC KIDNEY DISEASE AFFECT HBA1C?: A number of factors determine HbA1c other than the level of glucose exposure alone. In an subset analysis of the Atherosclerosis Risk in Communities study of 941 diabetic people with varying degrees of chronic kidney disease (CKD), as well as 724 who did not have CKD, and mean age in the eighth decade, Jung et al. ask whether HbA1c is reliable as an indicator of glycemia in people with kidney disease (CKD) to the same degree as in those not having kidney disease, and, if not, whether measures of glycated serum proteins may be more useful. The only available measure of glycemia for comparison was a single fasting glucose level, and the authors acknowledge that this gives an incomplete measure, particularly in people with relatively mild diabetes, whose mean HbA1c was 6.4%, with most having levels of 7.5% or lower. In patients of this sort, postprandial glucose levels may better explain variations in mean HbA1c. Recognizing that the dataset may be limited, Jung et al. nevertheless give an intriguingly negative answer to the first question, of the reliability of HbA1c with kidney disease. Using Deming regression analysis, Jung et al. showed that the correlation between HbA1c and fasting glucose weakens as renal function worsens, and, moreover, that this appears particularly to be the case in people with anemia (hemoglobin men and women, respectively), confirming earlier observations. Among those diabetic people with neither anemia nor CKD, the correlation coefficient between HbA1c and fasting glucose was r = 0.70, compared with r = 0.35 among those with both anemia and very severe CKD (estimated glomerular filtration rate [eGFR] perform SMBG to more adequately interpret HbA1c results. \u00a9 2017 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.\n[A economia cubana no in\u00edcio do s\u00e9culo XXI: avalia\u00e7\u00e3o do desempenho e debate sobre o futuro](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-62762003000100008) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMesa-Lago Carmelo\n2003-01-01\nFull Text Available No in\u00edcio do s\u00e9culo 21, a economia cubana parecia continuar em seu longo e lento processo de recupera\u00e7\u00e3o, depois da grave crise dos anos noventa. Mas v\u00e1rios fatores negativos surgiram em 2001 e na primeira metade de 2002, como os ataques terroristas de 11 de setembro de 2001; a recess\u00e3o que come\u00e7ou em mar\u00e7o de 2001 e se agravou em setembro; a queda dos pre\u00e7os mundiais do n\u00edquel; o furac\u00e3o Michelle que atingiu a ilha no dia 4 de novembro; o fechamento da base russa de vigil\u00e2ncia em Lurdes; a queda do investimento estrangeiro direto e a deterioria\u00e7\u00e3o da situa\u00e7\u00e3o pol\u00edtica na Venezuela em 2002. Baseado principalmente em estat\u00edsticas e informa\u00e7\u00f5es de fontes cubanas, este artigo avalia o desempenho econ\u00f4mico e social de Cuba em 2000-2001 e na primeira metade de 2002; a situa\u00e7\u00e3o neste per\u00edodo \u00e9 contrastada com a de 1989 (anterior \u00e0 crise e de 1993 (o pior ponto da crise.\n[Effects of \u03b1-Thalassemia on HbA1c Measurement.](https://www.ncbi.nlm.nih.gov/pubmed/27184351)\nXu, Anping; Ji, Ling; Chen, Weidong; Xia, Yong; Zhou, Yu\n2016-11-01\n\u03b1-Thalassemia is a benign condition that is often present in patients with diabetes mellitus. Here, we evaluated the effects of different genotypes \u03b1-thalassemia on HbA 1c measurement. A total of 189 samples from nondiabetic patients were analyzed. HbA 1c analysis was performed by ion-exchange high-performance liquid chromatography, boronate affinity HPLC, immunoassay, and capillary electrophoresis. Fasting glucose, fructosamin, and HbA 2 were also performed. All samples were confirmed by genotyping for thalassemia. In patients with two or three functional \u03b1-genes, HbA 1c values were not significantly different from those of controls (P > 0.05); however, in individuals with \u03b1-thalassemia with one functional \u03b1-gene (i.e., HbH disease), HbA 1c levels were significantly different from those of controls (P 0.05). In this study, HbA 1c values in samples from individuals with two or three functional \u03b1-genes basically reflected the normal mean blood glucose level, while those in samples from individuals with one functional \u03b1-gene did not. \u00a9 2016 Wiley Periodicals, Inc.\n[Formaci\u00f3n y desarrollo de competencias en la educaci\u00f3n superior cubana](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1727-81202014000100010&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nNancy Montes de Oca Recio\nFull Text Available La formaci\u00f3n basada en competencias es una orientaci\u00f3n educativa que pretende dar respuestas a las necesidades de la sociedad contempor\u00e1nea; el t\u00e9rmino competencia, a pesar de su amplia utilizaci\u00f3n y reconocimiento desde las Ciencias Pedag\u00f3gicas, ha tenido diversas significaciones y es objeto de m\u00faltiples interpretaciones a partir de las dis\u00edmiles posturas epistemol\u00f3gicas de los investigadores. En el art\u00edculo fueron valoradas algunas de las propuestas realizadas en el \u00faltimo decenio por varios autores sobre la formaci\u00f3n de competencias, lo cual permiti\u00f3 asumir posiciones acerca de esta problem\u00e1tica de acuerdo con los retos y problemas del contexto social, comunitario, profesional y organizacional de la universidad cubana.\n[Metodolog\u00eda para caracterizar el proceso de innovaci\u00f3n tecnol\u00f3gica en la empresa sidero-mec\u00e1nica cubana.](http://www.elcriterio.com/revista/ajoica/contenidos_4/341ndez.pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGarc\u00eda, Yulian\n2009-12-01\nFull Text Available El presente trabajo resume los resultados obtenidos mediante la aplicaci\u00f3n de un procedimiento general de diagn\u00f3stico que permite caracterizar los procesos tecnol\u00f3gicos y de innovaci\u00f3n en la industria sidero-mec\u00e1nica cubana. El estudio se realiz\u00f3 en una muestra representativa de las empresas que integran el sector sidero-mec\u00e1nico de la provincia de Villa Clara.\n[Nuclear translocation of the cytoplasmic domain of HB-EGF induces gastric cancer invasion](http://www.biomedcentral.com/1471-2407/12/205) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nShimura Takaya\n2012-05-01\nFull Text Available Abstract Background Membrane-anchored heparin-binding epidermal growth factor-like growth factor (proHB-EGF yields soluble HB-EGF, which is an epidermal growth factor receptor (EGFR ligand, and a carboxy-terminal fragment of HB-EGF (HB-EGF-CTF after ectodomain shedding. We previously reported that HB-EGF-CTF and unshed proHB-EGF which has the cytoplasmic domain of proHB-EGF (HB-EGF-C, translocate from the plasma membrane to the nucleus and regulate cell cycle after shedding stimuli. However, the significance of nuclear exported HB-EGF-C in human gastric cancer is unclear. Methods We investigated the relationship between intracellular localization of HB-EGF-C and clinical outcome in 96 gastric cancer patients treated with gastrectomy. Moreover, we established stable gastric cancer cell lines overexpressing wild-type HB-EGF (wt-HB-EGF and mutated HB-EGF (HB-EGF-mC, which prevented HB-EGF-C nuclear translocation after shedding. Cell motility between these 2 gastric cancer cell lines was investigated using a transwell invasion assay and a wound healing assay. Results Of the 96 gastric cancer cases, HB-EGF-C immunoreactivity was detected in both the nucleus and cytoplasm in 19 cases (19.8 % and in the cytoplasm only in 25 cases (26.0 %. The nuclear immunoreactivity of HB-EGF-C was significantly increased in stage pT3/4 tumors compared with pT1/2 tumors (T1/2 vs. T3/4: 11.1 % vs. 36.4 %, P Conclusions Both the function of HB-EGF as an EGFR ligand and a novel signal for HB-EGF-C nuclear translocation induce gastric cancer growth, whereas HB-EGF-C nuclear translocation independently plays a critical role in gastric cancer invasion. The present study demonstrated that HB-EGF-C nuclear translocation might be crucial in gastric cancer invasion. HB-EGF-C nuclear translocation may offer a prognostic marker and a new molecular target for gastric cancer therapy.\n[Modelos de transici\u00f3n en presencia de p\u00e9rdidas intermitentes: implementaci\u00f3n y ejemplo de aplicaci\u00f3n a un ensayo cl\u00ednico cubano](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2011000200003&lng=es&nrm=iso) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRolando Uranga\n2011-08-01\nFull Text Available El presente trabajo brinda una herramienta \u00fatil para enfrentar el ajuste de los modelos de transici\u00f3n bajo el problem\u00e1tico escenario de patrones de p\u00e9rdidas intermitentes en datos recolectados de tipo longitudinal. Mediante las facilidades impl\u00edcitas en la instrucci\u00f3n NLMIXED del software estad\u00edstico SAS (Statistical Analysis System para Windows, versi\u00f3n 9.1.3, se da soluci\u00f3n a esta problem\u00e1tica. Se ofrece, adem\u00e1s, una aplicaci\u00f3n pr\u00e1ctica, donde se ajusta un modelo de transici\u00f3n a los datos de laboratorio cl\u00ednico de un ensayo que evalu\u00f3, entre otros objetivos, la seguridad de una vacuna cubana contra el melanoma cut\u00e1neo metast\u00e1sico.\n[The optical emission from the supernova remnant HB 3](https://ntrs.nasa.gov/search.jsp?R=19830048737&hterms=hb&qs=N%3D0%26Ntk%3DAll%26Ntx%3Dmode%2Bmatchall%26Ntt%3Dhb)\nFesen, R. A.; Gull, T. R.\n1983-01-01\nThe supernova remnant HB 3 was first detected as a radio source by Brown and Hazard (1953). On the basis of subsequent radio studies, it was concluded that the object was a supernova remnant (SNR). HB 3 is located at the far western edge of the H II region/molecular cloud complex W3-W4-W5 (IC 1795-1805-1848). However, a physical association of HB 3 with this complex is uncertain. In the present investigation, attention is called to the probability that HB 3 exhibits a more extensive optical emission structure than previously realized, and one which agrees well with both the position and morphology of the radio emission. It is found that narrow-passband optical images strongly suggest an almost complete optical emission shell for HB 3. Spectroscopic observations are, however, required to confirm that this emission is characteristic of a SNR.\n[Predicci\u00f3n de ep\u00edtopos T y B de la prote\u00edna NS4b del virus dengue tipo 3](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2013000300004&lng=es&nrm=iso) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nNevis Amin\n2013-12-01\nFull Text Available El dengue se considera una enfermedad emergente y la principal de las afecciones virales transmitidas por artr\u00f3podos en t\u00e9rminos de morbilidad y mortalidad. A pesar de los m\u00faltiples esfuerzos realizados por la comunidad cient\u00edfica internacional, a\u00fan no existe una vacuna licenciada contra esta entidad. La NS4b, una de las m\u00e1s peque\u00f1as prote\u00ednas del virus del dengue induce respuesta de anticuerpo y de inmunomediadores en pacientes infectados por este virus. Sin embargo, poco es conocido sobre su estructura antig\u00e9nica. En el campo de dise\u00f1o de vacunas es muy \u00fatil la aplicaci\u00f3n de las t\u00e9cnicas in silico, tanto para el descubrimiento y desarrollo de vacunas nuevas como para las existentes. Numerosos ep\u00edtopos predichos se han verificado experimentalmente, lo que demostr\u00f3 la utilidad de tales predicciones. En este trabajo fueron aplicados los programas de predicci\u00f3n: BcePred, ABCpred, HLApred, ProPred y Proped1, para la b\u00fasqueda de nuevos ep\u00edtopos de la prote\u00edna NS4b del virus dengue tipo 3. Se identificaron 27 ep\u00edtopos de c\u00e9lulas B y 126 de la T. La secuencia de amino\u00e1cidos del mimotopo de la prote\u00edna NS4b (FEKQLGQV fue predicha como ep\u00edtopo B por el servidor Bcepred, con la puntuaci\u00f3n m\u00e1s alta. El an\u00e1lisis te\u00f3rico de la potencialidad del ep\u00edtopo T-FEKQLGQV tuvo una alta cobertura para ser presentado por una muestra de la poblaci\u00f3n cubana. Del total de ep\u00edtopos T predichos, 13 resultaron promiscuos, que pudieran ser potenciales candidatos vacunales. La importancia de estos resultados radica en sentar las bases moleculares para el desarrollo de una vacuna profil\u00e1ctica de subunidades.\n[Entre controversias cient\u00edfico-m\u00e9dicas y movilizaciones populares. Poblaci\u00f3n epid\u00e9mica y vacunas contra la fiebre hemorr\u00e1gica argentina 1958-1990](http://asclepio.revistas.csic.es/index.php/asclepio/article/view/546/568) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAgnese, Graciela\n2013-06-01\nFull Text Available The emergence and gradual extension of a new epidemic disease, as it has been the Haemorrhagic Fever Argentina, from the Decade of the \u2018 50s, prompted the medical scientific research with the aim of finding a vaccine. In the period 1959-1990 developed three projects of vaccines with different results. This article aims to consider the behavior assumed by the epidemic population around the three vaccines in response to the tensions that exist between population and physicians and researchers in charge of vaccination campaigns; the struggles between the various scientific groups; the role of the press and the State.La irrupci\u00f3n y la progresiva extensi\u00f3n de una nueva enfermedad epid\u00e9mica, como ha sido la Fiebre Hemorr\u00e1gica Argentina, a partir de la d\u00e9cada del \u201950, impuls\u00f3 la investigaci\u00f3n cient\u00edfica m\u00e9dica con el objetivo fundamental de encontrar una vacuna. En el per\u00edodo 1959-1990 se desarrollaron tres proyectos de vacunas con distintos resultados. El objetivo de este art\u00edculo es considerar las conductas asumidas por la poblaci\u00f3n epid\u00e9mica en torno a las tres vacunas atendiendo a las tensiones existentes entre la poblaci\u00f3n y los m\u00e9dicos e investigadores a cargo de las campa\u00f1as de vacunaci\u00f3n; las pugnas entre los distintos grupos cient\u00edficos; el rol de la prensa y del estado.\n[Structured education using Dose Adjustment for Normal Eating (DAFNE) reduces long-term HbA1c and HbA1c variability.](https://www.ncbi.nlm.nih.gov/pubmed/29573459)\nWalker, G S; Chen, J Y; Hopkinson, H; Sainsbury, C A R; Jones, G C\n2018-06-01\nPrevious evidence has demonstrated that participation in the Dose Adjustment for Normal Eating (DAFNE) education programme can reduce HbA 1c and severe hypoglycaemia in people with Type 1 diabetes. In a number of studies, increased HbA 1c variability has been associated with higher diabetic morbidity and mortality. No studies have examined the impact of structured education on HbA 1c variability in Type 1 diabetes. People with Type 1 diabetes who had attended DAFNE were identified for inclusion from the Scottish Care Information-Diabetes dataset. HbA 1c median and variability, expressed as coefficient of variation (CV) before and after DAFNE was calculated. Some 1061 individuals participated in DAFNE education and 687 met the inclusion criteria. A significant median reduction in HbA 1c [-3.5 mmol/mol (-0.3%)] was seen at 12 months with a significant reduction [-1.5 mmol/mol (-0.1%)] still seen at 60 months of follow-up. HbA 1c variability as measured by CV was significantly lower during the post-DAFNE period: 0.08 (IQR 0.05-0.12) reduced to 0.07 (IQR 0.05-0.10); P = 0.002. The data confirm that DAFNE participation improves glycaemic control in Type 1 diabetes with benefits being sustained for 5 years. This study is the first to demonstrate reduced HbA 1c variability after completion of structured education. This is new evidence of the beneficial impact of DAFNE on glycaemic profile. \u00a9 2018 Diabetes UK.\n[The significance of disulfide bonding in biological activity of HB-EGF, a mutagenesis approach](http://dx.doi.org/10.1016/j.bbrc.2008.08.062) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nHoskins, J.T.; Zhou, Z.; Harding, P.A.\n2008-01-01\nA site-directed mutagenesis approach was taken to disrupt each of 3 disulfide bonds within human HB-EGF by substituting serine for both cysteine residues that contribute to disulfide bonding. Each HB-EGF disulfide analogue (HB-EGF-Cys/Ser 108/121 , HB-EGF-Cys/Ser 116/132 , and HB-EGF-Cys/Ser 134/143 ) was cloned under the regulation of the mouse metallothionein (MT) promoter and stably expressed in mouse fibroblasts. HB-EGF immunoreactive proteins with M r of 6.5, 21 and 24 kDa were observed from lysates of HB-EGF and each HB-EGF disulfide analogue. HB-EGF immunohistochemical analyses of each HB-EGF stable cell line demonstrated ubiquitous protein expression except HB-EGF-Cys/Ser 108/121 and HB-EGF-Cys/Ser 116/132 stable cell lines which exhibited accumulated expression immediately outside the nucleus. rHB-EGF, HB-EGF, and HB-EGF 134/143 proteins competed with 125 I-EGF in an A431 competitive binding assay, whereas HB-EGF-Cys/Ser 108/121 and HB-EGF-Cys/Ser 116/132 failed to compete. Each HB-EGF disulfide analogue lacked the ability to stimulate tyrosine phosphorylation of the 170 kDa EGFR. These results suggest that HB-EGF-Cys/Ser 134/143 antagonizes EGFRs\n[Estabilidad de una formulaci\u00f3n cubana de albendazol tabletas Stability study of a Cuban formulation of Albendazole tablets](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::1ea120f5c5649aaca65d523215f29803)\nJorge Enrique Rodr\u00edguez Chanfrau; Iverlys D\u00edaz Polanco; Jos\u00e9. Manuel Gil Apan; Viviana Fuste Moreno\n2012-01-01\nIntroducci\u00f3n: el albendazol es un medicamento cuya acci\u00f3n farmacol\u00f3gica lo define como un antihelm\u00edntico de amplio espectro. Como parte del proceso de desarrollo de la industria farmac\u00e9utica cubana, se ha investigado e introducido una tecnolog\u00eda para la producci\u00f3n de tabletas de 200 mg de albendazol. Objetivo: evaluar la estabilidad qu\u00edmica y microbiol\u00f3gica del medicamento. M\u00e9todos: tres lotes de 5 kg cada uno fueron preparados acorde con el proceso tecnol\u00f3gico desarrollado previamente. Los l...\n[Vacunas y timerosal: no hay evidencias cient\u00edficas que muestren riesgo de autismo y desordenes neurol\u00f3gicos](https://www.openaire.eu/search/publication?articleId=od______3056::c178bdb2747b8762099be70feeaa7237)\nCabezas, C\u00e9sar\n2008-01-01\nEl timerosal es un compuesto org\u00e1nico que contiene etilmercurio, el cual ha sido usado como preservante de algunas vacunas, sobre todo en la presentaci\u00f3n de multidosis, desde los a\u00f1os 30. El etilmercurio es diferente delmetilmercurio, este \u00faltimo s\u00ed se conoce que es neurot\u00f3xico; sin embargo, el metabolismo del etilmercurio es diferente del metilmercurio. En realidad, se quiso inferir que la toxicidad del metilmercurio era similar al etilmercurio presente en el timerosal.\n[Complex Interaction of Hb Q-Thailand (HBA1: c.223G>C) with \u03b2-Thalassemia/Hb E (HBB: c.79G>A) Disease.](https://www.ncbi.nlm.nih.gov/pubmed/29484903)\nPanyasai, Sitthichai; Satthakarn, Surada; Pornprasert, Sakorn\n2018-01-01\nHb Q-Thailand [\u03b174(EF3)Asp\u2192His (\u03b11), GAC>CAC, HBA1: c.223G>C] is an abnormal hemoglobin (Hb) frequently found in Thailand and Southeast Asian countries. The association of the \u03b1 Q-Thailand allele with other globin gene disorders has important implications in diagnosis. Here, we report how to diagnose the coinheritance of Hb Q-Thailand with \u03b2-thalassemia (\u03b2-thal)/Hb E disease in four Thai samples from high performance liquid chromatography (HPLC) and capillary electrophoresis (CE) testing results. Understanding of the HPLC chromatogram and CE electropherogram patterns of this complex mutation is important for interpretation of testing results and providing genetic counseling.\n[The heparin-binding domain of HB-EGF mediates localization to sites of cell-cell contact and prevents HB-EGF proteolytic release](http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=988640) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nPrince, Robin N.; Schreiter, Eric R.; Zou, Peng; Wiley, H. S.; Ting, Alice Y.; Lee, Richard T.; Lauffenburger, Douglas A.\n2010-07-01\nHeparin-binding EGF-like growth factor (HB-EGF) is a ligand for EGF receptor (EGFR) and possesses the ability to signal in juxtacrine, autocrine and/or paracrine mode, with these alternatives being governed by the degree of proteolytic release of the ligand. Although the spatial range of diffusion of released HB-EGF is restricted by binding heparan-sulfate proteoglycans (HSPGs) in the extracellular matrix and/or cellular glycocalyx, ascertaining mechanisms governing non-released HB-EGF localization is also important for understanding its effects. We have employed a new method for independently tracking the localization of the extracellular EGFlike domain of HB-EGF and the cytoplasmic C-terminus. A striking observation was the absence of the HB-EGF transmembrane proform from the leading edge of COS-7 cells in a wound-closure assay; instead, this protein localized in regions of cell-cell contact. A battery of detailed experiments found that this localization derives from a trans interaction between extracellular HSPGs and the HBEGF heparin-binding domain, and that disruption of this interaction leads to increased release of soluble ligand and a switch in cell phenotype from juxtacrine-induced growth inhibition to autocrine-induced proliferation. Our results indicate that extracellular HSPGs serve to sequester the transmembrane pro-form of HB-EGF at the point of cell-cell contact, and that this plays a role in governing the balance between juxtacrine versus autocrine and paracrine signaling.\n[Reacciones adversas a la vacuna contra influenza A (H1N1 en trabajadores de salud de una instituci\u00f3n p\u00fablica peruana](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832011000300003&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nPedro P. \u00c1lvarez-Falcon\u00ed\n2011-07-01\nFull Text Available Introducci\u00f3n: En abril de 2009 se produjo un brote de influenza en la frontera de M\u00e9xico y EE UU por el nuevo virus A(H1N1 2009. La pandemia no fue severa y la vacuna aplicada en diversos pa\u00edses produjo diversas reacciones adversas a medicamentos (RAM. Objetivos: Evaluar la posible relaci\u00f3n entre las RAM notificadas espont\u00e1neamente y la vacunaci\u00f3n en trabajadores de salud de un instituto. As\u00ed mismo, identificar t\u00f3picos afines a las RAM por dicha vacuna. Dise\u00f1o: Estudio prospectivo y descriptivo basado en la notificaci\u00f3n espont\u00e1nea. Instituci\u00f3n: Local central del Instituto Nacional de Salud en Lima. Participantes: Trabajadores de salud. Metodolog\u00eda: Las RAM notificadas espont\u00e1neamente fueron registradas en Hojas RAM. Se aplic\u00f3 un algoritmo para buscar una relaci\u00f3n causa-efecto. Principales medidas de resultados: Reacciones adversas a la vacuna influenza A(H1N1. Resultados: Hubo tres notificaciones espont\u00e1neas entre 148 trabajadores de salud vacunados (2% contra la influenza A(H1N1 2009. La relaci\u00f3n causa-efecto fue \u2018cierta\u2019 para fiebre y fatiga y \u2018posible\u2019 para afecciones respiratorias en tres mujeres (faringitis aguda, catarro nasal agudo, bronquitis catarral. Conclusiones: Entre los pocos trabajadores de salud que presentaron RAM, las afecciones respiratorias con una relaci\u00f3n considerada \u2018posible\u2019 podr\u00eda interpretarse que las mujeres ser\u00edan m\u00e1s sensibles para esa RAM comparadas con los varones. Las RAM fiebre y fatiga alcanzaron una relaci\u00f3n considerada \u2018cierta\u2019. La menor cantidad de infectados en personas de tercera edad en el pa\u00eds y en otros podr\u00eda explicarse por la presencia de \u2018anticuerpos protectores\u2019 en ellos.\n[The Hb E (HBB: c.79G>A), Mean Corpuscular Volume, Mean Corpuscular Hemoglobin Cutoff Points in Double Heterozygous Hb E/- -SEA \u03b1-Thalassemia-1 Carriers are Dependent on Hemoglobin Levels.](https://www.ncbi.nlm.nih.gov/pubmed/28413893)\nLeckngam, Prapapun; Limweeraprajak, Ektong; Kiewkarnkha, Tiemjan; Tatu, Thanusak\n2017-01-01\nIdentifying double heterozygosities in Hb E (HBB: c.79 G>A)/- - SEA (Southeast Asian) (\u03b1-thalassemia-1) (\u03b1-thal-1) in patients first diagnosed as carrying Hb E is important in thalassemia control. Low Hb E, mean corpuscular volume (MCV) and mean corpuscular hemoglobin (Hb) (MCH) levels have been observed in this double heterozygosity. However, the cutoff points of these parameters have never been systematically established. Here, we analyzed Hb E and red blood cell (RBC) parameters in 372 Hb E patients grouped by Hb levels, by the status of - - SEA and -\u03b1 3.7 (\u03b1-thal-2; rightward) deletions, to establish the cutoff points. Then, the established cutoff points were evaluated in 184 Hb E patients. It was found that the cutoff points of Hb E, MCV, MCH were significantly dependent on the Hb levels. In the group having Hb levels Hb E, MCV and MCH were 21.2%, 64.9 fL and 21.0 pg, respectively, and were 25.6%, 72.8 fL and 23.9 pg, respectively, in the group having Hb levels 10.0-11.9 g/dL. Finally, in the group having Hb levels \u226512.0 g/dL, the cutoff points of Hb E, MCV and MCH were 27.1%, 76.7 fL and 25.3 pg, respectively. Thus, to screen for the double heterozygous Hb E/- - SEA anomaly in patients initially diagnosed as carrying Hb E, the Hb levels must be taken into account in choosing the suitable cutoff points of these three parameters.\n[Is insulin the preferred treatment for HbA1c >9%?](https://www.ncbi.nlm.nih.gov/pubmed/28589542)\nBloomgarden, Zachary\n2017-09-01\nThe algorithms and guidelines of the American Association of Clinical Endocrinologists and the American Diabetes Association recommend that insulin administration be strongly considered for people with type 2 diabetes (T2D) with HbA1c levels exceeding 9.0% and 10%, respectively. Although the caveat is given in both sets of recommendations that this is particularly appropriate when patients are \"symptomatic,\" referring to urinary frequency with increased thirst and appetite, weight loss, and ketosis, the clinical definition of such presentations may be ill-defined, and it is noteworthy that both documents consider insulin to offer particular benefit under such circumstances. However, with multiple options for glycemic treatment, it is of interest to reconsider this argument for insulin use. It should be recalled that in the UK Prospective Diabetes Study, diet alone was associated with a reduction in HbA1c from 9% to 7%. Drug-na\u00efve people with T2D do often show surprisingly strong reductions in HbA1c with metformin-based dual-agent oral treatment approaches; a recent report showed that even with baseline HbA1c >11%, the combination of metformin with a sulfonylurea, pioglitazone, or sitagliptin was associated with reduction in HbA1c from 11.6% to 6.0%. A 32-week study of the combination of rosiglitazone with metformin in patients with mean baseline HbA1c 8.9% showed a mean HbA1c reduction of 2.3%, and an open-label cohort with baseline HbA1c 11.8% had a reduction in HbA1c to 7.8%. With metformin plus sitagliptin, a mean placebo-adjusted HbA1c reduction of 2.1% from a baseline of 8.8% was reported, with those patients with baseline HbA1c >9% having a 2.6% reduction in HbA1c, and an open-label cohort with baseline HbA1c 11.2% having a 2.9% reduction in HbA1c. Similar 2% HbA1c reductions from baseline levels of 9.1% were seen with metformin in initial combination with the sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin. Although such dual oral agent\n[Formation of hemoglobin (Hb)-octadecylamine (ODA) Langmuir-Blodgett (LB) film by spreading Hb solution directly onto subphase covered with a layer of ODA and its electrochemical property](http://dx.doi.org/10.1016/j.tsf.2005.07.044) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nYin Fan; Shin, Hoon-Kyu; Kwon, Young-Soo\n2006-01-01\nThe formation of hemoglobin (Hb)-octadecylamine (ODA) Langmuir-Blotgett (LB) film by spreading Hb solution directly onto subphase covered with a layer of ODA and its electrochemical properties were studied in this paper. This method ensured better electrode activity because almost no protein was adsorbed onto electrode surface before depositing Hb-ODA monolayer onto electrode surface. The optimum equilibrium time of Hb interacted with ODA layer, the optimum protein amount spread onto subphase's interface and the optimum ionic strength and pH of subphase were obtained from the experimental results. The compressibility analyses of Hb-ODA films showed that the surface pressure of this film from liquid-expanded to liquid-condensed state ranged between 16 and 40 mN/m. Direct electron transfer of Hb immobilized on gold electrode by LB technique was observed by cyclic voltammetry. Results showed that Hb molecules still kept their electrochemical activity. The electrode with Hb-ODA LB film displayed the fastest electron transfer rate when the film transferred under the surface pressure of 35 mN/m\n[Formation of hemoglobin (Hb)-octadecylamine (ODA) Langmuir-Blodgett (LB) film by spreading Hb solution directly onto subphase covered with a layer of ODA and its electrochemical property](http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=20810878) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nYin Fan [Department of Electrical Engineering, Dong-A University, Busan 604-714 (Korea, Republic of); Department of Chemistry, Changshu Institute of Technology, Changshu, 215500 (China); Shin, Hoon-Kyu [Department of Electrical Engineering, Dong-A University, Busan 604-714 (Korea, Republic of); Kwon, Young-Soo [Department of Electrical Engineering, Dong-A University, Busan 604-714 (Korea, Republic of)]. E-mail: yskwon@daunet.donga.ac.kr\n2006-03-21\nThe formation of hemoglobin (Hb)-octadecylamine (ODA) Langmuir-Blotgett (LB) film by spreading Hb solution directly onto subphase covered with a layer of ODA and its electrochemical properties were studied in this paper. This method ensured better electrode activity because almost no protein was adsorbed onto electrode surface before depositing Hb-ODA monolayer onto electrode surface. The optimum equilibrium time of Hb interacted with ODA layer, the optimum protein amount spread onto subphase's interface and the optimum ionic strength and pH of subphase were obtained from the experimental results. The compressibility analyses of Hb-ODA films showed that the surface pressure of this film from liquid-expanded to liquid-condensed state ranged between 16 and 40 mN/m. Direct electron transfer of Hb immobilized on gold electrode by LB technique was observed by cyclic voltammetry. Results showed that Hb molecules still kept their electrochemical activity. The electrode with Hb-ODA LB film displayed the fastest electron transfer rate when the film transferred under the surface pressure of 35 mN/m.\n[A Mosaic Expression of a Hb J-Amiens (HBB: c.54G > T; p.Lys18Asn) and its Interference with Hb A1c Analysis.](https://www.ncbi.nlm.nih.gov/pubmed/26372398)\nSchiemsky, Toon; Van Hoovels, Lieve; Desmet, Koen J O; Phylipsen, Marion; Harteveld, Cornelis L; Kieffer, Davy M J\n2015-01-01\nWe report the case of a 56-year-old Caucasian woman in whom hemoglobinopathy screening was triggered following an aberrant Hb A1c analysis. Preliminary diagnosis of the hemoglobin (Hb) variant was obtained through cation exchange high performance liquid chromatography (HPLC) and gel electrophoresis. DNA analysis confirmed the presence of Hb J-Amiens [\u03b217(A14)Lys\u2192Asn; HBB: c.[54G > C or 54G > T)]. However, an unbalanced ratio between wild type and mutant signal after direct sequencing and a lower than expected percentage of this Hb variant led to the suggestion of a mosaic expression. Furthermore, different methods [capillary zone electrophoresis (CZE), cation exchange HPLC and boronate affinity] were tested to study the possible interference of this variant with Hb A1c measurements. These investigations showed a clinically relevant difference between the methods tested. Hb A1c analysis may lead to the discovery of new Hb variants or mosaicism for previously described Hb variants. This may have genetic consequences for the offspring of carriers and brings about the question of partner testing.\n[Use of Fructosyl Peptide Oxidase for HbA1c Assay](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4604587)\nYonehara, Satoshi; Inamura, Norio; Fukuda, Miho; Sugiyama, Koji\n2015-01-01\nARKRAY, Inc developed the world\u2019s first automatic glycohemoglobin analyzer based on HPLC (1981). After that, ARKRAY developed enzymatic HbA1c assay \u201cCinQ HbA1c\u201d with the spread and diversification of HbA1c measurement (2007). CinQ HbA1c is the kit of Clinical Chemistry Analyzer, which uses fructosyl peptide oxidase (FPOX) for a measurement reaction. This report mainly indicates the developmental background, measurement principle, and future of the enzymatic method HbA1c reagent. PMID:25633966\n[The Long and Winding Road to Optimal HbA1c Measurement](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4762213)\nLittle, Randie R.; Rohlfing, Curt\n2016-01-01\nThe importance of hemoglobin A1c (HbA1c) as an indicator of mean glycemia and risks for complications in patients with diabetes mellitus was established by the results of long-term clinical trials, most notably the Diabetes Control and Complications Trial (DCCT) and United Kingdom Prospective Diabetes Study (UKPDS), published in 1993 and 1998 respectively. However, clinical application of recommended HbA1c targets that were based on these studies was difficult due to lack of comparability of HbA1c results among assay methods and laboratories. Thus, the National Glycohemoglobin Standardization Program (NGSP) was initiated in 1996 with the goal of standardizing HbA1c results to those of the DCCT/UKPDS. HbA1c standardization efforts have been highly successful; however, a number of issues have emerged on the \u201clong and winding road\u201d to better HbA1c, including the development of a higher-order HbA1c reference method by the International Federation of Clinical Chemistry (IFCC), recommendations to use HbA1c to diagnose as well as monitor diabetes, and point-of-care (POC) HbA1c testing. Here, we review the past, present and future of HbA1c standardization and describe the current status of HbA1c testing, including limitations that healthcare providers need to be aware of when interpreting HbA1c results. PMID:23318564\n[Relevance of Helicobacter pylori virulence factors for vaccine development Relevancia de los factores de virulencia de helicobacter pylori para el desarrollo de vacunas](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342009000900010) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLuz del Carmen Hern\u00e1ndez-Hern\u00e1ndez\n2009-01-01\n\u00ed, los individuos infectados por cepas que expresan estos factores de virulencia probablemente desarrollan enfermedades severas como el c\u00e1ncer g\u00e1strico. Sin embargo, la ancestral relaci\u00f3n entre H. pylori y los humanos sugiere que algunas cepas pueden ser beneficiosas para la salud humana. Por lo tanto, la administraci\u00f3n generalizada de tratamientos con antibi\u00f3tico podr\u00eda eventualmente causar problemas. El desarrollo de vacunas con base en factores de virulencia que confieran protecci\u00f3n a largo plazo es la mejor estrategia para el control y/o eliminaci\u00f3n de cepas pat\u00f3genas. Los diferentes esquemas y formulaciones de inmunizaci\u00f3n dise\u00f1ados para evaluar las vacunas con base en factores de virulencia en modelos animales han dado resultados prometedores. Sin embargo, ha sido necesario probar si estos resultados pueden ser reproducidos en humanos. Este trabajo revisa los recientes estudios de vacunaci\u00f3n que han explorado esta posibilidad: vacunas orales usando ureasa o c\u00e9lulas completas-inactivadas con LT como adyuvante y ureasa expresada en vectores de Salmonella spp.; adem\u00e1s de una vacuna intramuscular multicomponente con hidr\u00f3xido de aluminio como adyuvante. Aunque estos estudios han logrado limitado \u00e9xito han establecido las bases para el desarrollo de una vacuna eficaz contra esta infecci\u00f3n.\n[LA VACUNACI\u00d3N ANTI-NEUMOC\u00d3CICA CON LA VACUNA CONJUGADA 13-VALENTE EN POBLACI\u00d3N INMUNOCOMPETENTE DE 65 A\u00d1OS: ANALISIS DEL IMPACTO PRESUPUESTARIO EN ESPA\u00d1A APLICANDO UN MODELO DE TRANSMISI\u00d3N DIN\u00c1MICA](http://www.redalyc.org/articulo.oa?id=17043728001) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nReyes Lorente Anto\u00f1anzas\n2016-01-01\nFull Text Available Fundamentos: Las infecciones causadas por el Streptococcus pneumoniae en el adulto tienen repercusiones importantes en la salud. El objetivo fue analizar el impacto econ\u00f3mico y sanitario en 5 a\u00f1os de la vacunaci\u00f3n de la cohorte espa\u00f1ola de 65 a\u00f1os inmunocompetente con la vacuna antineumoc\u00f3cica conjugada 13-valente.M\u00e9todos: Mediante un modelo de transmisi\u00f3n din\u00e1mica basado en ecuaciones diferenciales se analiz\u00f3 la carga de la enfermedad neumoc\u00f3cica (EN en sujetos de 65 a\u00f1os en 5 a\u00f1os, siendo vacunada anualmente el 36,5% de la cohorte. Se aplic\u00f3 la eficacia de la vacuna del 52,5% observada en el estudio CAPITA en pacientes de 65 a\u00f1os inmunocompetentes, cobertura de serotipos vacunales del 63,4% (estudio CAPA, incidencia de infecci\u00f3n neumoc\u00f3cica de 162,2/100.000 casos a\u00f1o (CMBD 2010-2013 y proporci\u00f3n de vacunados previamente al arranque del modelo del 0,99%. La perspectiva fue la del Sistema Nacional de Salud (SNS. Costes de casos de EN seg\u00fan CMBD y precio de venta de laboratorio de la vacuna conjugada.Resultados: En 5 a\u00f1os la vacunaci\u00f3n con vacuna conjugada 13-valente espera evitar 10.360 casos de EN (7.411 hospitalizaciones por neumon\u00edas y 699 muertes (14.736 a\u00f1os de vida ganados -AVG-, en una cohorte de 65 a 69 a\u00f1os de edad. El coste de vacunaci\u00f3n esperado de 36,5 millones de euros se compensar\u00eda completamente por la reducci\u00f3n de 41,5 millones de costes m\u00e9dicos evitados, con un ahorro neto acumulado de 3,8 millones de euros a precios constantes (4,9 a precios corrientes.Conclusi\u00f3n: La vacunaci\u00f3n con vacuna conjugada 13-valente en adultos de 65 a\u00f1os inmunocompetentes resulta eficiente para el Sistema Nacional de Salud, reduciendo la carga de enfermedad y evitando un n\u00famero importante de muertes.\n[El suicidio en la novela rom\u00e1ntica cubana](http://babel.revues.org/876) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAbdeslam Azougarh\n2012-08-01\nFull Text Available Souligner les traits sp\u00e9cifiques de pays r\u00e9cemment ind\u00e9pendants, avec l'intention de cr\u00e9er chez les diff\u00e9rents secteurs de la population hispano-am\u00e9ricaine une mentalit\u00e9 appropri\u00e9e pour la consolidation de nations nouvelles et souveraines est une des caract\u00e9ristiques les plus importantes du romantisme hispano-am\u00e9ricain. Il s\u2019agit d\u2019examiner la dimension id\u00e9ologique de l\u2019exposition nationaliste et am\u00e9ricaniste des \u00e9crivains en nous basant sur la repr\u00e9sentation du suicide principalement dans le roman romantique cubain Cecilia Vald\u00e9s o la Loma del \u00e1ngel de Cirilo Villaverde.Destacar los rasgos diferenciales de los pa\u00edses reci\u00e9n independizados con el objetivo de crear entre los distintos sectores de la poblaci\u00f3n hispanoamericana de una mentalidad apropiada para la consolidaci\u00f3n de naciones nuevas y soberanas es una de las caracter\u00edsticas m\u00e1s importantes del romanticismo hispanoamericano.Se trata de examinar la dimensi\u00f3n ideol\u00f3gica del planteamiento nacionalista y americanista de los escritores bas\u00e1ndonos en la representaci\u00f3n del suicidio principalmente en la novela rom\u00e1ntica cubana Cecilia Vald\u00e9s o la Loma del \u00e1ngel de Cirilo Villaverde.\n[Recent Progress in Electrochemical HbA1c Sensors: A Review](http://www.mdpi.com/1996-1944/8/3/1187) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nBaozhen Wang\n2015-03-01\nFull Text Available This article reviews recent progress made in the development of electrochemical glycated hemoglobin (HbA1c sensors for the diagnosis and management of diabetes mellitus. Electrochemical HbA1c sensors are divided into two categories based on the detection protocol of the sensors. The first type of sensor directly detects HbA1c by binding HbA1c on the surface of an electrode through bio-affinity of antibody and boronic acids, followed by an appropriate mode of signal transduction. In the second type of sensor, HbA1c is indirectly determined by detecting a digestion product of HbA1c, fructosyl valine (FV. Thus, the former sensors rely on the selective binding of HbA1c to the surface of the electrodes followed by electrochemical signaling in amperometric, voltammetric, impedometric, or potentiometric mode. Redox active markers, such as ferrocene derivatives and ferricyanide/ferrocyanide ions, are often used for electrochemical signaling. For the latter sensors, HbA1c must be digested in advance by proteolytic enzymes to produce the FV fragment. FV is electrochemically detected through catalytic oxidation by fructosyl amine oxidase or by selective binding to imprinted polymers. The performance characteristics of HbA1c sensors are discussed in relation to their use in the diagnosis and control of diabetic mellitus.\n[Transcriptional regulation of Hb-\u03b1 and Hb-\u03b2 through nuclear factor E2-related factor-2 (Nrf2) activation in human vaginal cells: A novel mechanism of cellular adaptability to oxidative stress.](https://www.ncbi.nlm.nih.gov/pubmed/28224676)\nSaha, Debarchana; Koli, Swanand; Reddy, Kudumula Venkata Rami\n2017-06-01\nHemoglobin (Hb), a major protein involved in transport of oxygen (O 2 ), is expressed by erythroid lineages. Until recently, it was not known whether non-erythroid cells express Hb. The objective was to evaluate the expression and functional significance of Hb-\u03b1 and Hb-\u03b2 in human primary vaginal epithelial cells (hPVECs) and decipher downstream signaling. RT-PCR, qRT-PCR, flow cytometry, Western blot, immunofluorescence were used to evaluate the expression of Hb-\u03b1, Hb-\u03b2, and nuclear factor E2-related factor-2(Nrf2) after hydrogen peroxide (H 2 O 2 ) induction. Electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation (ChIP) assay were used to determine the binding efficiency of Nrf2 on the Hb-\u03b1 promoter. Stimulation of hPVECs and human vaginal epithelial cell line, VK2/E6E7 with H 2 O 2 augmented the expression of Hb-\u03b1, Hb-\u03b2, Nrf2, heme oxygenase-1 (HO-1), and reactive oxygen species (ROS). Treatment of these cells with Nrf2 inhibitor, trigonelline (Trig) inhibited Hb-\u03b1 and Hb-\u03b2 expressions. Hb-\u03b1 and Hb-\u03b2 overexpression downregulated H 2 O 2 -induced ROS. The presence of Nrf2 binding domain was demonstrated within Hb-\u03b1 promoter. The results revealed for the first time that Hb-\u03b1 and Hb-\u03b2 were induced by oxidative stress through the activation of Nrf2. Overexpression of Hb-\u03b1 and Hb-\u03b2 ameliorated H 2 O 2 -induced oxidative stress, indicating one of the possible mechanism(s) to protect hPVECS from oxidative stress. \u00a9 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.\n[Ferulic acid modification enhances the anti-oxidation activity of natural Hb in vitro.](https://www.ncbi.nlm.nih.gov/pubmed/29533098)\nQi, Donglai; Li, Qian; Chen, Chen; Wang, Xiang\n2018-03-13\nDuring the development of artificial red blood cell (RBC) substitutes, oxidation side reaction is one of the major factors that hinder the application of haemoglobin (Hb)-based oxygen carriers (HBOCs). In order to avoid oxidation toxicity, we designed and prepared natural Hb conjugated with ferulic acid (FA) via simple chemical modification. In addition, the thiol groups on Hb surface were increased via the reaction of Hb with 2-iminothiolane (2-IT) and then modified with FA for the study of anti-oxidant ability. It was showed that Hb modified with FA (FA-Hb) had similar oxygen-binding capacity to natural Hb. Moreover, the anti-oxidant ability of FA-Hb in vitro in different systems was superior to natural Hb and in proportion to the degree of modification of FA. The results indicate that FA-Hb might have the potential to serve as a novel oxygen carrier with the capacity to reduce oxidative side reaction.\n[Desarrollo de una vacuna profil\u00e1ctica de segunda generaci\u00f3n contra el papilomavirus humano Development of a second generation prophylactic vaccine against human papillomavirus](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802011000500015) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAlonso Leonardo\n2011-06-01\nFull Text Available Los papilomavirus humanos (HPV son el agente etiol\u00f3gico del c\u00e1ncer cervical (CC, la segunda causa de muerte por c\u00e1ncer en mujeres. Se estima que medio mill\u00f3n de nuevos c\u00e1nceres se diagnostica cada a\u00f1o, ocurriendo la mayor\u00eda de ellos en pa\u00edses en v\u00edas de desarrollo debido a la ausencia o ineficiencia de los programas masivos de detecci\u00f3n temprana. Recientemente se han introducido en el mercado dos vacunas profil\u00e1cticas contra las principales cepas oncog\u00e9nicas de HPV, la cepa 16 y 18, responsables por el 80% de todos los CC. Estas vacunas se obtienen en forma recombinante y han demostrado ser extremadamente seguras y eficaces. Sin embargo, su impacto inmediato en la incidencia de la infecci\u00f3n por HPV en pa\u00edses en v\u00edas de desarrollo ser\u00e1 m\u00ednimo, debido principalmente al alto costo de las mismas. Existe la necesidad de contar con vacunas de segunda generaci\u00f3n, de bajo costo y de aplicaci\u00f3n masiva que permitan disminuir sensiblemente el n\u00famero de CC en la poblaci\u00f3n. Con este objetivo hemos desarrollado una plataforma de expresi\u00f3n recombinante que permite obtener part\u00edculas tipo virus (VLPs con las cuales es posible formular vacunas efectivas y accesibles contra la infecci\u00f3n por HPV.Human papillomaviruses (HPV are the etiologic agent for cervical cancer (CC, the second cause of cancer death in women worldwide. It is estimated that half a million new cases are diagnosed each year, mostly in developing countries due to the lack of massive programs for early detection of the virus. Recently, two prophylactic vaccines against the main oncogenic HPV types 16 and 18 (responsible for 80% of CC have been introduced into market. Both of these vaccines, obtained as recombinants, have been shown to be safe and effective; however, their high cost works against its immediate impact in the incidence of HPV infection in developing and low-income countries. There is a need to have in hand second generation, low cost vaccines of massive use\n[Stat5 phosphorylation is responsible for the excessive potency of HB-EGF.](https://www.ncbi.nlm.nih.gov/pubmed/29274275)\nHeo, Jeongyeon; Kim, Jae Geun; Kim, Sunghwan; Kang, Hara\n2017-12-23\nHeparin-binding EGF-like growth factor (HB-EGF) is a potent growth factor involved in wound healing and tumorigenesis. Despite the sequence similarity between HB-EGF and EGF, HB-EGF induces cellular proliferation and migration more potently than EGF. However, the differential regulation by HB-EGF and EGF has not been thoroughly elucidated. In this study, we compared signaling pathways activated by HB-EGF and EGF to understand the details of the molecular mechanism of the high potency induced by HB-EGF. HB-EGF specifically induced the phosphorylation of EGFR-Y1045 and activated Stat5, which is responsible for promoting cell proliferation, and migration. The competition of phosphorylated EGFR-Y1045 inhibited Stat5 activation and consequently lowered the effect of HB-EGF on cell proliferation, suggesting that the phosphorylation of EGFR-Y1045 is essential for the activation of Stat5. The phosphorylation of EGFR-Y1045 and Stat5 induced by HB-EGF was prevented by sequestering the heparin-binding domain, suggesting that the heparin-binding domain is critical for HB-EGF-mediated signaling and cellular responses. In conclusion, the heparin-binding domain of HB-EGF was responsible for EGFR-mediated Stat5 activation, resulting in a more potent cellular proliferation, and migration than that mediated by EGF. This molecular mechanism is useful for understanding ligand-specific EGFR signaling and developing biomedicines for wound healing or cancer therapy. \u00a9 2017 Wiley Periodicals, Inc.\n[Hb TAYBE: clinical and morphological findings IN 43 patients.](https://www.ncbi.nlm.nih.gov/pubmed/26519868)\nKoren, Ariel; Levin, Carina; Zalman, Luci; Palmor, Haya; Filon, Dvora; Chubar, Evgeny; Resnitzky, Peretz; Bennett, Michael\n2016-08-01\nHereditary sequence variants in globin genes are usually silent and are rarer in \u03b1-globin chains than \u03b2-globin chains. Some may lead to an unstable protein with a hemolytic or thalassemic phenotype. Hb Taybe is an unstable \u03b1-chain hemoglobin variant caused by the deletion of a threonine residue at codon 38 or 39 of the \u03b11 globin gene. This deletion results in a structural abnormality that affects the \u03b11 \u03b22 contact and the \u03b11 \u03b21 interface, producing a highly unstable Hb. We describe the clinical, laboratory, and morphological characteristics of 43 patients with Hb Taybe, sixteen of whom are heterozygous, eight are homozygous, and nineteen are double heterozygous for Hb Taybe and other \u03b1-gene mutations or deletions. The clinical presentation is very variable from a mild hemolytic anemia to the need for red cell transfusion. Morphological characteristics include erythroid hyperplasia, defective hemoglobin production, and dyserythropoietic features. On electron microscopy dyserythropoiesis and cytoplasmic precipitation of globin compatible optical dense material is seen. This is the largest report of Hb Taybe patients. Previous reported cohorts are not related to these cases. We conclude that patients carrying Hb Taybe have a unique hematological and clinical phenotype distinct from other hemoglobinopathies and from congenital dyserythropoietic anemia. \u00a9 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.\n[Vacuna fenol-insoluble contra la brucelosis humana: evaluacion del poder inmunogenico en cobayos Phenol insoluble extract vaccine for the prevention of brucellosis in humans: evaluation in guinea pigs](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46651991000100005) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJ. Bolpe\n1991-02-01\nFull Text Available Se examin\u00f3 una vacuna dise\u00f1ada para inmunizar al hombre, preparada con extracto de fenol insoluble, para determinar si proteg\u00eda a cobayos contra el desaf\u00edo con la cepa virulenta B. abortus 2308. Se incluyeron en el experimento las vacunas vivas atenuadas B. abortus cepa 19 y B. melitensis Rev. 1, para comparar los resultados. Se vacunaron 93 animales en cada grupo, que fueron subdivididos en subgrupos de 31 y se los desafi\u00f3 con 10(4, 10\u00b3 y 10\u00b2 unidades formadoras de colonias de la cepa B. abortus 2308 virulenta. El an\u00e1lisis global de los resultados demostr\u00f3 una protecci\u00f3n del 11.9% en animales vacunados con el extracto de fenol insoluble, 65% en los vacunados con B. abortus cepa 19 y 95% en el grupo que recibi\u00f3 vacuna B. melitensis Rev. 1.A phenol insoluble extract vaccine proposed to immunize men against brucellosis was tested for its ability in protecting guinea pigs against challenge with virulent Brucella abortus strain 2308. Living attenuated Brucella abortus strain 19 and B. melitensis Rev. 1 were included in the experiment for comparison. Ninety three animals were vaccinated in each group and subdivided in subgroups of 31 for challenge with 10(4,10\u00b3 and 10\u00b2 colony forming units of virulent B. abortus 2308. A global analysis of the results showed protection of 11.9%, 65% and 95% in animals vaccinated with phenol insoluble extract, strain 19 and Rev. 1, respectively.\n[Avalia\u00e7\u00e3o de Hb A2 e Hb F em doadores de sangue de regi\u00e3o malar\u00edgena da Amaz\u00f4nia Oriental brasileira por HPLC Evaluation of Hb A2 and Hb F by HPLC in blood donors from the malaria endemic region of Eastern Amazon of Brazil](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842003000400013) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nWanessa C. Souza\n2003-01-01\nFull Text Available In malaria endemic regions of Africa, resistance to infection by Plasmodium has been observed in under 6-month-old children, when there are higher fetal hemoglobin (Hb F levels. Research performed in the S\u00e3o Jos\u00e9 do Rio Preto region, central-east Brazil, reported increased levels of Hb F in blood donors. The purpose of this work was to evaluate the A2 hemoglobin (Hb A2 and Hb F concentrations in blood donors deriving from the Brazilian malaria endemic region. Forty-five blood donor samples from Macap\u00e1, from patients with varying genders, ages and ethnic origins, were collected by venous puncture after informed consent was obtained. The samples were analyzed by High Performance Liquid Chromatography (HPLC - System Variant (Bio-Rad. The HPLC demonstrated sensitivity and rapidity in the identification and measurement of the hemoglobins and gave precise results. Moreover, it provided measurement of hemoglobin variants, even when they were present in small amounts, providing a diagnosis of hemoglobinopathies. Hb F levels above the normal were observed in 33.3% of the analyzed samples. The presence of increased Hb F can suggest resistance to infection by Plasmodium falciparum, as there have been reports that infected red blood cells interfere in the development of the parasite.\n[Thrombosis in Hb Taybe [codons 38/39 (-ACC) (\u03b11)](http://www.forskningsdatabasen.dk/en/catalog/233181859) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nJuul, Maja Bech; Vestergaard, Hanne; Petersen, Jesper\n2012-01-01\nHb Taybe is a highly unstable hemoglobin (Hb) variant caused by a 3 bp deletion at codons 38/39 (-ACC) on the \u03b11-globin gene. We report for the first time, a patient with a compound heterozygosity for Hb Taybe and a 5 bp deletion at the splice donor site of IVS-I on the \u03b12-globin gene and ischemic...\n[Fatores associados \u00e0 cobertura vacinal em adolescentes Factores asociados a la cobertura por vacunas en adolescentes Factors associated to the vaccination covering in adolescents](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-21002010000600013) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAyla Maria Calixto de Carvalho\n2010-01-01\nFull Text Available OBJETIVO: Analisar os fatores associados \u00e0 condi\u00e7\u00e3o de estar vacinado entre adolescentes de uma \u00e1rea da Estrat\u00e9gia Sa\u00fade da Fam\u00edlia de Teresina - PI. M\u00c9TODOS: Estudo de natureza quantitativa e do tipo seccional. A amostra foi constitu\u00edda por 261 adolescentes e a an\u00e1lise foi realizada por meio da estat\u00edstica descritiva. RESULTADOS: A cobertura vacinal contra rub\u00e9ola, sarampo e caxumba foi de 5,4%; para a vacina contra difteria e t\u00e9tano, foi de 22,9%; para a vacina contra hepatite-B: foi 27,2% e 35,2% para a vacina contra febre amarela. CONCLUS\u00c3O: A baixa cobertura vacinal encontrada neste estudo est\u00e1 relacionada: \u00e0s oportunidades perdidas de vacina\u00e7\u00e3o (65,5%; \u00e0 defici\u00eancia de conhecimento sobre as vacinas, a faixa et\u00e1ria maior de 15 anos (Raz\u00e3o da Preval\u00eancia (RP = 2,85; \u00cdndice de Confian\u00e7a (IC 95% = 1,63-4,99; o sexo masculino (RP = 2,04; IC95% =1,15-3,62.OBJETIVO: Analizar los factores asociados a la condici\u00f3n de estar vacunado entre adolescentes, en un \u00e1rea de la Estrategia Salud de la Familia, en la ciudad de Teresina, en el estado de Piau\u00ed. M\u00c9TODOS: Estudio de naturaleza cuantitativa y de tipo seccional. La muestra fue constituida por 261 adolescentes y el an\u00e1lisis fue realizado por medio de la estad\u00edstica descriptiva. RESULTADOS: La cobertura por vacuna contra rub\u00e9ola, sarampi\u00f3n e caxumba fue de 5,4%; para la vacuna contra la difteria y t\u00e9tano, fue de 22,9%; para la vacuna contra hepatitis-B, fue 27,2% y de 35,2% para la vacuna contra la fiebre amarilla. CONCLUSI\u00d3N: La baja cobertura por vacunaci\u00f3n encontrada en este estudio est\u00e1 relacionada a: 1 las oportunidades perdidas de vacunaci\u00f3n (65,5%; a la deficiencia de conocimiento sobre las vacunas, al intervalo de edad mayor de 15 a\u00f1os [Raz\u00f3n de la Prevalencia (RP = 2,85; \u00cdndice de Confianza (IC 95% = 1,63-4,99]; al sexo masculino (RP = 2,04; IC95% =1,15-3,62.OBJECTIVE: To analyze the factors associated to the condition of to be vaccinated among\n[AN\u00c1LISIS BIBLIOM\u00c9TRICO EN UNA UNIVERSIDAD CUBANA COMO HERRAMIENTA PARA LA INTELIGENCIA EMPRESARIAL](http://periodicos.ufpb.br/ojs2/index.php/pgc/article/view/27377) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDarlenis Herrera-Vallejera\n2016-01-01\nFull Text Available La Bibliometr\u00eda es una herramienta para realizar estudios de tendencias, estos \u00faltimos son considerados uno de los servicios de la Inteligencia Empresarial. En la actualidad la Bibliometr\u00eda constituye un \u00e1rea instrumental v\u00e1lida para la evaluaci\u00f3n de la actividad cient\u00edfica; usada para determinar el comportamiento del desempe\u00f1o cient\u00edfico individual e institucional de la comunidad cient\u00edfica y acad\u00e9mica, liderazgo cient\u00edfico y \u00e1reas emergentes del conocimiento, aspectos que se consideran por los programas internacionales para financiar proyectos de investigaci\u00f3n e innovaci\u00f3n; as\u00ed como por las pol\u00edticas institucionales para otorgar mejores plazas y validar doctorados. La dimensi\u00f3n evaluativa de la Bibliometr\u00eda se enmarca en tres variables: producci\u00f3n cient\u00edfica, colaboraci\u00f3n cient\u00edfica e impacto cient\u00edfico. En este orden de ideas, la presente investigaci\u00f3n se bas\u00f3 en la Bibliometr\u00eda, como herramienta de la inteligencia empresarial, a trav\u00e9s de un estudio de caso aplicado a una Universidad cubana. Se aplic\u00f3 la metodolog\u00eda bibliom\u00e9trica para la evaluaci\u00f3n de la actividad cient\u00edfica, desarrollada por el Instituto de Informaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica de Cuba. Se compil\u00f3 la producci\u00f3n cient\u00edfica de la universidad en la base de datos bibliogr\u00e1fica SCOPUS durante el per\u00edodo 2005-2012 y se emple\u00f3 el Bibexcel y Ucinet 6.1 para el procesamiento matricial y la visualizaci\u00f3n de los datos. Como resultado, se obtuvo que los profesores m\u00e1s productivos son los doctores en ciencias, predominando el g\u00e9nero masculino. Se concluye que la aplicaci\u00f3n de la Bibliometr\u00eda como m\u00e9todo para realizar an\u00e1lisis de tendencias fue de gran utilidad para la toma de decisiones, por la direcci\u00f3n de ciencia y tecnolog\u00eda de la Universidad cubana.\n[A targetable HB-EGF-CITED4 axis controls oncogenesis in lung cancer.](https://www.ncbi.nlm.nih.gov/pubmed/28092674)\nHsieh, C-H; Chou, Y-T; Kuo, M-H; Tsai, H-P; Chang, J-L; Wu, C-W\n2017-05-25\nAberrant epidermal growth factor (EGF) receptor (EGFR) signaling contributes to neoplastic initiation and progression in lung. Mutated EGFR has become as an important therapeutic target in lung cancer, whereas targeted treatment is not available for wild-type EGFR or its ligands. In this study, we found that heparin-binding (HB)-EGF, a member of the EGF family, was highly expressed in a subset of lung cancer, proliferation of which was dependent on HB-EGF signaling. Silencing of HB-EGF with RNA interference inhibited cell cycle progression in lung cancer cells. We observed that, upon HB-EGF induction, CITED4 was induced through a signal transducer and activator of transcription 3 (STAT3)-dependent pathway, regulating cell proliferation. CITED4 interacted with MYC and potentiated MYC-mediated transactivation of the CCND1 promoter, leading to cell cycle progression. Correlation analysis revealed that HB-EGF and CITED4 were significantly positively associated in primary lung tumors, and expression of HB-EGF predicted a poor survival outcome in patients. In vitro and in vivo experiments revealed that pharmacological inhibition of HB-EGF with CRM197 significantly attenuated tumor cell growth. Thus, CITED4 functions as a molecular switch in HB-EGF-induced growth control, and HB-EGF provides a novel therapeutic target for lung cancer intervention.\n[Mechanosensitive promoter region in the human HB-GAM gene](http://www.forskningsdatabasen.dk/en/catalog/2115115) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nLiedert, Astrid; Kassem, Moustapha; Claes, Lutz\n2009-01-01\nMechanical loading is essential for maintaining bone mass in the adult skeleton. However, the underlying process of the transfer of the physical stimulus into a biochemical response, which is termed mechanotransduction is poorly understood. Mechanotransduction results in the modulation of gene...... cells. Analysis of the human HB-GAM gene upstream regulatory region with luciferase reporter gene assays revealed that the upregulation of HB-GAM expression occurred at the transcriptional level and was mainly dependent on the HB-GAM promoter region most upstream containing three potential AP-1 binding...\n[Excess HB-EGF, which promotes VEGF signaling, leads to hydrocephalus](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4886677)\nShim, Joon W.; Sandlund, Johanna; Hameed, Mustafa Q.; Blazer-Yost, Bonnie; Zhou, Feng C.; Klagsbrun, Michael; Madsen, Joseph R.\n2016-01-01\nHeparin binding epidermal growth factor-like growth factor (HB-EGF) is an angiogenic factor mediating radial migration of the developing forebrain, while vascular endothelial growth factor (VEGF) is known to influence rostral migratory stream in rodents. Cell migratory defects have been identified in animal models of hydrocephalus; however, the relationship between HB-EGF and hydrocephalus is unclear. We show that mice overexpressing human HB-EGF with \u03b2-galactosidase reporter exhibit an elevated VEGF, localization of \u03b2-galactosidase outside the subventricular zone (SVZ), subarachnoid hemorrhage, and ventriculomegaly. In Wistar polycystic kidney rats with hydrocephalus, alteration of migratory trajectory is detected. Furthermore, VEGF infusions into the rats result in ventriculomegaly with an increase of SVZ neuroblast in rostral migratory stream, whereas VEGF ligand inhibition prevents it. Our results support the idea that excess HB-EGF leads to a significant elevation of VEGF and ventricular dilatation. These data suggest a potential pathophysiological mechanism that elevated HB-EGF can elicit VEGF induction and hydrocephalus. PMID:27243144\n[Predictors of HbA1c levels in patients initiating metformin.](https://www.ncbi.nlm.nih.gov/pubmed/27552675)\nMartono, Doti P; Hak, Eelko; Lambers Heerspink, Hiddo; Wilffert, Bob; Denig, Petra\n2016-12-01\nThe aim was to assess demographic and clinical factors as predictors of short (6 months) and long term (18 months) HbA1c levels in diabetes patients initiating metformin treatment. We conducted a cohort study including type 2 diabetes patients who received their first metformin prescription between 2007 and 2013 in the Groningen Initiative to Analyze Type 2 Diabetes Treatment (GIANTT) database. The primary outcome was HbA1c level at follow-up adjusted for baseline HbA1c; the secondary outcome was failing to achieve the target HbA1c level of 53 mmol/mol. Associations were analyzed by linear and logistic regression. Multiple imputation was used for missing data. Additional analyses stratified by dose and adherence level were conducted. The cohort included 6050 patients initiating metformin. Baseline HbA1c at target consistently predicted better HbA1c outcomes. Longer diabetes duration and lower total cholesterol level at baseline were predictors for higher HbA1c levels at 6 months. At 18 months, cholesterol level was not a predictor. Longer diabetes duration was also associated with not achieving the target HbA1c at follow-up. The association for longer diabetes duration was especially seen in patients starting on low dose treatment. No consistent associations were found for comorbidity and comedication. Diabetes duration was a relevant predictor of HbA1c levels after 6 and 18 months of follow-up in patients initiating metformin treatment. Given the study design, no causal inference can be made. Our study suggests that prompt treatment intensification may be needed in patients who have a longer diabetes duration at treatment initiation.\n[Effect of once-weekly dulaglutide on glycated haemoglobin (HbA1c) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline HbA1c.](https://www.ncbi.nlm.nih.gov/pubmed/28817231)\nGallwitz, Baptist; Dagogo-Jack, Samuel; Thieu, Vivian; Garcia-Perez, Luis-Emilio; Pavo, Imre; Yu, Maria; Robertson, Kenneth E; Zhang, Nan; Giorgino, Francesco\n2018-02-01\nTo evaluate the efficacy and safety of dulaglutide 1.5 and 0.75 mg in patients with type 2 diabetes by subgroups of gender, duration of diabetes and baseline glycated haemoglobin (HbA1c) in the dulaglutide clinical development programme (AWARD-1 to -6 and -8 clinical trials). Change in HbA1c was analysed by gender, duration of diabetes (baseline HbA1c (baseline in weight, hypoglycaemia and gastrointestinal adverse events were evaluated for individual trials. In the pooled analysis of patients treated with dulaglutide 1.5 mg at 6 months, the reductions in HbA1c from baseline were similar across gender (men: least squares [LS] mean -1.26% [95% confidence interval {CI} -1.36, -1.16]; women: LS mean -1.33% [95% CI -1.43, -1.24]) and among duration of diabetes subgroups (baseline HbA1c \u22658.5% had greater HbA1c reductions than patients with baseline HbA1c baseline HbA1c subgroups, respectively; women had a numerically greater weight loss or less weight gain than men with both dulaglutide doses. There was no clinically meaningful difference in hypoglycaemia trends by gender or duration of diabetes. Hypoglycaemia incidence and rate were generally lower in patients with baseline HbA1c \u22658.5% than in those with baseline HbA1c, with greater HbA1c and FBG reductions in patients with a higher baseline HbA1c. Dulaglutide was well tolerated, with a safety profile similar to other glucagon-like peptide-1 receptor agonists. \u00a9 2017 John Wiley & Sons Ltd.\n[La historiograf\u00eda colonial cubana y la modernidad](http://revistas.unimagdalena.edu.co/index.php/clioamerica/article/view/342) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nArturo Sorhegui\n2013-10-01\nFull Text Available El n\u00facleo argumental de este art\u00edculo es demostrar como la historiograf\u00eda hispanoamericana \u2013tomando como muestra la cubana, en la \u00e9poca colonial\u2013 fue capaz de propiciar, por si misma, algunas de las tendencias historiogr\u00e1ficas establecidas como corrientes en el siglo XIX europeo, en la medida que debi\u00f3 enfrentarse a las mismas problem\u00e1ticas que en Europa le dieron origen; lo \u00fanico que adecuadas a las circunstancias de la realidad americana. Se argumenta con la historiograf\u00eda criolla iluminista del XVIII y la \u201cHistoria de la Esclavitud\u201d de Jos\u00e9 Antonio Saco del XIX.Palabras Clave: Ilustraci\u00f3n americana; corrientes historiogr\u00e1ficas; desarrollo propio; Modernidad; Historia de la Esclavitud. The Cuban colonial historiography and modernityAbstractThe argumental nucleus of this article is to demonstrate as the Hispano-American historiography \u2013taking as it shows the Cuban, at the colonial time\u2013 he was able to cause, by itself, some of the established historiogr\u00e1ficas tendencies like currents in European century XIX, in the measurement that had to face same the problematic ones that in Europe they gave origin him; only that adapted to the circumstances of the American reality. Jos\u00e9 Antonio Saco from the XIX argues itself with the iluminista Creole historiography of the XVIII and the \u201cHistory of the Slavery\u201d.Keywords: American illustration; historiogr\u00e1ficas currents; own development; Modernity; History of the Slavery.\n[Modeling Single-Phase PV HB-ZVR Inverter Connected to Grid](http://www.forskningsdatabasen.dk/en/catalog/194464157) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nGuo, Yougui; Zeng, Ping; Zhu, Jieqiong\n2011-01-01\nPLECS is used to model the PV H-bridge zero voltage rectifier (HB-ZVR) inverter connected to grid and good results are obtained. First, several common topologies of PV inverters are introduced. Then the unipolar PWM control strategy is described for PV HB-ZVR inverter. Third, PLECS is briefly...... introduced. Fourth, the modeling of PV HB-ZVR inverter is presented with PLECS. Finally, a series of simulations are carried out. The simulation results tell us PLECS is very powerful tool to real power circuits and it is very easy to simulate LCL filter. They have also verified that the unipolar PWM control...... strategy is feasible to control the PV HB-ZVR inverter....\n[HB-EGF expression as a potential biomarker of acquired middle ear cholesteatoma.](https://www.ncbi.nlm.nih.gov/pubmed/28498080)\nXie, Shumin; Wang, Xiaoli; Ren, Hongmiao; Liu, Xiaoyu; Ren, Jihao; Liu, Wei\n2017-08-01\nThe heparin-binding epidermal growth factor-like growth factor (HB-EGF) plays an essential role in the development and invasiveness of cholesteatoma. This study may help to realize the molecular mechanisms underlying the pathogenesis of cholesteatoma and make HB-EGF a promising target for drug intervention of cholesteatoma. To detect HB-EGF expression in human surgical specimens of acquired middle ear cholesteatoma and analyze its functional role as a regulator of epithelial keratinocytes hyperproliferation. A total of 34 patients who underwent surgical treatment for middle ear cholesteatoma were recruited in the study. The mRNA and protein expression of HB-EGF in middle ear cholesteatoma tissues and normal postauricular skin tissues was investigated by real-time quantitative reverse-transcription-polymerase chain reaction (RT-qPCR), immunohistochemical staining, and western blot. The correlation between bone resorption degree and HB-EGF expression was also analyzed. On average, compared with normal postauricular skin, expression of HB-EGF mRNA in the cholesteatoma epithelium was significantly elevated 2.41-fold by RT-qPCR, and HB-EGF protein significantly upregulated 2.32-fold by western blot. Positive HB-EGF immunostaining observed in the basal and suprabasal layers of cholesteatoma epithelium was significantly stronger than in normal postauricular skin. Meanwhile, an obviously positive correlation between HB-EGF protein expression and bone resorption degree was discovered.\n[Should Studies of Diabetes Treatment Stratification Correct for Baseline HbA1c?](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4822872)\nJones, Angus G.; Lonergan, Mike; Henley, William E.; Pearson, Ewan R.; Hattersley, Andrew T.; Shields, Beverley M.\n2016-01-01\nAims Baseline HbA1c is a major predictor of response to glucose lowering therapy and therefore a potential confounder in studies aiming to identify other predictors. However, baseline adjustment may introduce error if the association between baseline HbA1c and response is substantially due to measurement error and regression to the mean. We aimed to determine whether studies of predictors of response should adjust for baseline HbA1c. Methods We assessed the relationship between baseline HbA1c and glycaemic response in 257 participants treated with GLP-1R agonists and assessed whether it reflected measurement error and regression to the mean using duplicate \u2018pre-baseline\u2019 HbA1c measurements not included in the response variable. In this cohort and an additional 2659 participants treated with sulfonylureas we assessed the relationship between covariates associated with baseline HbA1c and treatment response with and without baseline adjustment, and with a bias correction using pre-baseline HbA1c to adjust for the effects of error in baseline HbA1c. Results Baseline HbA1c was a major predictor of response (R2 = 0.19,\u03b2 = -0.44,pHbA1c were associated with response, however these associations were weak or absent after adjustment for baseline HbA1c. Bias correction did not substantially alter associations. Conclusions Adjustment for the baseline HbA1c measurement is a simple and effective way to reduce bias in studies of predictors of response to glucose lowering therapy. PMID:27050911\n[ERGEBNISSE DER UNTERSUCHUNG VON HB-AL BEI 94 PATIENTEN MIT NIERENINSUFFIZIENZ](http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/5100.pdf&manuscript_id=5100) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nA\n1983-05-01\nFull Text Available We have qua nt i t a l ed Hb- Al ~n 125 patients . 74 pa t ient s had chronic Renal Failure . 20 of them had Diabetes wi th Renal Fai lure , 21 Diabetics and 10 patients were evaluat ed as control. We have divided the patients with Renal Failure i n 3 groups according to t heir serum c reatin i ne . Hb-Al in a ll groups \"as not correlated wi th serum creat i ne. Hb-Al in Diabetic gr oup was highe r than Diabetic patients with Renal Failure . This group a lso had mor e HbA1 than t he gr oup with Renal ~ailure a nd no Diabetes ,and control group . , Hb-Al was correlated with Blood suger i n all pa t i e nt s s o we can u se\"nal Failure the me a sureme nt of Hb-Al i n pati ents with Renunder Dial ys i s with gl ucose solution fo r evalua t i o n of sugar meta boli s m.\n[Psicolog\u00eda de la Salud cubana: apuntes hist\u00f3ricos y proyecciones en los inicios del siglo XXI](http://www.redalyc.org/articulo.oa?id=80125017008) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJorge A. Grau Abalo\n2012-01-01\nFull Text Available Se sistematizan aspectos hist\u00f3ricos del desarrollo de la Psicolog\u00eda de la Salud cubana a lo largo de m\u00e1s de 42 a\u00f1os de su inserci\u00f3n en el Sistema Nacional de Salud, considerando tres grupos de determinantes: en el primer grupo, se combina la aparici\u00f3n de una nueva forma de pensamiento con el reconocimiento del modelo biopsicosoc ial tras la transformaci\u00f3n del viejo modelo biom\u00e9dico, la nueva conceptualizaci\u00f3n del proceso salud-enfermedad y el conocimiento creciente de factores psi col\u00f3gicos y soc iales asociados a este proceso, la transici\u00f3n en los perfiles epidemiol\u00f3gicos, la irrupci\u00f3n de los conceptos de bienestar y calidad de vida relacionada con la salud, la incorporaci\u00f3n de la atenci\u00f3n primaria como \u00e1mbito fundamental para muchas acciones de salud y la importancia del trabajo en equipos interdisciplinarios. El segundo, est\u00e1 relacionado con los cambios sociales ocurridos en Cuba despu\u00e9s de la d\u00e9cada de los 60 y que materializaron estas nuevas concepciones con un enfoque preventivo, de proyecci\u00f3n social. El tercero, vincula el desarrollo mismo de la Psicolog\u00eda con campos espec\u00edficos de actuaci\u00f3n. Adem\u00e1s, se intentan identificar las tareas prioritarias para la Psicolog\u00eda de la salud cubana en el presente y formular sus proyecciones b\u00e1sicas, para los pr\u00f3ximos a\u00f1os en el contexto de las tendencias mundiales en esta disciplina.\n[GENETIC FACTORS INFLUENCING HEMOGLOBIN F LEVEL IN \u03b2-THALASSEMIA/HB E DISEASE.](https://www.ncbi.nlm.nih.gov/pubmed/27086429)\nRuangrai, Waraporn; Jindadamrongwech, Sumalee\n2016-01-01\nGenetic factors influencing Hb F content in adult red blood cells include \u03b2-thalassemia genotypes, co-inheritance of \u03b1-thalassemia traits and single nucleotide polymorphisms (SNPs). Genotyping of \u03b1- and \u03b2-thalassemia and five SNPs in \u03b2-globin gene cluster previously identified in genome-wide association studies as being markers of elevated Hb F in \u03b2-thalassemia were performed in 81 subjects diagnosed with \u03b2-thalassemia/Hb E. Hb F levels are higher (0.9-7.1 g/dl) in subjects (n = 57) with the severe compared to mild \u03b2-thalassemia (0.8-2.5 g/ dl) (n = 4) genotypes, and are similarly low (0.7-3.5 g/dl) in those (n = 15) with \u03b1-thalassemia co-inheritance. Hb F levels in non-thalassemia controls (n = 150) range from 0 to 0.15 g/dl. The presence of homozygous minor alleles of the 5 SNPs are significant indicators of \u03b2-thalassemia/Hb E individuals with high Hb F (> 4 g/dl), independent of their thalassemia genotypes. Given that re-activation of \u03b3-globin genes leads to amelioration of \u03b2-thalassemia severity, understanding how genetic factors up-regulate Hb F production may lead to possible therapeutic interventions, genetically or pharmacologically, of this debilitating disease in the not too distant future.\n[Relationship of HbA1c variability, absolute changes in HbA1c, and all-cause mortality in type 2 diabetes](http://www.forskningsdatabasen.dk/en/catalog/2262879396) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nSkriver, Mette Vinther; Sandb\u00e6k, Annelli; Kristensen, Jette Kolding\n2015-01-01\nOBJECTIVE: We assessed the relationship of mortality with glycated hemoglobin (HbA1c) variability and with absolute change in HbA1c. DESIGN: A population-based prospective observational study with a median follow-up time of 6 years. METHODS: Based on a validated algorithm, 11 205 Danish individua...\n[La econom\u00eda y la pol\u00edtica econ\u00f3mica cubana en el per\u00edodo de entreguerras](https://www.openaire.eu/search/publication?articleId=od______1106::9226084bf3884fcadfc72593ce73fd24)\nSantamar\u00eda Garc\u00eda, Antonio\n1999-01-01\nAn\u00e1lisis de como se reconfigur\u00f3 la econom\u00eda cubana en el per\u00edodo entre las dos guerras mundiales para hacer frente a las crisis de sus exportaciones azucarera y sus efectos socio-econ\u00f3micos y mantener la especializaci\u00f3n productiva del pa\u00eds. El modo en que se hizo permiti\u00f3 mantener la posici\u00f3n del pa\u00eds entre los l\u00edderes econ\u00f3micos latinaomericanos y restablecer el crecimiento con mejoras distributivas para restabelcer el orden social, aunque el enquistamiento posterior de tales medidas ocasion...\n[Aceptabilidad de la vacuna contra el virus del papiloma humano en madres de la provincia de Valencia (Espa\u00f1a)](https://www.openaire.eu/search/publication?articleId=od_______935::69e2b78c0813ba798e7f18af9d21bb8d)\nNavarro Illana, Pedro; Caballero P\u00e9rez, Pablo; Tuells Hern\u00e1ndez, Jos\u00e9; Puig Barber\u00e1, Joan; D\u00edez-Domingo, Javier\n2015-01-01\nIntroducci\u00f3n: La Comunidad Valenciana inici\u00f3 en octubre del 2008 el programa de vacunaci\u00f3n contra el virus del papiloma humano (VPH) en ni\u00f1as de 14 a\u00f1os. El objetivo de este estudio es evaluar los conocimientos sobre la infecci\u00f3n por VPH y su vacuna en madres de adolescentes e identificar los factores asociados a la predisposici\u00f3n de vacunar a sus hijas. Material y m\u00e9todos: Estudio observacional transversal mediante cuestionario dirigido a madres de alumnas nacidas en 1995 matriculadas en cen...\n[Desarrollo de vacunas contra el virus de la inmunodeficiencia humana tipo 1: Relevancia de la inmunidad celular contra subtipos](https://www.openaire.eu/search/publication?articleId=doajarticles::3941e408f16fd779b922d875bd01b15f)\nAna Mar\u00eda Rodr\u00edguez; Gabriela Turk; Mar\u00eda Fernanda Pascutti; Juliana Falivene; Mar\u00eda Magdalena Gherardi\n2010-01-01\nHan pasado casi 30 a\u00f1os de la detecci\u00f3n de los primeros casos de infecci\u00f3n con HIV-1 y a\u00fan no se ha conseguido desarrollar una vacuna efectiva y segura. A pesar del impacto positivo sobre la pandemia que se ha conseguido gracias a los avances en la terapia antirretroviral (TARV), el HIV/sida sigue constituyendo un grave problema para la salud p\u00fablica, especialmente en los pa\u00edses en desarrollo, donde es dif\u00edcil el acceso al tratamiento. En el mundo, 33 millones de personas viven con el virus d...\n[Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.](https://www.ncbi.nlm.nih.gov/pubmed/29191924)\nInoue, Yuki; Shimazawa, Masamitsu; Nakamura, Shinsuke; Takata, Shinsuke; Hashimoto, Yuhei; Izawa, Hiroshi; Masuda, Tomomi; Tsuruma, Kazuhiro; Sakaue, Tomohisa; Nakayama, Hironao; Higashiyama, Shigeki; Hara, Hideaki\n2018-01-01\nThe incidence of blindness is increasing because of the increase in abnormal ocular neovascularization. Anti-VEGF (vascular endothelial growth factor) therapies have led to good results, although they are not a cure for the blindness. The purpose of this study was to determine what role HB-EGF (heparin-binding epidermal growth factor-like growth factor) plays in ocular angiogenesis. We examined the role played by HB-EGF in ocular neovascularization in 2 animal models of neovascularization: laser-induced choroidal neovascularization (CNV) and oxygen-induced retinopathy. We also studied human retinal microvascular endothelial cells in culture. Our results showed that the neovascularization was decreased in both the CNV and oxygen-induced retinopathy models in HB-EGF conditional knockout mice compared with that in wild-type mice. Moreover, the expressions of HB-EGF and VEGF were increased after laser-induced CNV and oxygen-induced retinopathy, and their expression sites were located around the neovascular areas. Exposure of human retinal microvascular endothelial cells to HB-EGF and VEGF increased their proliferation and migration, and CRM-197 (cross-reactive material-197), an HB-EGF inhibitor, decreased the HB-EGF-induced and VEGF-induced cell proliferation and migration. VEGF increased the expression of HB-EGF mRNA. VEGF-dependent activation of EGFR (epidermal growth factor receptor)/ERK1/2 (extracellular signal-regulated kinase 1/2) signaling and cell proliferation of endothelial cells required stimulation of the ADAM17 (a disintegrin and metalloprotease) and ADAM12. CRM-197 decreased the grades of the fluorescein angiograms and size of the CNV areas in marmoset monkeys. These findings suggest that HB-EGF plays an important role in the development of CNV. Therefore, further investigations of HB-EGF are needed as a potential therapeutic target in the treatment of exudative age-related macular degeneration. \u00a9 2017 American Heart Association, Inc.\n[Efectividad y duraci\u00f3n de la inmunidad de la vacuna frente al meningococo serogrupo A y C](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::079e97a5d510c0250481d9007f374dfc)\nGarc\u00eda Comas Luis; Ram\u00edrez Fern\u00e1ndez Rosa; Casta\u00f1eda L\u00f3pez Rosario; Sanz Moreno Juan Carlos; V\u00e1zquez Moreno Julio; Lasheras Carbajo M\u00aa Dolores; Barranco Ordo\u00f1ez Dolores; Ruiz Contreras Jes\u00fas; Jover Ibarra Jos\u00e9\n2000-01-01\nFUNDAMENTO: La Comunidad de Madrid detect\u00f3 a partir de 1995 un incremento del n\u00famero de casos de enfermedad meningoc\u00f3cica por serogrupo C. En 1997 se realiz\u00f3 una campa\u00f1a de inmunizaci\u00f3n masiva sobre la poblaci\u00f3n de 18 meses a 19 a\u00f1os. El objetivo de este estudio es conocer la respuesta inmunitaria producida por la vacuna y su relaci\u00f3n con la edad. M\u00c9TODOS: Se seleccion\u00f3 una muestra de 1.003 ni\u00f1os vacunados durante la campa\u00f1a. Se extrajo una muestra de sangre antes de la vacunaci\u00f3n y tras uno,...\n[Estudio histopatol\u00f3gico entre ratones infectados con Salmonella typhi sin vacunar y vacunados por diferentes v\u00edas con las vacunas polisacar\u00eddica y de c\u00e9lulas enteras](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2000000400004&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJuan F. Infante\n2000-12-01\nFull Text Available La fiebre tifoidea constituye una enfermedad propia del hombre. La misma es causada por Salmonella typhi y produce una respuesta inflamatoria en el tracto intestinal. Con el fin de establecer su control por vacunaci\u00f3n el Instituto Finlay ha desarrollado una vacuna a partir del polisac\u00e1rido capsular Vi. Para su estudio experimental no existe un modelo animal que reproduzca los s\u00edntomas y la patogenia de la enfermedad. El desarrollo de modelos experimentales y los estudios histopatol\u00f3gicos aportan informaciones al conocimiento de la enfermedad y a la interpretaci\u00f3n de los procesos inmunol\u00f3gicos. Nos propusimos caracterizar el cuadro histopatol\u00f3gico en los ratones utilizados en las pruebas de potencia de la vacuna antitifo\u00eddica basada en polisac\u00e1rido Vi purificado y su comparaci\u00f3n con la vacuna de c\u00e9lulas enteras. Se utilizaron 240 ratones de ambos sexos pertenecientes a la l\u00ednea C57BL/6 procedentes del Centro Nacional para la Producci\u00f3n de Animales de Laboratorio (CENPALAB, con un peso comprendido entre 18 y 22 g. Se evalu\u00f3 la protecci\u00f3n comparativa entre las v\u00edas intraperitoneal y subcut\u00e1nea utilizando dos inmun\u00f3genos, a partir del polisac\u00e1rido Vi y con la variante de c\u00e9lulas enteras. Se logr\u00f3 una considerable eficacia en rat\u00f3n C57BL/6 para reproducir las lesiones compatibles con Salmonella typhi en h\u00edgado y bazo. La sobrevivencia del grupo no vacunado fue de un 15%. La sobrevivencia de los ratones correspondientes al grupo vacunado con polisac\u00e1rido Vi oscil\u00f3 entre 90% y 100% para ambas v\u00edas, mientras que los vacunados con c\u00e9lulas enteras variaron entre 50% y 100% para la v\u00eda subcut\u00e1nea y entre 60% y 100% para la v\u00eda intraperitoneal todo lo cual evidencia la superioridad de la vacuna a partir del polisac\u00e1rido capsular Vi sobre la variante de c\u00e9lulas enteras en la especie rat\u00f3n C57BL/6\n[The immunogenicity and safety of the new, Indonesian DTwP-HB-Hib vaccine compared to the DTwP/HB vaccine given with the Hib vaccine](https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/1288) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nNovilia Sjafri Bachtiar\n2017-06-01\nFull Text Available Background Haemophilus influenzae type b (Hib causes infection with predominant manifestations of pneumonia, meningitis, and other invasive diseases, occurring primarily in children aged under 2 years, particularly in infants. The World Health Organization (WHO and Indonesian Technical Advisory Group for Immunization recommend to include the Hib vaccine into the national immunization program. The newly developed DTwP-HB-Hib combination vaccine is anticipated to be the preferred choice for Hib vaccine introduction; it is efficient, simple, and has higher coverage. Objective To evaluate the immunogenicity and safety of a new, combined Bio Farma DTwP-HB-Hib vaccine, compared to the registered Hib monovalent vaccine given simultaneously with the local DTwP-HB vaccine, when used as the primary vaccination of Indonesian infants. Methods A prospective, randomized, open-label, phase II study was conducted on the DTwP-HB-Hib vaccine compared to the Hib (registered vaccine given simultaneously with the DTwP-HB vaccine, in Bandung from July 2011 to January 2012. Infants were serially vaccinated at 6-11, 10-15, and 14-19 weeks. Serological assessments were done prior to the first vaccine dose and 28 days after the third dose. Safety was assessed from the time of first injection until 1 month after the last injection. Results Of 220 healthy infants enrolled, 211 completed the study, with 105 receiving the combined vaccine and 106 the two separate vaccines. All vaccines were well tolerated. No differences in rates of local and systemic reactions were seen between the two methods of administration. No serious adverse events were considered to be related to the vaccines. In the DTwP-HB-Hib primary-vaccination group, at least 98% of the infants reached protective levels of antibodies (seropositivity against the antigens employed in the vaccines while 96% in the control group. Conclusion The DTwP-HB-Hib combined vaccine is immunogenic and safe, as well as\n[The significance of disulfide bonding in biological activity of HB-EGF, a mutagenesis approach](https://www.openaire.eu/search/publication?articleId=od_______908::b5af65e02d9cf002bdf116019402dcb0)\nHoskins, J.T.; Zhou, Z.; Harding, P.A.\n2008-01-01\nA site-directed mutagenesis approach was taken to disrupt each of 3 disulfide bonds within human HB-EGF by substituting serine for both cysteine residues that contribute to disulfide bonding. Each HB-EGF disulfide analogue (HB-EGF-Cys/Ser108/121, HB-EGF-Cys/Ser116/132, and HB-EGF-Cys/Ser134/143) was cloned under the regulation of the mouse metallothionein (MT) promoter and stably expressed in mouse fibroblasts. HB-EGF immunoreactive proteins with Mr of 6.5, 21 and 24kDa were observed from lys...\n[Obtenci\u00f3n y evaluaci\u00f3n preliminar de un virus canarypox recombinante como candidato a vacuna antirr\u00e1bica Development and preliminary assessment of a recombinant canarypox virus as an antirabic vaccine candidate](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412012000200004) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nFlavia Zanetti\n2012-06-01\nFull Text Available En la Argentina, la rabia est\u00e1 circunscripta a algunas provincias del norte. La disponibilidad de nuevas vacunas que eliminen la manipulaci\u00f3n del virus r\u00e1bico y que permitan el control de la enfermedad es de importancia estrat\u00e9gica nacional y regional. Las vacunas basadas en poxvirus recombinantes se han utilizado con \u00e9xito como vacunas antirr\u00e1bicas a nivel mundial. SI bien estos sistemas no est\u00e1n disponibles comercialmente, la plataforma de obtenci\u00f3n de virus canarypox (CNPV recombinantes ya ha sido implementada en nuestro laboratorio. El objetivo de este trabajo fue obtener y evaluar un candidato a vacuna antirr\u00e1bica basado en CNPV recombinantes que expresan la glicoprote\u00edna G (RG del virus r\u00e1bico (RV. Se construy\u00f3 un virus recombinante que expresa la secuencia codificante de RG (CNPV-RG. La inoculaci\u00f3n de ratones con este virus indujo altos t\u00edtulos de anticuerpos seroneutralizantes de RV (3,58 y 9,76 Ul/ml despu\u00e9s de una o dos inmunizaciones, respectivamente y protegi\u00f3 al 78 % de los animales desafiados intracerebralmente con RV. Adem\u00e1s, se determin\u00f3 que el CNPV-RG posee una potencia relativa de 3,5 Ul/ml. Los resultados obtenidos constituyen la primera etapa en la evaluaci\u00f3n del CNPV-RG como candidato a vacuna antirr\u00e1bica. Se requerir\u00e1n nuevos ensayos para confirmar su utilidad en especies de inter\u00e9s veterinario.In Argentina, rabies is limited to some northern provinces. Availability of new vaccines abolishing the handling of the rabies virus and allowing disease control has regional and national strategic importance. Vaccines based on recombinant poxviruses have been successfully used as antirabic vaccines worldwide. Although these systems are not commercially available, the platform to obtain recombinant canarypox viruses (CNPV has been previously set up in our laboratory. The aim of this work was the development and evaluation of an antirabic vaccine candidate based on recombinant CNPV expressing the rabies virus (RV\n[Description of Three New \u03b1 Variants and Four New \u03b2 Variants: Hb Montluel [\u03b1110(G17)Ala \u2192 Val; HBA1: c.332C > T], Hb Cap d'Agde [\u03b1131(H14)Ser \u2192 Cys; HBA2: c.395C > G] and Hb Corsica [\u03b1100(G7)Leu \u2192 Pro; HBA1: 302T > C]; Hb N\u00eemes [\u03b2104(G6)Arg \u2192 Gly; HBB: c.313A > G], Hb Saint Marcellin [\u03b2112(G14)Cys \u2192 Gly; HBB: c.337T > G], Hb Saint Chamond [\u03b280(EF4)Asn \u2192 0; HBB: c.241_243delAAC] and Hb Dompierre [\u03b229(B11)Gly \u2192 Arg; HBB: c.88G > C].](https://www.ncbi.nlm.nih.gov/pubmed/26100115)\nRenoux, C\u00e9line; Feray, C\u00e9cile; Joly, Philippe; Lacan, Philippe; Francina, Alain\n2015-01-01\nWe present here seven new hemoglobin (Hb) variants identified during routine Hb analysis. All of them are caused by a missense mutation except Hb Saint Chamond, which results from an in-frame deletion of the asparagine residue at \u03b280. All these variants are clinically silent in the heterozygous state but two of them (Hb Cap d'Agde and Hb Dompierre) may be unstable, whereas Hb N\u00eemes could present a very slightly elevated oxygen affinity. These data are to be confirmed by appropriate biochemical tests.\n[Posterior transverse interarch discrepancy on HbE \u03b2 thalassemia patients](http://e-journal.unair.ac.id/index.php/MKG/article/view/879) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nYuniar Zen\n2011-03-01\nFull Text Available Background: One of the symptoms that often arises on thalassemia patients is disharmony dentofacial, class II skeletal malocclusion, as a result of the malrelation of maxilla and mandible. This malrelation can be affected by either maxillary bone position, dentoalveolar maxillary position, mandibular bone position, dentoalveolar mandibular position, or combinations of those components. Purpose: The study was aimed to examine whether there is posterior transverse interarch discrepancy on the HbE \u03b2 thalassemia patients or not. Methods: This study is an observational research with cross-sectional design. The sample consisted of 33 HbE \u03b2 thalassemia patients and 33 non-thalassemia patients as a control group aged 12\u201314 years. Lateral cephalogram was carried out and dental casts of maxillary and mandibular dental arches were also taken in all of those patients. Results: There was no difference between the maxillary intermolar width of the HbE \u03b2 thalassemia patients and that of the normal ones, but the mandibular intermolar width of the HbE \u03b2 thalassemia patients was significantly smaller than that of the normal ones. Beside that, posterior transverse interarch discrepancy of of the HbE \u03b2 thalassemia patients was significantly greater than that of the normal ones, which showed great difference between maxillary and mandibular intermolar widths. Conclusion: Posterior transverse interarch discrepancy of the HbE \u03b2 thalassemia patients was different from that of the normal ones. The dentofacial abnormalities on the HbE \u03b2 thalassemia patients aged 12\u201314 years primarily was due to disporposional dentofacial growth in the vertical, sagittal, and transversal directions, especially in the posterior region.Latar belakang: Salah satu akibat yang sering timbul pada penderita talasemia adalah disharmoni dentofasial berupa maloklusi skeletal kelas II yang merupakan kelainan hubungan maksila dan mandibula. Malrelasi ini dapat dipengaruhi oleh posisi\n[Nota sobre ant\u00edgeno relacionado \u00e0 hepatite (HB Ag e anticorpo (HB Ab em popula\u00e7\u00e3o do territ\u00f3rio Federal do Amap\u00e1](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86821974000200007) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nHermann G. Schatzmayr\n1974-04-01\nFull Text Available 53 amostras de soro, provenientes de Ferreira Gomes, no Amap\u00e1, foram testados para ant\u00edgeno HB Ag e anticorpo HB Ab, com uma positividade de 3,7% para HB Ag, sub-tipo D. Os autores acentuam a necessidade de inqu\u00e9ritos em popula\u00e7\u00f5es brasileiras a fim de estabelecer os sub-tipos associados \u00e0 hepatite.3,7% of 53 serum samples from healthy inhabitants of Ferreira Gomes, Amap\u00e1, were positive for HB Ag, subtype D. The authors s\u00edress the needs of surveys to deteet the prevalent types of antigens associated with viral hepatitis in different areas of Brazil.\n[HbA1c, fasting plasma glucose and the prediction of diabetes](https://hal.archives-ouvertes.fr/inserm-00659373/document) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nSoulimane, Soraya; Simon, Dominique; Shaw, Jonathan\n2012-01-01\nWith diabetes defined by HbA1c\u22656.5% and/or FPG\u22657.0mmol/l and/or diabetes treatment, we investigated HbA1c and fasting plasma glucose (FPG) thresholds/change-points above which the incidence of diabetes increases.......With diabetes defined by HbA1c\u22656.5% and/or FPG\u22657.0mmol/l and/or diabetes treatment, we investigated HbA1c and fasting plasma glucose (FPG) thresholds/change-points above which the incidence of diabetes increases....\n[Diversidad y distinci\u00f3n taxon\u00f3mica de la macrofauna en fondos blandos de la plataforma norte y suroccidental cubana](http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0718-560X2015000500005&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGema Hidalgo\n2015-11-01\nFull Text Available Se evalu\u00f3 la diversidad de la macrofauna en fondos blandos de la plataforma marina cubana norte y suroccidental. Se utilizaron \u00edndices de variaci\u00f3n taxon\u00f3mica que aportan una nueva dimensi\u00f3n en la interpretaci\u00f3n de la diversidad de las comunidades, que son independientes del tipo de h\u00e1bitat y del esfuerzo de muestreo, y tienen respuesta monot\u00f3nica ante las perturbaciones del ambiente. La heterogeneidad de taxones fue significativamente mayor en los biotopos areno-fangoso con vegetaci\u00f3n, arenoso con vegetaci\u00f3n y arenoso con vegetaci\u00f3n sobre fondo duro. La diversidad por biotopos reflej\u00f3 un gradiente de menor a mayor tama\u00f1o de part\u00edcula y de ausencia a presencia de vegetaci\u00f3n. La distinci\u00f3n taxon\u00f3mica promedio (\u0394+ esperada en estas zonas de la plataforma cubana es de 92,5, con l\u00edmites de confianza de 95% entre 76,7 y 100. Las estaciones con distinci\u00f3n taxon\u00f3mica promedio <92,5 y fuera del l\u00edmite de confianza inferior, se pueden considerar con condiciones ambientales de deterioro o que favorecen la diversidad de alg\u00fan grupo en particular. Los grupos dominantes en esta fracci\u00f3n del bentos son crust\u00e1ceos y poliquetos, como ocurre en otras regiones tropicales y templadas. Estos resultados sirven de base para la evaluaci\u00f3n y monitoreo ambiental del macrozoobentos como componente clave del funcionamiento de ecosistemas marinos en fondos blandos de Cuba.\n[Avalia\u00e7\u00e3o eletrofor\u00e9tica, cromatogr\u00e1fica e molecular da Hb D Los Angeles no Brasil Electrophoretical, chromatographic and molecular valuations of Hb D Los Angeles in Brazil](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842003000300007) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAna R. Chinelato-Fernandes\n2003-01-01\nFull Text Available A variante de hemoglobina (Hb D mais comum, Hb D Los Angeles ou D Punjab, \u00e9 originada de uma transvers\u00e3o GAA->CAA no c\u00f3don 121 da globina beta; essa muta\u00e7\u00e3o resulta na substitui\u00e7\u00e3o do \u00e1cido glut\u00e2mico por glutamina na prote\u00edna. \u00c9 a terceira variante de hemoglobina mais freq\u00fcente da popula\u00e7\u00e3o brasileira. Como as hemoglobinas D apresentam migra\u00e7\u00e3o similar \u00e0 hemoglobina S em pH alcalino, e com a hemoglobina A em pH \u00e1cido, s\u00e3o necess\u00e1rios v\u00e1rios testes para o correto diagn\u00f3stico. No presente estudo objetivou-se relacionar os diferentes procedimentos laboratoriais de rotina diagn\u00f3stica, al\u00e9m da an\u00e1lise molecular, para estabelecer o perfil de Hb D Los Angeles no Brasil. Foram analisados 47 indiv\u00edduos da popula\u00e7\u00e3o brasileira com prov\u00e1vel Hb D Los Angeles, por v\u00e1rios procedimentos eletrofor\u00e9ticos em diferentes condi\u00e7\u00f5es de pH, al\u00e9m da cromatografia l\u00edquida de alta press\u00e3o, e testes moleculares para confirma\u00e7\u00e3o da muta\u00e7\u00e3o. Foram encontrados quatro tipos de combina\u00e7\u00f5es de hemoglobinas: 42 indiv\u00edduos portadores de hemoglobina AD Los Angeles, dois indiv\u00edduos com doen\u00e7a de Hb S/D Los Angeles, dois indiv\u00edduos com Hb D Los Angeles e talassemia beta e um indiv\u00edduo com Hb D Los Angeles e Hb Lepore. Os indiv\u00edduos heterozigotos para D Los Angeles s\u00e3o assintom\u00e1ticos, entretanto, em associa\u00e7\u00e3o com outras variantes e talassemias podem apresentar graus vari\u00e1veis de manifesta\u00e7\u00f5es cl\u00ednicas. Os resultados apresentados enfatizaram a necessidade da associa\u00e7\u00e3o de v\u00e1rias metodologias para a identifica\u00e7\u00e3o da Hb D Los Angeles, al\u00e9m de auxiliar na elucida\u00e7\u00e3o de combina\u00e7\u00f5es raras.The most common Hb D variant, the Hb D-Los Angeles, also know as Hb D-Punjab, originates through a GAA->CAA change at the 121 codon of the beta globin gene; this mutation results in the replacement of glutamic acid for glutamine in the protein. It is the third most common hemoglobin variant in the Brazilian population. This variant has\n[Cell model for the study of receptor and regulatory functions of human proHB-EGF](http://ukrbiochemjournal.org/wp-content/uploads/2015/06/Korotkevych_4_14.pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nN. V. Korotkevych\n2014-08-01\nFull Text Available Developing of new models and approaches, particularly with fluorescent techniques, for investigation of intracellular transport of proHB-EGF and its ligand-receptor complexes is strongly required. In order to create a model for studying proHB-EGF functions the genetic construction pEGFP-N1-proHB-EGF, encoding proHB-EGF-EGFP which is fluorescent-labeled form of proHB-EGF with enhanced green fluorescent protein EGFP in the cytoplasmic terminus of the molecule, was obtained. Eukaryotic cells expressing fusion protein proHB-EGF-EGFP on the cell surface were obtained by transfection with pEGFP-N1-proHB-EGF. Expressed in the Vero cells proHB-EGF-EGFP could bind fluorescent derivative of nontoxic receptor-binding subunit B of diphtheria toxin mCherry-SubB. After stimulation of transfected cells with TPA (12-O-Tetradecanoylphorbol-13-acetate, proHB-EGF-EGFP formed a fluorescentl-labeled C-terminal fragment of the molecule \u2013 CTF-EGFP. Thus, the obtained genetic construction pEGFP-N1-proHB-EGF could be helpful in visualization of molecules proHB-EGF and CTF in cells, may open new possibilities for the studying of their functions, such as receptor function of proHB-EGF for diphtheria toxin, intracellular translocation of CTF and provide possibilities for natural proHB-EGF ligands search.\n[Impact of Mean Cell Hemoglobin on Hb A1c-Defined Glycemia Status.](https://www.ncbi.nlm.nih.gov/pubmed/27679433)\nRodriguez-Segade, Santiago; Garcia, Javier Rodriguez; Garc\u00eda-L\u00f3pez, Jos\u00e9 M; Gude, Francisco; Casanueva, Felipe F; Rs-Alonso, Santiago; Cami\u00f1a, F\u00e9lix\n2016-12-01\nSeveral hematological alterations are associated with altered hemoglobin A 1c (Hb A 1c ). However, there have been no reports of their influence on the rates of exceeding standard Hb A 1c thresholds by patients for whom Hb A 1c determination is requested in clinical practice. The initial data set included the first profiles (complete blood counts, Hb A 1c , fasting glucose, and renal and hepatic parameters) of all adult patients for whom such a profile was requested between 2008 and 2013 inclusive. After appropriate exclusions, 21844 patients remained in the study. Linear and logistic regression models were adjusted for demographic, hematological, and biochemical variables excluded from the predictors. Mean corpuscular hemoglobin (MCH) and mean corpuscular volume (MCV) correlated negatively with Hb A 1c . Fasting glucose, MCH, and age emerged as predictors of Hb A 1c in a stepwise regression that discarded sex, hemoglobin, MCV, mean corpuscular hemoglobin concentration (MCHC), serum creatinine, and liver disease. Mean Hb A 1c in MCH interdecile intervals fell from 6.8% (51 mmol/mol) in the lowest (\u226427.5 pg) to 6.0% (43 mmol/mol) in the highest (>32.5 pg), with similar results for MCV. After adjustment for fasting glucose and other correlates of Hb A 1c , a 1 pg increase in MCH reduced the odds of Hb A 1c -defined dysglycemia, diabetes and poor glycemia control by 10%-14%. For at least 25% of patients, low or high MCH or MCV levels are associated with increased risk of an erroneous Hb A 1c -based identification of glycemia status. Although causality has not been demonstrated, these parameters should be taken into account in interpreting Hb A 1c levels in clinical practice. \u00a9 2016 American Association for Clinical Chemistry.\n[Recomendaci\u00c3\u00b3n sobre la vacuna contra la tosferina para los preadolescentes y adolescentes (Whooping Cough Vaccine Recommendation for Preteens and Teens)](https://www2c.cdc.gov/podcasts/player.asp?f=8636392) [Centers for Disease Control (CDC) Podcasts](http://www2c.cdc.gov/podcasts/search.asp)\n2015-04-13\nEste podcast proporciona informaci\u00c3\u00b3n acerca de la tosferina y la recomendaci\u00c3\u00b3n de que todos los preadolescentes reciban la vacuna Tdap a los 11 o 12 a\u00c3\u00b1os para ayudar a protegerlos contra esta grave enfermedad. Created: 4/13/2015 by National Center for Immunization and Respiratory Diseases (NCIRD), Division of Bacterial Diseases (DBD), Meningitis and Vaccine Preventable Diseases Branch (MVPDB). Date Released: 4/13/2015.\n[Caracterizaci\u00f3n del proceso de formaci\u00f3n de la cultura art\u00edstico-literaria cubana desde la biblioteca universitaria](https://www.openaire.eu/search/publication?articleId=doajarticles::3fce4732c2a56c9ba98c537539d5200b)\nAna Luisa Figueredo Figueredo; Maritza de la Caridad Figueredo Matos; Carlos Aponte Cabrera\n2012-01-01\nEn el art\u00edculo se aborda el proceso de formaci\u00f3n de la cultura art\u00edstico-literaria desde la biblioteca universitaria y su influencia en la preparaci\u00f3n acad\u00e9mica de la comunidad universitaria, formaci\u00f3n general integral y enriquecimiento cultural. Se analizan los antecedentes hist\u00f3ricos del proceso de formaci\u00f3n de la cultura art\u00edstico _ literaria cubana desde la biblioteca universitaria y se se\u00f1alan referentes sociol\u00f3gicos, gnoseol\u00f3gicos, psicol\u00f3gicos y pedag\u00f3gicos de este proceso de formac...\n[HbA1c for diagnosis and prognosis of gestational diabetes mellitus.](https://www.ncbi.nlm.nih.gov/pubmed/26344325)\nKwon, Soon Sung; Kwon, Ja-Young; Park, Yong-Won; Kim, Young-Han; Lim, Jong-Baeck\n2015-10-01\nHbA1c is a widely used marker in diagnosing type 2 diabetes mellitus (DM), but its clinical utility in diagnosing gestational diabetes mellitus (GDM) is not established. Here, we evaluated the clinical usefulness of HbA1c in diagnosing GDM and predicting the risk of future type 2 DM development among GDM patients. This retrospective, cross-sectional study included 321 subjects who underwent 100-g oral glucose tolerance tests (OGTT) during pregnancy. HbA1c and other variables were analyzed to evaluate their diagnostic performance for GDM. To evaluate the clinical usefulness of HbA1c in predicting future type 2 DM development, we classified GDM subjects who had more than 3 months of follow-up data into two subgroups: those who developed postpartum type 2 DM (PDM) and those who did not. HbA1c was significantly higher in the GDM group than in the normal control group. With the 100-g OGTT as reference, HbA1c showed 91.3% sensitivity and 62% specificity at a cut-off value of 5.05% (32 mmol/mol) for GDM diagnosis. At a cut-off value of 5.25% (34 mmol/mol), sensitivity was 73.6% and specificity was 77.2%. HbA1c levels during pregnancy were higher in those with PDM than in those without PDM (5.91 [41 mmol/mol] vs. 5.44% [36 mmol/mol], p<0.001). The prognostic value of HbA1c for PDM was evaluated by ROC curve analysis, with sensitivity of 78.6% and specificity of 72.5% at a cut-off value of 5.55% (37 mmol/mol). HbA1c showed high sensitivity with relatively low specificity for diagnosis of GDM in pregnant women and was a potential predictor of PDM. HbA1c may be able to be used as a simple and less invasive alternative screening test for OGTT in GDM patients. Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.\n[Evaluation of the DCA Vantage analyzer for HbA 1c assay.](https://www.ncbi.nlm.nih.gov/pubmed/18588431)\nSzymezak, Jean; Leroy, Nathalie; Lavalard, Emmanuelle; Gillery, Philippe\n2008-01-01\nMeasurement of HbA 1c is key in monitoring diabetic patients in both laboratories and clinical units, where HbA 1c results are used as part of patient education. We have evaluated the DCA Vantage, a new device for immunological assay of HbA 1c. HbA 1c results obtained were evaluated in terms of precision, linearity, specificity and practicability, and were compared with results obtained by a Variant II HPLC method. The method exhibited intra- and inter-assay coefficients of variation lower than 2.6% and 4.0%, respectively, and good correlation with the comparison HPLC method (r2=0.9776). No interference was noted in the presence of labile HbA 1c or carbamylated hemoglobin. The new device exhibited improved practicability characteristics and allowed better sample identification, better management of quality control routines and greater connectivity possibilities compared to the previous DCA 2000 analyzer. This new analyzer exhibited analytical and practical characteristics very suitable for HbA 1c assay for laboratory or point-of-care use according to good laboratory practice.\n[Analysis of HbA1c on an automated multicapillary zone electrophoresis system.](https://www.ncbi.nlm.nih.gov/pubmed/27768851)\nRollborn, Niclas; \u00c5kerfeldt, Torbj\u00f6rn; Nordin, Gunnar; Xu, Xiao Yan; Mandic-Havelka, Aleksandra; Hansson, Lars-Olof; Larsson, Anders\n2017-02-01\nHemoglobin A1c (HbA1c) is a frequently requested laboratory test and there is thus a need for high throughput instruments for this assay. We evaluated a new automated multicapillary zone electrophoresis instrument (Capillarys 3 Tera, Sebia, Lisses, France) for analysis of HbA1c in venous samples. Routine requested HbA1c samples were analyzed immunologically on a Roche c6000 instrument (n = 142) and then with the Capillarys 3 Tera instrument. The Capillarys 3 Tera instrument performed approximately 70 HbA1c tests/hour. There was a strong linear correlation between Capillarys 3 Tera and Roche Tina-Quant HbA1c Gen 3 assay (y = 1.003x - 0.3246 R 2 = .996). The total CV for the 12 capillaries varied between 0.8 and 2.2% and there was a good agreement between duplicate samples (R 2 = .997). In conclusion, the Capillarys 3 Tera instrument has a high assay capacity for HbA1c. It has a good precision and agreement with the Roche Tina-Quant HbA1c method and is well suited for high volume testing of HbA1c.\n[Evaluaci\u00f3n del impacto econ\u00f3mico de la vacuna antirrotav\u00edrica en Venezuela Assessment of the economic impact of the antiretroviral vaccine in Venezuela](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892006000900001) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDagna Constenla\n2006-10-01\nFull Text Available OBJETIVO: El objetivo de este estudio fue evaluar el costo de la atenci\u00f3n m\u00e9dica de la gastroenteritis por rotavirus y la relaci\u00f3n costo-efectividad de la vacuna antirrotav\u00edrica en la poblaci\u00f3n venezolana menor de 5 a\u00f1os de edad. M\u00c9TODOS: Se utiliz\u00f3 un modelo econ\u00f3mico que integra la informaci\u00f3n epidemiol\u00f3gica, la eficacia de la vacuna y los costos de atenci\u00f3n m\u00e9dica de la gastroenteritis por rotavirus, desde la perspectiva de la sociedad. Para determinar la efectividad de la vacuna, se estim\u00f3 el n\u00famero de casos de hospitalizaci\u00f3n, de consultas m\u00e9dicas y de muertes evitados despu\u00e9s de su administraci\u00f3n. La relaci\u00f3n costo-efectividad de la vacuna se evalu\u00f3 partiendo del n\u00famero de a\u00f1os de vida ajustados por discapacidad (AVAD y de casos evitados. RESULTADOS: En Venezuela, los servicios de salud invierten, aproximadamente, 4,2 millones de d\u00f3lares estadounidenses (US$ por a\u00f1o para cubrir los costos de atenci\u00f3n m\u00e9dica causados por el rotavirus. Un programa de vacunaci\u00f3n antirrotav\u00edrica evitar\u00eda aproximadamente el 52% (186 de las muertes, el 54% (7 232 de las hospitalizaciones y el 50% (55 168 de las consultas ambulatorias durante los primeros cinco a\u00f1os de vida, en una cohorte vacunada. Para un precio estimado de US$ 24 por r\u00e9gimen de vacuna, se genera una relaci\u00f3n costo-efectividad de US$ 1 352 por AVAD. CONCLUSIONES: Los resultados de este estudio apuntan a que la vacunaci\u00f3n antirrotav\u00edrica es una estrategia costoefectiva en la prevenci\u00f3n de la gastroenteritis por rotavirus en Venezuela, ya que puede evitar muertes y a\u00f1os de vida ajustados por discapacidad en la poblaci\u00f3n menor de cinco a\u00f1os de edad.OBJECTIVE: To assess the cost of medical care for rotavirus gastroenteritis and the cost-effectiveness of the antiretroviral vaccine in Venezuelan children under five. METHODS: We used an economic model that comprises epidemiologic information, vaccine efficacy, and the cost of medical care in connection with\n[Vectores recombinantes basados en el virus modificado de ankara (MVA) como vacunas preventivas y terap\u00e9uticas contra el SIDA](https://www.openaire.eu/search/publication?articleId=od______1106::f4d741f2ddd69717da31854495ecc2ce)\nHeeney, Jonathan L.; Mooij, Petra; N\u00e1jera Garc\u00eda, Jos\u00e9 Luis; Jim\u00e9nez, Victoria; Esteban, Mariano; G\u00f3mez, Carmen E.\n2005-01-01\nVectores Recombinantes basados en el Virus Modificado de Ankara (MVA) como Vacunas Preventivas y Terap\u00e9uticas contra el SIDA. Losvirus recombinantes de la invenci\u00f3n contienen secuencias que se encuentran insertadas en el mismo sitio de inserci\u00f3n del MVA y permiten la expresi\u00f3n simult\u00e1nea de varios ant\u00edgenos, una prote\u00edna Env del VIH-I consistente en una prote\u00edna gpl20 carente de secuencias correspondientes a la prote\u00edna gp41, y una prote\u00edna quim\u00e9ricade fusi\u00f3n de Gag, Pol y Nef. Son virus esta...\n[Impacto y efectividad de la vacunaci\u00f3n infantil con la vacuna neumoc\u00f3cica conjugada 13-valente en Navarra](https://www.openaire.eu/search/publication?articleId=od______2347::862e193bff7f2aed1ec83096ecbe1486)\nGuevara Eslava, Marcela\n2015-01-01\nLa vacuna neumoc\u00f3cica conjugada 7 valente (VNC7) comenz\u00f3 a estar disponibles en Espa\u00f1a en 2001, la 10-valente (VNC10) en 2009 y la 13-valente (VNC13) en 2010. En Navarra, sin estar incluidas en el calendario oficial de vacunaciones, se ha extendido su uso en los ni\u00f1os. Los objetivos de este estudio han sido evaluar el impacto de la vacunaci\u00f3n infantil con la VNC13 sobre la epidemiolog\u00eda de la enfermedad neumoc\u00f3cica invasiva (ENI) en la poblaci\u00f3n de Navarra de todas las edade...\n[Prevenci\u00f3n de las neumon\u00edas mediante vacunas](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312014000200012&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRoberto Raz\u00f3n Behar\nFull Text Available La neumon\u00eda es una infecci\u00f3n respiratoria aguda que afecta a los pulmones. La neumon\u00eda adquirida en la comunidad, es la principal causa individual de mortalidad infantil en todo el mundo. Se calcula que cada a\u00f1o mueren por su causa m\u00e1s de 1,5 millones de ni\u00f1os menores de 5 a\u00f1os, lo que supone el 18 % de todas las defunciones de este grupo etario en todo el mundo. Diversos agentes infecciosos, particularmente los virus y bacterias, causan neumon\u00eda, y son los m\u00e1s comunes el Streptococcus pneumoniae -la causa m\u00e1s com\u00fan de neumon\u00eda bacteriana en ni\u00f1os-; el Haemophilus influenzae de tipo b -la segunda causa m\u00e1s com\u00fan de neumon\u00eda bacteriana-; as\u00ed como el virus sincitial respiratorio. La prevenci\u00f3n de la neumon\u00eda infantil es un componente fundamental de toda estrategia para reducir la mortalidad infantil. La inmunizaci\u00f3n, particularmente contra el Haemophilus influenzae de tipo b, los neumococos, el sarampi\u00f3n y la tos ferina, es la forma m\u00e1s eficaz de prevenirla. Por tal motivo se considera importante una revisi\u00f3n y actualizaci\u00f3n de las principales vacunas existentes hoy en d\u00eda.\n[Dynamics of \u03b1-Hb chain binding to its chaperone AHSP depends on heme coordination and redox state.](https://www.ncbi.nlm.nih.gov/pubmed/24060751)\nKiger, Laurent; Vasseur, Corinne; Domingues-Hamdi, Elisa; Truan, Gilles; Marden, Michael C; Baudin-Creuza, V\u00e9ronique\n2014-01-01\nAHSP is an erythroid molecular chaperone of the \u03b1-hemoglobin chains (\u03b1-Hb). Upon AHSP binding, native ferric \u03b1-Hb undergoes an unprecedented structural rearrangement at the heme site giving rise to a 6th coordination bond with His(E7). Recombinant AHSP, WT \u03b1-Hb:AHSP and \u03b1-Hb(HE7Q):AHSP complexes were expressed in Escherichia coli. Thermal denaturation curves were measured by circular dichroism for the isolated \u03b1-Hb and bound to AHSP. Kinetics of ligand binding and redox reactions of \u03b1-Hb bound to AHSP as well as \u03b1-Hb release from the \u03b1-Hb:AHSP complex were measured by time-resolved absorption spectroscopy. AHSP binding to \u03b1-Hb is kinetically controlled to prevail over direct binding with \u03b2-chains and is also thermodynamically controlled by the \u03b1-Hb redox state and not the liganded state of the ferrous \u03b1-Hb. The dramatic instability of isolated ferric \u03b1-Hb is greatly decreased upon AHSP binding. Removing the bis-histidyl hexacoordination in \u03b1-HbH58(E7)Q:AHSP complex reduces the stabilizing effect of AHSP binding. Once the ferric \u03b1-Hb is bound to AHSP, the globin can be more easily reduced by several chemical and enzymatic systems compared to \u03b1-Hb within the Hb-tetramer. \u03b1-Hb reduction could trigger its release from AHSP toward its final Hb \u03b2-chain partner producing functional ferrous Hb-tetramers. This work indicates a preferred kinetic pathway for Hb-synthesis. The cellular redox balance in Hb-synthesis should be considered as important as the relative proportional synthesis of both Hb-subunits and their heme cofactor. The in vivo role of AHSP is discussed in the context of the molecular disorders observed in thalassemia. \u00a9 2013 Elsevier B.V. All rights reserved.\n[La Revoluci\u00f3n cubana y la historiograf\u00eda](http://estudiosamericanos.revistas.csic.es/index.php/estudiosamericanos/article/view/106/111) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAguilera Manzano, Jos\u00e9 Mar\u00eda\n2008-06-01\nFull Text Available The aim of this article is the study of the Cuban historiography from the beginning of the Revolution (1959 until the present, so that researchers interested in the history of Cuba can know what lines has been followed up to now and what is the path in the future. I have divided the text in three parts that correspond with each one of the stages of the period. The last phase is integrated by the current historians; this generation has been preceded by that one who shared its youth with the victory of the Cuban Revolution, and the one that was educated at the university after the deep transformations happened in 1968.\nEl objetivo de este art\u00edculo es el estudio de la historiograf\u00eda cubana desde el comienzo de la Revoluci\u00f3n (1959 hasta la actualidad, para que los interesados en la historia de Cuba puedan conocer qu\u00e9 l\u00edneas ha seguido \u00e9sta hasta ahora y por donde continuar\u00e1. El texto se ha dividido en tres partes que corresponden a cada una de las etapas del per\u00edodo. La \u00faltima fase est\u00e1 integrada por los historiadores actuales; a esta generaci\u00f3n le ha precedido la que comparti\u00f3 su juventud con el triunfo de la Revoluci\u00f3n de 1959 y la que accedi\u00f3 a la Universidad despu\u00e9s de las profundas transformaciones acaecidas en 1968.\n[The isolation of the \u03b3 subunit of fetal hemoglobin (HbF) and its use in a radioimmunoassay for HbF](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=11525338) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nJames, R.F.L.; Shuster, J.; Freedman, S.O.; Gold, P.\n1980-01-01\nA method is described for the purification, from fetal hemoglobin (HbF), of the fetal specific globin chain (\u03b3 chain) in its native state. In the absence of \u03b1 chain (the globin chain common to all adult human hemoglobins) \u03b3 chain, when used as an immunogen, is able to express its unique antigenicity. Here, a specific, high titer antiserum raised against \u03b3 chain has been used to establish a sensitive radioimmunoassay for HbF. This approach may be applicable to the measurement of other normal and abnormal hemoglobins. (Auth.)\n[Hb A1c Separation by High Performance Liquid Chromatography in Hemoglobinopathies](http://dx.doi.org/10.1155/2016/2698362) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nVani Chandrashekar\n2016-01-01\nFull Text Available Hb A1c measurement is subject to interference by hemoglobin traits and this is dependent on the method used for determination. In this paper we studied the difference between Hb A1c measured by HPLC in hemoglobin traits and normal chromatograms. We also studied the correlation of Hb A1c with age. Hemoglobin analysis was carried out by high performance liquid chromatography. Spearman\u2019s rank correlation was used to study correlation between A1c levels and age. Mann-Whitney U test was used to study the difference in Hb A1c between patients with normal hemoglobin and hemoglobin traits. A total of 431 patients were studied. There was positive correlation with age in patients with normal chromatograms only. No correlation was seen in Hb E trait or beta thalassemia trait. No significant difference in Hb A1c of patients with normal chromatograms and patients with hemoglobin traits was seen. There is no interference by abnormal hemoglobin in the detection of A1c by high performance liquid chromatography. This method cannot be used for detection of A1c in compound heterozygous and homozygous disorders.\n[HB+ prepares for insertion into the CMS solenoid](https://cdsweb.cern.ch/record/938513)\nDave Barney, CERN\n2006-01-01\nWith calibration of the first half of the barrel Hadron Calorimeter (HB+) complete (using a radioactive source), preparations begin for its insertion into the solenoid for the Magnet Test and Cosmic Challenge (MTCC). It was moved out of its alcove at the beginning of March - a non-trivial (but completely successful) operation due to the proximity of one of the barrel yoke rings (YB+1). The other half of the barrel Hadron Calorimeter (HB-) and one of the endcaps (HE+) should also be calibrated before the MTCC.\n[HB+ inserted into the CMS Solenoid](https://cdsweb.cern.ch/record/944771)\nTejinder S. Virdee, CERN\n2006-01-01\nThe first half of the barrel hadron calorimeter (HB+) has been inserted into the superconducting solenoid of CMS, in preparation for the magnet test and cosmic challenge. The operation went smoothly, lasting a couple of days.\n[Serum levels of antioxidant vitamins in foetal haemoglobin (HbF ...](https://www.ajol.info/index.php/aam/article/view/8356) [African Journals Online (AJOL)](http://www.ajol.info/index.php)\nBackground: sickle cell anaemia (SCA) is one of the commonest health problems of Nigerian children. Method: The serum levels of antioxidant vitamins A (retinol), C (ascorbic acid) and E (alpha-tocopherol) were determined in foetal haemogbobin persistent sickle cell anaemic (Hb SS + F), sickle cell anaemic (Hb SS) and ...\n[\u03b1-Thalassemia Associated with Hb Instability: A Tale of Two Features. The Case of Hb Rogliano or \u03b11 Cod 108(G15)Thr\u2192Asn and Hb Policoro or \u03b12 Cod 124(H7)Ser\u2192Pro.](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4346585)\nMusollino, Gennaro; Cardiero, Giovanna; Flagiello, Angela; La Porta, Gaetana; Lagona, Laura; Prezioso, Romeo; Qualtieri, Gabriele; Gaudiano, Carlo; Medulla, Emilia; Merlino, Antonello; Pucci, Piero; Lacerra, Giuseppina\n2015-01-01\nWe identified two new variants in the third exon of the \u03b1-globin gene in families from southern Italy: the Hb Rogliano, \u03b11 cod108 ACC>AAC or \u03b11[\u03b1108(G15)Thr\u2192Asn] and the Hb Policoro, \u03b12 cod124 TCC>CCC or \u03b12[\u03b1124(H7)Ser\u2192Pro]. The carriers showed mild \u03b1-thalassemia phenotype and abnormal hemoglobin stability features. These mutations occurred in the G and H helices of the \u03b1-globin both involved in the specific recognition of AHSP and \u03b21 chain. Molecular characterization of mRNA, globin chain analyses and molecular modelling studies were carried out to highlight the mechanisms causing the \u03b1-thalassemia phenotype. The results demonstrated that the \u03b1-thalassemia defect associated with the two Hb variants originated by different defects. Hb Rogliano showed an intrinsic instability of the tetramer due to anomalous intra- and inter-chain interactions suggesting that the variant chain is normally synthesized and complexed with AHSP but rapidly degraded because it is unable to form the \u03b11\u03b21 dimers. On the contrary in the case of Hb Policoro two different molecular mechanisms were shown: the reduction of the variant mRNA level by an unclear mechanism and the protein instability due to impairment of AHSP interaction. These data highlighted that multiple approaches, including mRNA quantification, are needed to properly identify the mechanisms leading to the \u03b1-thalassemia defect. Elucidation of the specific mechanism leads to the definition of a given phenotype providing important guidance for the diagnosis of unstable variants. PMID:25730315\n[Prevalence and predictors of the sub-target Hb level in children on dialysis](http://www.forskningsdatabasen.dk/en/catalog/232208163) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nvan Stralen, Karlijn J; Krischock, Leah; Schaefer, Franz\n2012-01-01\nAnaemia is a common and potentially treatable co-morbidity of end-stage renal disease. We aimed to determine the prevalence of the sub-target haemoglobin (Hb) level among European children on dialysis and to identify factors associated with a low Hb level.......Anaemia is a common and potentially treatable co-morbidity of end-stage renal disease. We aimed to determine the prevalence of the sub-target haemoglobin (Hb) level among European children on dialysis and to identify factors associated with a low Hb level....\n[A Family with \u03b3-Thalassemia and High Hb A2 Levels.](https://www.ncbi.nlm.nih.gov/pubmed/27117568)\nParmeggiani, Giulia; Gualandi, Francesca; Selvatici, Rita; Rimessi, Paola; Bigoni, Stefania; Taddei Masieri, Marina; Dolcini, Bernadetta; Venturoli, Anna; Cappabianca, Maria P; Ferlini, Alessandra; Ravani, Anna\n2016-06-01\nWe describe a family carrying a \u03b3-globin gene deletion associated with an increase of Hb A2 level beyond the normal range. The family included the proband, his sister and their father, all with increased Hb A2 and normal Hb F levels. The proband and his sister showed borderline values of mean corpuscular volume (MCV) and reduced values of mean corpuscular hemoglobin (Hb) (MCH). The proband was referred to our Medical Genetics Service for preconception counseling together with his partner, a typical \u03b2-thalassemia (\u03b2-thal) carrier. The results were negative for the most frequent \u03b1-thalassemia (\u03b1-thal) mutations, and had no significant sequence variations of the coding sequences and promoter of the \u03b2- and \u03b4-globin genes. Quantitative analysis by multiplex ligation-dependent probe amplification (MPLA) of the \u03b2-globin gene cluster detected a heterozygous deletion, ranging between 2.1 and 4.7 kb, in the proband, his sister and the father. The deletion involved the (G)\u03b3 gene and (G)\u03b3-(A)\u03b3 intergenic region, whereas the 3' region of the (A)\u03b3 gene was preserved. A subsequent gap-polymerase chain reaction (gap-PCR) showed that a hybrid (GA)\u03b3 fusion gene was present. The deletion segregated with the elevation of Hb A2. The MLPA analysis of the \u03b2-globin gene cluster in 150 control alleles excluded a common polymorphism. Despite stronger evidence being needed, the described family suggests a possible role of this \u03b3-globin gene deletion in contributing to Hb A2 elevation, possibly by altering the transcription regulation of the cluster. We propose \u03b3-globin gene dosage analysis to be performed in patients with unexplained elevated Hb A2 levels.\n[HbA1c levels in individuals heterozygous for hemoglobin variants.](https://www.ncbi.nlm.nih.gov/pubmed/28614537)\nTavares, Ricardo Silva; Souza, F\u00e1bio Oliveira de; Francescantonio, Isabel Cristina Carvalho Medeiros; Soares, Weslley Carvalho; Mesquita, Mauro Meira\n2017-04-01\nTo evaluate the levels of glycated hemoglobin (HbA1c) in patients heterozygous for hemoglobin variants and compare the results of this test with those of a control group. This was an experimental study based on the comparison of HbA1c tests in two different populations, with a test group represented by individuals heterozygous for hemoglobin variants (AS and AC) and a control group consisting of people with electrophoretic profile AA. The two populations were required to meet the following inclusion criteria: Normal levels of fasting glucose, hemoglobin, urea and triglycerides, bilirubin > 20 mg/dL and non-use of acetylsalicylic acid. 50 heterozygous subjects and 50 controls were evaluated between August 2013 and May 2014. The comparison of HbA1c levels between heterozygous individuals and control subjects was performed based on standard deviation, mean and G-Test. The study assessed a test group and a control group, both with 39 adults and 11 children. The mean among heterozygous adults for HbA1c was 5.0%, while the control group showed a rate of 5.74%. Heterozygous children presented mean HbA1c at 5.11%, while the controls were at 5.78%. G-Test yielded p=0.93 for children and p=0.89 for adults. Our study evaluated HbA1c using ion exchange chromatography resins, and the patients heterozygous for hemoglobin variants showed no significant difference from the control group.\n[HbA1c measurements from dried blood spots : validation and patient satisfaction](https://www.narcis.nl/publication/RecordID/oai%3Apure.rug.nl%3Apublications%2F760f75fa-4e77-4bbf-8276-fc423008490a/uquery/HBA1C/id/6/Language/EN)\nFokkema, Margaretha; Bakker, Andries J; de Boer, Fokje; Kooistra, Jeltsje; de Vries, Sifra; Wolthuis, Albert\n2009-01-01\nBackground: This study evaluates HbA1c measurements from dried blood spots collected on filter paper and compares HbA1c from filter paper (capillary blood) with HbA1c measured in venous blood. Methods: Patient satisfaction was evaluated using a questionnaire. The performance with the filter paper\n[Hb Presbyterian (HBB: c.327C>G) in a Nicaraguan Family.](https://www.ncbi.nlm.nih.gov/pubmed/28395541)\nPernudy-Ubau, Allan; Salinas-Molina, Jaslyn; Requenez, Yaneris; Ortiz-Lopez, Marianela; Puller, Ann-Christin; Garc\u00eda-Rosales, Kenia; Rodr\u00edguez-Estrada, Anaishelle; Rodr\u00edguez-Romero, Walter; Mej\u00eda-Baltodano, Gerardo; Luo, Hong-Yuan; Chui, David H K\n2017-01-01\nHemoglobin (Hb) is the protein responsible for oxygen transportation. It is a tetrameric protein comprising two \u03b1- and two \u03b2-globin subunits. In the literature, a large number of mutations in the \u03b1- and \u03b2-globin genes have been documented. Among these mutations, Hb Presbyterian (HBB: c.327 C>G), is a naturally occurring mutant exerting low oxygen affinity. The C to G exchange (AAC>AAG) at codon 108 of the \u03b2-globin gene results in the substitution of asparagine by lysine. Here, we document the identification of HBB: c.327 C>G in a 6-year-old female patient and her father from Nicaragua and Cuba, respectively. The presence of the abnormal Hb was confirmed by cellulose acetate electrophoresis, high performance liquid chromatography (HPLC) and genomic DNA sequencing. The \u03b2-globin gene sequences for both, father and daughter, disclosed the heterozygous mutation at codon 108 to be Hb Presbyterian or HBB: c.327 C>G. The mutant Hb was previously reported in four families from North America, Germany, Japan and Spain, respectively. This is the fifth family carrying HBB: c.327 C>G described to date and the first report from Latin America.\n[Two \u03b11-Globin Gene Point Mutations Causing Severe Hb H Disease.](https://www.ncbi.nlm.nih.gov/pubmed/29115167)\nJiang, Hua; Huang, Lv-Yin; Zhen, Li; Jiang, Fan; Li, Dong-Zhi\nHb H disease is generally a moderate form of \u03b1-thalassemia (\u03b1-thal) that rarely requires regular blood transfusions. In this study, two Chinese families with members carrying transfusion-dependent Hb H disease were investigated for rare mutations on the \u03b1-globin genes (HBA1, HBA2). In one family, Hb Z\u00fcrich-Albisrieden [\u03b159(E8)Gly\u2192Arg; HBA1: c.178G>C] in combination with the Southeast Asian (- - SEA ) deletion was the defect responsible for the severe phenotype. In another family, a novel hemoglobin (Hb) variant named Hb Sichuan (HBA1: c.393_394insT), causes \u03b1-thal and a severe phenotype when associated with the - - SEA deletion. As these two HBA1 mutations can present as continuous blood transfusion-dependent \u03b1-thal, it is important to take this point into account for detecting the carriers, especially in couples in which one partner is already a known \u03b1 0 -thal carrier.\n[Consideraciones te\u00f3rico-cr\u00edticas para el estudio de la literatura cubana del Periodo Especial](http://www.revistas.unal.edu.co/index.php/lthc/article/view/37135) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nIvonne S\u00e1nchez Becerril\n2013-02-01\nFull Text Available La transformaci\u00f3n de la literatura cubana en el marco del Periodo especial en tiempos de paz est\u00e1 vinculada con la detonaci\u00f3n de las tensiones acumuladas. El presente ensayo postula que la emergencia de una serie de po\u00e9ticas narrativas es indisociable de un complejo contexto socio-hist\u00f3rico marcado por un cambio de referentes, la ruptura con el modelo literario impuesto y la formulaci\u00f3n de conceptos particulares de la literatura desde los textos de creaci\u00f3n. Para ello se resumen las coordenadas culturales, las influencias te\u00f3ricas, la funci\u00f3n de la cr\u00edtica literaria y la avidez las casas editoriales extranjeras como principales promotores literarios, as\u00ed como la adaptaci\u00f3n de la censura a las nuevas condiciones.\n[Caracterizaci\u00f3n del proceso de formaci\u00f3n de la cultura art\u00edstico-literaria cubana desde la biblioteca universitaria](http://biblios.pitt.edu/ojs/index.php/biblios/article/view/51) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAna Luisa Figueredo Figueredo\n2012-06-01\nFull Text Available En el art\u00edculo se aborda el proceso de formaci\u00f3n de la cultura art\u00edstico-literaria desde la biblioteca universitaria y su influencia en la preparaci\u00f3n acad\u00e9mica de la comunidad universitaria, formaci\u00f3n general integral y enriquecimiento cultural. Se analizan los antecedentes hist\u00f3ricos del proceso de formaci\u00f3n de la cultura art\u00edstico _ literaria cubana desde la biblioteca universitaria y se se\u00f1alan referentes sociol\u00f3gicos, gnoseol\u00f3gicos, psicol\u00f3gicos y pedag\u00f3gicos de este proceso de formaci\u00f3n.\n[Evaluaci\u00f3n de un modelo de infecci\u00f3n murino para la evaluaci\u00f3n de vacunas hom\u00f3logas y heter\u00f3logas contra Brucella canis Evaluation of a mouse infection model to evaluate homologue and heterologue vaccines against Brucella canis in mouse model](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::ece01fbd6d31d8575f7f4ae84e6b72a6)\nM Clausse; S.M. Estein\n2011-01-01\nLa brucelosis canina es una enfermedad zoon\u00f3tica que afecta a los caninos y provoca importantes p\u00e9rdidas econ\u00f3micas en criaderos. En la actualidad, no existe una vacuna para la prevenci\u00f3n de esta enfermedad. Una limitante en el desarrollo de una vacuna eficaz es la falta de un modelo experimental que permita evaluar la infecci\u00f3n con Brucella canis. En este trabajo, se desarroll\u00f3 un modelo rat\u00f3n para evaluar la infecci\u00f3n espl\u00e9nica por B. canis empleando distintas dosis, tiempos de sacrificio y...\n[Diagnostic accuracy of HbA1c in diabetes between Eastern and Western.](https://www.ncbi.nlm.nih.gov/pubmed/23634648)\nYan, Shuang; Liu, Siying; Zhao, Yashuang; Zhang, Wencui; Sun, Xiaohui; Li, Jianing; Jiang, Fuli; Ju, Jiaming; Lang, Ning; Zhang, Yingqi; Zhou, Weiyu; Li, Qiang\n2013-07-01\nIn 2010, the American Diabetes Association recommended the use of HbA1c as a diagnostic criterion for diabetes. However, HbA1c is not an accepted diagnostic tool for diabetes in Eastern Asia, because genetic differences compromise the standardization of the diagnostic cut-off point. This study evaluated differences in the use of HbA1c for diagnosing diabetes in Eastern and Western populations and investigated whether HbA1c cut-off point of \u2265 6.5% is diagnostic of diabetes in patients from Eastern Asia. Literature was obtained from MEDLINE, EMBASE and Cochrane databases. The pooled sensitivity and specificity of each HbA1c cut-off point were extracted and compared between Western and Eastern populations. Differences in the cut-off point for diagnosing diabetes in each region were compared by examining differences in the area under summary receiver operating characteristic (SROC) curves. Twelve publications from Eastern countries (n = 59,735) and 13 from Western countries (n = 22,954) were included in the analysis. Areas under SROC curves in the Eastern and Western groups were 0.9331 and 0.9120, respectively (P = 0.98). The cut-off point of the highest Youden index was 6.0%. At the HbA1c cut-off point of 6.5%, the pooled sensitivity and specificity were 58.7% and 98.4% for Eastern countries and 65.5% and 98.1% for Western countries, respectively. HbA1c exhibits the same diagnostic value for diabetes in Eastern and Western populations. In both populations, HbA1c levels > 6.0% identify the population at high risk of diabetes, and HbA1c > 6.5% is diagnostic of clinically established diabetes. \u00a9 2013 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd.\n[HB-EGF is necessary and sufficient for M\u00fcller glia dedifferentiation and retina regeneration](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3285435)\nWan, Jin; Ramachandran, Rajesh; Goldman, Daniel\n2011-01-01\nSummary M\u00fcller glia (MG) dedifferentiation into a cycling population of multipotent progenitors is crucial to zebrafish retina regeneration. The mechanisms underlying MG dedifferentiation are unknown. Here we report that heparin-binding epidermal-like growth factor (HB-EGF) is rapidly induced in MG residing at the injury site and that proHB-EGF ectodomain shedding is necessary for retina regeneration. Remarkably, HB-EGF stimulates the formation of multipotent MG-derived progenitors in the uninjured retina. We show that HB-EGF mediates its effects via an EGFR/MAPK signal transduction cascade that regulates the expression of regeneration-associated genes, like ascl1a and pax6b. We also uncover an HB-EGF/Ascl1a/Notch/hb-egfa signaling loop that helps define the zone of injury-responsive MG. Finally, we show that HB-EGF acts upstream of the Wnt/\u03b2-catenin signaling cascade that controls progenitor proliferation. These data provide a link between extracellular signaling and regeneration-associated gene expression in the injured retina and suggest strategies for stimulating retina regeneration in mammals. PMID:22340497\n[Co-inheritance of the rare \u03b2 hemoglobin variants Hb Yaounde, Hb G\u00f6rwihl and Hb City of Hope with other alterations in globin genes: impact in genetic counseling.](https://www.ncbi.nlm.nih.gov/pubmed/25113778)\nVinciguerra, Margherita; Passarello, Cristina; Leto, Filippo; Cassar\u00e0, Filippo; Cannata, Monica; Maggio, Aurelio; Giambona, Antonino\n2015-04-01\nNearly 1183 different molecular defects of the globin genes leading to hemoglobin variants have been identified (http://globin.bx.psu.edu) over the past decades. The purpose of this study was to report three cases, never described in the literature, of co-inheritance of three \u03b2 hemoglobin variants with other alterations in globin genes and to evaluate the clinical significance to conduct an appropriate genetic counseling. We report the molecular study performed in three probands and their families, sampling during the screening program conducted at the Laboratory for Molecular Prenatal Diagnosis of Hemoglobinopathies at Villa Sofia-Cervello Hospital in Palermo, Italy. This work allowed us to describe the co-inheritance of three rare \u03b2 hemoglobin variants with other alterations in globin genes: the \u03b2 hemoglobin variant Hb Yaounde [\u03b2134(H12)Val>Ala], found for the first time in combination with \u03b1\u03b1\u03b1(anti3.7) arrangement, and the \u03b2 hemoglobin variants Hb G\u00f6rwihl [\u03b25(A2)Pro>Ala] and Hb City of Hope [\u03b269(E13)Gly>Ser], found both in association with \u03b2(0) -thalassemia. The present work emphasizes the importance of a careful evaluation of the hematological data, especially in cases of atypical hematological parameters, to carry out an adequate and complete molecular study and to formulate an appropriate genetic counseling for couples at risk. \u00a9 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.\n[Role of HbA1c in predicting risk for congenital malformations.](https://www.ncbi.nlm.nih.gov/pubmed/25676138)\nHammouda, Sahar Ali Ibrahim; Hakeem, Rubina\n2015-12-01\nAssociation between conventionally identified hyperglycemias and rates of congenital abnormalities is known; however there is less information about role of HbA1c in determining gestational hyperglycemias and associated risks. This study tried to explore the association between HbA1c in women without known diabetes at first antenatal visit and risk of congenital malformations (CM) among Saudi women living at Al-Madinah Al-Monawarah. Eleven hundred and eighty (1180), healthy, first-trimester pregnant Saudi females without known diabetes, were selected from various antenatal care clinics of Al-Madinah Al-Monawarah city. General clinical and biochemical data was collected for this study by researchers at first visit and the time of delivery. Nearly one fifth (19.6%) of mothers had above normal HbA1c (>5.7) at first visit. Rates of CM had significant positive association with level of HbA1c. Rate of CM among those who had HbA1c in diabetes range, pre-diabetes range or normal range was 27.8%, 9.8% and 3.0%, respectively. The difference was significant between normal and pre-diabetes at the level P=0.000 and between pre-diabetes and diabetes at level P=0.038. In this study HbA1c is found to be a valuable predictor of risk of congenital malformations. This observation calls for further studies and establishment of policies for care of pregnant mothers having higher than normal HbA1c at first visit. Copyright \u00a9 2015 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.\nState Council of Higher Education for Virginia, 2015\n2015-01-01\nStaff provides this baseline report as a summary of its preliminary considerations and initial research in fulfillment of the requirements of HB2320 from the 2015 session of the General Assembly. Codified as \u00a7 23-7.4:7, this legislation compels the Education Secretary and the State Council of Higher Education for Virginia (SCHEV) Director, in\u2026\n[HbQ-India associated with microcytosis: An uncommon hemoglobin variant associated with a common hematologic condition](http://www.journalagent.com/z4/download_fulltext.asp?pdir=tjh&plng=eng&un=TJH-42243) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAmit Kumar Yadav\n2010-09-01\nFull Text Available HbQ-India is a rare alpha chain variant that usually presents in the heterozygous state. Normally, HbQ-India is clinically silent. It becomes symptomatic when present in association with other conditions. We report a case of HbQ-India with concomitant presence of iron deficiency anemia. A 16-year-old female presented with weakness and pallor intermittently for six years. Complete blood count showed severe microcytic hypochromic anemia. Hemoglobin electrophoresis showed a prominent band in the S,D,G region. Tests for sickling were negative. High performance liquid chromatography (HPLC showed a peak in the unknown window (4.70-4.90 min suggestive of HbQ-India. Serum iron profile was suggestive of iron deficiency anemia. Based on the above findings, a diagnosis of coexistent HbQ-India\u2013iron deficiency anemia was made. A family study revealed the father as having moderate anemia with similar findings while the mother was normal. Abnormal hemoglobin in the patient was confirmed by molecular diagnosis.HbQ variants are the alpha globin chain variants due to structural mutations (\u03b164 Asp\u2192His inherited in autosomal dominant fashion. Three molecular variant types have been documented, namely HbQ-India, HbQ-Thailand and HbQ-Iran. Normally, HbQ is clinically silent. Therefore, careful screening of the samples using routine techniques like Hb electrophoresis and HPLC are needed for identification of such abnormal hemoglobin variants like HbQ-India.\n[2,3-DPG-Hb complex: a hypothesis for an asymmetric binding.](https://www.ncbi.nlm.nih.gov/pubmed/10852312)\nPomponi, M; Bertonati, C; Fuglei, E; Wiig, O; Derocher, A E\n2000-05-15\nThis study was undertaken to test the symmetry of 2,3-diphosphoglycerate (2,3-DPG) binding site in hemoglobin (Hb). From Arnone's study [A. Arnone, Nature (London) 237 (1972) 146] the 2,3-DPG binding site is located at the top of the cavity, that runs through the center of the deoxy-Hb molecule. However, it is possible that this symmetry reported by Arnone, for crystals of 2,3-DPG-Hb complex, might not be conserved in solution. In this paper, we report the 31P nuclear magnetic resonances of the 2,3-DPG interaction with Hb. The 2,3-DPG chemical shifts of the P2 and P3 resonance are both pH- and hemoglobin-dependent [protein from man, polar bear (Ursus maritimus), Arctic fox (Alopex lagopus) and bovine]. 2,3-DPG binds tightly to deoxyhemoglobin and weakly, nevertheless significantly, to oxyhemoglobin. In particular, our results suggest similar spatial position of the binding site of 2,3-DPG in both forms of Hb in solutions. However, the most unexpected result was the apparent loss of symmetry in the binding site, which might correlate with the ability of the hemoglobin to modulate its functional behavior. The different interactions of the phosphate groups indicate small differences in the quaternary structure of the different deoxy forms of hemoglobin. Given the above structural perturbation an asymmetric binding in the complex could justify, at least in part, different physiological properties of Hb. Regardless, functionally relevant effects of 2,3-DPG seem to be measured and best elucidated through solution studies.\n[Decontamination and decommissioning of the MTR-603 HB-2 cubicle](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=19047070) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nSmith, D.L.\n1987-01-01\nThe decontamination and decommissioning (D and D) of the MTR-603 HB-2 cubicle located at the Idaho National Engineering Laboratory (INEL) are described. The HP-2 cubicle became radioactively contaminated during out-of-pile circulating water loop experiments conducted in the Materials Testing Reactor in the 1950s and 1960s. The work performed to accomplish the D and D objectives of reducing the high radiation fields caused by contamination inside the cubicle, preventing future contamination spread, and making about 1400 ft 2 of floor space available for reuse are discussed. Decommissioning of the HB-2 cubicle consisted of total dismantlement of the cubicle and its contents and was performed without disrupting ongoing laboratory work being conducted in areas surrounding the HB-2 cubicle\n[Hb H disease resulting from the association of an \u03b1\u00ba-thalassemia allele [-(\u03b120.5] with an unstable \u03b1-globin variant [Hb Icaria]: first report on the occurrence in Brazil](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572009000400007) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nElza M. Kimura\n2009-01-01\nFull Text Available Hb H Disease is caused by the loss or inactivation of three of the four functional a-globin genes. Patients present chronic hemolytic anemia and splenomegaly. In some cases, occasional blood transfusions are required. Deletions are the main cause of this type of thalassemia (\u03b1-thalassemia. We describe here an unusual case of Hb H disease caused by the combination of a common \u03b1\u00ba deletion [-(\u03b120.5] with a rare point mutation (c.427T > A, thus resulting in an elongated and unstable \u03b1-globin variant, Hb Icaria, (X142K, with 31 additional amino-acid residues. Very high levels of Hb H and Hb Bart's were detected in the patient's red blood cells (14.7 and 19.0%, respectively. This is the first description of this infrequent association in the Brazilian population.\n[Isolation and characterization of atrazine mineralizing Bacillus subtilis strain HB-6.](http://europepmc.org/articles/PMC4169520?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJinhua Wang\nFull Text Available Atrazine is a widely used herbicide with great environmental concern due to its high potential to contaminate soil and waters. An atrazine-degrading bacterial strain HB-6 was isolated from industrial wastewater and the 16S rRNA gene sequencing identified HB-6 as a Bacillus subtilis. PCR assays indicated that HB-6 contained atrazine-degrading genes trzN, atzB and atzC. The strain HB-6 was capable of utilizing atrazine and cyanuric acid as a sole nitrogen source for growth and even cleaved the s-triazine ring and mineralized atrazine. The strain demonstrated a very high efficiency of atrazine biodegradation with a broad optimum pH and temperature ranges and could be enhanced by cooperating with other bacteria, suggesting its huge potential for remediation of atrazine-contaminated sites. To our knowledge, there are few Bacillus subtilis strains reported that can mineralize atrazine, therefore, the present work might provide some new insights on atrazine remediation.\n[HbA2 measurements in \u03b2-thalassemia and in other conditions](http://www.pagepressjournals.org/index.php/thal/article/view/1832) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGiovanni Ivaldi\n2014-09-01\nFull Text Available Quite a few papers have been written on the significance of elevated hemoglobin (Hb A2 as a parameter for the diagnosis of \u03b2-thalassemia trait, on the cutoff values to be used in diagnostics and on the significance and effects of factors reducing or elevating the expression of HbA2 and last but not least on the need for reliable measurement methods and precise calibrations with accurate standards. However, little has been published on the causes that elevate or reduce the HbA2 levels in \u03b2- and a-thalassemia and in other conditions. For a better understanding of the value of a precise measurement of this parameter we summarize and elucidate in this review the direct and indirect mechanisms that cause the variations in HbA2 expression and that influence the value of this parameter in particular conditions. We conclude by explaining the advantages and disadvantages of trusting on a precise measurement in the complete diagnostic contest.\n[Nivel de corte de los ELISAs para cuantificaci\u00f3n de anticuerpos inducidos por la vacuna antimeningoc\u00f3cica VA-MENGOC-BC](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2001000200002&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRolando Ochoa\n2001-06-01\nFull Text Available Para medir el grado de protecci\u00f3n inducido por vacunas antimeningoc\u00f3cicas se ha establecido el Ensayo Bactericida en Suero (EBS y se perfeccionan otros ensayos inmunobiol\u00f3gicos, sin embargo, es necesario contar con pruebas sencillas como el ELISA, capaz de evaluar un gran n\u00famero de muestras. Se estim\u00f3 el nivel de corte de los ELISAs para la cuantificaci\u00f3n de IgG humana contra los ant\u00edgenos de VA-MENGOC-BC, vacuna antimeningoc\u00f3cica compuesta por ves\u00edculas proteicas de membrana externa de meningococo B y polisac\u00e1rido capsular de meningococo C, con respecto a un panel de muestras de suero de lactantes, caracterizado por Ensayo Bactericida en Sangre Total (EBST. Los valores correspondientes a la m\u00e1xima sensibilidad y especificidad fueron respectivamente; 2 \u03bcg/mL y 12 \u03bcg/mL para antipolisac\u00e1rido C, y 1000 U/mL y 7000 U/mL para antiprote\u00ednas de membrana externa. La mayor coincidencia se obtuvo con 6 \u03bcg/mL y 2500 U/mL. Se evalu\u00f3 otro panel de muestras de suero de adolescentes entre 14 y 18 a\u00f1os, por ELISA y EBS para Neisseria meningitidis serogrupos B y C, alcanz\u00e1ndose una buena concordancia. Doce a\u00f1os despu\u00e9s de la inmunizaci\u00f3n con VA-MENGOC-BC persiste una importante concentraci\u00f3n de anticuerpos contra los ant\u00edgenos vacunales en los sueros estudiados.\n[Validaci\u00f3n de un m\u00e9todo de an\u00e1lisis para la determinaci\u00f3n de raloxifeno en una formulaci\u00f3n cubana](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75152014000100003&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJorge E Rodr\u00edguez Chanfrau\nFull Text Available Introducci\u00f3n: el raloxifeno es un modulador selectivo del receptor estrog\u00e9nico, perteneciente a la familia de los benzotiofenos. Los resultados de varios ensayos cl\u00ednicos han mostrado que este f\u00e1rmaco reduce la p\u00e9rdida del hueso en la espina dorsal y puede aumentar la masa del hueso en ciertos sitios. Objetivo: validar un m\u00e9todo de an\u00e1lisis para la determinaci\u00f3n de raloxifeno en una formulaci\u00f3n cubana. M\u00e9todos: se desarroll\u00f3 un m\u00e9todo de an\u00e1lisis por cromatograf\u00eda l\u00edquida de alta resoluci\u00f3n. Se emplearon para ello una columna Lichrospher\u00ae 100, RP 18. Se utilizaron como fase m\u00f3vil una mezcla de metanol-agua desionizada-trietanolamina (70:30:0,1 y detector ultravioleta a una longitud de onda de 286 nm. El flujo de la fase m\u00f3vil fue de 1,5 mL/min y el volumen de inyecci\u00f3n fue de 20 mL. Resultados: el m\u00e9todo empleado para la cuantificaci\u00f3n de raloxifeno en la formulaci\u00f3n cubana result\u00f3 espec\u00edfico, preciso, exacto y lineal. Conclusiones: en las condiciones de estudio se demuestra que el m\u00e9todo propuesto cumple con los par\u00e1metros de validaci\u00f3n, por lo que puede ser utilizado en el control de la calidad de dicho medicamento.\n[Recomendaci\u00c3\u00b3n sobre la vacuna contra la tosferina para los beb\u00c3\u00a9s y ni\u00c3\u00b1os peque\u00c3\u00b1os(Whooping Cough Vaccine Recommendation for Babies and Young Children)](https://tools.cdc.gov/medialibrary/index.aspx#/media/id/303180) [Centers for Disease Control (CDC) Podcasts](http://www2c.cdc.gov/podcasts/search.asp)\nEste podcast proporciona informaci\u00c3\u00b3n acerca de la tosferina y la recomendaci\u00c3\u00b3n de que todos los ni\u00c3\u00b1os reciban la vacuna DTaP seg\u00c3\u00ban el calendario recomendado por los CDC para ayudar a protegerlos contra esta grave enfermedad.\n[The changing relationship between HbA1c and FPG according to different FPG ranges.](https://www.ncbi.nlm.nih.gov/pubmed/26385729)\nGuan, X; Zheng, L; Sun, G; Guo, X; Li, Y; Song, H; Tian, F; Sun, Y\n2016-05-01\nSince the American Diabetes Association included hemoglobin A1c (HbA1c) in the diagnostic criteria for diabetes in 2010, the clinical use of HbA1c has remained controversial. We explored the use of HbA1c for diagnosing diabetes and intermediate hyperglycemia in comparison with fasting plasma glucose (FPG). We screened 3710 adult subjects (mean age = 55.24 years) comprising 1704 males and 2006 females. We drew an receiver operating characteristic (ROC) curve to evaluate the ability of HbA1c to diagnose diabetes and intermediate hyperglycemia according to FPG. We used Kappa coefficient and Pearson's correlation coefficient to evaluate the relationship between HbA1c and FPG in different FPG ranges. The areas under ROC curve to diagnose diabetes and intermediate hyperglycemia were 0.859 (95 % CI 0.827-0.892) and 0.633 (95 % CI 0.615-0.651). The kappa coefficients between FPG and HbA1c for diagnosis of diabetes and intermediate hyperglycemia were 0.601 (P HbA1c was 0.640 (P HbA1c and FPG changed according to the different FPG ranges. When FPG was higher, the relationship was stronger. HbA1c and FPG were highly consistent in diagnosing diabetes, but they were not in predicting intermediate hyperglycemia.\n[Estado de salud bucal de la poblaci\u00f3n cubana, 1995](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75071999000300005) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLuis Delgado M\u00e9ndez\n1999-12-01\nFull Text Available Se realiz\u00f3 una investigaci\u00f3n epidemiol\u00f3gica nacional en el a\u00f1o 1995 con el objetivo de analizar el estado de la salud bucal de la poblaci\u00f3n cubana. Se analiz\u00f3 una muestra de 3 805 personas de 16 \u00e1reas de salud, correspondientes a 11 provincias; se utiliz\u00f3 el modelo recomendado por la OMS para este tipo de estudio; se capacitaron y calibraron a 6 estomat\u00f3logos y sus respectivas asistentes. Los datos se procesaron en computadora mediante el programa EPINFO. Los resultados se confrontaron con las metas propuestas por la OMS para el a\u00f1o 2000. Se observ\u00f3 que las metas n\u00famero 1, 2, 3 y 4 se cumplen seg\u00fan lo previsto, no as\u00ed la meta 5.In 1995, an epidemiological research at national level was performed in order to analyse buccal health status of Cuban population. We studied a sample of 3 805 persons from 16 health areas, corresponding to 11 provinces. Model recommended by World Health Organization (WHO for this type of study was used. 6 stomatologists were trained and sized up as well as their respective assistants. Data were processed in a computer by EPINFO program. Results were compared with planned aims by WHO for 2000 year. Aims 1, 2, 3, and 4 are fulfilled according planning, except for number 5.\n[Hb and dyslipidaemia as predicting markers of serum alanine aminotransferase elevation in Chinese adolescents.](https://www.ncbi.nlm.nih.gov/pubmed/26328752)\nChao, Kuo-Ching; Chang, Chun-Chao; Owaga, Eddy; Bai, Chyi-Huey; Huang, Tzu-chieh; Pan, Wen-Harn; Chang, Jung-Su\n2016-04-01\nFe is an essential element for erythropoiesis and Hb synthesis. High Hb levels affect the blood's viscosity and are associated with cardiovascular dysfunction. The aim of the present study was to examine relationships of Hb and cardiometabolic abnormalities with the risk of alanine aminotransferase (ALT) elevation in adolescents. A population-based, cross-sectional study. National Nutrition and Health Survey in Taiwan (2010-2011, adolescents). Healthy adolescents aged 13-18 years. In total, 1941 adolescents (963 boys and 978 girls) were entered in the study. The mean age was 15\u00b73 (sd 0\u00b71) years (boys, 15\u00b73 (sd 0\u00b71) years; girls, 15\u00b72 (sd 0\u00b71) years). ALT tertile cut-off points for boys were 11 and 16 U/l, and for girls were 9 and 12 U/l. Girls without dyslipidaemia and presenting in the highest quartile (Q1) of Hb (>13\u00b76 g/dl) were 1\u00b789 and 3\u00b776 times more likely to have raised serum ALT (9 and >12 U/l, respectively) than the reference (lowest quartile of Hb (Q1), 12 U/l) than the reference (Q1 of Hb, 15\u00b74 g/dl), who were 7\u00b740 times more likely to have elevated serum ALT of >16 U/l than the reference (Q1 of Hb, Hb level is a predictor of elevated serum ALT in adolescent girls with dyslipidaemia. Our study also highlights the importance of further research to establish cut-off points for Hb and its utility in diagnosing and preventing the onset of dyslipidaemia in adolescents.\n[HbA1c as a predictor of diabetes after gestational diabetes mellitus.](https://www.ncbi.nlm.nih.gov/pubmed/27692850)\nClaesson, Rickard; Ignell, Claes; Shaat, Nael; Berntorp, Kerstin\n2017-02-01\nWe wanted to investigate third-trimester HbA1c as a predictor of diabetes after gestational diabetes mellitus (GDM). Women with GDM were followed up prospectively for five years from pregnancy to detect the development of diabetes. The ability of HbA1c to predict diabetes was evaluated with receiver-operating characteristic (ROC) curves and logistic regression analysis. By five years, 73 of 196 women had been diagnosed with diabetes. An optimal cut-off point for HbA1c of 36mmol/mol (5.4%) could predict diabetes with 45% sensitivity and 92% specificity. For HbA1c \u226539mmol/mol (\u22655.7%), sensitivity, specificity, and positive predictive value were 30%, 97%, and 91%, respectively. In logistic regression analysis, adjusting for the diagnostic glucose concentration during pregnancy, HbA1c levels in the upper quartile (\u226536mmol/mol) were associated with a 5.5-fold increased risk of diabetes. Third-trimester HbA1c levels in the pre-diabetes range revealed women with post-partum diabetes with high specificity and high positive predictive value. HbA1c testing could be used as a strategy to select high-risk women for lifestyle interventions aimed at prevention of diabetes starting during pregnancy. The results should encourage further validation in other populations using new diagnostic criteria for GDM. Copyright \u00a9 2016 The Author(s). Published by Elsevier Ltd.. All rights reserved.\n[TGF\u03b2 induces proHB-EGF shedding and EGFR transactivation through ADAM activation in gastric cancer cells](http://dx.doi.org/10.1016/j.bbrc.2010.09.130) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nEbi, Masahide; Kataoka, Hiromi; Shimura, Takaya; Kubota, Eiji; Hirata, Yoshikazu; Mizushima, Takashi; Mizoshita, Tsutomu; Tanaka, Mamoru; Mabuchi, Motoshi; Tsukamoto, Hironobu; Tanida, Satoshi; Kamiya, Takeshi; Higashiyama, Shigeki; Joh, Takashi\n2010-01-01\nResearch highlights: \u2192 TGF\u03b2 induces EGFR transactivation through proHB-EGF shedding by activated ADAM members in gastric cancer cells. \u2192 TGF\u03b2 induces nuclear translocation of HB-EGF-CTF cleaved by ADAM members. \u2192 TGF\u03b2 enhances cell growth by EGFR transactivation and HB-EGF-CTF nuclear translocation and ADAM inhibitors block these effects. \u2192 Silencing of ADAM17 also blocks EGFR transactivation, HB-EGF-CTF nuclear translocation and cancer cell growth by TGF\u03b2. \u2192 ADAM17 may play a crucial role in this TGF\u03b2-HB-EGF signal transduction. -- Abstract: Background and aims: Transforming growth factor-beta (TGF\u03b2) is known to potently inhibit cell growth. Loss of responsiveness to TGF\u03b2 inhibition on cell growth is a hallmark of many types of cancer, yet its mechanism is not fully understood. Membrane-anchored heparin-binding EGF-like growth factor (proHB-EGF) ectodomain is cleaved by a disintegrin and metalloproteinase (ADAM) members and is implicated in epidermal growth factor receptor (EGFR) transactivation. Recently, nuclear translocation of the C-terminal fragment (CTF) of pro-HB-EGF was found to induce cell growth. We investigated the association between TGF\u03b2 and HB-EGF signal transduction via ADAM activation. Materials and methods: The CCK-8 assay in two gastric cancer cell lines was used to determine the effect for cell growth by TGF\u03b2. The effect of two ADAM inhibitors was also evaluated. Induction of EGFR phosphorylation by TGF\u03b2 was analyzed and the effect of the ADAM inhibitors was also examined. Nuclear translocation of HB-EGF-CTF by shedding through ADAM activated by TGF\u03b2 was also analyzed. EGFR transactivation, HB-EGF-CTF nuclear translocation, and cell growth were examined under the condition of ADAM17 knockdown. Result: TGF\u03b2-induced EGFR phosphorylation of which ADAM inhibitors were able to inhibit. TGF\u03b2 induced shedding of proHB-EGF allowing HB-EGF-CTF to translocate to the nucleus. ADAM inhibitors blocked this nuclear translocation. TGF\ufffd\n[Establishment of an in vivo potency assay for the recombinant hepatit is B surface antigen in monovalent and combined vaccines](http://scielo.sld.cu/scielo.php?script=sci_pdf&pid=S1025-028X2014000300002&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMabel Izquierdo-L\u00f3pez\n2014-12-01\nFull Text Available In this paper the development of potency assay in animals (mice was made, with the objective of demonstrating the immunogenic power of the recombinant Hepatitis B surface antigen in monovalent and combined vaccines, produced at the Center of Genetic Engineering and Biotechnology. The potency test is a parameter in quality control and it is also a tool to demonstrate the consistency of the production process. Parameters such as duration of the test, number of animals in the test, as well as different areas for the maintenance of the animals were evaluated. The results on the applicability of the potency test, to two presentations of the vaccines; monovalent Heberbiovac HB and pentavalent liquid in one vial Heberpenta-L are shown, for which specificity studies, evaluating different vaccine lots, the behavior of linearity, and parallelism, as well as establishing quality specification of the test were performed. This assay led to the obtainment of reliable results for the vaccines evaluated, the consistent evaluation of the immunogenic power and the monitoring of different production processes.\n[Complex structure of the supernova remnant HB 3](https://ntrs.nasa.gov/search.jsp?R=19850060859&hterms=hb&qs=N%3D0%26Ntk%3DAll%26Ntx%3Dmode%2Bmatchall%26Ntt%3Dhb)\nLeahy, D. A.; Venkatesan, D.; Long, K. S.; Naranan, S.\n1985-01-01\nHB 3 is an old, large (84 pc diameter) supernova remnant associated with the W3 H II region/molecular cloud complex. Observations of the imaging proportional counter (IPC) onboard the Einstein X-ray astronomy satellite have been reprocessed to yield a contour map of X-ray brightness and spectra of various regions of this remnant. The measured IPC flux is 2.4 x 10 to the -11th ergs per sq cm per s, giving a 0.2-4 keV luminosity of 1.6 x 10 to the 35th ergs/s for a column densityof 6 x 10 to the 21st per sq cm. The measured X-ray temperatures reveal a decrease from center to limb of the remnant of 1-0.3 keV. HB 3 is in the late adiabatic blast-wave phase of evolution, 30,000 to 50,000 yr old and with an initial blast energy of 3 x 10 to the 50th ergs. The X-ray map is compared with available radio and optical images. In X-rays, HB 3 has two components - a diffuse emission inside the 84 pc radio remnant and a ring of emission at the center of 30 pc in diameter. The diffuse emission is similar to that from other supernova remnants which are moderately obscured (column density, nH approximately 10 to the 22nd per sq cm). Three possibilities for the origin of the ring are explored: (1) a second supernova remnant, (2) a shocked shell in the interstellar medium surrounding HB 3, and (3) reverse-shock heated ejecta. There is no hot neutron star within the remnant.\n[Spinal Hb9::Cre-derived excitatory interneurons contribute to rhythm generation in the mouse.](https://www.ncbi.nlm.nih.gov/pubmed/28128321)\nCaldeira, Vanessa; Dougherty, Kimberly J; Borgius, Lotta; Kiehn, Ole\n2017-01-27\nRhythm generating neurons are thought to be ipsilaterally-projecting excitatory neurons in the thoracolumbar mammalian spinal cord. Recently, a subset of Shox2 interneurons (Shox2 non-V2a INs) was found to fulfill these criteria and make up a fraction of the rhythm-generating population. Here we use Hb9::Cre mice to genetically manipulate Hb9::Cre-derived excitatory interneurons (INs) in order to determine the role of these INs in rhythm generation. We demonstrate that this line captures a consistent population of spinal INs which is mixed with respect to neurotransmitter phenotype and progenitor domain, but does not overlap with the Shox2 non-V2a population. We also show that Hb9::Cre-derived INs include the comparatively small medial population of INs which continues to express Hb9 postnatally. When excitatory neurotransmission is selectively blocked by deleting Vglut2 from Hb9::Cre-derived INs, there is no difference in left-right and/or flexor-extensor phasing between these cords and controls, suggesting that excitatory Hb9::Cre-derived INs do not affect pattern generation. In contrast, the frequencies of locomotor activity are significantly lower in cords from Hb9::Cre-Vglut2 \u0394/\u0394 mice than in cords from controls. Collectively, our findings indicate that excitatory Hb9::Cre-derived INs constitute a distinct population of neurons that participates in the rhythm generating kernel for spinal locomotion.\n[Identification of diphtheria toxin R domain mutants with enhanced inhibitory activity against HB-EGF.](https://www.ncbi.nlm.nih.gov/pubmed/25432160)\nSuzuki, Keisuke; Mizushima, Hiroto; Abe, Hiroyuki; Iwamoto, Ryo; Nakamura, Haruki; Mekada, Eisuke\n2015-05-01\nHeparin-binding epidermal growth factor-like growth factor (HB-EGF), a ligand of EGF receptor, is involved in the growth and malignant progression of cancers. Cross-reacting material 197, CRM197, a non-toxic mutant of diphtheria toxin (DT), specifically binds to the EGF-like domain of HB-EGF and inhibits its mitogenic activity, thus CRM197 is currently under evaluation in clinical trials for cancer therapy. To develop more potent DT mutants than CRM197, we screened various mutant proteins of R domain of DT, the binding site for HB-EGF. A variety of R-domain mutant proteins fused with maltose-binding protein were produced and their inhibitory activity was evaluated in vitro. We found four R domain mutants that showed much higher inhibitory activity against HB-EGF than wild-type (WT) R domain. These R domain mutants suppressed HB-EGF-dependent cell proliferation more effectively than WT R domain. Surface plasmon resonance revealed their higher affinity to HB-EGF than WT R domain. CRM197(R460H) carrying the newly identified mutation showed increased cell proliferation inhibitory activity and affinity to HB-EGF. These results suggest that CRM197(R460H) or other recombinant proteins carrying newly identified mutation(s) in the R domain are potential therapeutics targeting HB-EGF. \u00a9 The Authors 2014. Published by Oxford University Press on behalf of the Japanese Biochemical Society. All rights reserved.\n[Impacto econ\u00f3mico de la introducci\u00f3n de la vacuna inactivada inyectable contra la poliomielitis en Colombia Economic impact of introducing the injectable inactivated polio vaccine in Colombia](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892010000500005) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nNelson Alvis\n2010-05-01\nFull Text Available OBJETIVOS: Evaluar la relaci\u00f3n costo-efectividad de la introducci\u00f3n de la vacuna inyectable contra la poliomielitis (VIP en Colombia con respecto al sistema actual basado en el empleo de la vacuna oral (VOP. M\u00c9TODOS: Se dise\u00f1\u00f3 un modelo de Markov basado en una cohorte hipot\u00e9tica de reci\u00e9n nacidos que recibir\u00eda la VIP o la VOP con un seguimiento de dos a\u00f1os y estimaciones mensuales del n\u00famero de casos de poliomielitis paral\u00edtica asociada con la vacuna (PPAV. El an\u00e1lisis del costo se realiz\u00f3 desde la perspectiva del asegurador (costos a lo largo de la vida y la sociedad (casos de PPAV evitados y a\u00f1os de vida ajustados por discapacidad [AVAD] evitados. RESULTADOS: Entre 1988 y 1998 se aplicaron en Colombia 22,5 millones de dosis de la VOP y se detectaron nueve casos de PPAV, para una tasa de 4,0 \u00a5 10-7 por dosis. Seg\u00fan el modelo, se podr\u00edan esperar entre 2 y 4 casos de PPAV en los dos a\u00f1os de seguimiento. El costo de tratar los casos de PPAV ser\u00eda de US$ 302 008, con costos de vacunaci\u00f3n con la VOP de US$ 737 037 y de US$ 5 527 777 con la VIP. La vacunaci\u00f3n con la VIP permitir\u00eda evitar 64 AVAD con un costo de US$ 71 062 por AVAD evitado; evitar un caso de PPAV mediante la sustituci\u00f3n de la VOP por la VIP costar\u00eda entre US$ 1,8 millones y US$ 2,2 millones. CONCLUSIONES: La sustituci\u00f3n de la VOP por la VIP no es una medida efectiva en funci\u00f3n del costo en Colombia, incluso si se sustituyera la vacuna celular contra la tos ferina, actualmente en uso, por una vacuna acelular combinada con una VIP.OBJECTIVE: Evaluate the cost-effectiveness of introducing the injectable inactivated polio vaccine (IPV in Colombia versus the current system based on the use of the oral vaccine (OPV. METHODS: A Markov model was designed, based on a hypothetical cohort of newborns that would receive the IPV or the OPV vaccine, with a two-year follow-up and monthly estimates of the number of cases of vaccine-associated paralytic poliomyelitis (VAPP\n[Registration of a High Yielding Malt Barley Variety HB1454 for the ...](https://www.ajol.info/index.php/ejas/article/download/144689/134351) [African Journals Online (AJOL)](http://www.ajol.info/index.php)\nelse\nBayeh and Berhane 2011). Even though Ethiopia has favorable environment and .... malting profile for HB1454 is better than Beka for kernel weight, plump kernels, hectoliter weight and grain protein. HB1454 has shown relatively low percentage.\n[La articulaci\u00f3n p\u00fablico-privada en la producci\u00f3n de vacunas en M\u00e9xico](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-11042016000400009&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSilvia Tamez\nFull Text Available RESUMEN El art\u00edculo analiza el proceso de privatizaci\u00f3n de la atenci\u00f3n a la salud: la Articulaci\u00f3n P\u00fablico-Privada (APP. Espec\u00edficamente estudia la producci\u00f3n de vacunas em M\u00e9xico, tomando como caso los Laboratorios de Biol\u00f3gicos y Reactivos de M\u00e9xico, S.A. de C.V. (Birmex, empresa paraestatal, responsable de producir, distribuir e investigar biol\u00f3gicos y reactivos en M\u00e9xico. Interesa destacar el comportamiento de Birmex durante el periodo de la pandemia de influenza de 2009, producida por el virus de la influenza A subtipo H1N1. Los resultados muestran que gracias al impulso de las pol\u00edticas de liberalizaci\u00f3n y desregulaci\u00f3n, existe una apertura de los servicios p\u00fablicos a las corporaciones supranacionales.\n[First Cases of Hb Agrinio Described in Patients from the Republic of Macedonia.](https://www.ncbi.nlm.nih.gov/pubmed/29219637)\nDimishkovska, Marija; Kuzmanovska, Maja; Kocheva, Svetlana; Martinova, Kata; Karanfilski, Oliver; Stojanoski, Zlate; Plaseska-Karanfilska, Dijana\nPrevious molecular analyses of \u03b1-thalassemia (\u03b1-thal) in the Republic of Macedonia have identified the following genetic defects: -\u03b1 3.7 (rightward), -(\u03b1) 20.5 and - - MED I deletions and Hb Icaria [\u03b1142, Term\u2192Lys (\u03b12), HBA2: c.427T>A] and polyadenylation signal (polyA) [AATAAA>AATGAA (\u03b12), HBA2: c.*92A>G] point mutations. Here, we report two unrelated patients from the Romani population in the Republic of Macedonia, homozygotes for the \u03b12-globin gene variant Hb Agrinio [\u03b129(B10)Leu\u2192Pro; HBA2: c.89T>C]. To date, Hb Agrinio has been described only in individuals of Greek, Cypriot and Spanish origin. Both of our patients had early presentation of the disease (3.5 years and 2 months, respectively) with frequent blood transfusions from early infancy. They have a severe intermediate phenotype of thalassemia (Hb H disease) with hemoglobin (Hb) levels of 7.8 and 7.7 g/dL, respectively. Although the HBA2: c.89T>C mutation results in an \u03b1 + allele, the severe phenotype of the homozygotes is due to the production of hyperunstable \u03b1 chains that undergo post translational precipitation. This leads to a greater degree of red cell damage and hemolytic anemia. The detection of Hb Agrinio in two unrelated families of Romani ethnic origin, may suggest it is a founder mutation in this population living in the Republic of Macedonia. Considering the severity of the clinical presentation of the homozygotes or compound heterozygotes for this rare Hb variant, a targeted molecular screening for Hb Agrinio mutation carriers should be considered in all patients of Romani ethnic origin with manifested microcytosis.\n[La influencia del marxismo en el pensamiento y los debates de la campa\u00f1a por la escuela cubana en Cuba Libre en 1941](http://revistanuestramerica.cl/ojs/index.php/nuestramerica/article/view/83) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRegina de la Caridad Algramonte Rosell\n2014-01-01\nFull Text Available Resumen: El presente trabajo es resultado de una investigaci\u00f3n sobre un hecho de importancia trascendental en la Cuba de 1941: la campa\u00f1a Por la escuela cubana en Cuba Libre, luego de las sesiones de debate de la Asamblea Constituyente de 1940. Se determin\u00f3 como objetivo central analizar el lugar del marxismo en la atm\u00f3sfera intelectual-cultural cubana en los a\u00f1os 40, para lo cual result\u00f3 necesario un acercamiento a los principales debates sobre la educaci\u00f3n propiciados por el Partido Comunista, los marxistas y las personas afines a su pol\u00edtica educacional teniendo en cuenta aciertos y desaciertos en los modos de actuaci\u00f3n de las mujeres y hombres que protagonizaron la historia. Palabras clave: Marxismo, educaci\u00f3n, Cuba. Abstract: This paper is the result of a research about a transcendental event in Cuba in 1941: the Campaign for the Cuban school in Cuba Libre after the debate sessions of the Constituent Assembly of 1940. The main objective of this research was to analyze the role of Marxism in the Cuban intellectual-cultural atmosphere in the 40s. To do this, it was necessary to approach the main debates about education that the Communist Party, Marxists and supporters of this educational policy promoted. In addition, the strengths and weaknesses of the way of acting of the leading men and women who took part in history were taken into account. Key words: Marxism, education, Cuba.\n[To establish trimester-specific reference ranges for glycated haemoglobin (HbA1c) in pregnancy](http://www.lenus.ie/hse/handle/10147/238825) [LENUS (Irish Health Repository)](http://www.lenus.ie/hse/)\nO'Connor, CM\n2011-09-01\nBackground and aims: Diabetes in Pregnancy imposes additional risks to both mother and infant. These poor outcomes are considered to be primarily related to glycaemic control which is monitored longitudinally through pregnancy by means of HbA1c. The correlation between HbA1c levels with clinical outcomes emphasises the need to measure HbA1c accurately, precisely and for data interpretation comparison to appropriately defined reference intervals. From July 1st 2010, the HbA1c assay in Irish laboratories became fully metrologically traceable to the IFCC standard, permitting HbA1c to be reported in IFCC units (mmol\\\\/mol) and derived DCCT\\\\/NGSP units (%) using the IFCC-DCCT\\\\/NGSP master equation (DCCT = Diabetes Control and Complications Trial, NGSP = National Glycohemoglobin standardisation program). The aim of this project is to establish trimester-specific reference ranges in pregnancy for IFCC standardised HbA1c in non-diabetic Caucasian women. This will allow us to define the goal for HbA1c during pregnancy complicated by diabetes.\\\\r\\\n[Electrochemical sensor based on magnetic molecularly imprinted nanoparticles modified magnetic electrode for determination of Hb.](https://www.ncbi.nlm.nih.gov/pubmed/28049107)\nSun, Binghua; Ni, Xinjiong; Cao, Yuhua; Cao, Guangqun\n2017-05-15\nA fast and selective electrochemical sensor for determination of hemoglobin (Hb) was developed based on magnetic molecularly imprinted nanoparticles modified on the magnetic glassy carbon electrode. The nanoparticles Fe 3 O 4 @SiO 2 with a magnetic core and a molecularly imprinted shell had regular structures and good monodispersity. Hb could be determined directly by electrochemical oxidization with the modified electrode. A magnetic field increased electrochemical response to Hb by two times. Imprinting Hb on the surface of Fe 3 O 4 @SiO 2 shortened the response time within 7min. Under optimum conditions, the imprinting factor toward the non-imprinted sensor was 2.8, and the separation factor of Hb to horseradish peroxidase was 2.6. The oxidation peak current had a linear relationship with Hb concentration ranged from 0.005mg/ml to 0.1mg/ml with a detection limit (S/N =3) of 0.0010mg/ml. The sensors were successfully applied to analysis of Hb in whole blood samples with recoveries between 95.7% and 105%. Copyright \u00a9 2016 Elsevier B.V. All rights reserved.\n[Effects of a healthier snack on snacking habits and glycated Hb (HbA1c): a 6-week intervention study.](https://www.ncbi.nlm.nih.gov/pubmed/28065181)\nYan, Mary R; Parsons, Andrew; Whalley, Gillian A; Rush, Elaine C\n2016-12-01\nDietary behaviour modification may change eating habits and reduce the impact of poor nutrition. This study aimed to evaluate the effects of daily consumption of a healthier snack bar on snacking habits and glycated Hb (HbA1c) within a 6-week intervention. In all, twenty-eight participants were randomly allocated to two groups to either consume the bars as the main snack for 6 weeks (n 14) or receipt of the bars was delayed for 6 weeks (n 14) following a stepped-wedge design. All participants had HbA1c concentrations measured at weeks -1, 0, 4, 6, 10 and 12. A short dietary habits questionnaire was self-completed at weeks 0, 6 and 12. Participants consumed the bars they received instead of other snacks, and found that the healthier snack bar was acceptable as part of their daily dietary pattern. Over the 12 weeks, there was a significant reduction in intake of biscuits, cakes and pies (approximately 2 servings/week, Psnack intervention and a trend towards a favourable effect on glucose homoeostasis. Habitual snacking behaviour has the potential to be improved through changes in the food supply, and in the longer term may reduce the impact of poor nutrition on public health.\n[Hb A1c Separation by High Performance Liquid Chromatography in Hemoglobinopathies](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::2c7550e41cc1b600c078d86db0fb4ab3)\nChandrashekar, Vani\n2016-01-01\nHb A1c measurement is subject to interference by hemoglobin traits and this is dependent on the method used for determination. In this paper we studied the difference between Hb A1c measured by HPLC in hemoglobin traits and normal chromatograms. We also studied the correlation of Hb A1c with age. Hemoglobin analysis was carried out by high performance liquid chromatography. Spearman's rank correlation was used to study correlation between A1c levels and age. Mann-Whitney U test was used to st...\n[Hereditary Persistence of Fetal Hemoglobin Caused by Single Nucleotide Promoter Mutations in Sickle Cell Trait and Hb SC Disease.](https://www.ncbi.nlm.nih.gov/pubmed/26372199)\nAkinbami, Anthony O; Campbell, Andrew D; Han, Zeqiu J; Luo, Hong-Yuan; Chui, David H K; Steinberg, Martin H\n2016-01-01\nHereditary persistence of fetal hemoglobin (HPFH) can be caused by point mutations in the \u03b3-globin gene promoters. We report three rare cases: a child compound heterozygous for Hb S (HBB: c.20A > T) and HPFH with a novel point mutation in the (A)\u03b3-globin gene promoter who had 42.0% Hb S, 17.0% Hb A and 38.0% Hb F; a man with Hb SC (HBB: c.19G > A) disease and a point mutation in the (G)\u03b3-globin gene promoter who had 54.0% Hb S, 18.0% Hb C and 25.0% Hb F; a child heterozygous for Hb S and HPFH due to mutations in both the (A)\u03b3- and (G)\u03b3-globin gene promoters in cis [(G)\u03b3(A)\u03b3(\u03b2(+)) HPFH], with 67.0% Hb A, 6.5% Hb S and 25.0% Hb F.\n[Hemoglobin A1c (HbA1c) Test: MedlinePlus Lab Test Information](https://medlineplus.gov/labtests/hemoglobina1chba1ctest.html)\n... page: https://medlineplus.gov/labtests/hemoglobina1chba1ctest.html Hemoglobin A1c (HbA1c) Test To use the sharing features on this page, please enable JavaScript. What is a hemoglobin A1c (HbA1c) test? A hemoglobin A1c (HbA1c) test measures ...\n[Elevated HbA1c and Fasting Plasma Glucose in Predicting Diabetes Incidence Among Older Adults](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3836095)\nLipska, Kasia J.; Inzucchi, Silvio E.; Van Ness, Peter H.; Gill, Thomas M.; Kanaya, Alka; Strotmeyer, Elsa S.; Koster, Annemarie; Johnson, Karen C.; Goodpaster, Bret H.; Harris, Tamara; De Rekeneire, Nathalie\n2013-01-01\nOBJECTIVE To determine which measures\u2014impaired fasting glucose (IFG), elevated HbA1c, or both\u2014best predict incident diabetes in older adults. RESEARCH DESIGN AND METHODS From the Health, Aging, and Body Composition study, we selected individuals without diabetes, and we defined IFG (100\u2013125 mg/dL) and elevated HbA1c (5.7\u20136.4%) per American Diabetes Association guidelines. Incident diabetes was based on self-report, use of antihyperglycemic medicines, or HbA1c \u22656.5% during 7 years of follow-up. Logistic regression analyses were adjusted for age, sex, race, site, BMI, smoking, blood pressure, and physical activity. Discrimination and calibration were assessed for models with IFG and with both IFG and elevated HbA1c. RESULTS Among 1,690 adults (mean age 76.5, 46% men, 32% black), 183 (10.8%) developed diabetes over 7 years. Adjusted odds ratios of diabetes were 6.2 (95% CI 4.4\u20138.8) in those with IFG (versus those with fasting plasma glucose [FPG] HbA1c (versus those with HbA1c HbA1c were considered together, odds ratios were 3.5 (1.9\u20136.3) in those with IFG only, 8.0 (4.8\u201313.2) in those with elevated HbA1c only, and 26.2 (16.3\u201342.1) in those with both IFG and elevated HbA1c (versus those with normal FPG and HbA1c). Addition of elevated HbA1c to the model with IFG resulted in improved discrimination and calibration. CONCLUSIONS Older adults with both IFG and elevated HbA1c have a substantially increased odds of developing diabetes over 7 years. Combined screening with FPG and HbA1c may identify older adults at very high risk for diabetes. PMID:24135387\n[Detection of the Unstable Hb K\u00f6ln (HBB: c.295G>A) by a Capillary Electrophoresis Method.](https://www.ncbi.nlm.nih.gov/pubmed/28361589)\nLi, You-Qiong; Ye, Li-Hua; Mo, Yun\n2016-11-01\nHb K\u00f6ln (HBB: c.295G>A) is an unstable \u03b2-globin gene variant with a GTG>ATG substitution at codon 98. This variant is quite frequent in Europe and the USA but rare in China. It can easily be misdiagnosed as Hb Constant Spring (Hb CS; HBA2: c.427T>C) by high performance liquid chromatography (HPLC), but detection and quantification of both Hb K\u00f6ln and degraded Hb K\u00f6ln by capillary electrophoresis (CE) are possible. Thus, we concluded that CE was the preferred method for Hb K\u00f6ln detection.\n[Changing from glucose to HbA1c for diabetes diagnosis](http://www.forskningsdatabasen.dk/en/catalog/266213608) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nNielsen, Aneta Aleksandra; Petersen, Per Hyltoft; Green, Anders\n2014-01-01\nBACKGROUND: In Denmark, the use of HbA1c in the diagnosis of diabetes was adopted from March 2012. We evaluated the change in the number of diabetes cases diagnosed by haemoglobin A1c (HbA1c) versus fasting venous plasma glucose (FPG), and estimated the influence of analytical variation and bias ...\n[Antibacterial activity of a modified unfilled resin containing a novel polymerizable quaternary ammonium salt MAE-HB.](https://www.ncbi.nlm.nih.gov/pubmed/27659279)\nHuang, Li; Yu, Fan; Sun, Xiang; Dong, Yan; Lin, Ping-Ting; Yu, Hao-Han; Xiao, Yu-Hong; Chai, Zhi-Guo; Xing, Xiao-Dong; Chen, Ji-Hua\n2016-09-23\nResins with strong and long-lasting antibacterial properties are critical for the prevention of secondary dental caries. In this study, we evaluated the antibacterial effect and the underlying mechanism of action of an unfilled resin incorporating 2-methacryloxylethyl hexadecyl methyl ammonium bromide (MAE-HB) against Streptococcus mutans UA159 (S. mutans UA159). MAE-HB was added into unfilled resin at 10 mass%, and unfilled resin without MAE-HB served as the control. Bacterial growth was inhibited on 10%-MAE-HB unfilled resin compared with the control at 1 d, 7 d, 30 d, or 180 d (P 0.05). No significant differences in the antibacterial activities of eluents from control versus 10%-MAE-HB unfilled resins were observed at any time point (P > 0.05). The number of bacteria attached to 10%-MAE-HB unfilled resin was considerably lower than that to control. Fe-SEM and CLSM showed that 10%-MAE-HB unfilled resin disturbed the integrity of bacterial cells. Expression of the bacterial glucosyltransferases, gtfB and gtfC, was lower on 10%-MAE-HB unfilled resin compared to that on control (P HB confers unfilled resin with strong and long-lasting antibacterial effects against S. mutans.\n[IMPLEMENTACI\u00d3N DEL COMERCIO ELECTR\u00d3NICO EN LA EMPRESA CUBANA](http://rii.cujae.edu.cu/index.php/revistaind/article/view/225) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAriel Garc\u00eda Mugica\n2002-10-01\nFull Text Available El mundo se encuentra en un proceso de globalizaci\u00f3n econ\u00f3mica sin precedentes. Los avances en tecnolog\u00edas y comunicaciones digitales est\u00e1n creando en algunos sectores una econom\u00eda sin fronteras. Dentro de este contexto,\nEl mundo se encuentra en un proceso de globalizaci\u00f3n econ\u00f3mica sin precedentes. Los avances en tecnolog\u00edas y comunicaciones digitales est\u00e1n creando en algunos sectores una econom\u00eda sin fronteras. Dentro de este contexto,internet es la fuente generadora de una tendencia revolucionaria en el comercio, cuyos efectos son dif\u00edciles de predecir y con el fulminante crecimiento en los \u00faltimos a\u00f1os de la autopista de la informaci\u00f3n, esta nueva forma de intercambiar bienes y servicios a trav\u00e9s de redes inform\u00e1ticas ha generado el denominado comercio electr\u00f3nico, el cual ha ido ganando inter\u00e9s para las empresas. Pero ante esta revoluci\u00f3n del comercio a nivel mundial en Cuba surgen varias interrogantes: \u00bfCuentan las empresas cubanas con la organizaci\u00f3n adecuada para su introducci\u00f3n en el comercio electr\u00f3nico? \u00bfCu\u00e1les son los pasos para introducirse en este nuevo negocio? Uno de los resultados de este trabajo es la elaboraci\u00f3n de un m\u00e9todo pr\u00e1ctico que permite a las empresas interesadas, participar en esta nueva forma de ventas, as\u00ed como lograr el cambio, lo que significa un paso adelante en el aumento de la competitividad de la misma.\n[Comparison of two recombinant hepatitis B vaccines and their interchangeability in Argentine infants Comparaci\u00f3n de dos vacunas recombinantes contra la hepatitis B y su intercambiabilidad en lactantes argentinos](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892004000100006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMiguel Tregnaghi\n2004-01-01\n-B.OBJETIVO: Comparar dos vacunas pedi\u00e1tricas recombinantes contra la hepatitis B -Euvax-B y la vacuna de referencia Engerix-B- en cuanto a su inmunogenicidad y reactogenicidad, e investigar su intercambiabilidad, es decir, si el esquema de vacunaci\u00f3n contra la hepatitis B de tres dosis comenzado con una primera dosis de Engerix-B puede completarse con dos dosis de Euvax-B. M\u00c9TODOS: Este estudio se llev\u00f3 a cabo en la ciudad de C\u00f3rdoba, Argentina, entre marzo de 1999 y febrero de 2000. Se vacun\u00f3 contra la hepatitis B a tres grupos de 100 lactantes argentinos a los 0, 1 y 6 meses de edad. El grupo A recibi\u00f3 tres dosis de Euvax-B; el grupo B, tres dosis de Engerix-B; y el grupo C, una dosis de Engerix-B seguida de dos dosis de Euvax-B. Para evaluar la reactogenicidad se utiliz\u00f3 la informaci\u00f3n brindada por los padres acerca de determinados fen\u00f3menos locales o sist\u00e9micos solicitados por los investigadores que hubieran ocurrido durante los siete d\u00edas posteriores a la vacunaci\u00f3n. Para establecer si eran id\u00e9nticas cl\u00ednicamente las vacunas Euvax-B y Engerix-B se utilizaron las tasas de seroprotecci\u00f3n -es decir, t\u00edtulos de anticuerpos contra el ant\u00edgeno de superficie de hepatitis B (anti-HBsAg > 10 miliunidades internacionales por mililitro (mUI/mL- alcanzados dos meses despu\u00e9s de la tercera dosis. RESULTADOS: La reactogenicidad fue baja en los tres grupos de estudio. A los 5 meses de la segunda dosis (es decir, inmediatamente antes de la tercera dosis, las tasas de seroprotecci\u00f3n fueron 95,9%, 94,7% y 90,2% en los grupos A, B y C, respectivamente. Dos meses despu\u00e9s de la tercera dosis, todos los lactantes se encontraban protegidos, con concentraciones medias geom\u00e9tricas de anti-HBsAg de 2 468,1 mUI/mL en el grupo A, de 1 714,8 mUI/mL en el grupo B y de 2 075,3 mUI/mL en el grupo C. CONCLUSIONES: Las dos vacunas recombinantes contra la hepatitis B estudiadas fueron bien toleradas y altamente inmunog\u00e9nicas. La vacuna Euvax-B fue cl\u00ednicamente id\u00e9ntica (no inferior a la\n[Changes in proHB-EGF expression after functional activation of the immune system cells](http://ukrbiochemjournal.org/2017/12/changes-in-prohb-egf-expression-after-functional-activation-of-the-immune-system-cells.html) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nT. O. Chudina\n2017-12-01\nFull Text Available The level of proHB-EGF expression on J774, Raji, KG-1 cells derived from different types of human and mouse immune system cells under the standard in vitro culture conditions and during functional activation of these cells was investigated. Changes in the proHB-EGF expression on the cell surface were found to depend on the density of cell population, the content of fetal bovine serum in the culture medium, the effect of mitogenic factors \u2013 bacterial lipopolysaccharide, an inactive full-size form of diphtheria toxin (CRM197 and recombinant soluble HB-EGF \u2013 rsHB-EGF. The results obtained are important for the understanding of the functional role of proHB-EGF receptor on the surface of macrophage-like cells and B lymphocytes and indicate the involvement of this receptor in immune response regulation in an organism.\n[Mild Microcytic Anemia in an Infant with a Compound Heterozygosity for Hb C (HBB: c.19G > A) and Hb Osu Christiansborg (HBB: c.157G > A).](https://www.ncbi.nlm.nih.gov/pubmed/27117572)\nBoucher, Maria O; Chui, David H K; Woda, Bruce A; Newburger, Peter E\n2016-06-01\nWe report an infant with a compound heterozygosity for Hb C (HBB: c.19G > A) and Hb Osu Christiansborg (HBB: c.157G > A) and a phenotype of mild microcytic anemia with target cell morphology but without overt hemolysis.\n[Frecuencia fenot\u00edpica y g\u00e9nica de los ant\u00edgenos HLA en una muestra de la poblaci\u00f3n cubana](https://www.openaire.eu/search/publication?articleId=od_______623::95730adb527958be28a6c0f4c800bce7)\nMorera Barrios, Luz M; R, Catalino; Garc\u00eda, Ust\u00e1riz; Garc\u00eda Garc\u00eda, Mar\u00eda A.; D\u00edaz B\u00e1ez, Nelioska; Lam D\u00edaz, Rosa M; Guerreiro Hern\u00e1ndez, Ana M; Hern\u00e1ndez Ram\u00edrez, Porfirio; Ballester Santovenia, Jos\u00e9 M\n2005-01-01\nSe realiz\u00f3 un estudio de la frecuencia fenot\u00edpica y g\u00e9nica de los ant\u00edgenos del sistema principal de histocompatibilidad HLA en personas no relacionadas, supuestamente sanas, tomadas como muestra de la poblaci\u00f3n cubana. Se analiz\u00f3 la distribuci\u00f3n de 87 ant\u00edgenos HLA clase I ( loci A, B y C) y 25 clase II ( loci DR y DQ). Se emplearon las t\u00e9cnicas de microlinfocitotoxicidad (serol\u00f3gica) descrita por Terasaki y modificada por el NIH para los ant\u00edgenos de clase I, y las t\u00e9cnicas de biolog\u00eda mole...\n[Desarrollo y pruebas de campo de la vacuna sint\u00e9tica contra la malaria SPf66](https://revistas.unal.edu.co/index.php/revfacmed/article/view/27236) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMauricio Rojas\n1993-04-01\nFull Text Available De acuerdo a estad\u00edsticas recientes de la Organizaci\u00f3n Mundial de la Salud, se estima que 2100 millones de personas habitan en cerca de 100 pa\u00edses donde la malaria es una enfermedad end\u00e9mica, afectando cerca de 270 millones de individuos anualmente y siendo la causa directa de por 10 menos dos millones de muertos al a\u00f1o, especialmente de ni\u00f1os menores de cinco a\u00f1os de edad. Las medidas de control del vector y del par\u00e1sito con insecticidas y quimioterapia parec\u00edan ser suficientes para la erradicaci\u00f3n, pero a lo largo del tiempo se ha demostrado la poca eficacia de estas medidas, hacienda que el desarrollo de una vacuna sea esencial como un componente efectivo para el control y erradicaci\u00f3n de la malaria especialmente en los pa\u00edses del tercer mundo.\n[An alternative approach to modelling HbA1c trajectories in patients with type 2 diabetes mellitus.](https://www.ncbi.nlm.nih.gov/pubmed/28026908)\nMcEwan, Phil; Bennett, Hayley; Qin, Lei; Bergenheim, Klas; Gordon, Jason; Evans, Marc\n2017-05-01\nTime-dependent HbA1c trajectories in health economic models of type 2 diabetes mellitus (T2DM) are typically informed by the UK Prospective Diabetes Study (UKPDS). However, this approach may not accurately predict HbA1c progression in patients who do not conform to the demographic profile of the original UKPDS cohort. This study aimed to develop an alternative mathematical model (MM) to simulate HbA1c progression in T2DM. A systematic literature review identified studies, published between 2005 and 2015, that reported HbA1c in adult T2DM patients over a minimum duration of 18 months. Pooled data from eligible studies were used to develop an alternative MM equation for HbA1c progression, which was then contrasted with the UKPDS 68 progression equation in illustrative scenarios. A total of 68 studies were eligible for data extraction (mean follow-up time 4.1 years). HbA1c progression was highly heterogeneous across studies, varying with baseline HbA1c, treatment group and patient age. The MM equation was fitted with parameters for mean baseline HbA1c (8.3%), initial change in HbA1c (-0.62%) and upper quartile of maximum observed HbA1c (9.3%). Differences in HbA1c trajectories between the MM and UKPDS approaches altered the timing of therapy escalation in illustrative scenarios. The MM represents an alternative approach to simulate HbA1c trajectories in T2DM models, as UKPDS data may not adequately reflect the heterogeneity of HbA1c profiles observed in clinical studies. However, the choice of approach should ultimately be determined by the characteristics of individual patients under consideration and the clinical face validity of the modelled trajectories. \u00a9 2016 John Wiley & Sons Ltd.\n[NEAR-IR PHOTOMETRIC PROPERTIES OF HB, MSTO, AND SGB FOR METAL POOR GALACTIC GLOBULAR CLUSTERS](http://ocean.kisti.re.kr/downfile/volume/kosss/OJOOBS/2007/v24n1/OJOOBS_2007_v24n1_39.pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJ.-W. Kim\n2007-03-01\nFull Text Available We report photometric features of the HB, MSTO, and SGB for a set of metal-poor Galactic globular clusters on the near-IR CMDs. The magnitude and color of the MSTO and SGB are measured on the fiducial normal points of the CMDs by applying a polynomial fit. The near-IR luminosity functions of horizontal branch stars in the classical second parameter pair M3 and M13 indicate that HB stars in M13 are dominated by hot stars that are rotatively faint in the infrared, whereas HB stars in M3 are brighter than those in M13. The luminosity functions of HB stars in the observed bulge clusters, except for NGC 6717, show a trend that the fainter hot HB stars are dominated in the relatively metal-poor clusters while the relatively metal-rich clusters contain the brighter HB stars. It is suggestive that NGC 6717 would be an extreme example of the second-parameter phenomenon for the bulge globular clusters.\n[[Application of the polymerase chain reaction (PCR) in the diagnosis of Hb S-beta(+)-thalassemia].](https://www.ncbi.nlm.nih.gov/pubmed/1920879)\nHarano, K; Harano, T; Kushida, Y; Ueda, S\n1991-08-01\nIsoelectric focusing of the hemolysate prepared from a two-year-old American black boy with microcytic hypochromia showed the presence of a high percentage (63.3%) of such Hb variant as Hb S, while the levels of Hb A, Hb F and Hb A2 were 20.0%, 12.7%, and 4.0%, respectively. The ratio of the non-alpha-chain to the alpha-chain of the biosynthesized globin chains was 0.49. The variant was identified as Hb S by amino acid analysis of the abnormal peptide (beta T-1) and digestion of DNA amplified by the polymerase chain reaction with enzyme Eco 81 I. This was further confirmed by DNA sequencing. DNA sequencing of a beta-gene without the beta s-mutation revealed a nucleotide change of T to C in the polyadenylation signal sequence AATAAA 3' to the beta-gene, resulting in beta(+)-thalassemia. These results are consistent with the existence of a beta s-gene and a beta(+)-thalassemia gene in trans.\n[Association of plasma PCB levels and HbA1c concentration in Iran.](https://www.ncbi.nlm.nih.gov/pubmed/29881441)\nEftekhari, Sahar; Aminian, Omid; Moinfar, Zeinab; Schettgen, Thomas; Kaifie, Andrea; Felten, Michael; Kraus, Thomas; Esser, Andr\u00e9\n2018-01-01\nThe rapid increase in prevalence of diabetes mellitus over the last decades warrants more attention to the effects of environmental and occupational exposures on glucose metabolism. Our study aimed to assess the association between the plasma levels of various congeners of polychlorinated biphenyls (PCBs) and the serum concentration of glycated haemoglobin (HbA1c). Our study population consisted of 140 Iranian adults from seven different occupational groups and a group of non-occupationally exposed female participants. The plasma concentration of PCBs were determined at the laboratory of occupational toxicology at RWTH Aachen University, Germany. We considered an HbA1c concentration of 5.7% and more as indicating a disturbed glucose metabolism. Logistic regression was used to assess the association between quartiles of concentrations of PCB congeners and serum HbA1c. Participants with an increased HbA1c value had higher plasma levels of PCB 138, 153, 180 and the PCB sum, although this association was statistically not significant. There was no significant difference between the levels of PCB 138, 153, 180, the sum of these congeners, and PCB 118 in their quartiles when comparing with HbA1c concentrations. For our cohort, we could not demonstrate a significant association between PCB and HbA1c concentrations indicating a disturbance of glucose metabolism.\n[HbA1c, systolic blood pressure variability and diabetic retinopathy in Asian type 2 diabetics.](https://www.ncbi.nlm.nih.gov/pubmed/27043025)\nFoo, Valencia; Quah, Joanne; Cheung, Gemmy; Tan, Ngiap Chun; Ma Zar, Kyi Lin; Chan, Choi Mun; Lamoureux, Ecosse; Tien Yin, Wong; Tan, Gavin; Sabanayagam, Charumathi\n2017-02-01\nThe aim of the present study was to examine the association between variability in HbA1c or systolic blood pressure (SBP) and diabetes-specific moderate retinopathy in Asians with type 2 diabetes (T2D). A retrospective study was conducted of 172 cases of moderate diabetic retinopathy (DR) cases and 226 controls without DR, matched for age, sex, and ethnicity. Serial HbA1c and SBP (range 3-6 readings) over the 2 years prior to photographic screening of DR were collected. Intrapersonal mean and SD values for HbA1c (iM-HbA1c and iSD-HbA1c) and SBP (iM-SBP and iSD-SBP) were derived. Moderate DR was assessed from digital retinal photographs and defined as levels >43 using the Early Treatment Diabetic Retinopathy Study scale. Cases of moderate DR had higher iM-HbA1c (8.2 % vs 7.3 %; P = 0.001), iSD-HbA1c (1.22 vs 0.64; P = 0.001), iM-SBP (136.8 vs 129.6 mmHg; P = 0.001) and iSD-SBP (13.3 vs 11.1; P = 0.002) than controls. In the multivariate regression model adjusted for age, gender, ethnicity, duration of diabetes, SBP, and HbA1c, iM-HbA1c and iM-SBP were significantly associated with moderate DR (odds ratio [OR] 1.80, 95 % confidence interval [CI] 1.37-2.36; and OR 1.03, 95 % CI 1.01-1.05, respectively). Neither iSD-HbA1c nor iSD-SBP were associated with moderate DR. When stratified by HbA1c HbA1c levels and SBP, but not their variability, were associated with moderate DR. Among those with good glycemic control, wider variability of SBP is associated with moderate DR. \u00a9 2016 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.\n[Analytical verification and quality assessment of the Tosoh HLC-723GX HbA1c analyzer](http://www.sciencedirect.com/science/article/pii/S2352551716300245) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMarko Ris\n2017-04-01\nFull Text Available Objectives: Ion-exchange high-performance liquid chromatography (IE-HPLC has long been used as a reproducible and versatile analytical tool for HbA1c measurement.In this study, we performed analytical verification and quality assessment of the recently introduced small IE-HPLC Tosoh HLC-723GX HbA1c analyzer, and a comparison of results to immunoassay (IA and capillary electrophoresis (CE. Design and methods: The total imprecision of Tosoh HLC-723GX was verified according to CLSI EP15-A2 protocol using commercial control materials (C-QC and pooled human whole blood samples (HWB. The Sigma metric was used for the evaluation of quality targets. HbA1c results were compared to automated CE (MiniCap Flex Piercing, Sebia, France and IA (Tina-quant HbA1c Gen 2, Cobas Integra 400+, Roche Diagnostics, USA procedures. Results: The total imprecision of Tosoh HLC-723GX-HbA1c for IFCC(mmol/mol and NGSP(% units was: 1.91/1.25% (HbA1c=31\u00c2 mmol/mol/5.0% and 0.51/0.63% (HbA1c=84\u00c2 mmol/mol/9.8% for C-QC, and 0.39/0.2% (HbA1c=47\u00c2 mmol/mol/6.5% and 0.77/0.46% (HbA1c=94\u00c2 mmol/mol/10.8% in HWB samples, respectively. Bland-Altman analysis did not reveal any deviation of the results between Tosoh HLC-723GX and CE: mean difference 0.0% (95%CI: \u00e20.02927 to 0.02653%, while the mean HbA1c difference against IA was \u00e20.07% (95%CI: \u00e20.1039 to \u00e20.02765. At the selected HbA1c clinical decision level (48\u00c2 mmol/mol/6,5%, six sigma analysis gave \u00cf value of 3.91, within a desirable classification of performance. Conclusion: The analytical performance of the Tosoh HLC-723GX complies with the rigorous quality criteria for clinical use of HbA1c, with the results comparable to the CE procedure. Tosoh HLC-723GX provides a plausible analytical choice for reliable HbA1c measurement in low-volume laboratories. Keywords: HbA1c, Quality targets, Six sigma, Tosoh HLC-723GX analyzer\n[Novel interactions of two \u03b1-Hb variants with SEA deletion \u03b10-thalassemia: hematological and molecular analyses.](https://www.ncbi.nlm.nih.gov/pubmed/28945175)\nSrivorakun, Hataichanok; Singha, Kritsada; Fucharoen, Goonnapa; Fucharoen, Supan\n2018-04-01\nTo report the hematological and molecular features as well as diagnostic aspects of the hitherto un-described interactions of two rare \u03b1-globin chain variants with \u03b1 0 -thalassemia commonly found among Southeast Asian populations. The study was done on two adult Thai patients (P1 and P2) who had hypochromic microcytic anemia. Hb analysis was carried out using high performance liquid chromatography (HPLC) and capillary electrophoresis (CE). Mutations were identified by PCR and related techniques. Hb analysis of P1 using HPLC showed a normal Hb pattern, but CE demonstrated an abnormal peak at zone 7. DNA sequencing identified a CCG-CTG mutation at codon 95 of the \u03b12 globin gene corresponding to the Hb G-Georgia [\u03b195(G2)Pro \u2192 Leu(\u03b12)] previously undescribed in the Thai population. In contrast, Hb analysis of P2 demonstrated an abnormal peak not fully separated from Hb A on HPLC, but not on CE. DNA analysis identified the rarely described Hb Nakhon Ratchasima [\u03b163(E12)Ala \u2192 Val(\u03b12)] mutation. Routine DNA analysis detected the SEA deletion \u03b1 0 -thalassemia in trans to the Hb variants in both cases. Hematological parameters were compared with those of patients with compound heterozygote for other \u03b1-globin variants and \u03b1 0 -thalassemia previously documented. Identification of the patients confirmed that interaction of these rare Hb variants with \u03b1 0 -thalassemia does not lead to the Hb H disease. Differentiation of these two Hb variants from other clinically relevant hemoglobinopathies in a routine setting is, however, necessary. This can be accomplished using a combined Hb-HPLC and CE analysis followed by PCR-RFLP assays.\n[HB-Line Dissolution of Glovebox Floor Sweepings](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=30026502) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nGray, J.H.\n1998-02-01\nTwo candidate flowsheets for dissolving glovebox floor sweepings in the HB-Line Phase I geometrically favorable dissolver have been developed.Dissolving conditions tested and modified during the laboratory program were based on the current processing scheme for dissolving high-fired Pu-238 oxide in HB-Line. Subsequent adjustments made to the HB-Line flowsheet reflected differences in the dissolution behavior between high-fired Pu-238 oxide and the MgO sand/PuF 4 /PuO 2 mixture in glovebox floor sweepings. Although both candidate flowsheets involved two separate dissolving steps and resulted incomplete dissolution of all solids, the one selected for use in HB-Line will require fewer processing operations and resembles the initial flowsheet proposed for dissolving sand, slag, and crucible material in F-Canyon dissolvers. Complete dissolution of glovebox floor sweepings was accomplished in the laboratory by initially dissolving between 55 and 65 degree in a 14 molar nitric acid solution. Under these conditions, partial dissolution of PuF 4 and complete dissolution of PuO 2 and MgO sand were achieved in less than one hour. The presence of free fluoride in solution,uncomplexed by aluminum, was necessary for complete dissolution of the PuO 2 .The remaining PuF 4 dissolved following addition of aluminum nitrate nonahydrate (ANN) to complex the fluoride and heating between 75 and 85 degree C for an additional hour. Precipitation of magnesium and/or aluminum nitrates could occur before, during, and after transfer of product solutions. Both dilution and/or product solution temperature controls may be necessary to prevent precipitation of these salts. Corrosion of the dissolver should not be an issue during these dissolving operations. Corrosion is minimized when dissolving at 55-65 degree C for one to three hours at a maximum uncomplexed free fluoride concentration of 0.07 molar and by dissolving at 75-85 degree C at a one to one aluminum to fluoride mole ratio for another\n[Association of fibrinogen with HbA1C in diabetic foot ulcer](http://adsabs.harvard.edu/abs/2018E%26ES..125a2165P)\nPase, M. A.; Gatot, D.; Lindarto, D.\n2018-03-01\nFibrinogen is one of the inflammatory markers of vascular changes and endothelial dysfunction in diabetic patients. The aim of this study to associate serum fibrinogen levels with HbA1C in diabetic foot ulcer (DFU). This study was cross-sectional and retrospective in DFU patients from January to July 2017 in Haji Adam Malik Central General Hospital. The patients enrolled in the study were T2DM with DFU as a complication. The grading of DFU was evaluated according to the Wagner\u2019s Classification. Serum fibrinogen level, HbA1C and ankle-brachial index (ABI) were carried out directly in the patients. Fibrinogen serum levels were found significantly with HbA1C (P=0.001, r=0.387) and ABI (P=0.008, r=-0.454). Fibrinogen serum levels in DFU patients were positively correlated with HbA1C and significantly higher in patients with poor glycemic control.\n[Trajectories of HbA1c Levels in Children and Youth with Type 1 Diabetes](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4183551)\nPinhas-Hamiel, Orit; Hamiel, Uri; Boyko, Valentina; Graph-Barel, Chana; Reichman, Brian; Lerner-Geva, Liat\n2014-01-01\nPurpose To illustrate the distribution of Hemoglobin A1c (HbA1c) levels according to age and gender among children, adolescents and youth with type 1 diabetes (T1DM). Methods Consecutive HbA1c measurements of 349 patients, aged 2 to 30 years with T1DM were obtained from 1995 through 2010. Measurement from patients diagnosed with celiac disease (n = 20), eating disorders (n = 41) and hemoglobinopathy (n = 1) were excluded. The study sample comprised 4815 measurements of HbA1c from 287 patients. Regression percentiles of HbA1c were calculated as a function of age and gender by the quantile regression method using the SAS procedure QUANTREG. Results Crude percentiles of HbA1c as a function of age and gender, and the modeled curves produced using quantile regression showed good concordance. The curves show a decline in HbA1c levels from age 2 to 4 years at each percentile. Thereafter, there is a gradual increase during the prepubertal years with a peak at ages 12 to 14 years. HbA1c levels subsequently decline to the lowest values in the third decade. Curves of females and males followed closely, with females having HbA1c levels about 0.1% (1.1 mmol/mol) higher in the 25th 50th and 75th percentiles. Conclusion We constructed age-specific distribution curves for HbA1c levels for patients with T1DM. These percentiles may be used to demonstrate the individual patient's measurements longitudinally compared with age-matched patients. PMID:25275650\n[Empirically establishing blood glucose targets to achieve HbA1c goals.](https://www.ncbi.nlm.nih.gov/pubmed/24513588)\nWei, Nancy; Zheng, Hui; Nathan, David M\n2014-04-01\nOBJECTIVE To determine the average fasting, postprandial, and bedtime self-monitored blood glucose (SMBG) concentrations associated with specified HbA1c levels using data from the A1c-Derived Average Glucose (ADAG) study. RESEARCH DESIGN AND METHODS The ADAG study was a multicenter observational study that used continuous glucose monitoring and SMBG testing to determine the relationship between mean average glucose and HbA1c. We used the SMBG data from 470 of the ADAG study participants (237 with type 1 diabetes and 147 with type 2 diabetes) to determine the average fasting, premeal, 90-min postmeal, and bedtime blood glucose (BG) for predefined target HbA1c groups between 5.5 and 8.5% (37-69 mmol/mol). t Tests were used to compare mean BG values between type 1 and type 2 diabetes groups. RESULTS The average fasting BG needed to achieve predefined HbA1c target levels of 5.5-6.49% (37-47 mmol/mol), 6.5-6.99% (48-52 mmol/mol), 7.0-7.49% (52-58 mmol/mol), 7.5-7.99% (58-64 mmol/mol), and 8.0-8.5% (64-69 mmol/mol) were 122 mg/dL with 95% CI 117-127, 142 mg/dL (135-150), 152 mg/dL (143-162), 167 mg/dL (157-177), and 178 mg/dL (164-192), respectively. Postmeal BG to achieve the HbA1c level of 6.5-6.99% (48-52 mmol/mol) and 7.0-7.49% (52-58 mmol/mol) were 139 mg/dL (134-144) and 152 mg/dL (147-157), respectively. Bedtime BG was 153 mg/dL (145-161) and 177 mg/dL (166-188), respectively. CONCLUSIONS We have determined the average BG at premeal, postmeal, and bedtime to achieve a variety of HbA1c targets. These results, based on empirical data, will help patients and providers set realistic day-to-day SMBG targets to achieve individualized HbA1c goals.\n[Perspectivas para el desarrollo de vacunas e inmunoterapia contra c\u00e1ncer cervicouterino Perspectives for vaccines and immunotherapy against cervical cancer](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36341998000100006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLILIANA GUZM\u00c1N-ROJAS\n1998-01-01\nFull Text Available El c\u00e1ncer cervicouterino representa un grave problema de salud p\u00fablica, debido a la asociaci\u00f3n de la neoplasia con el virus del papiloma humano; actualmente se realizan estudios usando estrategias dirigidas a combatir este pat\u00f3geno, mediante vacunas, que podr\u00edan ser de gran utilidad para el control de la progresi\u00f3n de la enfermedad. El estudio tanto de la inmunolog\u00eda humoral como celular ha servido para el desarrollo de vacunas. As\u00ed, la utilizaci\u00f3n de part\u00edculas virales sint\u00e9ticas para el estudio de anticuerpos neutralizantes y el uso de prote\u00ednas tempranas virales, entre otras, para la inducci\u00f3n de inmunidad mediada por c\u00e9lulas, han sido la pauta para realizar estudios que dirijan la respuesta inmune para prevenir la infecci\u00f3n celular tanto hacia c\u00e9lulas infectadas no transformadas como hacia c\u00e9lulas transformadas viralmente con resultados favorables.Cervical cancer represents a severe public health problem and has been associated to the presence of human papillomavirus. Strategies are presently being tested which target the virus to attempt to control disease progress. Studies on the humoral and cell-mediated immunity of the papillomavirus infection have been useful in the development of a vaccine. Synthetic virus-like particles have been validated as vaccine against several animal papillomaviruses and used to map the seroepidemiology of the human papillomavirus infection, and define neutralizing antibodies. Induction of cell-mediated immunity to HPV early proteins is bound to become a therapeutic approach to HPV infections. Recent advances have centered on directing the immune response to prevent infection, to virus-infected cells and to virally transformed cells, with favourable results.\n[Decontamination and decommissioning of the MTR [Materials Testing Reactor]-603 HB-2 cubicle](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=19047111) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nSmith, D.L.\n1987-10-01\nThis paper describes the decontamination and decommissioning (D and D) of the MTR-603 HB-2 cubicle located at the Idaho National Engineering Laboratory (INEL). The HB-2 cubicle became radioactively contaminated during out-of-pile circulating water loop experiments conducted in the Materials Testing Reactor in the 1950s and 1960s. This paper describes work performed to accomplish the D and D objectives of reducing the high radiation fields caused by contamination inside the cubicle, preventing future contamination spread, and making about 1400 ft 2 of floor space available for reuse. Decommissioning of the HB-2 cubicle consisted of total dismantlement of the cubicle and its contents and was performed without disrupting ongoing laboratory work being conducted in areas surrounding the HB-2 cubicle. 3 refs., 7 figs., 4 tabs\n[B\u00fasqueda e identificaci\u00f3n de nuevos candidatos a vacuna contra la malaria producida por Plasmodium vivax](https://revistas.unal.edu.co/index.php/actabiol/article/view/27394) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAndr\u00e9s Mauricio Pinz\u00f3n Velasco\n2004-07-01\nbioinform\u00e1ticas, estableciendo diversos patrones de alineamiento, as\u00ed como niveles de similitud no menores al 40%. A pesar de un riguroso enmascaramiento tanto de las secuencias prot\u00e9icas de P. falciparum, como del genoma de P. vivax, en este \u00faltimo fue evidente una alta presencia de regiones repetitivas que no fueron enmascaradas por ninguna de las fuentes de ADN repetitivo presente en la base de datos de REPBASE, lo cual lleva a pensar que dichas regiones pueden ser espec\u00edficas de este tipo de organismos. Finalmente se encontraron coincidencias entre 76 secuencias proteicas con actividad antig\u00e9nica de P. falciparum y el genoma hasta ahora secuenciado de P. vivax, que cumpl\u00edan con los requisitos m\u00ednimos para establecer los niveles de coincidencia, entre las cuales se determin\u00f3 que cuatro constituyen importantes candidatos a una vacuna contra la malaria producida por P. vivax.\n[Fetal Anemia and Hydrops Fetalis Associated with Homozygous Hb Constant Spring (HBA2: c.427T > C).](https://www.ncbi.nlm.nih.gov/pubmed/26757782)\nHe, Yi; Zhao, Ying; Lou, Ji-Wu; Liu, Yan-Hui; Li, Dong-Zhi\n2016-01-01\nHb Constant Spring (Hb CS, HBA2: c.427T > C) is a common nondeletional \u03b1-thalassemia (\u03b1-thal) that results from a nucleotide substitution at the termination codon of the \u03b12-globin gene. Homozygosity for Hb CS (\u03b1(CS)\u03b1/\u03b1(CS)\u03b1) is relatively rare, and generally characterized with mild hemolytic anemia, jaundice, and splenomegaly. In this report we present a fetus with cardiomegaly, pericardial effusion, enlarged placenta and increased middle cerebral artery-peak systolic velocity (MCA-PSV) at 24 weeks' gestation. Fetal blood sampling revealed the severe anemia [hemoglobin (Hb) level being 4.8 g/dL] and Hb H (\u03b24) disease-like hematological findings with Hb Bart's (\u03b34) level of 17.9%. DNA sequencing of the \u03b1-globin genes found that both partners were Hb CS carriers and the fetus was an Hb CS homozygote. Therefore, this was a rare case of homozygous Hb CS which demonstrated an unusual and serious anemia and hydrops fetalis in utero.\n[HbA1c Identifies Subjects With Prediabetes and Subclinical Left Ventricular Diastolic Dysfunction.](https://www.ncbi.nlm.nih.gov/pubmed/28973588)\nDi Pino, Antonino; Mangiafico, Sarah; Urbano, Francesca; Scicali, Roberto; Scandura, Salvatore; D'Agate, Veronica; Piro, Salvatore; Tamburino, Corrado; Purrello, Francesco; Rabuazzo, Agata Maria\n2017-10-01\nPrediabetes is associated with subclinical cardiac changes associated with heart failure development. We investigated diastolic function and its association with markers of glycation and inflammation related to cardiovascular disease in patients with prediabetes. We focused on individuals with prediabetes identified only by glycated hemoglobin A1c [HbA1c; 5.7% to 6.4% and normal fasting glucose (NFG) and normal glucose tolerance (NGT) after an oral glucose tolerance test (OGTT)]. Cross-sectional study. Departments of Clinical and Experimental Medicine and Cardiology, University of Catania, Catania, Italy. HbA1c, OGTT, Doppler echocardiography, soluble receptor for advanced glycation end products (sRAGEs), and endogenous secretory RAGE (esRAGE) were evaluated. We recruited 167 subjects with NFG/NGT who were stratified according to HbA1c level: controls (HbA1c prediabetes (HbA1c 5.7% to 6.4%). Patients with HbA1c prediabetes (n = 106) showed a lower peak mitral inflow in early diastole (E wave) to late diastolic atrial filling velocity (A wave) ratio (E/A ratio) than controls (n = 61) (1.10 \u00b1 0.24 vs 1.18 \u00b1 0.23; P prediabetes exhibited subclinical cardiac alterations associated with sRAGE, esRAGE, and HbA1c. These subjects would not have been classified as having prediabetes on the basis of fasting glycemia or post-OGTT values. Copyright \u00a9 2017 Endocrine Society\n[Dr. Alberto Germ\u00e1n Mora Docampo: ejemplo de integridad y dedicaci\u00f3n al servicio de la medicina cubana](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192015000200020&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nNatacha Mora Pacheco\n2015-02-01\nFull Text Available En el presente trabajo se rese\u00f1an los aspectos m\u00e1s significativos de la vida y obra del Dr. Alberto Germ\u00e1n Mora Docampo y se resaltan los elementos m\u00e1s importantes de su etapa estudiantil, especialmente de la universitaria, donde se destac\u00f3 por su disciplina, constante estudio, modestia y humanismo, a la vez que descubri\u00f3 su pasi\u00f3n por la cirug\u00eda y decidi\u00f3 luchar desde entonces por la justicia social y la Revoluci\u00f3n. Sus cualidades humanas y la destacada participaci\u00f3n en las organizaciones pol\u00edticas y de masas, as\u00ed como los numerosos reconocimientos, premios, distinciones y condecoraciones que le fueron otorgados, lo concept\u00faan como paradigma de la medicina cubana\n[Los precios de la carne vacuna en Buenos Aires colonial. Una interpelaci\u00f3n historiogr\u00e1fica e hist\u00f3rica](https://revistas.utadeo.edu.co/index.php/TyE/article/view/945/984) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAndrea Dupuy\n2014-12-01\nFull Text Available En el \u00e1mbito de los estudios de mercado, los precios constituyen los principales indicadores del comportamiento de la econom\u00eda, aun los de Antiguo R\u00e9gimen. El objetivo del presente trabajo es abordar el an\u00e1lisis de los precios de la carne vacuna de la ciudad de Buenos Aires colonial partiendo de la idea de que este mercado, al igual que los de las distintas ciudades hispanoamericanas, present\u00f3 a lo largo de la etapa colonial una regularidad predominante. Y aun cuando estuvo atravesado por situaciones cr\u00edticas de escasez, estos factores no lograron modificar sustancialmente, desde una mirada de largo plazo, las caracter\u00edsticas del mismo.\n[Decontamination and decommissioning of the MTR-603 HB-2 cubicle. Final report](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=17060275) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nSmith, D.L.\n1985-12-01\nThis report describes the decontamination and decommissioning (D and D) of the MTR-603 HB-2 cubicle located at the Idaho National Engineering Laboratory (INEL). The HB-2 cubicle became radioactively contaminated during out-of-pile circulating water loop experiments conducted in the Materials Testing Reactor in the 1950s and 1960s. This report describes work performed to accomplish the D and D objectives of reducing the high radiation fields caused by contamination inside the cubicle, preventing future contamination spread, and making about 1400 ft 2 of floor space available for reuse. D and D of the HB-2 cubicle consisted of total dismantlement of the cubicle and its contents\n[HbA1c and the Prediction of Type 2 Diabetes in Children and Adults.](https://www.ncbi.nlm.nih.gov/pubmed/27810987)\nVijayakumar, Pavithra; Nelson, Robert G; Hanson, Robert L; Knowler, William C; Sinha, Madhumita\n2017-01-01\nLong-term data validating glycated hemoglobin (HbA 1c ) in assessing the risk of type 2 diabetes in children are limited. HbA 1c , fasting plasma glucose (FPG), and 2-h postload plasma glucose (2hPG) concentrations were measured in a longitudinal study of American Indians to determine their utility in predicting incident diabetes, all of which is thought to be type 2 in this population. Incident diabetes (FPG \u2265126 mg/dL [7.0 mmol/L], 2hPG \u2265200 mg/dL [11.1 mmol/L], HbA 1c \u22656.5% [8 mmol/mol], or clinical diagnosis) was determined in 2,095 children without diabetes ages 10-19 years monitored through age 39, and in 2,005 adults ages 20-39 monitored through age 59. Areas under the receiver operating characteristic (ROC) curve for HbA 1c , FPG, and 2hPG in predicting diabetes within 10 years were compared. During long-term follow-up of children and adolescents who did not initially have diabetes, the incidence rate of subsequent diabetes was fourfold (in boys) as high and more than sevenfold (in girls) as high in those with HbA 1c \u22655.7% as in those with HbA 1c \u22645.3%-greater rate ratios than experienced by adults in the same HbA 1c categories. Analyses of ROCs revealed no significant differences between HbA 1c , FPG, and 2hPG in sensitivity and specificity for identifying children and adolescents who later developed diabetes. HbA 1c is a useful predictor of diabetes risk in children and can be used to identify prediabetes in children with other type 2 diabetes risk factors with the same predictive value as FPG and 2hPG. \u00a9 2017 by the American Diabetes Association.\n[Normas farmacol\u00f3gicas cubanas: desarrollo e impacto](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75152003000200006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nCeleste Aurora S\u00e1nchez Gonz\u00e1lez\n2003-08-01\nFull Text Available Se describi\u00f3 la importancia como instrumento de consulta, del compendio nacional de sustancias activas y asociaciones de uso farmac\u00e9utico industrial aceptadas y rechazadas en Cuba. Se identific\u00f3 la informaci\u00f3n de seguridad para el uso racional que incorpora la clasificaci\u00f3n terap\u00e9utica adoptada y la estructura organizativa de estas Normas Farmacol\u00f3gicas Cubanas (NFC. Se cuantific\u00f3 su aplicaci\u00f3n por el Centro para el Control de la Calidad de los Medicamentos (CECMED, usuarios cubanos y extranjeros durante el per\u00edodo 1996 al 2000, para determinar grados de novedad y caracterizaci\u00f3n terap\u00e9utica, mediante el an\u00e1lisis de Ensayos Cl\u00ednicos Autorizados y Registros de Medicamentos otorgados. Se dimension\u00f3 el impacto en la Reglamentaci\u00f3n Farmac\u00e9utica Nacional y la interacci\u00f3n con otras regulaciones. Se identificaron las perspectivas de desarrollo en su alcance y contenido. Se concluy\u00f3 la utilidad de las NFC en la adecuada clasificaci\u00f3n del grado de novedad de los productos, el \u00e1gil y preciso manejo y evaluaci\u00f3n de tr\u00e1mites, as\u00ed como en la caracterizaci\u00f3n del enfoque terap\u00e9utico.The importance as a consultation tool of the National Compendium of active ingredients for industrial pharmaceutical use and its combinations that are accepted and refused in Cuba was described. The safety information for their rational use that includes the adopted therapeutic classification and the organizational structuring of the Cuban Pharmacological Standards were identified. Its application was quantified by the Center for Drug Quality Control (CECMED , by national and foreign users in the period 1996-2000, in order to identify the degree of novelty of products and the therapeutical characterization by analysing the authorised clinical trials and the register of provided drugs. The impact on the National Pharmaceutical Regulation, and the interrelation with other regulations were shown. The scope and contents of the development prospects were stated\n[Impact of Disease Management Programs on HbA1c Values in Type 2 Diabetes Patients in Germany.](https://www.ncbi.nlm.nih.gov/pubmed/27246670)\nKostev, Karel; Rockel, Timo; Jacob, Louis\n2017-01-01\nThe aim was to analyze the impact of disease management programs on HbA1c values in type 2 diabetes mellitus (T2DM) patients in Germany. This study included 9017 patients followed in disease management programs (DMPs) who started an antihyperglycemic treatment upon inclusion in a DMP. Standard care (SC) patients were included after individual matching (1:1) to DMP cases based on age, gender, physician (diabetologist versus nondiabetologist care), HbA1c values at baseline, and index year. The main outcome was the share of patients with HbA1c HbA1c level as a dependent variable and the potential predictor (DMP versus SC). The mean age was 64.3 years and 54.7% of the patients were men. The mean HbA1c level at baseline was equal to 8.7%. In diabetologist practices, 64.7% of DMP patients and 55.1% of SC patients had HbA1c levels HbA1c levels HbA1c levels HbA1c levels HbA1c levels lower than 7.5% or 6.5% after 6 months of therapy in both diabetologist and general care practices. The present study indicates that the enrollment of T2DM patients in DMPs has a positive impact on HbA1c values in Germany.\n[TGF{beta} induces proHB-EGF shedding and EGFR transactivation through ADAM activation in gastric cancer cells](http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=22202894) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nEbi, Masahide [Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya (Japan); Kataoka, Hiromi, E-mail: hkataoka@med.nagoya-cu.ac.jp [Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya (Japan); Shimura, Takaya; Kubota, Eiji; Hirata, Yoshikazu; Mizushima, Takashi; Mizoshita, Tsutomu; Tanaka, Mamoru; Mabuchi, Motoshi; Tsukamoto, Hironobu; Tanida, Satoshi; Kamiya, Takeshi [Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya (Japan); Higashiyama, Shigeki [Department of Biochemistry and Molecular Genetics, Ehime University Graduate School of Medicine, Ehime (Japan); Joh, Takashi [Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya (Japan)\n2010-11-19\nResearch highlights: {yields} TGF{beta} induces EGFR transactivation through proHB-EGF shedding by activated ADAM members in gastric cancer cells. {yields} TGF{beta} induces nuclear translocation of HB-EGF-CTF cleaved by ADAM members. {yields} TGF{beta} enhances cell growth by EGFR transactivation and HB-EGF-CTF nuclear translocation and ADAM inhibitors block these effects. {yields} Silencing of ADAM17 also blocks EGFR transactivation, HB-EGF-CTF nuclear translocation and cancer cell growth by TGF{beta}. {yields} ADAM17 may play a crucial role in this TGF{beta}-HB-EGF signal transduction. -- Abstract: Background and aims: Transforming growth factor-beta (TGF{beta}) is known to potently inhibit cell growth. Loss of responsiveness to TGF{beta} inhibition on cell growth is a hallmark of many types of cancer, yet its mechanism is not fully understood. Membrane-anchored heparin-binding EGF-like growth factor (proHB-EGF) ectodomain is cleaved by a disintegrin and metalloproteinase (ADAM) members and is implicated in epidermal growth factor receptor (EGFR) transactivation. Recently, nuclear translocation of the C-terminal fragment (CTF) of pro-HB-EGF was found to induce cell growth. We investigated the association between TGF{beta} and HB-EGF signal transduction via ADAM activation. Materials and methods: The CCK-8 assay in two gastric cancer cell lines was used to determine the effect for cell growth by TGF{beta}. The effect of two ADAM inhibitors was also evaluated. Induction of EGFR phosphorylation by TGF{beta} was analyzed and the effect of the ADAM inhibitors was also examined. Nuclear translocation of HB-EGF-CTF by shedding through ADAM activated by TGF{beta} was also analyzed. EGFR transactivation, HB-EGF-CTF nuclear translocation, and cell growth were examined under the condition of ADAM17 knockdown. Result: TGF{beta}-induced EGFR phosphorylation of which ADAM inhibitors were able to inhibit. TGF{beta} induced shedding of proHB-EGF allowing HB-EGF-CTF to\n[Significance of HbA1c and its measurement in the diagnosis of diabetes mellitus: US experience.](https://www.ncbi.nlm.nih.gov/pubmed/25349480)\nJuarez, Deborah Taira; Demaris, Kendra M; Goo, Roy; Mnatzaganian, Christina Louise; Wong Smith, Helen\n2014-01-01\nThe 2014 American Diabetes Association guidelines denote four means of diagnosing diabetes. The first of these is a glycosylated hemoglobin (HbA1c) >6.5%. This literature review summarizes studies (n=47) in the USA examining the significance, strengths, and limitations of using HbA1c as a diagnostic tool for diabetes, relative to other available means. Due to the relatively recent adoption of HbA1c as a diabetes mellitus diagnostic tool, a hybrid systematic, truncated review of the literature was implemented. Based on these studies, we conclude that HbA1c screening for diabetes has been found to be convenient and effective in diagnosing diabetes. HbA1c screening is particularly helpful in community-based and acute care settings where tests requiring fasting are not practical. Using HbA1c to diagnose diabetes also has some limitations. For instance, HbA1c testing may underestimate the prevalence of diabetes, particularly among whites. Because this bias differs by racial group, prevalence and resulting estimates of health disparities based on HbA1c screening differ from those based on other methods of diagnosis. In addition, existing evidence suggests that HbA1c screening may not be valid in certain subgroups, such as children, women with gestational diabetes, patients with human immunodeficiency virus, and those with prediabetes. Further guidelines are needed to clarify the appropriate use of HbA1c screening in these populations.\n[Las estrategias de legitimaci\u00f3n de la derecha hispano-cubana para con la Espa\u00f1a franquista: la acci\u00f3n y el discurso (1936-1939)](https://www.openaire.eu/search/publication?articleId=rcubrevistes::9dfff61308824eba56d96a517f753a50)\nFigueredo Cabrera, Katia\n2015-01-01\nEste trabajo analiza el desarrollo asociativo de las diferentes microfracciones de la derecha hispano-cubana vinculadas con la guerra civil espa\u00f1ola. En igual sentido recrea el impacto del Decreto de Unificaci\u00f3n para el grupo conservador residente en la mayor de las Antillas y el surgimiento, por consiguiente, de la FET y de las JONS de Cuba, una nueva forma de sociabilidad pol\u00edtica que activ\u00f3 las actividades pro franquistas en la isla hasta el final de la contienda. El art\u00edculo cierra con un...\n[Las estrategias de legitimaci\u00f3n de la derecha hispano-cubana para con la Espa\u00f1a franquista: la acci\u00f3n y el discurso (1936-1939)](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::ba3b6519697861405c1331692741b042)\nFigueredo Cabrera, Katia\n2011-01-01\nEste trabajo analiza el desarrollo asociativo de las diferentes microfracciones de la derecha hispano-cubana vinculadas con la guerra civil espa\u00f1ola. En igual sentido recrea el impacto del Decreto de Unificaci\u00f3n para el grupo conservador residente en la mayor de las Antillas y el surgimiento, por consiguiente, de la FET y de las JONS de Cuba, una nueva forma de sociabilidad pol\u00edtica que activ\u00f3 las actividades pro franquistas en la isla hasta el final de la contienda. El art\u00edculo cierra con un...\n[REFLEXIONES EPISTEMOL\u00d3GICAS QUE SUSTENTAN EN ABORDAJE DID\u00c1CTICO DE LA DISCIPLINA SOCIAL DESDE LA EDUCACI\u00d3N C\u00cdVICA EN LA EDUCACI\u00d3N SECUNDARIA B\u00c1SICA CUBANA](https://www.openaire.eu/search/publication?articleId=revistmanabi::7fbb7e71699112f7661a712545458c8b)\nWilson Rodr\u00edguez, Arianne; Fern\u00e1ndez Naranjo, Roberto\n2017-01-01\nEl art\u00edculo aborda las principales concepciones epistemol\u00f3gicas que sustentan el abordaje did\u00e1ctico de la disciplina social, en el contexto del proceso de ense\u00f1anza aprendizaje de la Educaci\u00f3n C\u00edvica, en la Educaci\u00f3n Secundaria B\u00e1sica Cubana, ello constituye un reclamo social, para contrarrestar las diferentes manifestaciones de indisciplinas sociales que tienen lugar en el contexto cubano contempor\u00e1neo. Al ser la Educaci\u00f3n C\u00edvica un espacio propicio para la formaci\u00f3n de la disciplina social ...\n[Bioequivalencia de una formulaci\u00f3n cubana de carbamazepina con el producto l\u00edder](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75152009000100006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAlejandro Sa\u00fal Padr\u00f3n Yaquis\n2009-04-01\nFull Text Available Se demostr\u00f3 la intercambiabilidad terap\u00e9utica mediante un estudio de bioequivalencia en 25 voluntarios sanos de una formulaci\u00f3n cubana de carbamazepina de 200 mg con respecto al producto innovador (Tegretol\u00ae, en condiciones de administraci\u00f3n a dosis \u00fanica; el dise\u00f1o experimental fue cruzado a doble ciegas y aleatorizado; el periodo de lavado fue de 15 d\u00edas. Las extracciones para la obtenci\u00f3n del plasma, se realizaron a las 0; 0,5; 1; 1,5; 2; 3; 4; 6; 8; 10; 12; 16; 20; 24; 48; 72; 96 y 120 h. Para el an\u00e1lisis se emple\u00f3 un m\u00e9todo anal\u00edtico por cromatograf\u00eda l\u00edquida de alta eficiencia, isocr\u00e1tico en fase reversa con detecci\u00f3n ultravioleta. Se estimaron mediante t\u00e9cnicas \"no compartimentales\" los par\u00e1metros farmacocin\u00e9ticos (AUC0-t, AUCt-\u00a5, Cmax, Tmax y T1/2 representativos de la biodisponibilidad en magnitud y velocidad. Sobre la base de los resultados estad\u00edsticos, ambas formulaciones resultaron bioequivalentes.\n[Influence of Erythropoiesis-Stimulating Agents on HbA1c and Fructosamine in Patients with Haemodialysis.](https://www.ncbi.nlm.nih.gov/pubmed/28407666)\nRasche, Franz Maximilian; Ebert, Thomas; Beckmann, Julia; Busch, Volker; Barinka, Filip; Rasche, Wilma Gertrud; Lindner, Tom H; Schneider, Jochen G; Schiekofer, Stephan\n2017-06-01\nHbA1c is the most accepted laboratory parameter for the long term observation of glucose control. There is still much of a debate about the use of HbA1c as a metabolic indicator in diabetic patients (DM) on haemodialysis (HD) and erythropoiesis-stimulating agent (ESA) therapy because of the altered erythrocyte turn over in patients with chronic kidney disease and haemodialysis (CKD5D). In 102 CKD5 patients with and without diabetes mellitus, we examined the dose dependent variability in HbA1c and fructosamine levels under haemodialysis and treated with epoetin \u03b1 (n=48) and a new generation agent with continuous stimulation of methoxy polyethylene glycol epoetin beta (C.E.R.A.; n=54). HbA1c levels were affected by therapy with ESA treatments. ESA dose was inversely correlated with HbA1c and an escalation of 10.000 IU per week induced an estimated decrease of HbA1c of 0.6 percent. In addition, the increase of reticulocyte number as a marker for erythropoiesis was significantly inversely correlated with the increase of \u0394HbA1c. ESA treatments had no such effect on the alternative metabolic parameter fructosamine. When compared, both therapeutic agents had comparable success in attaining haemoglobin (Hb) target values. C.E.R.A. showed better correlation and was more effective over a longer dose interval. Our results show that HbA1c levels in patients should be carefully interpreted based on interfering factors. Nevertheless, HbA1c is currently the most consistent parameter for use ascertaining metabolic status of patients suffering from diabetes mellitus. \u00a9 Georg Thieme Verlag KG Stuttgart \u00b7 New York.\n[Change in Sedentary Time, Physical Activity, Bodyweight, and HbA1c in High-Risk Adults.](https://www.ncbi.nlm.nih.gov/pubmed/28121795)\nMcCarthy, Matthew; Edwardson, Charlotte L; Davies, Melanie J; Henson, Joseph; Gray, Laura; Khunti, Kamlesh; Yates, Thomas\n2017-06-01\nIn recent years, there has been a migration toward the use of glycated hemoglobin (HbA1c) in determining glycemic control. This study aimed to quantify the associations between changes in body weight, sedentary time, and moderate to vigorous physical activity (MVPA) time with HbA1c levels for a 3-yr period among adults at high risk of type 2 diabetes. This study reports baseline and 3-yr follow-up data from the Walking Away from Type 2 Diabetes study. ActiGraph GT3X accelerometers captured sedentary time and MVPA. Linear regression examined the independent associations of changes in sedentary time, MVPA, and body weight with HbA1c between baseline and 3-yr follow-up. The sample composed of 489 participants (mean age = 64.2 \u00b1 7.3 yr, body mass index = 31.7 \u00b1 5.1, 63.4% male) with valid baseline and follow-up accelerometer, body weight, and HbA1c data. After adjustment for known confounders, an increase in MVPA time (per 30 min\u00b7d) was associated with a decrease in HbA1c percentage (\u03b2 = -0.11 [-0.18 to -0.05], P = 0.001), and an increase in body weight (per 6 kg) was associated with an increase in HbA1c percentage (\u03b2 = 0.08 [0.04-0.12], P HbA1c \u2265 6.0%) strengthened these associations (P HbA1c after adjustment for change in MVPA time. Increases in MVPA and body weight were associated with a reduction and increase in HbA1c, respectively, particularly in those with dysglycemia. Quantifying the effect that health behavior changes have on HbA1c can be used to inform prevention programs.\n[Serum testosterone levels of HbSS (sickle cell disease male subjects in Lagos, Nigeria](http://www.biomedcentral.com/1756-0500/4/298) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAdediran Adewumi\n2011-08-01\nFull Text Available Abstract Background Infertility is a major problem in sickle cell disease patients, especially in males. In addition to low serum testosterone, other abnormalities involving the accessory sex organs, such as the seminal vesicles and the prostate gland, as well as marked decrease in ejaculate volume may be observed in male HbSS patients. Hence, the need to study the role of sex hormones as a cause of infertility in male HbSS patients. Methods An unmatched case-control study was performed using seventy-five consenting subjects from Lagos University Teaching Hospital. These included 47 patients with haemoglobin phenotype SS from the Sickle cell clinic and 28 volunteered medical students and members of staff with haemoglobin phenotype AA. Demographic data were obtained using a self-administered questionnaire. A total of 5 mls of blood was collected from each subject between 9.00 am & 11.am, and assayed for serum testosterone concentration. Results The concentrations of serum testosterone in HbSS patients ranged from 0.2 to 4.3 ng/ml with a mean of 1.28 \u00b1 0.72 ng/ml whilst the values in HbAA controls ranged from 1.2 to 6.9 ng/ml with a mean of 2.63 \u00b1 1.04 ng/ml. Seven (25.0% of the 28 controls had serum testosterone concentration lower than the quoted reference (normal range whereas 44 (93.6% of the 47 HbSS subjects had serum testosterone concentration lower than the reference range. Conclusion Overall, subjects with HbSS have significantly lower mean serum testosterone than HbAA controls.\n[HB 1347 and Its Relationship to Foodservice Outsourcing in Illinois Public Schools](https://eric.ed.gov/?q=outsourcing&pg=3&id=ED547796)\nBrashear, Gary L.\n2012-01-01\nThis study examined foodservice outsourcing in the State of Illinois. School administrators currently outsourcing foodservice were surveyed about their perceptions of HB1347 and its components. This study looked at HB1347 in Illinois, and its effects on outsourcing in school districts. Data for this study was collected from a survey sent to 100%\u2026\n[High maternal HbA1c is associated with overweight in neonates](http://www.forskningsdatabasen.dk/en/catalog/190371253) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nMikkelsen, Maria R.; Nielsen, Sigrid Bruun; Stage, E\n2011-01-01\nThe aims of this study were to determine the prevalence of women with gestational diabetes mellitus (GDM) not obtaining HbA1c within the normal range (= 5.6%) before delivery and to examine whether elevated HbA1c values are associated with an increased risk of large for gestational age (LGA) infa...\n[PEGYLATION OF \u03b1\u03b1-Hb USING SUCCINIMIDYL PROPIONIC ACID PEG 5K](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4167218)\nMeng, Fantao; Tsai, Amy G.; Intaglietta, Marcos; Acharya, Seetharama A.\n2014-01-01\nPEGylation of intramolecularly crosslinked Hb has been studied here to overcome the limitation of dissociation of Hb tetramers. New hexa and deca PEGylated low oxygen affi nity PEG-\u03b1\u03b1-Hbs have been generated. Infl uence of PEG conjugation chemistry and the PEG shell structure on the functional properties as well as PEGylation induced plasma expander like properties of the protein has been delineated. The results have established that in the design of PEG-Hbs as oxygen therapeutics, the infl uence of conjugation chemistry and the PEG shell structure on the oxygen affi nity of Hb needs to be optimized independently besides optimizing the PEG shell structure for inducing resuscitation fluid like properties. PMID:24597567\n[HB-GAM (pleiotrophin) reverses inhibition of neural regeneration by the CNS extracellular matrix](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5037378)\nPaveliev, Mikhail; Fenrich, Keith K.; Kislin, Mikhail; Kuja-Panula, Juha; Kulesskiy, Evgeny; Varjosalo, Markku; Kajander, Tommi; Mugantseva, Ekaterina; Ahonen-Bishopp, Anni; Khiroug, Leonard; Kulesskaya, Natalia; Rougon, Genevi\u00e8ve; Rauvala, Heikki\n2016-01-01\nChondroitin sulfate (CS) glycosaminoglycans inhibit regeneration in the adult central nervous system (CNS). We report here that HB-GAM (heparin-binding growth-associated molecule; also known as pleiotrophin), a CS-binding protein expressed at high levels in the developing CNS, reverses the role of the CS chains in neurite growth of CNS neurons in vitro from inhibition to activation. The CS-bound HB-GAM promotes neurite growth through binding to the cell surface proteoglycan glypican-2; furthermore, HB-GAM abrogates the CS ligand binding to the inhibitory receptor PTP\u03c3 (protein tyrosine phosphatase sigma). Our in vivo studies using two-photon imaging of CNS injuries support the in vitro studies and show that HB-GAM increases dendrite regeneration in the adult cerebral cortex and axonal regeneration in the adult spinal cord. Our findings may enable the development of novel therapies for CNS injuries. PMID:27671118\n[Fundamentaci\u00f3n Cient\u00edfica de la Psiquiatr\u00eda Cubana Actual Current Cuban Psychiatry: Its scientific foundation](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1727-81202007000200003) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLiuba Y Pe\u00f1a Galb\u00e1n\n2007-08-01\nFull Text Available Se realiza un an\u00e1lisis metodol\u00f3gico conceptual de la Psiquiatr\u00eda como ciencia partiendo de los criterios de los psiquiatras cubanos, coincidiendo en que es una rama de las Ciencias M\u00e9dicas, en la cual el objeto de estudio es la enfermedad mental o el proceso salud enfermedad mental y sus acciones es el diagn\u00f3stico, tratamiento, etiopatogenia, rehabilitaci\u00f3n y prevenci\u00f3n de las mismas, as\u00ed como su estudio epidemiol\u00f3gico y que incluye el car\u00e1cter social e interdisciplinario. A partir de la reorientaci\u00f3n de la Psiquiatr\u00eda hacia la comunidad se hace una reflexi\u00f3n del significado e implicaciones de la misma. Se argumenta como en Cuba se aplica el Modelo de la Atenci\u00f3n Comunitaria de Salud Mental a trav\u00e9s de los Centros comunitarios de Salud Mental que constituyen la piedra angular del modelo cubano de atenci\u00f3n comunitaria, con los que constituye la Psiquiatr\u00eda comunitaria el nuevo paradigma de la Psiquiatr\u00eda cubana actual. Se reconoce que el fundamento filos\u00f3fico que sustenta a la Psiquiatr\u00eda cubana actual es la teor\u00eda Marxista LeninistaA conceptual and methodological analysis of Psychiatry as a science is made, taking the Cuban psychiatrists' criteria as a starting point, referring to it as a branch of the Medical Sciences, in which the object of study is the mental illness or the process health-mental illness, being its actions the diagnosis, treatment, ethiology and pathogenesis, rehabilitation and prevention, as well as its epidemiological study that is related to the social and interdisciplinary levels. Starting with redirecting Psychiatry towards the community, a reflection is made of the meaning and implications of this science. It is documented the application of the Community Mental Health Attention Model that is applied through the community Centers of Mental Health, which constitute the cornerstone of the Cuban model of community attention. Thus, community Psychiatry represents the new paradigm of current Cuban\n[Hb A1c Determination by Capillary Electrophoresis is an Efficient Method for Detecting \u03b2-Thalassemias and Hemoglobin Variants.](https://www.ncbi.nlm.nih.gov/pubmed/27535164)\nOrts, Juan A; Z\u00fa\u00f1iga, \u00c1ngel; Bello, Yanis; Fabregat, Aleix B; Vicente, Ana I\n2016-09-01\nGlycated hemoglobin (Hb A 1c ) determination by multicapillary zone electrophoresis (MZE) can additionally be used to detect Hb A 2 , Hb F and most common hemoglobin (Hb) variants. We assessed the effectiveness of this method for detecting \u03b2-thalassemia (\u03b2-thal), \u03b4\u03b2-thalassemia (\u03b4\u03b2-thal) and most common Hb variants. Moreover, Hb F/Hb A 2 is evaluated as an index for discriminating between \u03b2- and \u03b4\u03b2-thal traits. The theoretical \u03b2-thalassemia major (\u03b2-TM) birth rate in our healthcare area is calculated and contrasted with real data. A MZE technique was used for Hb A 1c measurements in 27,724 patients. Previous criteria for carrier detection were established and subsequently confirmed by molecular biology techniques. Positive predictive value (PPV) was 100.0%. The prevalence of \u03b2-thal trait (including \u03b4\u03b2-thal) was 0.34%. The most prevalent mutations (estimated per 100,000 population) were HBB: c.118C > T (57.7%), HBB: c.93-21G>A (50.5%), HBB: c.92 + 1G > A (43.3%), HBB: c.92 + 6T > C (32.5%) and HBB: c.20delA (18.0%) for \u03b2-thalassemias, and Hb S (HBB: c.20A > T) (32.5%) and Hb J-Baltimore (HBB:c.3880T>A) (28.9%) for Hb variants. We found a paradoxical result between the theoretical \u03b2-TM birth rate and real data. We calculated an optimal Hb F/Hb A 2 index cutoff of 0.71 for discriminating between \u03b2- and \u03b4\u03b2-thal traits. This method is highly cost-effective for detecting \u03b2-thalassemias and common Hb variants. Prevalence results match previous data for the Spanish population. Heterogeneity of mutations in Spain has markedly increased as a consequence of migration. The Hb F/Hb A 2 index cutoff could be used to predict \u03b4\u03b2-thal trait.\n[Determinantes de la organizaci\u00f3n de los espacios en los conjuntos educacionales. Una experiencia cubana](http://informesdelaconstruccion.revistas.csic.es/index.php/informesdelaconstruccion/article/view/1688/1882) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMart\u00ednez Pillot, Ledia\n1986-12-01\nFull Text Available This work sets forth criteria on determining factors which influence the desing of buildings groups, focused on from the general and conceptual point of view and it points out several concepts and Instruments which allow measuring the relations between the components and the stages which constitute the process of designing educational building groups. As part of the work on these determinants, the following aspects are studied: -Analysis of criteria for the selection of sites: how this activity is carried out within the Cuban political and social framework. -Treatment of exterior spaces: as part of the organic interpretation between educational spaces and the remaining areas, for a greater participation in the social and educational life of the pupil and of other inhabitants of the school center. -Analysis for growth: from the urban scale to physical plant-type spaces. Growth is a point to be taken into account in the process of analyzing the building group design so that it could maintain its integrity, considering certain degrees of flexibility which would permit adaptation to prospective changes in educational Systems. These determinants can be interpreted and reflected in the examples which constitute a practical Cuban experiment.Este trabajo expone criterios sobre determinantes que influyen en el Dise\u00f1o de Conjuntos, enfocados desde el punto de vista general y conceptual y se\u00f1ala algunos conceptos e instrumentos que permiten medir las relaciones entre los componentes y las etapas que constituyen el proceso de Dise\u00f1o de Conjuntos Educacionales. Como parte del trabajo de dichas determinantes, se desarrollan los aspectos siguientes: -An\u00e1lisis de criterios para la selecci\u00f3n de terrenos: c\u00f3mo se desarrolla esta actividad en la estructura pol\u00edtica y social cubana. -Tratamiento de los espacios exteriores: como parte de la integraci\u00f3n org\u00e1nica entre los espacios educativos y dem\u00e1s \u00e1reas, para una mayor participaci\u00f3n de la vida\n[M\u00c9TODOS MULTIVARIADOS PARA ENCAUZAR LA MEJORA DE LA CALIDAD DE UNA VACUNA CONTRA EL C\u00c1NCER](http://rii.cujae.edu.cu/index.php/revistaind/article/view/80) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAida Rodr\u00edguez Hern\u00e1ndez\n2007-09-01\nFull Text Available\nEste trabajo se realiz\u00f3 con el objetivo de encontrar las relaciones entre las variables del proceso productivo y el patr\u00f3n cromatogr\u00e1fico de una vacuna terap\u00e9utica contra el c\u00e1ncer, caracter\u00edstica esta indicativa de la reproducibilidad del producto. Primeramente se emple\u00f3 el an\u00e1lisis de conglomerados (an\u00e1lisis de cluster para agrupar lotes de producci\u00f3n y posteriormente se emple\u00f3 el an\u00e1lisis discriminante para encontrar la explicaci\u00f3n de estas agrupaciones seg\u00fan las variables del proceso. La determinaci\u00f3n de estas relaciones, unida a la b\u00fasqueda en la literatura, permiti\u00f3 se\u00f1alar un camino para mejorar el proceso, dirigiendo el control hacia las variables m\u00e1s influyentes en la variabilidad del producto.\n[Introducci\u00f3n de un ELISA como ensayo alternativo en la determinaci\u00f3n de la potencia de vacunas antitet\u00e1nicas](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2005000100001&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJuan Carlos Ram\u00edrez\n2005-05-01\nFull Text Available Por m\u00e1s de medio siglo de uso, la vacunaci\u00f3n con el toxoide tet\u00e1nico ha mostrado un elevado porcentaje de eficacia en la prevenci\u00f3n del t\u00e9tanos. Este trabajo pretende introducir un ensayo inmunoenzim\u00e1tico en fase s\u00f3lida (ELISA como m\u00e9todo alternativo a la prueba de seroneutralizaci\u00f3n in vivo utilizada en la evaluaci\u00f3n de la potencia de las vacunas antitet\u00e1nicas.Se desarroll\u00f3 un ELISA de tipo indirecto para la cuantificaci\u00f3n de antitoxina tet\u00e1nica en suero de curiel a partir de un est\u00e1ndar con 29 UI/mL, previamente calibrado. Se determin\u00f3 la precisi\u00f3n, exactitud y linealidad del ensayo. Se analiz\u00f3 la correlaci\u00f3n entre el ELISA y la prueba biol\u00f3gica mediante la evaluaci\u00f3n de un total de 75 muestras de sueros por ambos m\u00e9todos. Por \u00faltimo, se estudi\u00f3 la respuesta individual de un grupo de animales contra 15 lotes de toxoide tet\u00e1nico. El ensayo demostr\u00f3 ser preciso y exacto, con imprecisiones inferiores al 20% y valores de recuperaci\u00f3n entre el 90\u2013110%. Las desviaciones del paralelismo mostraron coeficientes de variaci\u00f3n alrededor del 10%. El an\u00e1lisis por regresi\u00f3n lineal mostr\u00f3 una buena correlaci\u00f3n entre el ELISA y el ensayo biol\u00f3gico (R2= 0,989. El m\u00e9todo alternativo desarrollado prob\u00f3 ser una herramienta \u00fatil para la determinaci\u00f3n de la potencia de vacunas antitet\u00e1nicas a partir de la evaluaci\u00f3n independiente de la respuesta de cada animal contra el toxoide tet\u00e1nico.Los niveles de seroprotecci\u00f3n alcanzados se encontraron entre el 83\u2013100%.\n[HbA1c Test as a Tool in the Diagnosis of Gestational Diabetes Mellitus.](http://europepmc.org/articles/PMC4546239?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nPaula Breitenbach Renz\nFull Text Available Gestational diabetes mellitus (GDM is a prevalent and potentially serious condition which may put both mothers and neonates at risk. The current recommendation for diagnosis is the oral glucose tolerance test (OGTT. This study aimed to determine the usefulness of HbA1c test as a diagnostic tool for GDM as compared to the traditional criteria based on the OGTT.This was a diagnostic test accuracy study. We performed OGTT and HbA1c test in women attending prenatal visits at a tertiary hospital. GDM was defined according to WHO1999 or ADA/WHO 2013 criteria. ROC curve was used to evaluate the diagnostic performance of HbA1c. Sensitivity, specificity and likelihood ratios for different HbA1c cut-off points were calculated.Of the 262 women in the third trimester of gestation enrolled in the study, 86 (33% were diagnosed with GDM. Only five of these women presented HbA1c \u226548 mmol/mol (6.5%. This cut-off point presented 100% specificity but very low sensitivity (7%. Based on ROC curve, and considering OGTT as the reference criterion, HbA1c \u226540 mmol/mol (5.8% showed adequate specificity in diagnosing GDM (94.9% but low sensitivity (26.4%. Unlike, HbA1c values of 31 mmol/mol (5.0% presented adequate sensitivity (89.7% but low specificity (32.6% to detect GDM. For women with HbA1c \u226540 mmol/mol (5.8%, the positive and negative likelihood ratios were 5.14 (95%CI 2.49-10.63 and 0.78 (0.68-0.88, respectively. The post-test probability of GDM was about 40%, representing a 4.0-fold increase in the mean pre-test probability. This cut-off point could eliminate the need for the unpleasant and laborious OGTT tests in almost one third of cases, as 38% of patients with GDM may be diagnosable by HbA1c test alone.Our results show that combined HbA1c and OGTT measurements may be useful in diagnosing GDM.\n[Prevalence of Diabetes and Prediabetes according to Fasting Plasma Glucose and HbA1c](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3816136)\nJeon, Ja Young; Ko, Seung-Hyun; Kwon, Hyuk-Sang; Kim, Nan Hee; Kim, Jae Hyeon; Kim, Chul Sik; Song, Kee-Ho; Won, Jong Chul; Lim, Soo; Choi, Sung Hee; Jang, Myoung-jin; Kim, Yuna; Oh, Kyungwon\n2013-01-01\nBackground Due to the inconvenience of performing oral glucose tolerance tests and day to day variability in glucose level, glycated hemoglobin (HbA1c) has been recommended by the American Diabetes Association as a method to diagnose diabetes. In addition, the Korean Diabetes Association has also recommended the use of HbA1c as a diagnostic test for diabetes. In this study, we evaluated the prevalence of diabetes according to fasting plasma glucose (FPG) level only or the combination of FPG and HbA1c tests. Methods Data from the 2011 Korea National Health and Nutrition Examination Survey (KNHANES) were analyzed. Among 5,811 subjects aged 30 years or older, 5,020 were selected after excluding the data of fasting time <8 hours, missing values from fasting glucose or HbA1c level, previous diagnosis of diabetes made by physicians, or current use of antidiabetic medications. Diabetes was defined as FPG \u2265126 mg/dL, previous diagnosis of diabetes made by a medical doctor, current use of antidiabetic medications, and/or HbA1c \u22656.5%. Prediabetes was defined as FPG of 100 to 125 mg/dL and/or HbA1c of 5.7% to 6.4%. Results When we used FPG only, the prevalence of diabetes and prediabetes were 10.5% (men, 12.6%; women, 8.5%) and 19.3% (men, 23.8%; women, 14.9%), respectively. When HbA1c was included as a diagnostic test, the prevalence of diabetes and prediabetes increased to 12.4% (men, 14.5%; women, 10.4%) and 38.3% (men, 41%; women, 35.7%), respectively. Participants with HbA1c \u22656.5% and fasting glucose level <126 mg/dL were older and had lower estimated glomerular filtration rate. Conclusion We concluded that using fasting glucose level only may result in an underestimation of diabetes and prediabetes. HbA1c is an acceptable complementary diagnostic test for diabetes in Korean patients. However, national standardization is needed to order to use HbA1c as a diagnostic method of diabetes and prediabetes. PMID:24199164\n[Prevalence of Diabetes and Prediabetes according to Fasting Plasma Glucose and HbA1c](http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-37-349.pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJa Young Jeon\n2013-10-01\nFull Text Available BackgroundDue to the inconvenience of performing oral glucose tolerance tests and day to day variability in glucose level, glycated hemoglobin (HbA1c has been recommended by the American Diabetes Association as a method to diagnose diabetes. In addition, the Korean Diabetes Association has also recommended the use of HbA1c as a diagnostic test for diabetes. In this study, we evaluated the prevalence of diabetes according to fasting plasma glucose (FPG level only or the combination of FPG and HbA1c tests.MethodsData from the 2011 Korea National Health and Nutrition Examination Survey (KNHANES were analyzed. Among 5,811 subjects aged 30 years or older, 5,020 were selected after excluding the data of fasting time <8 hours, missing values from fasting glucose or HbA1c level, previous diagnosis of diabetes made by physicians, or current use of antidiabetic medications. Diabetes was defined as FPG \u2265126 mg/dL, previous diagnosis of diabetes made by a medical doctor, current use of antidiabetic medications, and/or HbA1c \u22656.5%. Prediabetes was defined as FPG of 100 to 125 mg/dL and/or HbA1c of 5.7% to 6.4%.ResultsWhen we used FPG only, the prevalence of diabetes and prediabetes were 10.5% (men, 12.6%; women, 8.5% and 19.3% (men, 23.8%; women, 14.9%, respectively. When HbA1c was included as a diagnostic test, the prevalence of diabetes and prediabetes increased to 12.4% (men, 14.5%; women, 10.4% and 38.3% (men, 41%; women, 35.7%, respectively. Participants with HbA1c \u22656.5% and fasting glucose level <126 mg/dL were older and had lower estimated glomerular filtration rate.ConclusionWe concluded that using fasting glucose level only may result in an underestimation of diabetes and prediabetes. HbA1c is an acceptable complementary diagnostic test for diabetes in Korean patients. However, national standardization is needed to order to use HbA1c as a diagnostic method of diabetes and prediabetes.\n[Inmunogenicidad y capacidad protectora en hamsters de vacunas antileptospir\u00f3sicas monovalentes de c\u00e9lulas enteras del serogrupo Ballum Immunogenicity and protective capacity of leptospiral whole-cell monovalent serogroup Ballum vaccines in hamsters](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412005000400002) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nA. Gonz\u00e1lez\n2005-12-01\nFull Text Available El serogrupo Ballum de Leptospira constituye en la actualidad la primera causa de leptospirosis humana en Cuba. Vacunas de c\u00e9lulas enteras qu\u00edmicamente inactivadas fueron formuladas a partir de dos cepas cl\u00ednicas de Leptospira interrogans serogrupo Ballum empleando como adyuvante hidr\u00f3xido de aluminio. Los niveles de aglutininas inducidos en hamsters por una u otra preparaci\u00f3n vacunal fueron estimados mediante aglutinaci\u00f3n microsc\u00f3pica y la actividad IgG espec\u00edfica fue cuantificada mediante ELISA. La capacidad de protecci\u00f3n hom\u00f3loga y heter\u00f3loga contra la infecci\u00f3n letal y subletal se determin\u00f3 mediante el desaf\u00edo con 100 y 10 000 DL50 de cinco cepas virulentas pertenecientes a los serogrupos Ballum, Canicola, Icterohaemorrhagiae y Pomona. Las evaluaciones realizadas demostraron que ambas vacunas fueron inmunog\u00e9nicas e indujeron una completa protecci\u00f3n hom\u00f3loga en el modelo animal empleado. La protecci\u00f3n cruzada frente a serogrupos heter\u00f3logos solo fue significativa en una de las preparaciones monovalentes frente al desaf\u00edo con 100 DL50 de Canicola. Como resultado de este estudio se pudo comprobar la alta inmunogenicidad y capacidad protectora en hamsters de vacunas monovalentes de c\u00e9lulas enteras formuladas a partir de dos cepas candidatas vacunales del serogrupo de Leptospira de mayor circulaci\u00f3n en humanos en Cuba no incluido en la vacuna actualmente disponible.Leptospira serogroup Ballum is at present the first cause of human leptospirosis in Cuba. Killed whole-cell vaccines were formulated with two clinical isolates of Leptospira interrogans serogroup Ballum using aluminum hydroxide as adjuvant. Agglutinins levels induced by each vaccine in hamsters were estimated by microscopic agglutination test and specific IgG activities were quantified by a whole cell-based enzyme-linked immunosorbent assay. Homologous and cross protective capacity against lethal and sublethal infection were determined in vaccinated animals by\n[[Assays of HbA1c and Amadori products in human biology].](https://www.ncbi.nlm.nih.gov/pubmed/25220229)\nGillery, P\n2014-09-01\nDifferent Amadori products, formed during the early steps of the non-enzymatic glycation of proteins, may be assayed in current practice in human biology. The most important marker is HbA1c, resulting from the binding of glucose to the N-terminal extremity of HbA beta chains. HbA1c may be evaluated by various techniques (ion exchange or affinity high performance liquid chromatography, capillary electrophoresis, immunoassay, enzymatic technique) and is considered the best marker of diabetic patient survey. Due to its irreversible and cumulative formation, it provides a retrospective information on the glycemic balance over the four to eight weeks preceding blood collection. It benefits from an international standardization, based on a reference method using liquid chromatography coupled to capillary electrophoresis or mass spectrometry, maintained by an international network of reference laboratories. When HbA1c assay cannot be used (anemia, hemolysis, hemoglobinopathy) or when a shorter period of glycemic equilibrium must be evaluated (child and adolescent, pregnancy, therapeutic changes), other Amadori products may be assayed, like plasma fructosamine (all plasma glycated proteins) or glycated albumin. Nevertheless, these assays are less used in practice, because their semiological value has been less evidenced. Besides, fructosamine assay lacks specificity, and glycated albumin assay has been described recently. An expanding use of HbA1c assay is expected, especially for the diagnosis of diabetes mellitus and the evaluation of other risks, especially cardiovascular ones. Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.\n[La producci\u00f3n cient\u00edfica cubana en la bibliograf\u00eda espa\u00f1ola de ciencia y tecnolog\u00eda 1995-2001](http://redc.revistas.csic.es/index.php/redc/article/view/160/214) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nArencibia Jorge, Ricardo\n2004-12-01\nFull Text Available The present work is a bibliometric analysis about the Cuban scientific output in the Spanish Bibliography of Science and Technology. The registers were obtained from the Spanish Index of Science and Technology (ICYT, CD-ROM version, comprised in the period from 1995 to 2001, whenever a Cuban institution is identified in the affiliation. The bibliometric indicators used in the study were the annual scientific production of the researchers, the co-authorship index, and the inter-institutional co-operation. Total count was used in the analysis of the individual productivity. A total of 958 articles with Cuban authors were published in 103 Spanish serials. The average number of authors per article was 3,62, with an increasing trend. Half of the most productive authors is from the Food Industry Research Institute (IIIA. Spanish authors participated in 73% of the international cooperations with Cuba. A study about the Spanish Medical Index (IME and the Spanish Index of Social Sciences and Humanities (ISOC is necessary to have a general overview of the Cuban scientific production in the Spanish literature in Science and Technology, Medicine and Society.\nEl presente trabajo es un an\u00e1lisis bibliom\u00e9trico de la producci\u00f3n cient\u00edfica cubana en la Bibliograf\u00eda Espa\u00f1ola de Ciencia y Tecnolog\u00eda. Se utilizaron los registros recuperados de la versi\u00f3n en CD-ROM del Indice Espa\u00f1ol de Ciencia y Tecnolog\u00eda (ICYT durante el per\u00edodo comprendido entre 1995 y 2001, siempre que apareciera una instituci\u00f3n cubana en el campo de afiliaci\u00f3n. Se utilizaron como indicadores bibliom\u00e9tricos la producci\u00f3n cient\u00edfica anual de los investigadores, el \u00edndice de coautor\u00eda y los \u00edndices de colaboraci\u00f3n entre instituciones. Se utiliz\u00f3 el conteo directo para el an\u00e1lisis de la productividad individual de los autores. Se obtuvieron un total de 958 art\u00edculos con autores cubanos, publicados en 103 publicaciones seriadas espa\u00f1olas. El promedio de autores por art\n[Benchmarking by HbA1c in a national diabetes quality register--does measurement bias matter?](https://www.ncbi.nlm.nih.gov/pubmed/25503669)\nCarlsen, Siri; Thue, Geir; Cooper, John Graham; R\u00f8raas, Thomas; G\u00f8ransson, Lasse Gunnar; L\u00f8vaas, Karianne; Sandberg, Sverre\n2015-08-01\nBias in HbA1c measurement could give a wrong impression of the standard of care when benchmarking diabetes care. The aim of this study was to evaluate how measurement bias in HbA1c results may influence the benchmarking process performed by a national diabetes register. Using data from 2012 from the Norwegian Diabetes Register for Adults, we included HbA1c results from 3584 patients with type 1 diabetes attending 13 hospital clinics, and 1366 patients with type 2 diabetes attending 18 GP offices. Correction factors for HbA1c were obtained by comparing the results of the hospital laboratories'/GP offices' external quality assurance scheme with the target value from a reference method. Compared with the uncorrected yearly median HbA1c values for hospital clinics and GP offices, EQA corrected HbA1c values were within \u00b10.2% (2 mmol/mol) for all but one hospital clinic whose value was reduced by 0.4% (4 mmol/mol). Three hospital clinics reduced the proportion of patients with poor glycemic control, one by 9% and two by 4%. For most participants in our study, correcting for measurement bias had little effect on the yearly median HbA1c value or the percentage of patients achieving glycemic goals. However, at three hospital clinics correcting for measurement bias had an important effect on HbA1c benchmarking results especially with regard to percentages of patients achieving glycemic targets. The analytical quality of HbA1c should be taken into account when comparing benchmarking results.\n[Interaction between Hb E and Hb Yala (HBB:c.129delT); a novel frameshift beta globin gene mutation, resulting in Hemoglobin E/\u03b20 thalassemia.](https://www.ncbi.nlm.nih.gov/pubmed/28768465)\nEkwattanakit, Supachai; Riolueang, Suchada; Viprakasit, Vip\n2018-03-01\nThere are more than 200 known mutations found in patients with \u03b2-thalassemia, a possibility to identify an unknown or novel mutation becomes less possible. Here, we report a novel mutation in a patient from Thailand who presented with chronic hemolytic anemia. A comprehensive hematology and DNA analysis was applied in the index patient and her mother. Hematological and hemoglobin analyses were consistent with the clinical diagnosis of Hb E/\u03b2 0 -thalassemia. However, we could find only Hb E heterozygous mutation using our common polymerase chain reaction-based mutation detection of the \u03b2-globin genes. Furthermore, the molecular analysis demonstrated a novel T-deletion at codon 42 of the second exon of the \u03b2-globin gene which we named 'Hb Yala' according to the origin of this index family. This mutation was assumed to generate a truncated \u03b2-globin chain terminating at codon 60 with possible unstable variant leading to a 'null' or \u03b2 0 -thalassemia. However, the clinical phenotype was surprisingly mild and no other ameliorating genetic factors, including co-inheritance of \u03b1-thalassemia and high propensity of Hb F by Xmn I polymorphism, were found. This report has provided evidence that genotype-phenotype correlation in thalassemia syndromes is highly complex and a correct clinical severity classification of thalassemia should be mainly based on clinical evaluation.\n[Molecular Characteristics of Hb New York [\u03b2113(G15)Val\u2192Glu, HBB: c.341T>A] in Thailand.](https://www.ncbi.nlm.nih.gov/pubmed/29464999)\nChaibunruang, Attawut; Singha, Kritsada; Srivorakun, Hataichanok; Fucharoen, Goonnapa; Fucharoen, Supan\n2018-01-01\nHb New York or Hb Kaohsiung [\u03b2113(G15)Val\u2192Glu (GTG>GAG), HBB: c.341T>A] has been considered a rare \u03b2 hemoglobin (Hb) variant found originally in an Iranian woman and later in diverse populations but its genetic origin has not been elucidated. Here we report molecular and hematological descriptions of this variant found in the Thai population. Among 5643 subjects referred for hemoglobinopathy investigation during January 2015 to September 2017, 183 (3.2%) were found to carry several Hb variants, including \u03b2 chain variants (n = 135, 2.4%), \u03b1 chain variants (n = 33, 0.6%), Hb Lepore-Hollandia (NG_000007.3: g.63290_70702del) and Hb Lepore-Boston-Washington (NG_000007.3: g.63632_71046del) (\u03b4\u03b2 hybrid Hb) (n = 12, 0.2%) and \u03b4 chain variants (n = 3, 0.05%). Of patients with \u03b2 chain variants, six with normal high performance liquid chromatography (HPLC) patterns, had an abnormal Hb in zone 11 of capillary electrophoresis (CE), the amounts of which ranged from 29.6-45.4% with normal levels of Hb A 2 and Hb F. DNA analysis identified a heterozygous Hb New York mutation in all cases. Further screening of \u03b1-thalassemia (\u03b1-thal) identified coinheritance of \u03b1 + - and \u03b1 0 -thal in two of them who had reduced levels of Hb New York. Haplotype analysis suggested that the Thai Hb New York was likely associated with a single \u03b2-globin haplotype [+ - - - - + +], indicating that it was of the same origin. Hematological findings and simple DNA assay based on allele-specific polymerase chain reaction (PCR) for rapid detection of Hb New York are presented.\n[A study assessing the association of glycated hemoglobin A1C (HbA1C) associated variants with HbA1C, chronic kidney disease and diabetic retinopathy in populations of Asian ancestry.](https://www.ncbi.nlm.nih.gov/pubmed/24244560)\nChen, Peng; Ong, Rick Twee-Hee; Tay, Wan-Ting; Sim, Xueling; Ali, Mohammad; Xu, Haiyan; Suo, Chen; Liu, Jianjun; Chia, Kee-Seng; Vithana, Eranga; Young, Terri L; Aung, Tin; Lim, Wei-Yen; Khor, Chiea-Chuen; Cheng, Ching-Yu; Wong, Tien-Yin; Teo, Yik-Ying; Tai, E-Shyong\n2013-01-01\nGlycated hemoglobin A1C (HbA1C) level is used as a diagnostic marker for diabetes mellitus and a predictor of diabetes associated complications. Genome-wide association studies have identified genetic variants associated with HbA1C level. Most of these studies have been conducted in populations of European ancestry. Here we report the findings from a meta-analysis of genome-wide association studies of HbA1C levels in 6,682 non-diabetic subjects of Chinese, Malay and South Asian ancestries. We also sought to examine the associations between HbA1C associated SNPs and microvascular complications associated with diabetes mellitus, namely chronic kidney disease and retinopathy. A cluster of 6 SNPs on chromosome 17 showed an association with HbA1C which achieved genome-wide significance in the Malays but not in Chinese and Asian Indians. No other variants achieved genome-wide significance in the individual studies or in the meta-analysis. When we investigated the reproducibility of the findings that emerged from the European studies, six loci out of fifteen were found to be associated with HbA1C with effect sizes similar to those reported in the populations of European ancestry and P-value \u2264 0.05. No convincing associations with chronic kidney disease and retinopathy were identified in this study.\n[A study assessing the association of glycated hemoglobin A1C (HbA1C associated variants with HbA1C, chronic kidney disease and diabetic retinopathy in populations of Asian ancestry.](http://europepmc.org/articles/PMC3820602?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nPeng Chen\nFull Text Available Glycated hemoglobin A1C (HbA1C level is used as a diagnostic marker for diabetes mellitus and a predictor of diabetes associated complications. Genome-wide association studies have identified genetic variants associated with HbA1C level. Most of these studies have been conducted in populations of European ancestry. Here we report the findings from a meta-analysis of genome-wide association studies of HbA1C levels in 6,682 non-diabetic subjects of Chinese, Malay and South Asian ancestries. We also sought to examine the associations between HbA1C associated SNPs and microvascular complications associated with diabetes mellitus, namely chronic kidney disease and retinopathy. A cluster of 6 SNPs on chromosome 17 showed an association with HbA1C which achieved genome-wide significance in the Malays but not in Chinese and Asian Indians. No other variants achieved genome-wide significance in the individual studies or in the meta-analysis. When we investigated the reproducibility of the findings that emerged from the European studies, six loci out of fifteen were found to be associated with HbA1C with effect sizes similar to those reported in the populations of European ancestry and P-value \u2264 0.05. No convincing associations with chronic kidney disease and retinopathy were identified in this study.\n[Evaluation of the HB&L System for the Microbiological Screening of Storage Medium for Organ-Cultured Corneas.](https://www.ncbi.nlm.nih.gov/pubmed/24069532)\nCamposampiero, D; Grandesso, S; Zanetti, E; Mazzucato, S; Solinas, M; Parekh, M; Frigo, A C; Gion, M; Ponzin, D\n2013-01-01\nAims. To compare HB&L and BACTEC systems for detecting the microorganisms contaminating the corneal storage liquid preserved at 31\u00b0C. Methods. Human donor corneas were stored at 4\u00b0C followed by preservation at 31\u00b0C. Samples of the storage medium were inoculated in BACTEC Peds Plus/F (aerobic microorganisms), BACTEC Plus Anaerobic/F (anaerobic microorganisms), and HB&L bottles. The tests were performed (a) after six days of storage, (b) end of storage, and (c) after 24 hours of preservation in deturgescent liquid sequentially. 10,655 storage and deturgescent media samples were subjected to microbiological control using BACTEC (6-day incubation) and HB&L (24-hour incubation) systems simultaneously. BACTEC positive/negative refers to both/either aerobic and anaerobic positives/negatives, whereas HB&L can only detect the aerobic microbes, and therefore the positives/negatives depend on the presence/absence of aerobic microorganisms. Results. 147 (1.38%) samples were identified positive with at least one of the two methods. 127 samples (134 identified microorganisms) were positive with both HB&L and BACTEC. 14 HB&L+/BACTEC- and 6 BACTEC+/HB&L- were identified. Sensitivity (95.5%), specificity (99.8%), and positive (90.1%) and negative predictive values (99.9%) were high with HB&L considering a 3.5% annual contamination rate. Conclusion. HB&L is a rapid system for detecting microorganisms in corneal storage medium in addition to the existing methods.\n[Identification of Hb Constant Spring (HBA2: c.427T > C) by an Automated High Performance Liquid Chromatography Method.](https://www.ncbi.nlm.nih.gov/pubmed/26016900)\nWisedpanichkij, Raewadee; Jindadamrongwech, Sumalee; Butthep, Punnee\n2015-01-01\nLaboratory investigation of hemoglobinopathies includes complete blood count (CBC), hemoglobin (Hb) typing by high performance liquid chromatography (HPLC) and DNA analysis. DNA analysis is the most reliable method but requires a manually laborious procedure and is time consuming. A more practical method of detecting abnormal Hbs is the HPLC technique, because it is more rapid and easier to interpret. Hb Constant Spring (Hb CS; HBA2: c.427T > C) is an abnormal variant that is labile and difficult to detect using conventional methods. To evaluate the efficiency of Hb CS determination by HPLC, blood samples from 578 subjects were analyzed using an automated cell analyzer for hematological parameters, automated HPLC for Hb identification, and polymerase chain reaction (PCR) for \u03b1-thalassemia (\u03b1-thal) and Hb CS confirmation. These included 169 normal, 119 heterozygous \u03b1-thal-2, 30 homozygous \u03b1-thal-2, 177 heterozygous \u03b1-thal-1, 59 heterozygous Hb CS, seven homozygous Hb CS and 17 compound heterozygous \u03b1-thal-2 and Hb CS subjects. The results showed that sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of Hb CS by HPLC were 93.78, 99.80, 98.73 and 99.00%, respectively. The mean of misdiagnosis value of the three groups of Hb CS subjects (total 83) was 6.02% (n = 5), with percentages for heterozygous Hb CS, homozygous Hb CS, and compound heterozygous \u03b1-thal-2 and Hb CS being 6.8, 0.0 and 5.9%, respectively. The HPLC method yielded good results, although it may also lead to misdiagnosis of Hb CS due to the relatively small amount and lability.\n[A case of iron deficiency anemia with co-existing Hb Fontainebleau.](http://www.mjhid.org/index.php/mjhid/article/view/1403) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAbhishek HL Purohit\n2014-06-01\nFull Text Available Hb Fontainebleaue is a rare alpha chain variant in the Indian population which generates an unknown peak on hemoglobin HPLC study and does cause diagnostic difficulty to those who are not acquainted with this entity. We present a case of Hb Fontainebleau, an eighteen year old patient who presented with symptoms related to anemia to our department and unknown peak observed in HPLC plots lead us to family study and molecular characterization for this case.\n[Glycated haemoglobin (HbA1c), diabetes and trajectories of change in episodic memory performance.](https://www.ncbi.nlm.nih.gov/pubmed/27440936)\nPappas, Colleen; Andel, Ross; Infurna, Frank J; Seetharaman, Shyam\n2017-02-01\nAs the ageing population grows, it is important to identify strategies to moderate cognitive ageing. We examined glycated haemoglobin (HbA1c) and diabetes in relation to level and change in episodic memory in older adults with and without diabetes. Data from 4419 older adults with (n=950) and without (n=3469) diabetes participating in a nationally representative longitudinal panel study (the Health and Retirement Study) were examined. Average baseline age was 72.66 years and 58% were women. HbA1c was measured in 2006 and episodic memory was measured using immediate and delayed list recall over 4 biennial waves between 2006 and 2012. Growth curve models were used to assess trajectories of episodic memory change. In growth curve models adjusted for age, sex, education, race, depressive symptoms and waist circumference, higher HbA1c levels and having diabetes were associated with poorer baseline episodic memory (p=0.036 and HbA1c on episodic memory decline was smaller than the effect of age. The results were stronger for women than men and were not modified by age or race. When the main analyses were estimated for those with and without diabetes separately, HbA1c was significantly linked to change in episodic memory only among those with diabetes. Higher HbA1c and diabetes were both associated with declines in episodic memory, with this relationship further exacerbated by having diabetes and elevated HbA1c. HbA1c appeared more important for episodic memory performance among women than men. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.\n[Trimester-specific reference intervals for haemoglobin A(1c) (HbA(1c)) in pregnancy.](http://www.lenus.ie/hse/handle/10147/220231) [LENUS (Irish Health Repository)](http://www.lenus.ie/hse/)\nO'Connor, Catherine\n2011-11-26\nAbstract Background: Diabetes in pregnancy imposes additional risks to both mother and infant. These increased risks are considered to be primarily related to glycaemic control which is monitored by means of glycated haemoglobin (HbA(1c)). The correlation of HbA(1c) with clinical outcomes emphasises the need to measure HbA(1c) accurately, precisely and for correct interpretation, comparison to appropriately defined reference intervals. Since July 2010, the HbA(1c) assay in Irish laboratories is fully metrologically traceable to the IFCC standard. The objective was to establish trimester-specific reference intervals in pregnancy for IFCC standardised HbA(1c) in non-diabetic Caucasian women. Methods: The authors recruited 311 non-diabetic Caucasian pregnant (n=246) and non-pregnant women (n=65). A selective screening based on risk factors for gestational diabetes was employed. All subjects had a random plasma glucose <7.7 mmol\\\\/L and normal haemoglobin level. Pregnancy trimester was defined as trimester 1 (T1, n=40) up to 12 weeks +6 days, trimester 2 (T2, n=106) 13-27 weeks +6 days, trimester 3 (T3, n=100) >28 weeks to term. Results: The normal HbA(1c) reference interval for Caucasian non-pregnant women was 29-37 mmol\\\\/mol (Diabetes Control and Complications Trial; DCCT: 4.8%-5.5%), T1: 24-36 mmol\\\\/mol (DCCT: 4.3%-5.4%), T2: 25-35 mmol\\\\/mol (DCCT: 4.4%-5.4%) and T3: 28-39 mmol\\\\/mol (DCCT: 4.7%-5.7%). HbA(1c) was significantly decreased in trimesters 1 and 2 compared to non-pregnant women. Conclusions: HbA(1c) trimester-specific reference intervals are required to better inform the management of pregnancies complicated by diabetes.\n[Radioisotope Characterization of HB Line Low Activity Waste](https://www.osti.gov/servlets/purl/9562-YkLSaJ/webviewable/) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nSnyder, S.J.\n1999-01-01\nThe purpose of this document is to provide a physical, chemical, hazardous and radiological characterization of Low-Level Waste (LLW) generated in HB-Line as required by the 1S Manual, Savannah River Site Waste Acceptance Criteria Manual\n[Impact of demographics and disease progression on the relationship between glucose and HbA1c.](https://www.ncbi.nlm.nih.gov/pubmed/28412484)\nClaussen, Anetta; M\u00f8ller, Jonas B; Kristensen, Niels R; Klim, S\u00f8ren; Kjellsson, Maria C; Ingwersen, Steen H; Karlsson, Mats O\n2017-06-15\nSeveral studies have shown that the relationship between mean plasma glucose (MPG) and glycated haemoglobin (HbA1c) may vary across populations. Especially race has previously been referred to shift the regression line that links MPG to HbA1c at steady-state (Herman & Cohen, 2012). To assess the influence of demographic and disease progression-related covariates on the intercept of the estimated linear MPG-HbA1c relationship in a longitudinal model. Longitudinal patient-level data from 16 late-phase trials in type 2 diabetes with a total of 8927 subjects was used to study covariates for the relationship between MPG and HbA1c. The analysed covariates included age group, BMI, gender, race, diabetes duration, and pre-trial treatment. Differences between trials were taken into account by estimating a trial-to-trial variability component. Participants included 47% females and 20% above 65years. 77% were Caucasian, 9% were Asian, 5% were Black and the remaining 9% were analysed together as other races. Estimates of the change in the intercept of the MPG-HbA1c relationship due to the mentioned covariates were determined using a longitudinal model. The analysis showed that pre-trial treatment with insulin had the most pronounced impact associated with a 0.34% higher HbA1c at a given MPG. However, race, diabetes duration and age group also had an impact on the MPG-HbA1c relationship. Our analysis shows that the relationship between MPG and HbA1c is relatively insensitive to covariates, but shows small variations across populations, which may be relevant to take into account when predicting HbA1c response based on MPG measurements in clinical trials. Copyright \u00a9 2017 Elsevier B.V. All rights reserved.\n[Discordance in the diagnosis of diabetes: Comparison between HbA1c and fasting plasma glucose.](https://www.ncbi.nlm.nih.gov/pubmed/28817663)\nHo-Pham, Lan T; Nguyen, Uyen D T; Tran, Truong X; Nguyen, Tuan V\n2017-01-01\nHbA1c has been introduced as a complementary diagnostic test for diabetes, but its impact on disease prevalence is unknown. This study evaluated the concordance between HbA1c and fasting plasma glucose (FPG) in the diagnosis of diabetes in the general population. The study was designed as a population based investigation, with participants being sampled from the Ho Chi Minh City, Vietnam. Blood samples were collected after overnight fasting and analyzed within 4 hours after collection. HbA1c was measured with high pressure liquid chromatography (Arkray Adams, Japan). FPG was measured by the hexokinase method (Advia Autoanalyzer; Bayer Diagnostics, Germany). Diabetes was defined as HbA1c \u2265 6.5% or FPG \u2265 7.0 mmol/L. Prediabetes was classified as HbA1c between 5.7% and 6.4%. The study included 3523 individuals (2356 women) aged 30 years and above. Based on the HbA1c test, the prevalence of diabetes and prediabetes was 9.7% (95%CI, 8.7-10.7%; n = 342) and 34.6% (33.0-36.2; n = 1219), respectively. Based on the FPG test, the prevalence of diabetes and prediabetes was 6.3% (95%CI, 5.5-7.2%; n = 223) and 12.1% (11.1-13.2; n = 427). Among the 427 individuals identified by FPG as \"pre-diabetes\", 28.6% were classified as diabetes by HbA1c test. The weighted kappa statistic of concordance between HbA1c and FPG was 0.55, with most of the discordance being in the prediabetes group. These data indicate that there is a significant discordance in the diagnosis of diabetes between FPG and HbA1c measurements, and the discordance could have significant impact on clinical practice. FPG appears to underestimate the burden of undiagnosed diabetes.\n[Administraci\u00f3n de vacunas y casos de muerte s\u00fabita del lactante en el Per\u00fa, 2001. \u00bfAsociaci\u00f3n o coincidencia temporal?](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::e53e6396d7036924ac4edb136005a9b2)\nVargas H, Javier; Centro Nacional de Salud P\u00fablica, Instituto Nacional de Salud. Lima, Per\u00fa.; Su\u00e1rez J, Magna; Centro Nacional de Salud P\u00fablica, Instituto Nacional de Salud. Lima, Per\u00fa.; Llamoga S, Alejandro; Centro Nacional de Salud P\u00fablica, Instituto Nacional de Salud. Lima, Per\u00fa.; Quispe T, Neyda; Centro Nacional de Salud P\u00fablica, Instituto Nacional de Salud. Lima, Per\u00fa.; Alva R, Fernando; Chu C, Julia; Centro Nacional de Producci\u00f3n de Biol\u00f3gicos, Instituto Nacional de Salud. Lima Per\u00fa.; Pereyra S, H\u00e9ctor; Oficina General de Epidemiolog\u00eda, Ministerio de Salud. Lima, Per\u00fa.; Ticona Z, Mar\u00eda; Oficina General de Epidemiolog\u00eda, Ministerio de Salud. Lima, Per\u00fa.; Medrano G, Jorge; Direcci\u00f3n General de Salud de las Personas, Ministerio de Salud. Lima, Per\u00fa.; Cerna D, Carolina; Direcci\u00f3n General de Salud de las Personas, Ministerio de Salud. Lima, Per\u00fa.\n2006-01-01\nObjetivos: Describir las caracter\u00edsticas cl\u00ednicas, socioecon\u00f3micas, y patol\u00f3gicas de nueve casos de lactantes que fallecieron horas despu\u00e9s de administr\u00e1rseles vacunas antipolio y DPT junto con anti Haemophilus influenzae b o asociada con antihepatitis B o BCG. Materiales y m\u00e9todos: Revisi\u00f3n de la historia cl\u00ednica, entrevista con el equipo de salud a cargo de la vacunaci\u00f3n y con los padres del lactante fallecido. Revisi\u00f3n de los informes del protocolo de autopsia e informes de anatom\u00eda patol\u00f3...\n[MODELADO DE PROCESOS DE TRABAJO INTENSIVOS EN CONOCIMIENTO. UNA APLICACI\u00d3N EN LA INDUSTRIA DEL SOFTWARE CUBANA](http://rii.cujae.edu.cu/index.php/revistaind/article/view/267) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nCarlos Rolando Mac\u00edas Gelabert\n2009-09-01\nFull Text Available\nEn este documento se propone un m\u00e9todo general para el modelado de procesos de trabajo intensivos en conocimiento, donde se establece la necesidad de integrar los esfuerzos de mejoramiento de flujos de trabajo y del conocimiento. Se plantean criterios para la selecci\u00f3n del proceso utilizando enfoques cualitativos, su an\u00e1lisis a trav\u00e9s de la matriz de la estructura de dise\u00f1o y el modelado gen\u00e9rico de actividades, que contribuyen a determinar la dependencia y estructuraci\u00f3n del conocimiento en las actividades, respectivamente. Estas herramientas permiten identificar factores a considerar para la toma de decisiones de mejoramiento en dichos procesos de trabajo. El m\u00e9todo fue aplicado en una organizaci\u00f3n cubana de la industria del software.\n[HB-Line Material Control and Accountability Measurements at SRS](https://www.osti.gov/servlets/purl/812197-SDjaLW/native/) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nCasella, V.R.\n2003-01-01\nPresently, HB-Line work at the Savannah River Site consists primarily of the stabilization and packaging of nuclear materials for storage and the characterization of materials for disposition in H-Area. In order to ensure compliance with Material Control and Accountability (MC and A) Regulations, accountability measurements are performed throughout the HB-Line processes. Accountability measurements are used to keep track of the nuclear material inventory by constantly updating the amount of material in the MBAs (Material Balance Area) and sub-MBAs. This is done by subtracting the amount of accountable material that is added to a process and by adding the amount of accountable material that is put back in storage. A Physical Inventory is taken and compared to the ''Book Value'' listed in the Nuclear Material Accounting System. The difference (BPID) in the Book Inventory minus the Physical Inventory of a sub-account for bulk material must agree within the measurement errors combined in quadrature to provide assurance that nuclear material is accounted for. This work provides an overview of HB-Line processes and accountability measurements. The Scrap Recovery Line and Neptunium-237/Plutonium-239 Oxide Line are described and sampling and analyses for Phase II are provided. Recommendations for improvements are provided to improve efficiency and cost effectiveness\n[Glutathione Redox System in \u03b2-Thalassemia/Hb E Patients](http://dx.doi.org/10.1155/2013/543973) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRuchaneekorn W. Kalpravidh\n2013-01-01\nFull Text Available \u03b2-thalassemia/Hb E is known to cause oxidative stress induced by iron overload. The glutathione system is the major endogenous antioxidant that protects animal cells from oxidative damage. This study aimed to determine the effect of disease state and splenectomy on redox status expressed by whole blood glutathione (GSH/glutathione disulfide (GSSG and also to evaluate glutathione-related responses to oxidation in \u03b2-thalassemia/Hb E patients. Twenty-seven normal subjects and 25 \u03b2-thalassemia/Hb E patients were recruited and blood was collected. The GSH/GSSG ratio, activities of glutathione-related enzymes, hematological parameters, and serum ferritin levels were determined in individuals. Patients had high iron-induced oxidative stress, shown as significantly increased serum ferritin, a decreased GSH/GSSG ratio, and increased activities of glutathione-related enzymes. Splenectomy increased serum ferritin levels and decreased GSH levels concomitant with unchanged glutathione-related enzyme activities. The redox ratio had a positive correlation with hemoglobin levels and negative correlation with levels of serum ferritin. The glutathione system may be the body\u2019s first-line defense used against oxidative stress and to maintain redox homeostasis in thalassemic patients based on the significant correlations between the GSH/GSSH ratio and degree of anemia or body iron stores.\n[Defining a glycated haemoglobin (HbA1c) level that predicts increased risk of penile implant infection.](https://www.ncbi.nlm.nih.gov/pubmed/29124870)\nHabous, Mohamad; Tal, Raanan; Tealab, Alaa; Soliman, Tarek; Nassar, Mohammed; Mekawi, Zenhom; Mahmoud, Saad; Abdelwahab, Osama; Elkhouly, Mohamed; Kamr, Hatem; Remeah, Abdallah; Binsaleh, Saleh; Ralph, David; Mulhall, John\n2018-02-01\nTo re-evaluate the role of diabetes mellitus (DM) as a risk factor for penile implant infection by exploring the association between glycated haemoglobin (HbA1c) levels and penile implant infection rates and to define a threshold value that predicts implant infection. We conducted a multicentre prospective study including all patients undergoing penile implant surgery between 2009 and 2015. Preoperative, perioperative and postoperative management were identical for the entire cohort. Univariate analysis was performed to define predictors of implant infection. The HbA1c levels were analysed as continuous variables and sequential analysis was conducted using 0.5% increments to define a threshold level predicting implant infection. Multivariable analysis was performed with the following factors entered in the model: DM, HbA1C level, patient age, implant type, number of vascular risk factors (VRFs), presence of Peyronie's disease (PD), body mass index (BMI), and surgeon volume. A receiver operating characteristic (ROC) curve was generated to define the optimal HbA1C threshold for infection prediction. In all, 902 implant procedures were performed over the study period. The mean patient age was 56.6 years. The mean HbA1c level was 8.0%, with 81% of men having a HbA1c level of >6%. In all, 685 (76%) implants were malleable and 217 (24%) were inflatable devices; 302 (33.5%) patients also had a diagnosis of PD. The overall infection rate was 8.9% (80/902). Patients who had implant infection had significantly higher mean HbA1c levels, 9.5% vs 7.8% (P HbA1c level, we found infection rates were: 1.3% with HbA1c level of 9.5% (P HbA1c level, whilst a high-volume surgeon had a protective effect and was associated with a reduced infection risk. Using ROC analysis, we determined that a HbA1c threshold level of 8.5% predicted infection with a sensitivity of 80% and a specificity of 65%. Uncontrolled DM is associated with increased risk of infection after penile implant surgery\n[Significance of HbA1c and its measurement in the diagnosis of diabetes mellitus: US experience](http://www.dovepress.com/significance-of-hba1c-and-its-measurement-in-the-diagnosis-of-diabetes-peer-reviewed-article-DMSO) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJuarez DT\n2014-10-01\nFull Text Available Deborah Taira Juarez, Kendra M Demaris, Roy Goo, Christina Louise Mnatzaganian, Helen Wong SmithDaniel K Inouye College of Pharmacy, University of Hawaii at Hilo, Honolulu, HI, USAAbstract: The 2014 American Diabetes Association guidelines denote four means of diagnosing diabetes. The first of these is a glycosylated hemoglobin (HbA1c >6.5%. This literature review summarizes studies (n=47 in the USA examining the significance, strengths, and limitations of using HbA1c as a diagnostic tool for diabetes, relative to other available means. Due to the relatively recent adoption of HbA1c as a diabetes mellitus diagnostic tool, a hybrid systematic, truncated review of the literature was implemented. Based on these studies, we conclude that HbA1c screening for diabetes has been found to be convenient and effective in diagnosing diabetes. HbA1c screening is particularly helpful in community-based and acute care settings where tests requiring fasting are not practical. Using HbA1c to diagnose diabetes also has some limitations. For instance, HbA1c testing may underestimate the prevalence of diabetes, particularly among whites. Because this bias differs by racial group, prevalence and resulting estimates of health disparities based on HbA1c screening differ from those based on other methods of diagnosis. In addition, existing evidence suggests that HbA1c screening may not be valid in certain subgroups, such as children, women with gestational diabetes, patients with human immunodeficiency virus, and those with prediabetes. Further guidelines are needed to clarify the appropriate use of HbA1c screening in these populations.Keywords: diabetes mellitus, diagnosis, glycosylated hemoglobin, USA\n[Clinical and hematological response to hydroxyurea in a patient with Hb Lepore/beta-thalassemia.](https://www.ncbi.nlm.nih.gov/pubmed/9140718)\nRigano, P; Manfr\u00e9, L; La Galla, R; Renda, D; Renda, M C; Calabrese, A; Calzolari, R; Maggio, A\n1997-05-01\nThe possibility of increasing Hb F in vivo using drugs like 5-azacytidine, hydroxyurea, and butyrate has been established. However, in many cases this does not entail an increase in total hemoglobin. We report on a patient with Hb Lepore/beta-thalassemia being treated with hydroxyurea (30 mg/Kg/day) because of the presence of erythroid extramedullary masses with severe neurological abnormalities. During therapy the patient showed a remarkable improvement in neurological signs due to the reduction in extra-medullary masses, a significant increase in both total hemoglobin (from 5.8 to 9.7 g/dl) and Hb F (from 4.9 g/dl to 9.1 g/dl). The marked improvement in hemoglobin level in our patient with Hb Lepore/beta-thalassemia suggests gamma-globin gene activation due to the DNA structure determined by the crossover event.\n[HbE/\u03b2-Thalassemia and Oxidative Stress: The Key to Pathophysiological Mechanisms and Novel Therapeutics](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5421591)\nSibmooh, Nathawut; Fucharoen, Suthat\n2017-01-01\nAbstract Significance: Oxidative stress and generation of free radicals are fundamental in initiating pathophysiological mechanisms leading to an inflammatory cascade resulting in high rates of morbidity and death from many inherited point mutation-derived hemoglobinopathies. Hemoglobin (Hb)E is the most common point mutation worldwide. The \u03b2E-globin gene is found in greatest frequency in Southeast Asia, including Thailand, Malaysia, Indonesia, Vietnam, Cambodia, and Laos. With the wave of worldwide migration, it is entering the gene pool of diverse populations with greater consequences than expected. Critical Issues: While HbE by itself presents as a mild anemia and a single gene for \u03b2-thalassemia is not serious, it remains unexplained why HbE/\u03b2-thalassemia (HbE/\u03b2-thal) is a grave disease with high morbidity and mortality. Patients often exhibit defective physical development, severe chronic anemia, and often die of cardiovascular disease and severe infections. Recent Advances: This article presents an overview of HbE/\u03b2-thal disease with an emphasis on new findings pointing to pathophysiological mechanisms derived from and initiated by the dysfunctional property of HbE as a reduced nitrite reductase concomitant with excess \u03b1-chains exacerbating unstable HbE, leading to a combination of nitric oxide imbalance, oxidative stress, and proinflammatory events. Future Directions: Additionally, we present new therapeutic strategies that are based on the emerging molecular-level understanding of the pathophysiology of this and other hemoglobinopathies. These strategies are designed to short-circuit the inflammatory cascade leading to devastating chronic morbidity and fatal consequences. Antioxid. Redox Signal. 26, 794\u2013813. PMID:27650096\n[HbE/\u03b2-Thalassemia and Oxidative Stress: The Key to Pathophysiological Mechanisms and Novel Therapeutics.](https://www.ncbi.nlm.nih.gov/pubmed/27650096)\nHirsch, Rhoda Elison; Sibmooh, Nathawut; Fucharoen, Suthat; Friedman, Joel M\n2017-05-10\nOxidative stress and generation of free radicals are fundamental in initiating pathophysiological mechanisms leading to an inflammatory cascade resulting in high rates of morbidity and death from many inherited point mutation-derived hemoglobinopathies. Hemoglobin (Hb)E is the most common point mutation worldwide. The \u03b2 E -globin gene is found in greatest frequency in Southeast Asia, including Thailand, Malaysia, Indonesia, Vietnam, Cambodia, and Laos. With the wave of worldwide migration, it is entering the gene pool of diverse populations with greater consequences than expected. While HbE by itself presents as a mild anemia and a single gene for \u03b2-thalassemia is not serious, it remains unexplained why HbE/\u03b2-thalassemia (HbE/\u03b2-thal) is a grave disease with high morbidity and mortality. Patients often exhibit defective physical development, severe chronic anemia, and often die of cardiovascular disease and severe infections. Recent Advances: This article presents an overview of HbE/\u03b2-thal disease with an emphasis on new findings pointing to pathophysiological mechanisms derived from and initiated by the dysfunctional property of HbE as a reduced nitrite reductase concomitant with excess \u03b1-chains exacerbating unstable HbE, leading to a combination of nitric oxide imbalance, oxidative stress, and proinflammatory events. Additionally, we present new therapeutic strategies that are based on the emerging molecular-level understanding of the pathophysiology of this and other hemoglobinopathies. These strategies are designed to short-circuit the inflammatory cascade leading to devastating chronic morbidity and fatal consequences. Antioxid. Redox Signal. 26, 794-813.\n[Hb Heathrow [\u03b2103(G5)Phe\u2192Leu], a First Report in an Asian Patient with Erythrocytosis.](https://www.ncbi.nlm.nih.gov/pubmed/28332377)\nShin, Sang Yong; Kim, Hyun Young; Kim, Hee Jin; Kim, Hoon Gu\n2017-05-01\nCongenital erythrocytosis (CE) is a rare and heterogeneous disease. The high oxygen affinity hemoglobin (Hb) variants are the most common cause of CE. Herein, we report a Korean patient with isolated erythrocytosis. A 25-year-old man was referred to our hospital for evaluation of high Hb level (Hb 20.4 g/dL, hematocrit 58%, reticulocyte count 2.90%, white blood cell count 6.83\u00d710\u2079/L, and platelet count 195\u00d710\u2079/L). Bone marrow biopsy revealed normocellular marrow without myeloproliferative features. JAK2 (V617F, exon 12), CALR (exon 9), and MPL W515K/L mutations were not detected. P\u2085\u2080 (partial pressure at which Hb is half saturated with oxygen), which is an indicator of left-shift of oxygen dissociation curve (high oxygen affinity state), was 14.3 mm Hg (reference value 22.6-29.4 mm Hg). He was suspected to have CE. Mutation analysis of the HBB gene revealed the known Hb variant, Hb Heathrow [\u03b2103(G5)Phe\u2192Leu]. This is the first report of Hb Heathrow in Asian. \u00a9 Copyright: Yonsei University College of Medicine 2017.\n[Effects of common hemoglobin variants on HbA1c measurements in China: results for \u03b1- and \u03b2-globin variants measured by six methods.](https://www.ncbi.nlm.nih.gov/pubmed/29626415)\nXu, Anping; Chen, Weidong; Xia, Yong; Zhou, Yu; Ji, Ling\n2018-04-07\nHbA1c is a widely used biomarker for diabetes mellitus management. Here, we evaluated the accuracy of six methods for determining HbA1c values in Chinese patients with common \u03b1- and \u03b2-globin chains variants in China. Blood samples from normal subjects and individuals exhibiting hemoglobin variants were analyzed for HbA1c, using Sebia Capillarys 2 Flex Piercing (C2FP), Bio-Rad Variant II Turbo 2.0, Tosoh HLC-723 G8 (ver. 5.24), Arkray ADAMS A1c HA-8180V fast mode, Cobas c501 and Trinity Ultra2 systems. DNA sequencing revealed five common \u03b2-globin chain variants and three common \u03b1-globin chain variants. The most common variant was Hb E, followed by Hb New York, Hb J-Bangkok, Hb G-Coushatta, Hb Q-Thailand, Hb G-Honolulu, Hb Ube-2 and Hb G-Taipei. Variant II Turbo 2.0, Ultra2 and Cobas c501 showed good agreement with C2FP for most samples with variants. HLC-723 G8 yielded no HbA1c values for Hb J-Bangkok, Hb Q-Thailand and Hb G-Honolulu. Samples with Hb E, Hb G-Coushatta, Hb G-Taipei and Hb Ube-2 produced significant negative biases for HLC-723 G8. HA-8180V showed statistically significant differences for Hb E, Hb G-Coushatta, Hb G-Taipei, Hb Q-Thailand and Hb G-Honolulu. HA-8180V yielded no HbA1c values for Hb J-Bangkok. All methods showed good agreement for samples with Hb New York. Some common hemoglobin variants can interfere with HbA1c determination by the most popular methods in China.\n[Chronic cerebral hypoperfusion-induced impairment of A\u03b2 clearance requires HB-EGF-dependent sequential activation of HIF1\u03b1 and MMP9.](https://www.ncbi.nlm.nih.gov/pubmed/27431094)\nAshok, Anushruti; Rai, Nagendra Kumar; Raza, Waseem; Pandey, Rukmani; Bandyopadhyay, Sanghamitra\n2016-11-01\nChronic cerebral hypoperfusion (CCH) manifests Alzheimer's Disease (AD) neuropathology, marked by increased amyloid beta (A\u03b2). Besides, hypoxia stimulates Heparin-binding EGF-like growth factor (HB-EGF) mRNA expression in the hippocampus. However, involvement of HB-EGF in CCH-induced A\u03b2 pathology remains unidentified. Here, using Bilateral Common Carotid Artery Occlusion mouse model, we explored the mechanism of HB-EGF regulated A\u03b2 induction in CCH. We found that HB-EGF inhibition suppressed, while exogenous-HB-EGF triggered hippocampal A\u03b2, proving HB-EGF-dependent A\u03b2 increase. We also detected that HB-EGF affected the expression of primary A\u03b2 transporters, receptor for advanced glycation end-products (RAGE) and lipoprotein receptor-related protein-1 (LRP-1), indicating impaired A\u03b2 clearance across the blood-brain barrier (BBB). An HB-EGF-dependent loss in BBB integrity supported impaired A\u03b2 clearance. The effect of HB-EGF on Amyloid Precursor Protein pathway was relatively insignificant, suggesting a lesser effect on A\u03b2 generation. Delving into BBB disruption mechanism demonstrated HB-EGF-mediated stimulation of Matrix metalloprotease-9 (MMP9), which affected BBB via HB-EGF-ectodomain shedding and epidermal growth factor receptor activation. Examining the intersection of HB-EGF-regulated pathway and hypoxia revealed HB-EGF-dependent increase in transcription factor, Hypoxia-inducible factor-1alpha (HIF1\u03b1). Further, via binding to hypoxia-responsive elements in MMP9 gene, HIF1\u03b1 stimulated MMP9 expression, and therefore appeared as a prominent intermediary in HB-EGF-induced BBB damage. Overall, our study reveals the essential role of HB-EGF in triggering CCH-mediated A\u03b2 accumulation. The proposed mechanism involves an HB-EGF-dependent HIF1\u03b1 increase, generating MMP9 that stimulates soluble-HB-EGF/EGFR-induced BBB disintegration. Consequently, CCH-mediated hippocampal RAGE and LRP-1 deregulation together with BBB damage impair A\u03b2 transport and clearance\n[El Ateneo de Madrid y el problema colonial en las v\u00edsperas de la guerra de independencia cubana](http://revistadeindias.revistas.csic.es/index.php/revistadeindias/article/view/811/880) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGarc\u00eda Mora, Luis Miguel\n1996-08-01\nFull Text Available Spain\u2019s colonial problem on the eve of the Cuban War of Independence was a deeply debated subject at the time in the Athenaeum of Madrid, like in Parliament. The author's argument is that, rather than sponsoring a scientific debate on the matter, the Athenaeum wanted to influence Spain\u2019s public opinion and political \u00e9lite of its own ideas on colonial reform.\nEl problema colonial fue un tema debatido en profundidad en el Ateneo de Madrid en los momentos previos a la definitiva Guerra de Independencia Cubana (1895-1898. La idea que se defiende es que m\u00e1s que tener lugar un debate cient\u00edfico sobre el problema colonial contempor\u00e1neo, se trataba de aprovechar la plataforma atene\u00edsta para concienciar a la opini\u00f3n p\u00fablica y la \u00e9lite pol\u00edtica espa\u00f1ola de la necesidad de una reforma colonial que por las mismas fechas se discut\u00eda en el Parlamento.\n[Translating HbA1c measurements into estimated average glucose values in pregnant women with diabetes.](https://www.ncbi.nlm.nih.gov/pubmed/28105519)\nLaw, Graham R; Gilthorpe, Mark S; Secher, Anna L; Temple, Rosemary; Bilous, Rudolf; Mathiesen, Elisabeth R; Murphy, Helen R; Scott, Eleanor M\n2017-04-01\nThis study aimed to examine the relationship between average glucose levels, assessed by continuous glucose monitoring (CGM), and HbA 1c levels in pregnant women with diabetes to determine whether calculations of standard estimated average glucose (eAG) levels from HbA 1c measurements are applicable to pregnant women with diabetes. CGM data from 117 pregnant women (89 women with type 1 diabetes; 28 women with type 2 diabetes) were analysed. Average glucose levels were calculated from 5-7 day CGM profiles (mean 1275 glucose values per profile) and paired with a corresponding (\u00b11 week) HbA 1c measure. In total, 688 average glucose-HbA 1c pairs were obtained across pregnancy (mean six pairs per participant). Average glucose level was used as the dependent variable in a regression model. Covariates were gestational week, study centre and HbA 1c . There was a strong association between HbA 1c and average glucose values in pregnancy (coefficient 0.67 [95% CI 0.57, 0.78]), i.e. a 1% (11 mmol/mol) difference in HbA 1c corresponded to a 0.67 mmol/l difference in average glucose. The random effects model that included gestational week as a curvilinear (quadratic) covariate fitted best, allowing calculation of a pregnancy-specific eAG (PeAG). This showed that an HbA 1c of 8.0% (64 mmol/mol) gave a PeAG of 7.4-7.7 mmol/l (depending on gestational week), compared with a standard eAG of 10.2 mmol/l. The PeAG associated with maintaining an HbA 1c level of 6.0% (42 mmol/mol) during pregnancy was between 6.4 and 6.7 mmol/l, depending on gestational week. The HbA 1c -average glucose relationship is altered by pregnancy. Routinely generated standard eAG values do not account for this difference between pregnant and non-pregnant individuals and, thus, should not be used during pregnancy. Instead, the PeAG values deduced in the current study are recommended for antenatal clinical care.\n[Improving access to HbA1c in sub-Saharan Africa (IA3) cohort: cohort profile.](https://www.ncbi.nlm.nih.gov/pubmed/29187944)\nBalde, Naby; Camara, Alioune; Sobngwi-Tambekou, Joelle; Balti, Eric Vounsia; Tchatchoua, Alain; Fezeu, Leopold; Limen, Serge; Ngamani, Sylvie; Ngapout, Suzanne; Kengne, Andre Pascal; Sobngwi, Eugene\n2017-01-01\nGlycated haemoglobin (HbA1c) is the best surrogate of average blood glucose control in diabetic patients, and lowering HbA1c significantly reduces diabetes complications. Moreover, immediate feedback of HbA1c measurement to patients may improve control. However, HbA1c is unavailable in most parts of Africa, a continent with one of the highest burden of diabetes. To translate these evidences, we are conducting a multicentric project in 10 health care facilities in Guinea and Cameroon to evaluate the feasibility and one-year benefit of affordable HbA1c measurement with immediate feedback to patients on diabetes control and related outcomes. We consecutively enrolled patients with diabetes mellitus independently of the type of disease. We hypothesised an average 1%-decrease in HbA1c in a 1000-patient study population, with a 20% increase in the number of patients reaching treatment goals within 12 months of intervention and follow-up. A total of 1, 349 diabetic patients aged 56.2\u00b112.6 years are enrolled (813 in Cameroon and 536 in Guinea) of whom 59.8% are women. The mean duration of diabetes is 7.4\u00b16.3 years and baseline HbA1c is 9.7\u00b12.6% in Guinea and 8.6\u00b12.5% in Cameroon. To investigate whether the introduction of routine HbA1c measurement with immediate feedback to patients and provision of relevant education would improve diabetes control after one year. The impact of the intervention on diabetes associated-complications and mortality warrant further assessment in the long term.\n[Oxidized LDL but not total LDL is associated with HbA1c in individuals without diabetes.](https://www.ncbi.nlm.nih.gov/pubmed/28601670)\nSpessatto, D\u00e9bora; Brum, Liz Marina Bueno Dos Passos; Camargo, Jo\u00edza Lins\n2017-08-01\nThis study investigates the association between HbA1c, LDL and oxi-LDL in individuals without diabetes (DM). One hundred and ninety-six individuals, without DM, were enrolled and divided into three groups according to HbA1c and fasting plasma glucose values. HbA1c, oxi-LDL, LDL, and other biochemical measurements of lipid profile were also carried out. oxi-LDL levels showed significant differences among all groups and group 3 presented higher values [34U/L (27-46); 44U/L (37-70); and 86U/L (49-136); pHbA1c showed moderate positive associations with oxi-LDL (r=0.431; pHbA1c and TC (r=0.142; p=0.048), triglycerides (r=0.155; p=0.030), LDL (r=0.148; p=0.039), non-HDL (r=0.192; p=0.007) and Apo B (r=0.171, pHbA1c and oxi-LDL, oxi-LDL/HDL and oxi-LDL/LDL ratios remained significant even after adjustment by multiple linear regression analysis for the variables alcohol consumption, use of medicine, BMI, and age. oxi-LDL levels are significantly associated with HbA1c in non-diabetic individuals. However, the levels of traditional atherogenic lipids only showed a weak association with HbA1c levels. Those at high risk of developing DM or cardiovascular disease have higher levels of oxi-LDL. These data favor to the use of HbA1c as a biomarker to identify individuals at risk of developing complications even in non-diabetic glycemic levels. Copyright \u00a9 2017 Elsevier B.V. All rights reserved.\n[Biochemical and Molecular Analysis of the Hb Lepore Boston Washington in a Syrian Homozygous Child](http://dx.doi.org/10.1155/2017/1261972) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMonica Pirastru\n2017-01-01\nFull Text Available Hemoglobin (Hb Lepore is composed of two normal \u03b1 chains and two \u03b4\u03b2 fusion globins that arise from unequal crossover events between the \u03b4- and \u03b2-globin genes. The Hb Lepore is widespread all over the world and in many ethnic groups. It includes some of the few clinically significant Hb variants that are associated with a \u03b2-thalassemia phenotype. Here, we describe the first occurrence of Hb Lepore Boston Washington in a Syrian individual. The patient, a 10-year-old child, shows severe anemia with a Hb level of 6.85 g/dL and typical thalassemic red cell indices. The diagnostic procedure implies hematological, biochemical, and molecular analysis, including multiplex ligation-dependent probe amplification (MLPA assay, GAP-PCR, and DNA sequencing. This latter allowed us to define the correct structure of the hybrid \u03b4\u03b2-globin gene. The knowledge of the spectrum of mutations associated with different geographical areas is the prerequisite to set up large-scale screening programs and be able to offer genetic counseling to couples at risk.\n[Vaccines against papillomavirus infections and disease Vacunas contra el virus del papiloma humano y c\u00e1ncer cervical invasor](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342003000900019) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLuisa Lina Villa\n2003-01-01\nFull Text Available Squamous cell carcinoma of the uterine cervix is the second cause of cancer-related deaths in women, the higher incidence being observed in developing countries. Infection with oncogenic types of human papillomavirus (HPV is considered the major risk factor for the development of malignancies in the uterine cervix. However, HPV is considered to be a necessary but not sufficient cause for cervical cancer and, therefore, other factors contribute to the carcinogenic process, both present in the environment and from the host. Studies performed in animals, and more recently in humans, indicate that vaccination against the capsid proteins of the virus can prevent efficiently from infection. Furthermore, therapeutic vaccines are under investigation aiming the regression of papillomavirus induced tumors. The scientific basis for the development of papillomavirus vaccines and present status of clinical trials will be addressed in this chapter.El c\u00e1ncer de c\u00e9lulas escamosas del c\u00e9rvix uterino es la segunda causa de muerte relacionada con c\u00e1ncer en mujeres en el mundo; la incidencia m\u00e1s alta se ha observado en pa\u00edses en desarrollo. La infecci\u00f3n con tipos oncog\u00e9nicos de virus de papiloma humano es considerado el factor de riesgo principal para el desarrollo de malignidad en el c\u00e9rvix uterino. Sin embargo, el virus es considerado una causa necesaria pero no suficiente para desarrollo de c\u00e1ncer cervical y, por lo tanto, existen otros factores en el ambiente y en el hu\u00e9sped que contribuyen al proceso carcinog\u00e9nico. Estudios desarrollados en animales, y m\u00e1s recientemente en humanos, indican que la vacunaci\u00f3n en contra de la c\u00e1pside de las prote\u00ednas del virus puede prevenir eficientemente la infecci\u00f3n en forma profil\u00e1ctica; adem\u00e1s, las vacunas terap\u00e9uticas est\u00e1n bajo investigaci\u00f3n con el prop\u00f3sito de promover regresi\u00f3n de los tumores inducidos por virus de papiloma humano. Las bases cient\u00edficas de las vacunas desarrolladas contra este\n[COLOFONIA DE PIN\u00c1CEAS CUBANAS PARA EL CONTROL DE ENFERMEDADES TROPICALES TRANSMITIDAS POR MOLUSCOS](http://www.redalyc.org/articulo.oa?id=62913391004) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nY. Arteaga-Crespo\n2010-01-01\nFull Text Available La esquistosomiasis, enfermedad tropical transmitida por molusco, ocupa el segundo lugar en enfermedades parasitarias despu\u00e9s de la malaria. En Cuba no existe la esquistosomiasis aunque s\u00ed el riesgo a contraerla, puesto que en nuestra fauna se encuentran especies que pueden actuar como hospederos intermediarios del trem\u00e1todo causante de la enfermedad. El objetivo del trabajo fue evaluar el polvo de colofonia sobre larvas de Biomphalaria havanensis para el control de vectores que propagan la esquistosomiasis, seg\u00fan la metodolog\u00eda desarrollada por la Organizaci\u00f3n Mundial para la Salud (OMS y descrita por Mott para la evaluaci\u00f3n de plantas con acci\u00f3n molusquicida. Los resultados del estudio sugieren la acci\u00f3n molusquicida de colofonia obtenida de pin\u00e1ceas cubanas (Pinus caribaea y Pinus tropicalis sobre larvas de Biomphalaria havanensis en dosis letales (DL50 y DL90 son 44, 33 mg\u00b7L-1 y 141, 76 mg\u00b7L-1, respectivamente. La ecuaci\u00f3n de regresi\u00f3n correspondiente fue: Y = - 0, 412 + 1, 086 ln X con un valor del coeficiente de correlaci\u00f3n R 0, 99 y error est\u00e1ndar 0, 13. Las dosis revelan la efectividad de los componentes presentes en la colofonia, resultados comparables con publicaciones de extractos de otras especies de plantas.\n[Aldimine Formation Reaction, the First Step of the Maillard Early-phase Reaction, Might be Enhanced in Variant Hemoglobin, Hb Himeji.](https://www.ncbi.nlm.nih.gov/pubmed/26663794)\nKoga, Masafumi; Inada, Shinya; Shimizu, Sayoko; Hatazaki, Masahiro; Umayahara, Yutaka; Nishihara, Eijun\n2015-01-01\nHb Himeji (\u03b2140Ala\u2192Asp) is known as a variant hemoglobin in which glycation is enhanced and HbA1c measured by immunoassay shows a high value. The phenomenon of enhanced glycation in Hb Himeji is based on the fact that the glycation product of variant hemoglobin (HbX1c) shows a higher value than HbA1c. In this study, we investigated whether aldimine formation reaction, the first step of the Maillard early-phase reaction, is enhanced in Hb Himeji in vitro. Three non-diabetic subjects with Hb Himeji and four non-diabetic subjects without variant hemoglobin were enrolled. In order to examine aldimine formation reaction, whole blood cells were incubated with 500 mg/dl of glucose at 37\u00b0C for 1 hour and were analyzed by high-performance liquid chromatography. Both HbA1c and HbX1c were not increased in this condition. After incubation with glucose, labile HbA1c (LA1c) fraction increased in the controls (1.1\u00b10.3%). In subjects with Hb Himeji increases in the labile HbX1c (LX1c) fraction as well as the LA1c fraction were observed, and the degree of increase in the LX1c fraction was significantly higher than that of the LA1c fraction (1.8\u00b10.1% vs. 0.5\u00b10.2%, Preaction might be enhanced in Hb Himeji in vitro. The 140th amino acid in \u03b2 chain of hemoglobin is suggested to be involved in aldimine formation reaction. \u00a9 2015 by the Association of Clinical Scientists, Inc.\n[Role of HbA1c in the Screening of Diabetes Mellitus in a Korean Rural Community](http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-36-37.pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJae Hyun Kim\n2012-02-01\nFull Text Available BackgroundRecently, the measurement of glycated hemoglobin (HbA1c was recommended as an alternative to fasting plasma glucose or oral glucose tolerance tests for diagnosing diabetes mellitus (DM. In this study, we analyzed HbA1c levels for diabetes mellitus screening in a Korean rural population.MethodsWe analyzed data from 10,111 subjects from a Korean Rural Genomic Cohort study and generated a receiver operating characteristic curve to determine an appropriate HbA1c cutoff value for diabetes.ResultsThe mean age of the subjects was 56.3\u00b18.1 years. Fasting plasma glucose and 2-hour plasma glucose after 75 g oral glucose tolerance tests were 97.5\u00b125.6 and 138.3\u00b167.1 mg/dL, respectively. The mean HbA1c level of the subjects was 5.7\u00b10.9%. There were 8,809 non-DM patients (87.1% and 1,302 DM patients (12.9%. A positive relationship between HbA1c and plasma glucose levels and between HbA1c and 2-hour plasma glucose levels after oral glucose tolerance tests was found in a scatter plot of the data. Using Youden's index, the proper cutoff level of HbA1c for diabetes mellitus screening was 5.95% (sensitivity, 77%; specificity, 89.4%.ConclusionOur results suggest that the optimal HbA1c level for DM screening is 5.95%.\n[Characterization of Hb Bart's Hydrops Fetalis Caused by - -SEA and a Large Novel \u03b10-Thalassemia Deletion.](https://www.ncbi.nlm.nih.gov/pubmed/29493331)\nHe, Sheng; Li, Jihui; Huang, Peng; Zhang, Shujie; Lin, Li; Zuo, Yangjin; Tian, Xiaoxian; Zheng, Chenguang; Qiu, Xiaoxia; Chen, Biyan\n2018-01-01\nHb Bart's hydrops fetalis is the most severe and generally fatal clinical phenotype of \u03b1-thalassemia (\u03b1-thal), which is due to the deletion of all four functional \u03b1-globin genes of hemoglobin (Hb), resulting in no \u03b1-globin chain production (- -/- -). Homozygosity for the - - SEA (Southeast Asian) \u03b1-globin gene deletion is the main cause of the Hb Bart's hydrops fetalis in Asia, especially South China. Occasionally, other \u03b1 0 -thal deletions can also be found. In this study, we report a case with an atypical form of Hb Bart's hydrops fetalis that was caused by - - SEA and a large novel \u03b1 0 -thal deletion (- - GX ) (Guangxi). The fetus with Hb Bart's in our study presented fetal hydrops features in early gestation which was different from that of traditional Hb Bart's hydrops fetalis with a homozygous - - SEA deletion. The early onset of fetal hydrops is attributed to the decreased formation of embryonic Hb Portland (\u03b62\u03b32), which is proposed as a candidate for reactivation in cases of severe \u03b1-thal. Our findings indicated that it was important to characterize new or rare mutations, and highlighted the significance of using ultrasonography to identify signs of Hb Bart's hydrops fetalis.\n[Environmental regulation of lateral root emergence in Medicago truncatula requires the HD-Zip I transcription factor HB1.](https://www.ncbi.nlm.nih.gov/pubmed/20675575)\nAriel, Federico; Diet, Anouck; Verdenaud, Marion; Gruber, V\u00e9ronique; Frugier, Florian; Chan, Raquel; Crespi, Martin\n2010-07-01\nThe adaptation of root architecture to environmental constraints is a major agricultural trait, notably in legumes, the third main crop worldwide. This root developmental plasticity depends on the formation of lateral roots (LRs) emerging from primary roots. In the model legume Medicago truncatula, the HD-Zip I transcription factor HB1 is expressed in primary and lateral root meristems and induced by salt stress. Constitutive expression of HB1 in M. truncatula roots alters their architecture, whereas hb1 TILLING mutants showed increased lateral root emergence. Electrophoretic mobility shift assay, promoter mutagenesis, and chromatin immunoprecipitation-PCR assays revealed that HB1 directly recognizes a CAATAATTG cis-element present in the promoter of a LOB-like (for Lateral Organ Boundaries) gene, LBD1, transcriptionally regulated by auxin. Expression of these genes in response to abscisic acid and auxin and their behavior in hb1 mutants revealed an HB1-mediated repression of LBD1 acting during LR emergence. M. truncatula HB1 regulates an adaptive developmental response to minimize the root surface exposed to adverse environmental stresses.\n[Pneumococcal disease and vaccination in the Americas: an agenda for accelerated vaccine introduction Enfermedad neumoc\u00f3cica y vacunaci\u00f3n antineumoc\u00f3cica en las Am\u00e9ricas: programa de acci\u00f3n para la introducci\u00f3n acelerada de una vacuna](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892006000500007) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSalvador Garcia\n2006-05-01\nOrganizaci\u00f3n Panamericana de la Salud (OPS y el Plan para el Desarrollo Acelerado y la Introducci\u00f3n de Vacunas Antineumoc\u00f3cicas (PneumoADIP, por Pneumococcal Vaccines and Accelerated Development and Introduction Plan de la Alianza Mundial para Vacunas e Inmunizaci\u00f3n (GAVI, por Global Alliance for Vaccines and Immunization. Las personas que participaron en la reuni\u00f3n revisaron el estado de la vigilancia de las enfermedades neumoc\u00f3cicas en la Regi\u00f3n de las Am\u00e9ricas, as\u00ed como c\u00e1lculos de la carga de enfermedades neumoc\u00f3cicas, la distribuci\u00f3n de serotipos de Streptococcus pneumoniae que provocan enfermedad invasora, el estado de la introducci\u00f3n de vacunas antineumoc\u00f3cicas, an\u00e1lisis econ\u00f3micos sanitarios, y aspectos econ\u00f3micos de la introducci\u00f3n de la vacuna. Los participantes de la reuni\u00f3n tambi\u00e9n se dedicaron a identificar los pr\u00f3ximos pasos necesarios para generar la informaci\u00f3n esencial que hace falta para facilitar la toma de decisiones en torno a la introducci\u00f3n de una vacuna antineumoc\u00f3cica. La vigilancia coordinada de las enfermedades neumoc\u00f3cicas en la Regi\u00f3n de las Am\u00e9ricas se remonta a 1993, cuando la OPS estableci\u00f3 el proyecto conocido por Sistema Regional de Vacunas (SRV, dedicado a la vigilancia de la meningitis y la neumon\u00eda por bacterias, incluido el neumococo. Los datos obtenidos mediante las actividades de vigilancia del SRV indican que la distribuci\u00f3n de los principales serotipos en las Am\u00e9ricas ha sido estable a lo largo del tiempo (pero que la resistencia a los antibi\u00f3ticos va en aumento, siendo el serotipo 14 el que m\u00e1s se a\u00edsla en la mayor\u00eda de los pa\u00edses que participan en el SRV. Seg\u00fan se deduce de los datos sobre serotipos procedentes de seis de los pa\u00edses abarcados por el SRV (Argentina, Brasil, Chile, Colombia, M\u00e9xico y Uruguay, la vacuna septavalente cubrir\u00eda a alrededor de 65% de los serotipos, la nonavalente cubrir\u00eda a m\u00e1s de 77% y la undecavalente cubrir\u00eda a m\u00e1s de 83%.\n[Implantation of FRAPCON-2 code in HB computer](http://www.iaea.org/inis/collection/NCLCollectionStore/_Public/23/026/23026483.pdf?r=1) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nSilva, C.F. da.\n1987-05-01\nThe modifications carried out for implanting FRAPCON-2 computer code in the HB DPS-T7 computer are presented. The FRAPCON-2 code calculates thermo-mechanical response during long period of burnup in stationary state for fuel rods of PWR type reactors. (M.C.K.)\n[Safety and immunogenicity of a combined hepatitis B virus-Haemophilus influenzae type B vaccine comprising a synthetic antigen in healthy adults.](https://www.ncbi.nlm.nih.gov/pubmed/18441530)\nAguilar-Betancourt, Ar\u00edstides; Gonz\u00e1lez-Delgado, Carlos Alberto; Cinza-Est\u00e9vez, Z; Mart\u00ednez-Cabrera, Jesus; V\u00e9liz-R\u00edos, Gloria; Alem\u00e1n-Zald\u00edvar, Regis; Alonso-Mart\u00ednez, M I; Lago-Ba\u00f1os, M; Puble-Alvarez, N; Delahanty-Fernandez, A; Juvier-Madrazo, A I; Ortega-Le\u00f3n, D; Olivera-Ruano, L; Correa-Fern\u00e1ndez, A; Abreu-Reyes, D; Soto-Mestre, E; P\u00e9rez-P\u00e9rez, M V; Figueroa-Baile, N; P\u00e9rez, L Hernandez; Rodr\u00edguez-Silva, A; Mart\u00ednez-D\u00edaz, E; Guill\u00e9n-Nieto, G E; Muzio-Gonz\u00e1lez, Verena L\n2008-01-01\nThe combined HB-Hib vaccine candidate Hebervac HB-Hib (CIGB, La Habana), comprising recombinant HBsAg and tetanus toxoid conjugate synthetic PRP antigens has shown to be highly immunogenic in animal models. A phase I open, controlled, randomized clinical trial was carried out to assess the safety and immunogenicity profile of this bivalent vaccine in 25 healthy adults who were positive for antibody to HBsAg (anti-HBs). The trial was performed according to Good Clinical Practices and Guidelines. Volunteers were randomly allocated to receive the combined vaccine or simultaneous administration of HB vaccine Heberbiovac-HB and Hib vaccine QuimiHib (CIGB, La Habana). All individuals were intramuscularly immunized with a unique dose of 10 microg HBsAg plus 10 microg conjugated synthetic PRP. Adverse events were actively recorded after vaccine administration. Total anti-HBs and IgG anti-PRP antibody titers were evaluated using commercial ELISA kits at baseline and 30 days post-vaccination. The combined vaccine candidate was safe and well tolerated. The most common adverse reactions were local pain, febricula, fever and local erythema. These reactions were all mild in intensity and resolved without medical treatment. Adverse events were mostly reported during the first 6-72 hours post-vaccination. There were no serious adverse events during the study. No severe or unexpected events were either recorded during the trial. The combined vaccine elicited an anti-HBs and anti-PRP booster response in 100% of subjects at day 30 of the immunization schedule. Anti-HBs and anti-PRP antibody levels had at least a two-fold increase compared to baseline sera. Even more, anti-HBs antibody titer showed a four-fold increase in 100% of volunteers in the study group. The results indicate that the combined HB-Hib vaccine produces increased antibody levels in healthy adults who have previously been exposed to these two antigens. To our knowledge, this is the first demonstration of safety and\n[Problemas bio\u00e9ticos en la investigaci\u00f3n de nuevas vacunas: \u00bfobedecen a razones de salud p\u00fablica?](http://www.redalyc.org/articulo.oa?id=73138582007) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJuan Carlos Tealdi\n2015-01-01\nFull Text Available Los problemas \u00e9ticos de las investigaciones sobre vacunas han crecido en las \u00faltimas d\u00e9cadas en frecuencia y magnitud debido a la posici\u00f3n dominante de la industria farmac\u00e9utica en el desarrollo de esos estudios. Las tradicionales cuestiones de seguridad y eficacia se han visto agravadas por el conflicto de intereses introducido por la competencia comercial en un mercado a escala global de miles de millones de d\u00f3lares. La integridad profesional de los investigadores, la responsabilidad moral de los patrocinadores, y la regulaci\u00f3n y control por parte de los Estados nacionales, se muestra cuestionada en varios ejemplos. Los resultados de estos cambios son las amenazas a la protecci\u00f3n de los derechos de las personas incluidas en estas investigaciones y el discutible progreso que resulta para la salud p\u00fablica.\n[Acute Sickle Hepatic Crisis after Liver Transplantation in a Patient with Hb SC Disease](http://dx.doi.org/10.1155/2015/761740) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJ. H. Gillis\n2015-01-01\nFull Text Available Acute sickle hepatic crisis (ASHC has been observed in approximately 10% of patients with sickle cell disease. It occurs predominantly in patients with homozygous (Hb SS sickle cell anemia and to a lesser degree in patients with Hb SC disease, sickle cell trait, and Hb S beta thalassemia. Patients commonly present with jaundice, right upper quadrant pain, nausea, low-grade fever, tender hepatomegaly, and mild to moderate elevations in serum AST, ALT, and bilirubin. We describe the case of a patient with a history of hemoglobin SC disease and cirrhosis caused by hepatitis C presenting approximately 1 year after liver transplantation with an ASHC. The diagnosis was confirmed by liver biopsy. Our patient was treated with RBC exchange transfusions, IV hydration, and analgesia and made a complete recovery. Only a limited number of patients with sickle cell disease have received liver transplants, and, to our knowledge, this is the first case of ASHC after transplantation in a patient with Hb SC disease.\n[Rubber particle proteins, HbREF and HbSRPP, show different interactions with model membranes.](https://www.ncbi.nlm.nih.gov/pubmed/24036080)\nBerthelot, Karine; Lecomte, Sophie; Estevez, Yannick; Zhendre, Vanessa; Henry, Sarah; Th\u00e9venot, Julie; Dufourc, Erick J; Alves, Isabel D; Peruch, Fr\u00e9d\u00e9ric\n2014-01-01\nThe biomembrane surrounding rubber particles from the hevea latex is well known for its content of numerous allergen proteins. HbREF (Hevb1) and HbSRPP (Hevb3) are major components, linked on rubber particles, and they have been shown to be involved in rubber synthesis or quality (mass regulation), but their exact function is still to be determined. In this study we highlighted the different modes of interactions of both recombinant proteins with various membrane models (lipid monolayers, liposomes or supported bilayers, and multilamellar vesicles) to mimic the latex particle membrane. We combined various biophysical methods (polarization-modulation-infrared reflection-adsorption spectroscopy (PM-IRRAS)/ellipsometry, attenuated-total reflectance Fourier-transform infrared (ATR-FTIR), solid-state nuclear magnetic resonance (NMR), plasmon waveguide resonance (PWR), fluorescence spectroscopy) to elucidate their interactions. Small rubber particle protein (SRPP) shows less affinity than rubber elongation factor (REF) for the membranes but displays a kind of \"covering\" effect on the lipid headgroups without disturbing the membrane integrity. Its structure is conserved in the presence of lipids. Contrarily, REF demonstrates higher membrane affinity with changes in its aggregation properties, the amyloid nature of REF, which we previously reported, is not favored in the presence of lipids. REF binds and inserts into membranes. The membrane integrity is highly perturbed, and we suspect that REF is even able to remove lipids from the membrane leading to the formation of mixed micelles. These two homologous proteins show affinity to all membrane models tested but neatly differ in their interacting features. This could imply differential roles on the surface of rubber particles. \u00a9 2013.\n[Validation and determination of a reference interval for canine HbA1c using an immunoturbidimetric assay.](https://www.ncbi.nlm.nih.gov/pubmed/28387422)\nGoemans, Anne F; Spence, Susanna J; Ramsey, Ian K\n2017-06-01\nHemoglobin A1c (HbA1c) provides a reliable measure of glycemic control over 2-3 months in human diabetes mellitus. In dogs, presence of HbA1c has been demonstrated, but there are no validated commercial assays. The purpose of the study was to validate a commercially available automated immunoturbidimetric assay for canine HbA1c and determine an RI in a hospital population. The specificity of the assay was assessed by inducing glycosylation in vitro using isolated canine hemoglobin, repeatability by measuring canine samples 5 times in succession, long term inter-assay imprecision by measuring supplied control materials, stability using samples stored at 4\u00b0C over 5 days and -20\u00b0C over 8 weeks, linearity by mixing samples of known HbA1c in differing proportions, and the effect of anticoagulants with paired samples. An RI was determined using EDTA-anticoagulated blood samples from 60 nondiabetic hospitalized animals of various ages and breeds. Hemoglobin A1c was also measured in 10 diabetic dogs. The concentration of HbA1c increased proportionally with glucose concentration in vitro. For repeat measurements, the CV was 4.08% (range 1.16-6.10%). Samples were stable for 5 days at 4\u00b0C. The assay was linear within the assessed range. Heparin- and EDTA-anticoagulated blood provided comparable results. The RI for HbA1c was 9-18.5 mmol/mol. There was no apparent effect of age or breed on HbA1c. In diabetic dogs, HbA1c ranged from 14 to 48 mmol/mol. The assay provides a reliable method for canine HbA1c measurement with good analytic performance. \u00a9 2017 American Society for Veterinary Clinical Pathology.\n[Clinical and molecular genetic features of Hb H and AE Bart's diseases in central Thai children.](https://www.ncbi.nlm.nih.gov/pubmed/29662324)\nTraivaree, Chanchai; Boonyawat, Boonchai; Monsereenusorn, Chalinee; Rujkijyanont, Piya; Photia, Apichat\n2018-01-01\n\u03b1-Thalassemia, one of the major thalassemia types in Thailand, is caused by either deletion or non-deletional mutation of one or both \u03b1-globin genes. Inactivation of three \u03b1-globin genes causes hemoglobin H (Hb H) disease, and the combination of Hb H disease with heterozygous hemoglobin E (Hb E) results in AE Bart's disease. This study aimed to characterize the clinical and hematological manifestations of 76 pediatric patients with Hb H and AE Bart's diseases treated at Phramongkutklao Hospital, a tertiary care center for thalassemia patients in central Thailand. Seventy-six unrelated pediatric patients, 58 patients with Hb H disease and 18 patients with AE Bart's disease, were enrolled in this study. Their clinical presentations, transfusion requirement, laboratory findings, and mutation analysis were retrospectively reviewed and analyzed. A total of 76 pediatric patients with Hb H and AE Bart's diseases who mainly lived in central Thailand were included in this study. The clinical severities of patients with non-deletional mutations were more severe than those with deletional mutations. Eighty-six percent of patients with non-deletional AE Bart's disease required more blood transfusion compared to 12.5% of patients with deletional AE Bart's disease. Non-deletional AE Bart's disease also had a history of urgent blood transfusion with the average of 6\u00b10.9 times compared to 1\u00b10.3 times in patients with deletional Hb H disease. The difference was statistically significant. This study revealed the differences in clinical spectrum between patients with Hb H disease and those with AE Bart's disease in central Thailand. The differentiation of \u03b1-thalassemia is essential for appropriate management of patients. The molecular diagnosis is useful for diagnostic confirmation and genotype-phenotype correlation.\n[Eventos adversos temporalmente asociados a VAMENGOC- BC\u00ae. Municipio La Lisa, 1998-1999](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2000000400001&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nIv\u00e1n Edelberto Cuevas\n2000-12-01\nFull Text Available Con el objetivo de describir la frecuencia de eventos temporalmente asociados a la vacuna cubana VAMENGOC- BC\u00ae, se realiz\u00f3 un estudio observacional de tipo descriptivo, cuyo universo estuvo constituido por los lactantes en las edades comprendidas de tres (3549 y cinco meses (3832 de edad de las \u00e1reas de salud del Municipio La Lisa en Ciudad de La Habana. Hubo un 3,21% de ni\u00f1os con eventos adversos, con una mayor frecuencia despu\u00e9s de la primera dosis; sin diferencias apreciables por sexo. La clasificaci\u00f3n fue de un 52% de tipo sist\u00e9mico, locales un 19% y no solicitados un 29%. La mayor parte de los ni\u00f1os afectados fue en las primeras 72 horas posteriores a la vacunaci\u00f3n, y desaparecieron antes de 72 horas desde su comienzo. Las manifestaciones m\u00e1s frecuentes fueron fiebre (predomin\u00f3 entre todos los eventos adversos con 1,53 casos por 100 vacunados; la induraci\u00f3n (0,31 por 100 vacunados, eritema (0,30 por 100 vacunados y el dolor (0,136 por 100 vacunados en el sitio de administraci\u00f3n de la vacuna; irritabilidad (0,244 por 100 vacunados y p\u00e9rdida de apetito (0,311 por 100 vacunados. Los eventos no solicitados m\u00e1s frecuentes fueron la Enfermedad Respiratoria Aguda (0,637 por 100 vacunados, la Enfermedad Diarreica Aguda (0,311 por 100 vacunados y la Otitis Media (0,176 por 100 vacunados. Los eventos adversos serios fueron infrecuentes. No hubo fallecidos y todos los casos se recuperaron en menos de diez d\u00edas, sin secuelas, discapacidades ni minusval\u00edas\n[A revolu\u00e7\u00e3o cubana atinge a terceira idade](https://www.ifch.unicamp.br/ojs/index.php/proa/article/view/2326) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nVanessa Lea\n2016-11-01\nFull Text Available Minha primeira tentativa de visitar Cuba foi em 1972. Na \u00e9poca, eu vivia na Inglaterra e, devido \u00e0 recente expuls\u00e3o de um diplomata cubano do Reino Unido, meu visto n\u00e3o foi concedido. Eu pretendia estudar literatura cubana p\u00f3s-revolucion\u00e1ria na Universidade de Essex, na gradua\u00e7\u00e3o, influenciada pela disciplina de Estudos Latino-Americanos que, em 1971, abordava as Revolu\u00e7\u00f5es em Cuba e na Uni\u00e3o Sovi\u00e9tica. A oportunidade de visitar Cuba surgiu novamente em 2013 e, com ela, a possibilidade de comemorar meu anivers\u00e1rio de 60 anos em Havana, junto com o 60o anivers\u00e1rio da Revolu\u00e7\u00e3o, corporificando (embodying pessoalmente a dura\u00e7\u00e3o desse evento, j\u00e1 que nasci no dia do ataque rebelde ao Quartel Moncada \u2013 26 de julho de 1953. Durante a estadia em Cuba, cada vez que algu\u00e9m examinava meu passaporte, olhava-me com uma mistura de surpresa e curiosidade, ao se dar conta da coincid\u00eancia cronol\u00f3gica entre a Cuba p\u00f3s-revolucion\u00e1ria e a minha trajet\u00f3ria pessoal. Este texto, em alguma medida, \u00e9 uma maneira de digerir esta experi\u00eancia em Cuba, t\u00e3o contrastante com minhas recorda\u00e7\u00f5es enquanto aluna de gradua\u00e7\u00e3o. Durante tr\u00eas semanas, em companhia da minha filha, Julia, e do seu namorado, viajei cerca de 2.000 km pela metade ocidental do arquip\u00e9lago de Cuba. Julia \u00e9 parceira do joint-venture que resultou neste ensaio experimental. Mesmo de f\u00e9rias, a(o antrop\u00f3loga(o dificilmente consegue abdicar de sua observa\u00e7\u00e3o dos detalhes em cada situa\u00e7\u00e3o na qual se encontra. Este relato homenageia a energia inesgot\u00e1vel e a engenhosidade do povo cubano perante tantas adversidades.\n[Thermo-mechanical model optimization of HB-LED packaging](http://www.narcis.nl/publication/RecordID/oai%3Atudelft.nl%3Auuid%3A2bdc7c7d-b1a2-45d3-8584-41c89d679935/uquery/LED/id/7/Language/EN)\nYuan, C.A.; Erinc, M.; Gielen, A.W.J.; Waal, A. van der; Driel, W. van; Zhang, K.\n2011-01-01\nLighting is an advancing phenomenon both on the technology and on the market level due to the rapid development of the solid state lighting technology. The efforts in improving the efficacy of high brightness LED's (HB-LED) have concentrated on the packaging architecture. Packaging plays a\n[The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be Misleading.](https://www.ncbi.nlm.nih.gov/pubmed/28733374)\nBeck, Roy W; Connor, Crystal G; Mullen, Deborah M; Wesley, David M; Bergenstal, Richard M\n2017-08-01\nHbA 1c is a v aluable metric for comparing treatment groups in a randomized trial, for assessing glycemic trends in a population over time, or for cross-sectional comparisons of glycemic control in different populations. However, what is not widely appreciated is that HbA 1c may not be a good indicator of an individual patient's glycemic control because of the wide range of mean glucose concentrations and glucose profiles that can be associated with a given HbA 1c level. To illustrate this point, we plotted mean glucose measured with continuous glucose monitoring (CGM) versus central laboratory-measured HbA 1c in 387 participants in three randomized trials, showing that not infrequently HbA 1c may underestimate or overestimate mean glucose, sometimes substantially. Thus, if HbA 1c is to be used to assess glycemic control, it is imperative to know the patient's actual mean glucose to understand how well HbA 1c is an indicator of the patient's glycemic control. With knowledge of the mean glucose, an estimated HbA 1c (eA1C) can be calculated with the formula provided in this article to compare with the measured HbA 1c . Estimating glycemic control from HbA 1c alone is in essence applying a population average to an individual, which can be misleading. Thus, a patient's CGM glucose profile has considerable value for optimizing his or her diabetes management. In this era of personalized, precision medicine, there are few better examples with respect to the fallacy of applying a population average to a specific patient rather than using specific information about the patient to determine the optimal approach to treatment. \u00a9 2017 by the American Diabetes Association.\n[Baseline HbA1c to Identify High-Risk Gestational Diabetes: Utility in Early vs Standard Gestational Diabetes.](https://www.ncbi.nlm.nih.gov/pubmed/27797673)\nSweeting, Arianne N; Ross, Glynis P; Hyett, Jon; Molyneaux, Lynda; Tan, Kris; Constantino, Maria; Harding, Anna Jane; Wong, Jencia\n2017-01-01\nThe increasing prevalence of gestational diabetes mellitus (GDM) necessitates risk stratification directing limited antenatal resources to those at greatest risk. Recent evidence demonstrates that an early pregnancy glycated hemoglobin (HbA1c \u22655.9% (41 mmol/mol) predicts adverse pregnancy outcomes. To determine the optimal HbA1c threshold for adverse pregnancy outcomes in GDM in a treated multiethnic cohort and whether this differs in women diagnosed HbA1c (single-laboratory) measurement at the time of GDM diagnosis. Maternal clinical and pregnancy outcome data were collected prospectively. The association between baseline HbA1c and adverse pregnancy outcomes in early vs standard GDM. HbA1c was measured at a median of 17.6 \u00b1 3.3 weeks' gestation in early GDM (n = 844) and 29.4 \u00b1 2.6 weeks' gestation in standard GDM (n = 2254). In standard GDM, HbA1c >5.9% (41 mmol/mol) was associated with the greatest risk of large-for-gestational-age (odds ratio [95% confidence interval] = 2.7 [1.5-4.9]), macrosomia (3.5 [1.4-8.6]), cesarean section (3.6 [2.1-6.2]), and hypertensive disorders (2.6 [1.1-5.8]). In early GDM, similar HbA1c associations were seen; however, lower HbA1c correlated with the greatest risk of small-for-gestational-age (P trend = 0.004) and prevalence of neonatal hypoglycemia. Baseline HbA1c >5.9% (41 mmol/mol) identifies an increased risk of large-for-gestational-age, macrosomia, cesarean section, and hypertensive disorders in standard GDM. Although similar associations are seen in early GDM, higher HbA1c levels do not adequately capture risk-limiting utility as a triage tool in this cohort. Copyright \u00a9 2017 by the Endocrine Society\n[High Frequency of Hb E-Saskatoon (HBB: c.67G > A) in Brazilians: A New Genetic Origin?](https://www.ncbi.nlm.nih.gov/pubmed/27250692)\nWagner, Sandrine C; Lindenau, Juliana D; Castro, Simone M de; Santin, Ana Paula; Zaleski, Carina F; Azevedo, Laura A; Ribeiro Dos Santos, \u00c2ndrea K C; Dos Santos, Sidney E B; Hutz, Mara H\n2016-08-01\nHb E-Saskatoon [\u03b222(B4)Glu\u2192Lys, HBB: c.67G > A] is a rare, nonpathological \u03b2-globin variant that was first described in a Canadian woman of Scottish and Dutch ancestry and has since then been detected in several populations. The aim of the present study was to identify the origin of Hb E-Saskatoon in Brazil using \u03b2-globin haplotypes and genetic ancestry in carriers of this hemoglobin (Hb) variant. Blood samples were investigated by isoelectric focusing (IEF) and high performance liquid chromatography (HPLC) using commercial kits. Hb E-Saskatoon was confirmed by amplification of the HBB gene, followed by sequence analysis. Haplotypes of the \u03b2-globin gene were determined by polymerase chain reaction (PCR), followed by digestion with specific restriction enzymes. Individual ancestry was estimated with 48 biallelic insertion/deletions using three 16-plex PCR amplifications. The IEF pattern was similar to Hbs C (HBB: c.19G > A) and Hb E (HBB: c.79G > A) [isoelectric point (pI): 7.59-7.65], and HPLC results showed an elution in the Hb S (HBB: c.20A > T) window [retention time (RT): 4.26-4.38]. DNA sequencing of the amplified \u03b2-globin gene showed a mutation at codon 22 (GAA>AAA) corresponding to Hb E-Saskatoon. A total of 11 cases of this variant were identified. In nine unrelated individuals, Hb E-Saskatoon was in linkage disequilibrium with haplotype 2 [+ - - - -]. All subjects showed a high degree of European contribution (mean = 0.85). Hb E-Saskatoon occurred on the \u03b2-globin gene of haplotype 2 in all Brazilian carriers. These findings suggest a different genetic origin for this Hb variant from that previously described.\n[HbA1c Variability as an Independent Correlate of Nephropathy, but Not Retinopathy, in Patients With Type 2 Diabetes](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3714498)\nPenno, Giuseppe; Solini, Anna; Bonora, Enzo; Fondelli, Cecilia; Orsi, Emanuela; Zerbini, Gianpaolo; Morano, Susanna; Cavalot, Franco; Lamacchia, Olga; Laviola, Luigi; Nicolucci, Antonio; Pugliese, Giuseppe\n2013-01-01\nOBJECTIVE To examine the association of hemoglobin (Hb) A1c variability with microvascular complications in the large cohort of subjects with type 2 diabetes from the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study. RESEARCH DESIGN AND METHODS Serial (3\u20135) HbA1c values collected in a 2-year period before enrollment were available from 8,260 subjects from 9 centers (of 15,773 patients from 19 centers). HbA1c variability was measured as the intraindividual SD of 4.52 \u00b1 0.76 values. Diabetic retinopathy (DR) was assessed by dilated funduscopy. Chronic kidney disease (CKD) was defined based on albuminuria, as measured by immunonephelometry or immunoturbidimetry, and estimated glomerular filtration rate (eGFR) was calculated from serum creatinine. RESULTS Median and interquartile range of average HbA1c (HbA1c-MEAN) and HbA1c-SD were 7.57% (6.86\u20138.38) and 0.46% (0.29\u20130.74), respectively. The highest prevalence of microalbuminuria, macroalbuminuria, reduced eGFR, albuminuric CKD phenotypes, and advanced DR was observed when both HbA1c parameters were above the median and the lowest when both were below the median. Logistic regression analyses showed that HbA1c-SD adds to HbA1c-MEAN as an independent correlate of microalbuminuria and stages 1\u20132 CKD and is an independent predictor of macroalbuminuria, reduced eGFR, and stages 3\u20135 albuminuric CKD, whereas HbA1c-MEAN is not. The opposite was found for DR, whereas neither HbA1c-MEAN nor HbA1c-SD affected nonalbuminuric CKD. CONCLUSIONS In patients with type 2 diabetes, HbA1c variability affects (albuminuric) CKD more than average HbA1c, whereas only the latter parameter affects DR, thus suggesting a variable effect of these measures on microvascular complications. PMID:23491522\n[A fully liquid DTaP-IPV-HB-PRP-T hexavalent vaccine for primary and booster vaccination of healthy Turkish infants and toddlers](https://www.ncbi.nlm.nih.gov/pubmed/29156870)\nCeyhan, Mehmet; Y\u0131ld\u0131r\u0131m, \u0130nci; Tezer, Hasan; Devrim, \u0130lker; Feroldi, Emmanuel\n2017-08-23\nBackground/aim: Immunogenicity and safety of a primary series of a fully liquid, hexavalent DTaP-IPV-HB-PRP-T vaccine given at 2, 3, and 4 months of age compared to licensed comparators and a DTaP-IPV-HB-PRP-T booster at 15?18 months were evaluated. Materials and methods: This was a Phase III, randomized, open-label trial. Primary series (no hepatitis B [HB] at birth) of DTaP-IPV-HB-PRP-T (N = 155) (group 1) or licensed control vaccines (DTaP-IPV//PRP-T and standalone HB: N = 155) (group 2) and DTaP-IPV-HB-PRP-T booster were administered. Noninferiority was evaluated 1 month postprimary series for anti-HB seroprotection (SP). All other analyses were descriptive. Safety was assessed from parental reports. Results: Postprimary series noninferiority of anti-HB \u2265 10 mIU/mL was demonstrated for the DTaP-IPV-HB-PRP-T vaccine (94.0%) compared to the licensed control (96.1%). Postprimary series primary SP and seroconversion (SC) rates were high and similar for both groups. Antibody persistence (prebooster) was high for each antigen and similar between groups except for HB, which was lower for DTaP-IPV-HB-PRP-T than for standalone HB. For each antigen except HB, DTaP-IPV-HB-PRP-T booster responses were high and similar in each group. Safety was good for primary and booster series and similar between groups. Conclusion: The DTaP-IPV-HB-PRP-T vaccine is immunogenic and safe when administered in a challenging primary series schedule without HB vaccination at birth.\n[Enhancing Effect of Hydroxyurea on Hb F in Sickle Cell Disease: Ten-Year Egyptian Experience.](https://www.ncbi.nlm.nih.gov/pubmed/29251012)\nYoussry, Ilham; Abdel-Salam, Amina; Ismail, Rania; Bou-Fakhredin, Rayan; Mohamed Samy, Rania; Ezz El-Deen, Fatma; Taher, Ali T\nPatients with sickle cell disease experience hemolytic anemia and vaso-occlusions that result in pain, organ injury, and premature mortality. Several prospective studies have verified the efficacy and tolerability of hydroxyurea (HU), and demonstrated its efficacy in reducing painful vaso-occlusive crises (VOCs) in addition to its ability to increase Hb F levels. We aimed to evaluate the long-term effects of HU therapy on Hb F and assess its long term efficacy and safety in sickle cell disease patients. A retrospective study on 60 sickle cell disease patients was conducted. We studied the laboratory changes, frequency of VOCs per year, frequency of hospital admisions per year and number of transfusions per year, both before and after HU therapy. The follow-up period was 4 to 120 months. Hb F levels after HU therapy positively correlated with the duration of HU therapy, baseline Hb F levels and baseline total hemoglobin (Hb) (r = 0.4, p = 0.04; r = 0.45, p = 0.001; r = 0.5, p = 0.019, respectively) and inversely correlated with baseline total leucocyte count (r = -0.33, p = 0.034). Hydroxyurea therapy was associated with an increase in the total Hb and mean corpuscular volume (MCV) (p = 0.009, p = 0.000; respectively) and with a decrease in total leucocyte count, platelet count and reticulocyte count (p = 0.00, p = 0.03, p = 0.02, respectively). Moreover, a significant reduction in the frequency of VOCs, transfusion frequency and hospital admissions per year after HU therapy was shown in the studied subjects. Hydroxyurea induced an increase in Hb F level, which was maintained over time and was associated with clinical efficacy and acceptable safety.\n[Development of pro-inflammatory phenotype in monocytes after engulfing Hb-activated platelets in hemolytic disorders.](https://www.ncbi.nlm.nih.gov/pubmed/28039017)\nSinghal, Rashi; Chawla, Sheetal; Rathore, Deepak K; Bhasym, Angika; Annarapu, Gowtham K; Sharma, Vandana; Seth, Tulika; Guchhait, Prasenjit\n2017-02-01\nMonocytes and macrophage combat infections and maintain homeostatic balance by engulfing microbes and apoptotic cells, and releasing inflammatory cytokines. Studies have described that these cells develop anti-inflammatory properties upon recycling the free-hemoglobin (Hb) in hemolytic conditions. While investigating the phenotype of monocytes in two hemolytic disorders-paroxysmal nocturnal hemoglobinuria (PNH) and sickle cell disease (SCD), we observed a high number of pro-inflammatory (CD14 + CD16 hi ) monocytes in these patients. We further investigated in vitro the phenotype of these monocytes and found an estimated 55% of CD14 + cells were transformed into the CD14 + CD16 hi subset after engulfing Hb-activated platelets. The CD14 + CD16 hi monocytes, which were positive for both intracellular Hb and CD42b (platelet marker), secreted significant amounts of TNF-\u03b1 and IL-1\u03b2, unlike monocytes treated with only free Hb, which secreted more IL-10. We have shown recently the presence of a high number of Hb-bound hyperactive platelets in patients with both diseases, and further investigated if the monocytes engulfed these activated platelets in vivo. As expected, we found 95% of CD14 + CD16 hi monocytes with both intracellular Hb and CD42b in both diseases, and they expressed high TNF-\u03b1. Furthermore our data showed that these monocytes whether from patients or developed in vitro after treatment with Hb-activated platelets, secreted significant amounts of tissue factor. Besides, these CD14 + CD16 hi monocytes displayed significantly decreased phagocytosis of E. coli. Our study therefore suggests that this alteration of monocyte phenotype may play a role in the increased propensity to pro-inflammatory/coagulant complications observed in these hemolytic disorders-PNH and SCD. Copyright \u00a9 2016 Elsevier Inc. All rights reserved.\n[Comparison of the Current Diagnostic Criterion of HbA1c with Fasting and 2-Hour Plasma Glucose Concentration](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4997021)\nKarnchanasorn, Rudruidee; Huang, Jean; Feng, Wei; Chuang, Lee-Ming\n2016-01-01\nTo determine the effectiveness of hemoglobin A1c (HbA1c) \u2265 6.5% in diagnosing diabetes compared to fasting plasma glucose (FPG) \u2265 126 mg/dL and 2-hour plasma glucose (2hPG) \u2265 200 mg/dL in a previously undiagnosed diabetic cohort, we included 5,764 adult subjects without established diabetes for whom HbA1c, FPG, 2hPG, and BMI measurements were collected. Compared to the FPG criterion, the sensitivity of HbA1c \u2265 6.5% was only 43.3% (106 subjects). Compared to the 2hPG criterion, the sensitivity of HbA1c \u2265 6.5% was only 28.1% (110 subjects). Patients who were diabetic using 2hPG criterion but had HbA1c HbA1c \u2265 6.5%. The diagnostic agreement in the clinical setting revealed the current HbA1c \u2265 6.5% is less likely to detect diabetes than those defined by FPG and 2hPG. HbA1c \u2265 6.5% detects less than 50% of diabetic patients defined by FPG and less than 30% of diabetic patients defined by 2hPG. When the diagnosis of diabetes is in doubt by HbA1c, FPG and/or 2hPG should be obtained. PMID:27597979\n[Impact of HbA1c Testing at Point of Care on Diabetes Management](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5505423)\nSchnell, Oliver; Crocker, J. Benjamin; Weng, Jianping\n2016-01-01\nDiabetes is a highly prevalent disease also implicated in the development of several other serious complications like cardiovascular or renal disease. HbA1c testing is a vital step for effective diabetes management, however, given the low compliance to testing frequency and, commonly, a subsequent delay in the corresponding treatment modification, HbA1c at the point of care (POC) offers an opportunity for improvement of diabetes care. In this review, based on data from 1999 to 2016, we summarize the evidence supporting a further implementation of HbA1c testing at POC, discuss its limitations and propose recommendations for further development. PMID:27898388\n[Structural and Functional Characterization of a New Double Variant Haemoglobin (HbG-Philadelphia/Duarte \u03b1(2)\u03b2(2)).](https://www.ncbi.nlm.nih.gov/pubmed/22084702)\nFais, Antonella; Casu, Mariano; Ruggerone, Paolo; Ceccarelli, Matteo; Porcu, Simona; Era, Benedetta; Anedda, Roberto; Sollaino, Maria Carla; Galanello, Renzo; Corda, Marcella\n2011-01-01\nWE REPORT THE FIRST CASE OF COSEGREGATION OF TWO HAEMOGLOBINS (HBS): HbG-Philadelphia [\u03b168(E17)Asn \u2192 Lys] and HbDuarte [\u03b262(E6)Ala \u2192 Pro]. The proband is a young patient heterozygous also for \u03b2\u00b0-thalassaemia. We detected exclusively two haemoglobin variants: HbDuarte and HbG-Philadelphia/Duarte. Functional study of the new double variant HbG-Philadelphia/Duarte exhibited an increase in oxygen affinity, with a slight decrease of cooperativity and Bohr effect. This functional behaviour is attributed to \u03b262Ala \u2192 Pro instead of \u03b168Asn \u2192 Lys substitution. Indeed, HbG-Philadelphia isolated in our laboratory from blood cells donor carrier for this variant is not affected by any functional modification, whereas purified Hb Duarte showed functional properties very similar to the double variant. NMR and MD simulation studies confirmed that the presence of Pro instead of Ala at the \u03b262 position produces displacement of the E helix and modifications of the tertiary structure. The substitution \u03b168(E17)Asn \u2192 Lys does not cause significant structural and dynamical modifications of the protein. A possible structure-based rational of substitution effects is suggested.\n[Investigation of local heterogeneity of hbO2 and hb in working dog heart in situ under isovolemic hemodilution and critical coronary stenosis](http://adsabs.harvard.edu/abs/1996SPIE.2927..119K)\nKrug, Alfons; Kessler, Manfred D.; Khuri, Raja; Lust, Robert; Chitwood, Randolph\n1996-12-01\nA tissue spectrophotometer (EMPHO II) working with 70 micrometer micro lightguide sensors enables recording of spectra in the visible wavelength range (500 - 630 nm). During an initial period arterial hypoxia and hyperoxia were induced on working dog heart by mechanical ventilation with oxygen fractions (fiO2) of 0.1 and 0.5. Under these conditions the effects of low and high fiO2 on oxygenation distribution of intracapillary hemoglobin were investigated. In the second part of the experiment the relation between systemic hematocrit, local hemoglobin concentration, local hemoglobin oxygenation and the oxygen regulation mechanism were studied in detail. In the final part of the experiment the effect of critical coronary stenosis on hb and hbO2 was measured. Critical stenosis was achieved by partial clamping of the left anterior coronary artery (LAD).\n[Capsicum annuum homeobox 1 (CaHB1) is a nuclear factor that has roles in plant development, salt tolerance, and pathogen defense](http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=22242225) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nOh, Sang-Keun; Yoon, Joonseon [Department of Plant Science, College of Agriculture and Life Sciences, Seoul National University, Seou1 151-742 (Korea, Republic of); Choi, Gyung Ja [Screening Division, Korea Research Institute of Chemical Technology, Daejeon 305-600 (Korea, Republic of); Jang, Hyun A; Kwon, Suk-Yoon [Korea Research Institute of Bioscience and Biotechnology, Yusung, Daejeon 305-600 (Korea, Republic of); Choi, Doil, E-mail: doil@snu.ac.kr [Department of Plant Science, College of Agriculture and Life Sciences, Seoul National University, Seou1 151-742 (Korea, Republic of)\n2013-12-06\nHighlights: \u2022The CaHB1 is a nuclear factor, belonging to HD-Zip proteins. \u2022SA and ET, as signal molecules, modulate CaHB1-mediated responses. \u2022Overexpression of CaHB1 in tomato resulted in a thicker cell wall. \u2022CaHB1-transgenic tomato confers resistance to Phytophthora infestans. \u2022CaHB1 enhanced tolerance to saline stress in tomato. -- Abstract: Homeodomain-leucine zipper (HD-Zip) family proteins are unique to plants, but little is known about their role in defense responses. CaHB1 is a nuclear factor in peppers, belonging to subfamily II of HD-Zip proteins. Here, we determined the role of CaHB1 in the defense response. CaHB1 expression was induced when pepper plants were challenged with Phytophthora capsici, a plant pathogen to which peppers are susceptible, or environmental stresses such as drought and salt stimuli. CaHB1 was also highly expressed in pepper leaves following application of SA, whereas ethephon and MeJA had a moderate effect. To further investigate the function of CaHB1 in plants, we performed gain-of-function study by overexpression of CaHB1 in tomato. CaHB1-transgenic tomatoes showed significant growth enhancement including increased leaf thickness and enlarged cell size (1.8-fold larger than control plants). Microscopic analysis revealed that leaves from CaHB1-transgenic plants had thicker cell walls and cuticle layers than those from controls. Moreover, CaHB1-transgenic plants displayed enhanced resistance against Phytophthora infestans and increased tolerance to salt stress. Additionally, RT-PCR analysis of CaHB1-transgenic tomatoes revealed constitutive up-regulation of multiple genes involved in plant defense and osmotic stress. Therefore, our findings suggest roles for CaHB1 in development, salt stress, and pathogen defense.\n[Capsicum annuum homeobox 1 (CaHB1) is a nuclear factor that has roles in plant development, salt tolerance, and pathogen defense](http://dx.doi.org/10.1016/j.bbrc.2013.11.019) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nOh, Sang-Keun; Yoon, Joonseon; Choi, Gyung Ja; Jang, Hyun A; Kwon, Suk-Yoon; Choi, Doil\n2013-01-01\nHighlights: \u2022The CaHB1 is a nuclear factor, belonging to HD-Zip proteins. \u2022SA and ET, as signal molecules, modulate CaHB1-mediated responses. \u2022Overexpression of CaHB1 in tomato resulted in a thicker cell wall. \u2022CaHB1-transgenic tomato confers resistance to Phytophthora infestans. \u2022CaHB1 enhanced tolerance to saline stress in tomato. -- Abstract: Homeodomain-leucine zipper (HD-Zip) family proteins are unique to plants, but little is known about their role in defense responses. CaHB1 is a nuclear factor in peppers, belonging to subfamily II of HD-Zip proteins. Here, we determined the role of CaHB1 in the defense response. CaHB1 expression was induced when pepper plants were challenged with Phytophthora capsici, a plant pathogen to which peppers are susceptible, or environmental stresses such as drought and salt stimuli. CaHB1 was also highly expressed in pepper leaves following application of SA, whereas ethephon and MeJA had a moderate effect. To further investigate the function of CaHB1 in plants, we performed gain-of-function study by overexpression of CaHB1 in tomato. CaHB1-transgenic tomatoes showed significant growth enhancement including increased leaf thickness and enlarged cell size (1.8-fold larger than control plants). Microscopic analysis revealed that leaves from CaHB1-transgenic plants had thicker cell walls and cuticle layers than those from controls. Moreover, CaHB1-transgenic plants displayed enhanced resistance against Phytophthora infestans and increased tolerance to salt stress. Additionally, RT-PCR analysis of CaHB1-transgenic tomatoes revealed constitutive up-regulation of multiple genes involved in plant defense and osmotic stress. Therefore, our findings suggest roles for CaHB1 in development, salt stress, and pathogen defense\n[C-Window Peaks on CE-HPLC are Extremely Rare in Northern India, and Only Infrequently Represent HbC.](https://www.ncbi.nlm.nih.gov/pubmed/29398805)\nDass, Jasmita; Mittal, Suchi; Saraf, Amrita; Kotwal, Jyoti\n2018-01-01\nHemoglobin C (HbC, HBB:c.19G > A) is a structural variant that has been reported rarely from India. This was a retrospective review of all high performance liquid chromatography (HPLCs) submitted over a 14 year period to a tertiary care center in North India with an aim of finding hemoglobins that elute in the C-window. Of the 32,364 HPLCs screened, 6 cases showed peaks in the C-window. Of these 6 cases, only two cases contained hemoglobin C. These was one case each of HbC/\u03b2 thalassemia and compound heterozygosity for HbC and HbD. There were 4 cases which showed very similar red cell indices and chromatograms with multiple peaks eluting in D-window, C-window and an additional peak with a retention time of 4.74 min. These four cases were compound heterozygous for an \u03b1 chain variant HbQ-India and a \u03b2-chain variant HbD.\n[Serum Heparin-binding Epidermal Growth Factor-like Growth Factor (HB-EGF) as a Biomarker for Primary Ovarian Cancer.](https://www.ncbi.nlm.nih.gov/pubmed/28668900)\nMiyata, Kohei; Yotsumoto, Fusanori; Fukagawa, Satoshi; Kiyoshima, Chihiro; Ouk, Nam Sung; Urushiyama, Daichi; Ito, Tomohiro; Katsuda, Takahiro; Kurakazu, Masamitsu; Araki, Ryota; Sanui, Ayako; Miyahara, Daisuke; Murata, Masaharu; Shirota, Kyoko; Yagi, Hiroshi; Takono, Tadao; Kato, Kiyoko; Yaegashi, Nobuo; Akazawa, Kohei; Kuroki, Masahide; Yasunaga, Shin'ichiro; Miyamoto, Shingo\n2017-07-01\nOvarian cancer is the most lethal malignancy among gynaecological cancers. Although many anticancer agents have been developed for the treatment of ovarian cancer, it continues to have an extremely poor prognosis. Heparin-binding epidermal growth factor-like grown factor (HB-EGF) has been reported to be a rational therapeutic target for ovarian cancer. Here, we evaluated the clinical significance of serum HB-EGF by examining the association between prognosis and serum HB-EGF levels in patients with primary ovarian cancer. We found that high serum HB-EGF concentrations were significantly associated with poor prognosis in a combined cohort of patients with all stages of ovarian cancer, as well as in a subset of patients with advanced disease. In addition, serum HB-EGF levels increased as the cancer advanced. These data suggest that serum HB-EGF may be a target for the design of novel therapies for ovarian cancer. Copyright\u00a9 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.\n[La t\u00e9cnica de Western Blot como criterio de identidad para la vacuna antimeningoc\u00f3cica Men B Western Blot technique as an identity criterion for Men B antimeningococcal vaccine](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75152009000300004) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nR. Rosario Di\u00e9guez Castro\n2009-12-01\nFull Text Available Se desarroll\u00f3 y valid\u00f3 la t\u00e9cnica de Western Blot aplicada a la vacuna antimeningoc\u00f3cica Men B producida en el Instituto Finlay con el objetivo de demostrar un criterio de identidad. En el estudio de las prote\u00ednas antig\u00e9nicas de la vacuna, P1.15 y P1.4 en ves\u00edcula de membrana externa,monograneles y producto final se emplearon en la identificaci\u00f3n anticuerpos monoclonales espec\u00edficos para estas prote\u00ednas. Los par\u00e1metros desarrollados en la validaci\u00f3n de la t\u00e9cnica fueron: especificidad, l\u00edmite de detecci\u00f3n, repetibilidad, precisi\u00f3n intermedia, reproducibilidad y robustez. El m\u00e9todo cumpli\u00f3 con los par\u00e1metros se\u00f1alados, por lo que se consider\u00f3 validado.Western Blot technique was developed and validated, applied to Men B meningococcal vaccine produced in \"Carlos J, Finlay\" Institute to demonstrate an identity criterion. In study of antigenic proteins of the vaccine, we used P1.15 y P1.4 in vesicle of external membrane, monogranels, and end product to identify the monoclonal antibodies specific of these proteins. Parameters developed in technique validation included: specificity, detection limit, repetition, average accuracy, reproduction, and strength. Method fulfilled with specified parameters, thus considering its validation.\n[Ensayo precl\u00ednico de la vacuna candid #1 producida en Argentina contra la Fiebre Hemorr\u00e1gica Argentina Preclinical assay of Candid #1 vaccine against Argentine Hemorrhagic Fever made in Argentina](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802005000400008) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAna M. Ambrosio\n2005-08-01\nFull Text Available Se compar\u00f3 en cobayos la seguridad, inmunogenicidad y eficacia protectora de un lote de vacuna Candid #1(C#1 fabricada en Estados Unidos de Am\u00e9rica (EE.UU. y distintos lotes de la misma vacuna fabricados en Argentina (Arg. El lote TSI 5-1-92 (EE.UU. y los lotes Exp N\u00ba 3, 7A y 8A (Arg fueron inoculados (0.5 ml, IM en cobayos de 250-400 g. Para cada ensayo diez animales recibieron soluci\u00f3n fisiol\u00f3gica y sirvieron como control. Todos fueron desafiados con la cepa pat\u00f3gena P23790 de virus Junin. Se registr\u00f3: a temperatura rectal, b peso corporal, c presencia de anticuerpos neutralizantes (AcNT pre y post-vacunaci\u00f3n, d respuesta al desaf\u00edo. Todos los animales vacunados desarrollaron AcNT anti virus Junin (rango = 40- 81920 y sobrevivieron al desaf\u00edo. En cada grupo control 8/10 animales murieron (d\u00eda 23.3 \u00b1 5.4 post-desaf\u00edo. Los cobayos resultaron id\u00e9nticamente protegidos de una descarga letal de virus Junin por la vacuna importada y los diferentes lotes de C#1 producidos en Argentina.Candid #1 vaccine against Argentine Hemorrhagic Fever produced in USA versus lots of the same vaccine made in Argentina were compared in guinea pigs regarding safety, immunogenicity and protective efficacy against a challenge with pathogenic Junin virus. Lots N\u00ba Exp 3, 7A and 8A of Argentine origin as well as lot TSI 5-1-92 from USA were inoculated in guinea pigs of 250-400 g in two consecutive assays. Ten animals inoculated with saline performed as normal controls in each experiment. Parameters studied were: a temperature; b body weight; c neutralizing antibodies to Junin virus; d response to viral challenge. Animals gained weight and remained normothermic up to the challenge. Guinea pigs that received Candid #1 from any manufacturer elicited neutralizing antibodies to Junin virus (titles from 40 to 81920 and survived to challenge whilst 8/10 animals died in each control group. Data presented demonstrated that Candid #1 vaccines from USA or Argentine\n[Correlation of same-visit HbA1c test with laboratory-based measurements: A MetroNet study](http://www.biomedcentral.com/1471-2296/6/28) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nWest Patricia A\n2005-07-01\nFull Text Available Abstract Background Glycated hemoglobin (HbA1c results vary by analytical method. Use of same-visit HbA1c testing methodology holds the promise of more efficient patient care, and improved diabetes management. Our objective was to test the feasibility of introducing a same-visit HbA1c methodology into busy family practice centers (FPC and to calculate the correlation between the same-visit HbA1c test and the laboratory method that the clinical site was currently using for HbA1c testing. Methods Consecutive diabetic patients 18 years of age and older having blood samples drawn for routine laboratory analysis of HbA1c were asked to provide a capillary blood sample for same-visit testing with the BIO-RAD Micromat II. We compared the results of the same-visit test to three different laboratory methods (one FPC used two different laboratories. Results 147 paired samples were available for analysis (73 from one FPC; 74 from the other. The Pearson correlation of Micromat II and ion-exchange HPLC was 0.713 (p Conclusion For each of the laboratory methods, the correlation coefficient was lower than the 0.96 reported by the manufacturer. This might be due to variability introduced by the multiple users of the Micromat II machine. The mean HbA1c results were also consistently lower than those obtained from laboratory analysis. Additionally, the amount of dedicated time required to perform the assay may limit its usefulness in a busy clinical practice. Before introducing a same-visit HbA1c methodology, clinicians should compare the rapid results to their current method of analysis.\n[Cuantificaci\u00f3n de IGG contra los componentes inmunog\u00e9nicos de VA-ENGOC-BC en plasma de lactantes vacunados](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21251997000200008) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJos\u00e9 Rodr\u00edguez Canosa\n1997-04-01\nFull Text Available Debido a las caracter\u00edsticas particulares de la respuesta inmune en lactantes, as\u00ed como a la eficacia mostrada por la vacuna cubana antimeningoc\u00f3ccica VA-MENGOC-BC, nos propusimos cuantificar la respuesta de la inmunoglobulina G contra los componentes inmunog\u00e9nicos de los meningococos B y C presentes en la vacuna, en lactantes vacunados. Se tom\u00f3 muestra por punci\u00f3n capilar a 109 lactantes entre 3 y 6 meses de edad antes de la vacunaci\u00f3n a los 31,4 \u00b1 2 d\u00edas despu\u00e9s de la primera y 32,3 \u00b1 d\u00edas despu\u00e9s de la segunda dosis vacunal. Se determinaron las concentraciones de inmunoglobulina G contra cada inmun\u00f3geno de la vacuna. Los niveles de inmunoglobulina G espec\u00edfica prevacunaci\u00f3n, fueron elevadas contra el meningococo C. Se produjo un incremento estad\u00edsticamente significativo de anticuerpos para ambos inmun\u00f3genos despu\u00e9s de la primera y segunda dosis, m\u00e1s marcado contra el meningococo C en la primera y para el meningococo B en la segunda, lo que apoya la presencia de memoria inmunol\u00f3gicaDue to the particular characteristics of the immune response in infants and to the efficacy shown by the Cuban antimeningococcal vaccine denominated VA-MENGOC-BC, we propose ourselves to quantify the response of immunoglobulin G against the immunogenic components of the meningococci B and C present in the vaccine among the vaccinated infants. The sample was taken by capillary puncture from 109 infants between 3 and 6 months before vaccination, at 31.4\u00b12 days after the first dose and at 32.3\u00b1 days after the second one. The concentrations of immunoglobulin G against each immunogen of the vaccine were determined. The levels of prevaccination specific immunoglobulin G were elevated against meningococcus C. There was a statistically significant increase of atibodies for both immunogens after the first and second dose. It was more marked against meningococcus C in the first, and for meningococcus B in the secons one, which supports the presence of\n[Efficacy of acarbose and metformin in newly diagnosed type 2 diabetes patients stratified by HbA1c levels.](https://www.ncbi.nlm.nih.gov/pubmed/26331290)\nZhang, Jin-Ping; Wang, Na; Xing, Xiao-Yan; Yang, Zhao-Jun; Wang, Xin; Yang, Wen-Ying\n2016-07-01\nThe aim of the present study was to investigate whether the therapeutic efficacy of acarbose and metformin is correlated with baseline HbA1c levels in Chinese patients with newly diagnosed type 2 diabetes mellitus (T2DM). Data for 711 subjects were retrieved from the MARCH (Metformin and AcaRbose in Chinese as initial Hypoglycemic treatment) trial database and reviewed retrospectively. Patients were grouped according to baseline HbA1c levels (8%) and the results for these three groups were compared between acarbose and metformin treatments. Acarbose and metformin treatment significantly improved T2DM-associated parameters (weight, fasting plasma glucose [FPG], postprandial glucose [PPG], glucagon-like peptide-1 [GLP-1], HOMA-IR, and total cholesterol) across all HbA1c levels. Acarbose decreased PPG and HOMA-\u03b2 significantly more than metformin, but only in subjects with lower baseline HbA1c (PPG in the HbA1c levels (P HbA1c groups (all P HbA1c levels, whereas metformin induced greater reductions in FPG. These results may help guide selection of initial therapy based on baseline HbA1c. \u00a9 2015 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and Wiley Publishing Asia Pty Ltd.\n[Heparin-Binding EGF-like Growth Factor (HB-EGF) Therapy for Intestinal Injury: Application and Future Prospects](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3961526)\nYang, Jixin; Su, Yanwei; Zhou, Yu; Besner, Gail E.\n2014-01-01\nThroughout the past 20 years, we have been investigating the potential therapeutic roles of heparin-binding EGF-like growth factor (HB-EGF), a member of the epidermal growth factor family, in various models of intestinal injury including necrotizing enterocolitis (NEC), intestinal ischemia/reperfusion (I/R) injury, and hemorrhagic shock and resuscitation (HS/R). Our studies have demonstrated that HB-EGF acts as an effective mitogen, a restitution-inducing reagent, a cellular trophic factor, an anti-apoptotic protein and a vasodilator, via its effects on various cell types in the intestine. In the current paper, we have reviewed the application and therapeutic effects of HB-EGF in three classic animal models of intestinal injury, with particular emphasis on its protection of the intestines from NEC. Additionally, we have summarized the protective functions of HB-EGF on various target cells in the intestine. Lastly, we have provided a brief discussion focusing on the future development of HB-EGF clinical applications for the treatment of various forms of intestinal injury including NEC. PMID:24345808\n[Impacto del neumococo y de los virus influenza en ni\u00f1os y adultos : su prevenci\u00f3n con vacunas](http://www.anfamed.edu.uy/index.php/rev/article/view/123) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMar\u00eda Hortal\n2015-07-01\nFull Text Available Durante siglos las enfermedades infecciosas han diezmado a poblaciones enteras, por lo que se ha procurado descubrir su causa y as\u00ed lograr su prevenci\u00f3n. Actualmente, la vacunaci\u00f3n es una de las intervenciones en salud m\u00e1s costo-efectivas para reducir la morbilidad y mortalidad por enfermedades infecciosas. La historia as\u00ed lo confirma con la erradicaci\u00f3n de la viruela, y el control de la poliomielitis y del sarampi\u00f3n a nivel mundial. En Uruguay, el inicio de la vacunaci\u00f3n obligatoria contra la viruela se remonta a 1911, en tanto que la vacunaci\u00f3n contra la poliomielitis y el sarampi\u00f3n, se implementaron en 1957 y 1966 respectivamente. Dentro de las enfermedades inmunoprevenibles, las infecciones respiratorias agudas son notoriamente las m\u00e1s frecuentes. Su impacto urgi\u00f3 la necesidad de contar con medidas de control. La neumon\u00eda, aunque se observa en todas las edades, predomina en los extremos de la vida. En la infancia, en menores de cinco a\u00f1os, es una de las causas m\u00e1s frecuentes de hospitalizaci\u00f3n y en las poblaciones m\u00e1s desfavorecidas provoca elevada mortalidad. En los adultos con comorbilidades ocurre en todas las edades, pero es m\u00e1s frecuente en los mayores de 65 a\u00f1os, en los que patolog\u00edas asociadas aumentan el riesgo vital, que es mayor cuanto mayor es la persona. Una vez controladas las neumon\u00edas por la vacuna conjugada de Haemophilus influenzae tipo b, el agente bacteriano de mayor frecuencia es Streptococcus pneumoniae y, entre los virus respiratorios, los brotes anuales y las pandemias por virus influenza contribuyen al aumento de hospitalizaciones y decesos por neumon\u00eda. Cuando ambos agentes se asocian en un paciente, sus efectos se potencian mutuamente y sus resultados pueden ser fatales. En consecuencia, la prevenci\u00f3n de esas infecciones con las vacunas disponibles, neumoc\u00f3ccica y de influenza, es una prioridad de Salud P\u00fablica para asegurar la supervivencia infantil y disminuir costos sociales y econ\u00f3micos.\n[Vectores recombinantes basados en el virus modificado de ankara (MVA), con deleci\u00f3n en el gen C6L, como vacunas contra el VIH/SIDA y otras enfermedades](https://www.openaire.eu/search/publication?articleId=od______1106::9e316d1d40664e1f75d27ff2273fde6d)\nGarc\u00eda-Arriaza, J.; G\u00f3mez, Carmen E.; Esteban, Mariano\n2011-01-01\n[ES] La presente invenci\u00f3n engloba dentro de los campos de la biolog\u00eda molecular y de la biotecnolog\u00eda. Especificamente se refiere a virus recombinantes basados en el virus modificado de Ankara (MVA) que expresan los antigenos gp120 y Gag-Pol-Nef del virus de la inmunodeficienciahumana (VIH-1) de subtipo B (MVA-B), sobre los que see ha delecionado el gen de vaccinia C6L, y que han sido dise\u00f1ados para utilizarse como vacunas contra el VIH/SIDA y otras enfermedades.\n[Vectores recombinantes basados en el virus modificado de Ankara (MVA), con deleci\u00f3n en el gen C6L, como vacunas contra el VIH/SIDA y otras enfermedades](https://www.openaire.eu/search/publication?articleId=od______1106::1f22a06ee30018481e8bc9557c0923e8)\nGarc\u00eda-Arriaza, J.; G\u00f3mez, Carmen E.; Esteban, Mariano\n2011-01-01\nLa presente invenci\u00f3n se engloba dentro de los campos de la biolog\u00eda molecular y de la biotecnolog\u00eda. Espec\u00edficamente se refiere a virus recombinantes basados en el virus modificado de Ankara (MVA) que expresan los ant\u00edgenos gp120 y Gag-Pol-Nef del virus de la inmunodeficiencia humana (VIH-1) de subtipo B (MVA-B), sobre los que se ha delecionado el gen de vaccinia C6L, y que han sido dise\u00f1ados para utilizarse como vacunas contra el VIH/SIDA y otras enfermedades.\n[Carbonyl Functionalized Single-Walled Carbon Nanotube-Hb Crosslinked Network: A Novel Platform for Studying Bio-Electrochemistry and Electrocatalysis of Hemoglobin.](https://www.ncbi.nlm.nih.gov/pubmed/29442911)\nKafi, A K M; Yam, C C L; Azmi, N S; Yusoff, Mashitah M\n2018-04-01\nIn this work, the direct electrochemistry of hemoglobin (Hb), which was immobilized on carbonyl functionalized single walled carbon nanotube (SWCNT) and deposited onto a gold (Au) electrode has been described. The synthesis of the network of crosslinked SWCNT/Hb was done with the help of crosslinking agent EDC (1-ethyl-3-(3-dimethylaminopropyl) carbodiimide). The UV-Vis and FTIR spectroscopy of SWCNT/Hb networks showed that Hb maintained its natural structure and kept good stability. In addition with this, scanning electron microscopy (SEM) illustrated that SWCNT/Hb networks had a featured layered structure and Hb being strongly liked with SWCNT surface. Cyclic voltammetry (CV) was used to study and to optimize the performance of the resulting modified electrode. The cyclic voltammetric (CV) responses of SWCNT/Hb networks in pH 7.0 exhibit prominent redox couple for the FeIII/II redox process with a midpoint potential of -0.46 V and -0.34, cathodic and anodic respectively. Furthermore, SWCNT/Hb networks are utilized for the detection of hydrogen peroxide (H2O2). Electrochemical measurements reveal that the resulting SWCNT/Hb electrodes display high electrocatalytic activity to H2O2 with high sensitivity, wide linear range, and low detection limit. Overall, the electrochemical results are due to excellent biocompatibility and excellent electron transport efficiency of CNT as well as high Hb loading and synergistic catalytic effect of the modified electrode toward H2O2.\n[Plasma microRNA-451 as a novel hemolytic marker for \u03b20-thalassemia/HbE disease](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5428399)\nLeecharoenkiat, Kamonlak; Tanaka, Yuka; Harada, Yasuko; Chaichompoo, Porntip; Sarakul, Orawan; Abe, Yasunobu; Smith, Duncan Richard; Fucharoen, Suthat; Svasti, Saovaros; Umemura, Tsukuru\n2017-01-01\nIn Southeast Asia, particularly in Thailand, \u03b20-thalassemia/hemoglobin E (HbE) disease is a common hereditary hematological disease. It is associated with pathophysiological processes, such as the intramedullary destruction of immature erythroid cells and peripheral hemolysis of mature red blood cells. MicroRNA (miR) sequences, which are short non-coding RNA that regulate gene expression in a suppressive manner, serve a crucial role in human erythropoiesis. In the present study, the plasma levels of the erythroid-expressed miRNAs, miR-451 and miR-155, were analyzed in 23 patients with \u03b20-thalassemia/HbE and 16 control subjects. Reverse transcription-quantitative polymerase chain reaction analysis revealed significantly higher levels of plasma miR-451 and miR-155 in \u03b20-thalassemia/HbE patients when compared to the control subjects. Notably, among the \u03b20-thalassemia/HbE patients, a significant increase in miR-451 levels was detected in severe cases when compared with mild cases. The levels of plasma miR-451 correlated with reticulocyte and platelet counts. The results suggest that increased plasma miR-451 levels may be associated with the degree of hemolysis and accelerated erythropoiesis in \u03b20-thalassemia/HbE patients. In conclusion, miR-451 may represent a relevant biomarker for pathological erythropoiesis associated with \u03b20-thalassemia/HbE. PMID:28447765\n[Further studies on Hb Canebi\u00e8re [\u03b212(G4)Asn\u2192His], a low affinity hemoglobin variant](http://www.forskningsdatabasen.dk/en/catalog/2398248268) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nFroelund, Ulf; Sandbakken, Erik; Szecsi, Pal Bela\n2010-01-01\nA case of Hb Canebi\u00e8re [\u00df102(G4)Asn\u00bfHis] was diagnosed in an otherwise healthy 21-year-old Danish woman. The clinical consequences were minor, since her only symptom consisted of transient cyanosis in lips and fingers when exposed to cold environments. Whole blood p50 was 59.9 mmHg. The Hb Canebi...... Canebi\u00e8re variant could not be separated from Hb A by high performance liquid chromatography (HPLC) and isoelectric focusing (IEF), and it was thus missed by routine hemoglobin (Hb) fractionation techniques....\n[Further studies on Hb Canebi\u00e8re [\u03b212(G4)Asn\u2192His], a low affinity hemoglobin variant](http://www.forskningsdatabasen.dk/en/catalog/99481224) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nFroelund, Ulf; Sandbakken, Erik; Szecsi, Pal Bela\n2010-01-01\nA case of Hb Canebi\u00e8re [\u03b2102(G4)Asn\u2192His] was diagnosed in an otherwise healthy 21-year-old Danish woman. The clinical consequences were minor, since her only symptom consisted of transient cyanosis in lips and fingers when exposed to cold environments. Whole blood p50 was 59.9 mmHg. The Hb...... Canebi\u00e8re variant could not be separated from Hb A by high performance liquid chromatography (HPLC) and isoelectric focusing (IEF), and it was thus missed by routine hemoglobin (Hb) fractionation techniques....\n[MdHB1 down-regulation activates anthocyanin biosynthesis in the white-fleshed apple cultivar 'Granny Smith'.](https://www.ncbi.nlm.nih.gov/pubmed/28338881)\nJiang, Yonghua; Liu, Cuihua; Yan, Dan; Wen, Xiaohong; Liu, Yanli; Wang, Haojie; Dai, Jieyu; Zhang, Yujie; Liu, Yanfei; Zhou, Bin; Ren, Xiaolin\n2017-02-01\nColoration in apple (Malus\u00d7domestica) flesh is mainly caused by the accumulation of anthocyanin. Anthocyanin is biosynthesized through the \ufb02avonoid pathway and regulated by MYB, bHLH, and WD40 transcription factors (TFs). Here, we report that the HD-Zip I TF MdHB1 was also involved in the regulation of anthocyanin accumulation. MdHB1 silencing caused the accumulation of anthocyanin in 'Granny Smith' flesh, whereas its overexpression reduced the flesh content of anthocyanin in 'Ballerina' (red-fleshed apple). Moreover, flowers of transgenic tobacco (Nicotiana tabacum 'NC89') overexpressing MdHB1 showed a remarkable reduction in pigmentation. Transient promoter activation assays and yeast one-hybrid results indicated that MdHB1 indirectly inhibited expression of the anthocyanin biosynthetic genes encoding dihydro\ufb02avonol-4-reductase (DFR) and UDP-glucose:\ufb02avonoid 3-O-glycosyltransferase (UFGT). Yeast two-hybrid and bimolecular fluorescence complementation determined that MdHB1 acted as a homodimer and could interact with MYB, bHLH, and WD40 in the cytoplasm, consistent with its cytoplasmic localization by green fluorescent protein fluorescence observations. Together, these results suggest that MdHB1 constrains MdMYB10, MdbHLH3, and MdTTG1 to the cytoplasm, and then represses the transcription of MdDFR and MdUFGT indirectly. When MdHB1 is silenced, these TFs are released to activate the expression of MdDFR and MdUFGT and also anthocyanin biosynthesis, resulting in red flesh in 'Granny Smith'. \u00a9 The Author 2017. Published by Oxford University Press on behalf of the Society for Experimental Biology. All rights reserved. For permissions, please email: journals.permissions@oup.com.\n[Hb Belluno [\u03b2111(G13)Val\u2192Gly;\u03b2133(H11)Val\u2192Val (HBB: c.335T > G;402G > C)]: Incidental Detection of a New Clinically Silent \u03b2 Chain Variant During Hb A1c Determination by High Performance Liquid Chromatography.](https://www.ncbi.nlm.nih.gov/pubmed/27032675)\nPianezze, Graziano; Toniolo, Manuele; Taddei Masieri, Marina; Dolcini, Bernardetta; Ravani, Anna\n2016-06-01\nA previously unreported \u03b2 chain variant, Hb Belluno [\u03b2111(G13)Val\u2192Gly;\u03b2133(H11)Val\u2192Val (HBB: c.335T > G;402G > C)], was incidentally discovered in a woman suffering from diabetes, during glycated hemoglobin (Hb A1c) assay. Its presence was suspected because of a small abnormal peak with a retention time just shorter than that of normal Hb A1c. Standard high performance liquid chromatography (HPLC), capillary zone electrophoresis (CZE) and agarose gel electrophoresis did not allow to separate the variant from Hb A. The reversed phase HPLC of globin chains showed the presence of a heterozygous \u03b2-globin variant amounting to approximately 43.5% of the total \u03b2 chains. Later, this variant was found in five other members of the same family and DNA sequencing analysis confirmed a \u03b2-globin gene mutation. The variant is clinically silent in all patients and showed a slight instability with both heat and isopropanol tests. The other three mutations at this locus also affect stability. Hemoglobin (Hb) variants may invalidate the results of Hb A1c analysis and could result in mismanagement of diabetes. A comment alerting the requesting clinician to the presence of the Hb variant must be appended to the Hb A1c result. Additionally, many Hb variants can be chromatographically and/or electrophoretically silent. Therefore, when the clinician suspects a variant Hb, it is not sufficient to get a negative response from an HPLC screening test to rule it out. A dialogue with the pathologist is essential, involving exchange of information and sharing a diagnostic work-up including surveys to assess Hb stability and oxygen affinity, as much as DNA sequencing.\n[HPV vaccine introduction at the local level in a developing country: attitudes and criteria among key actors Introducci\u00f3n de la vacuna contra el VPH en niveles locales de un pa\u00eds en v\u00edas de desarrollo: actitudes y criterios de actores clave](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2010000500012) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMarion Pi\u00f1eros\n2010-05-01\nFull Text Available In most developing countries, HPV vaccines have been licensed but there are no national policy recommendations, nor is it clear how decisions on the introduction of this new vaccine are made. Decentralization processes in many Latin American countries favor decision-making at the local level. Through a qualitative study we explored knowledge regarding the HPV vaccine and the criteria that influence decision-making among local health actors in four regions of Colombia. We conducted a total of 14 in-depths interviews with different actors; for the analysis we performed content analysis. Results indicate that decision-making on the HPV vaccine at the local level has mainly been driven by pressure from local political actors, in a setting where there is low technical knowledge of the vaccine. This increases the risk of initiatives that may foster inequity. Local decisions and initiatives need to be strengthened technically and supported by national-level decisions, guidelines and follow-up.En gran parte de los pa\u00edses en v\u00edas de desarrollo, las vacunas contra el VPH tienen aprobaci\u00f3n para su comercializaci\u00f3n. Sin embargo, no hay recomendaciones y tampoco hay claridad sobre la forma en la que se toman las decisiones para su introducci\u00f3n. La reforma del sistema de salud en muchos pa\u00edses latinoamericanos permite la toma de decisiones en el nivel local. Mediante un estudio cualitativo con actores claves del sector salud en cuatro regiones de Colombia, exploramos el conocimiento sobre la vacuna del VPH y los criterios que influyen en la toma de decisiones. Se realizaron 14 entrevistas en profundidad y an\u00e1lisis de contenido. Los resultados indican que en el nivel local la toma de decisiones sobre la introducci\u00f3n de la vacuna est\u00e1 determinada en gran parte por la presi\u00f3n ejercida por figuras pol\u00edticas locales. Esto, sumado a un bajo nivel de conocimiento t\u00e9cnico, incrementa la posibilidad de iniciativas con implicaciones \u00e9ticas considerables\n[[Hb Burgos (\u03b11 CD64(E13)(Asp\u2192Asn)): a new hemoglobin variant detected during follow-up of diabetic patients].](https://www.ncbi.nlm.nih.gov/pubmed/25458507)\nde la Fuente-Gonzalo, F\u00e9lix; Mart\u00ednez Nieto, Jorge; Torrej\u00f3n, Mar\u00eda Jos\u00e9; Mayor, Luis Antonio; Velasco, Diego; Gonz\u00e1lez Fern\u00e1ndez, Fernando Ataulfo; Ropero Gradilla, Paloma\n2015-01-06\nThe glycated hemoglobin (HbA1c) test by high performance liquid chromatography is a useful tool for the follow-up of diabetes mellitus patients. Some structural hemoglobin (Hb) variants are known to cause interference in the analytical measurement of HbA1c. In this study, it has been characterized a new Hb variant in 4 patients during their regular control of HbA1c. Selective \u03b11 gene sequencing showed a mutation GAC>AAC at codon 64 within exon 2. This produces a change of aspartic acid (Asp) by asparagine (Asn) that does not produce any functional alteration so the resultant molecule behaves as a silent hemoglobinopathy. The structural Hb variants can be detected during the analysis of HbA1c and may alter its values. Though rare, this occurrence signals the need to being aware when measuring HbA1c. Copyright \u00a9 2014 Elsevier Espa\u00f1a, S.L.U. All rights reserved.\n[De alimento a poes\u00eda: la identidad cubana en Paradiso de Jos\u00e9 Lezama Lima](http://revistaperifrasis.uniandes.edu.co/index.php?option=com_content&view=article&id=112:de-alimento-a-poesia-la-identidad-cubana-en-paradiso-de-jose-lezama-lima-maria-adelaida-escobar-trujillo-mcgill-university&catid=37:volumen-1-numero-1&Itemid=65) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMar\u00eda Adelaida Escobar-Trujillo\n2012-06-01\nFull Text Available Partiendo de los estudios sobre lo cubano en Paradiso de Jos\u00e9 Lezama Lima, este trabajo busca contribuir al an\u00e1lisis de la transculturaci\u00f3n a trav\u00e9s del paisaje y la comida como im\u00e1genes que fundan la identidad cubana en la novela. Igualmente, se busca establecer la relaci\u00f3n entre comida y poes\u00eda a partir del proceso de preparaci\u00f3n, transformaci\u00f3n y presentaci\u00f3n que experimentan alimento y palabra. El trabajo est\u00e1 dividido en tres secciones: el producto vegetal primario, la elaboraci\u00f3n de los alimentos y, finalmente, su presentaci\u00f3n en los banquetes gastron\u00f3micos.Starting from works related to Cuban identity in Paradiso from Jos\u00e9 Lezama Lima, this paper will contribute to the study of the concept of transculturation by means of landscape and food that are presented as images used to build the Cuban identity in the novel. The paper will also establish a relationship between food and poetry based on the preparation, transformation and presentation of both, ingredients and words. The paper is divided in three sections: the primary vegetal products, food elaboration and food presentations through gastronomic banquets.\n[Validaci\u00f3n del m\u00e9todo de Ellman para la determinaci\u00f3n de la concentraci\u00f3n de grupos sulfhidrilosa muestras de la producci\u00f3n de la vacuna sint\u00e9tica contra el Haemophilus influenzae tipo b](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2014000200006&lng=es&nrm=iso) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMayra Wood-Duque\n2014-08-01\nFull Text Available e valid\u00f3 el m\u00e9todo de Ellman para la determinaci\u00f3n de grupos sulfhidrilos de la producci\u00f3n del Ingrediente Farmac\u00e9utico Activo de la vacuna contra el Haemophilusinfluenzaetipo b (Hib. Se evaluaron los par\u00e1metros: linealidad, rango de trabajo, especificidad, exactitud y precisi\u00f3n. El m\u00e9todo fue lineal en el rango de 0,25-4 mM/L. Se demostr\u00f3 que la t\u00e9cnica fue espec\u00edfica con una exactitud entre 95 y 105%. La repetibilidad y la precisi\u00f3n intermedia mostraron coeficientes de variaci\u00f3n inferiores al 5% y 10% respectivamente, por debajo de los criterios de aceptaci\u00f3n requeridos para estos par\u00e1metros. Se estableci\u00f3 el reactivo hidrocloruro de L-ciste\u00edna monohidratado como control positivo del m\u00e9todo. Este ensayo por su precisi\u00f3n, especificidad y exactitud se convierte en una eficaz herramienta para el control del proceso de obtenci\u00f3n de esta vacuna.\n[Performance of HbA1c as an early diagnostic indicator of type 1 diabetes in children and youth.](https://www.ncbi.nlm.nih.gov/pubmed/22699293)\nVehik, Kendra; Cuthbertson, David; Boulware, David; Beam, Craig A; Rodriguez, Henry; Legault, Laurent; Hyytinen, Mila; Rewers, Marian J; Schatz, Desmond A; Krischer, Jeffrey P\n2012-09-01\nThe aim of this study was to evaluate HbA(1c) as an alternative criterion for impaired glucose tolerance (IGT) or type 1 diabetes (T1D) in high-risk subjects TrialNet Natural History (TrialNet) studies and had an HbA(1c) within 90 days of an OGTT with a 2-h plasma glucose (2-hPG) measure were included. An OGTT of 140-199 mg/dL defined IGT, and an OGTT with 2-hPG \u2265200 mg/dL or fasting plasma glucose \u2265126 mg/dL defined diabetes. HbA(1c) \u22655.7% defined IGT, and HbA(1c) \u2265 6.5% defined diabetes. Receiver-operating characteristic curve analysis was used to assess diagnostic accuracy of HbA(1c) compared with OGTT. There were 587 subjects from DPT-1, 884 from TrialNet, 91 from TEDDY, and 420 from TRIGR. As an indicator for IGT, HbA(1c) sensitivity was very low across the studies (8-42%), and specificity was variable (64-95%). With HbA(1c) \u22656.5% threshold used for T1D diagnosis, the sensitivity was very low and specificity was high (sensitivity and specificity: DPT-1 24 and 98%, TrialNet 28 and 99%, TEDDY 34 and 98%, and TRIGR 33 and 99%, respectively). The positive predictive value of HbA(1c) \u22656.5% for the development of T1D was variable (50-94%) across the four studies. HbA(1c) \u22656.5% is a specific but not sensitive early indicator for T1D in high-risk subjects <21 years of age diagnosed by OGTT or asymptomatic hyperglycemia. Redefining the HbA(1c) threshold is recommended if used as an alternative criterion in diagnosing T1D.\n[Identification, Functional Study, and Promoter Analysis of HbMFT1, a Homolog of MFT from Rubber Tree (Hevea brasiliensis](http://www.mdpi.com/1422-0067/17/3/247) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nZhenghong Bi\n2016-03-01\nFull Text Available A homolog of MOTHER OF FT AND TFL1 (MFT was isolated from Hevea brasiliensis and its biological function was investigated. Protein multiple sequence alignment and phylogenetic analysis revealed that HbMFT1 conserved critical amino acid residues to distinguish MFT, FLOWERING LOCUS T (FT and TERMINAL FLOWER1 (TFL1-like proteins and showed a closer genetic relationship to the MFT-like group. The accumulation of HbMFT1 was generally detected in various tissues except pericarps, with the highest expression in embryos and relatively higher expression in roots and stems of seedlings, flowering inflorescences, and male and female flowers. HbMFT1 putative promoter analysis showed that tissue-specific, environmental change responsive and hormone-signaling responsive elements were generally present. HbMFT1 was strongly induced under a short-day condition at 28 \u00b0C, with the highest expression after the onset of a day. Overexpression of HbMFT1 inhibited seed germination, seedling growth, and flowering in transgenic Arabidopsis. The qRT-PCR further confirmed that APETALA1 (AP1 and FRUITFULL (FUL were drastically down-regulated in 35S::HbMFT1 plants. A histochemical \u03b2-glucuronidase (GUS assay showed that HbMFT1::GUS activity was mainly detected in stamens and mature seeds coinciding with its original expression and notably induced in rosette leaves and seedlings of transgenic Arabidopsis by exogenous abscisic acid (ABA due to the presence of ABA cis-elements in HbMFT1 promoter. These results suggested that HbMFT1 was mainly involved in maintenance of seed maturation and stamen development, but negatively controlled germination, growth and development of seedlings and flowering. In addition, the HbMFT1 promoter can be utilized in controlling transgene expression in stamens and seeds of rubber tree or other plant species.\n[Desarrollo de vacunas contra el virus de la inmunodeficiencia humana tipo 1: Relevancia de la inmunidad celular contra subtipos Development of vaccines for HIV-1: Relevance of subtype-specific cellular immunity](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802010000600014) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAna Mar\u00eda Rodr\u00edguez\n2010-12-01\nFull Text Available Han pasado casi 30 a\u00f1os de la detecci\u00f3n de los primeros casos de infecci\u00f3n con HIV-1 y a\u00fan no se ha conseguido desarrollar una vacuna efectiva y segura. A pesar del impacto positivo sobre la pandemia que se ha conseguido gracias a los avances en la terapia antirretroviral (TARV, el HIV/sida sigue constituyendo un grave problema para la salud p\u00fablica, especialmente en los pa\u00edses en desarrollo, donde es dif\u00edcil el acceso al tratamiento. En el mundo, 33 millones de personas viven con el virus del sida, mientras que en la Argentina se calcula que habr\u00eda unos 120 000 infectados. Uno de los desaf\u00edos para lograr una vacuna contra el HIV es la variabilidad viral. El grupo M, responsable de la pandemia, se encuentra dividido en 10 subtipos y varios sub-subtipos, adem\u00e1s de las 48 formas recombinantes circulantes y m\u00e1s de cien formas recombinantes \u00fanicas. La epidemia de HIV en nuestro pa\u00eds es tan compleja como en el resto del mundo, con la co-circulaci\u00f3n principalmente de virus pertenecientes al subtipo B y recombinantes BF (CRF12_BF y derivadas. A pesar de la cantidad de trabajos dedicados a la caracterizaci\u00f3n de la respuesta inmune y al desarrollo de vacunas, no queda claro cu\u00e1l es el impacto de la variabilidad en la elecci\u00f3n del ant\u00edgeno. Trabajos realizados en nuestro laboratorio demuestran el papel que juega la inmunidad celular con respecto a las variantes recombinantes BF, tanto en humanos como en modelos animales. Estos resultados son de importancia en el desarrollo de futuras vacunas para nuestra regi\u00f3n.It has been almost 30 years since the detection of the first HIV-1 cases and yet an effective and safe vaccine has not been developed. Although, advances in antiretroviral therapy (HAART have produced a major impact on the pandemic, and even though HIV/aids remains a major concern for developing countries, where access to therapy is limited. The last report from UNAIDS notified 33 million people living with HIV/aids, worldwide\n[Smoking: the influence of carboxyhemoglobin (HbCO) on tumor oxygenation and response to radiation](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=10458629) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nSiemann, D.W.; Hill, R.P.; Bush, R.S.\n1978-01-01\nThe effectiveness of localized x radiation on the transplantable KHT sarcoma was studied in nonanesthetized C3H mice possessing blood carboxyhemoglobin (HbCO) levels similar to those observed in heavy smokers. HbCO values of 10 percent were induced in tumor-bearing animals, either acutely just prior to irradiation or chronically during tumor growth and irradiation, by allowing the mice to breathe gas mixtures containing carbon monoxide (CO) in air. Tumors were irradiated either with single doses of 1500, 2000, or 2500 rad or with seven 500 rad fractions given at 24 hr intervals. Tumor cell survival was determined using an in vivo lung colony or an in vitro agar colony assay. The results with single doses of radiation indicate that under conditions of both acute and chronic exposure, the presence of 10 percent HbCO in the blood of the mice at the time of irradiation increases the survival of tumor cells in the hypoxic region of the survival curve by a factor of 2. During the fractionated irradiation, tumor cell survival in the presence of a 10 percent blood HbCO level (induced either acutely or chronically) was found to be significantly higher than that observed in air breathing mice. The results indicate that HbCO levels, such as are observed in heavy smokers, result in a larger fraction of hypoxic tumor cells. These findings suggest that heavy smoking prior to treatment may worsen the prognosis of patients undergoing radiotherapy\n[Association between effort-reward imbalance and glycosylated hemoglobin (HbA1c) among Chinese workers: results from SHISO study.](https://www.ncbi.nlm.nih.gov/pubmed/21626311)\nXu, Weixian; Hang, Juan; Gao, Wei; Zhao, Yiming; Li, Weihong; Wang, Xinyu; Li, Zhaoping; Guo, Lijun\n2012-02-01\nThe studies focusing on effort-reward imbalance and diabetes mellitus (DM)/glycosylated hemoglobin (HbA1c) are rare. We sought to examine the association between job stress evaluated by effort-reward imbalance (ERI) model and HbA1c in a Chinese population. We analyzed 680 subjects (465 men and 215 women) without DM or impaired glucose tolerance from the stress and health in Shenzhen workers (SHISO) study. Job stress was evaluated by effort-reward imbalance (ERI) model. HbA1c was measured by an automatic analyzer by means of high-performance liquid chromatography. The association between job stress and HbA1c was explored by variance analysis, partial correlations and multiple linear regression analysis. For women, effort, and ERI were positively associated with HbA1c (r = 0.22, p = 0,003; r = 0.21, p = 0.006, respectively), in contrast, reward was negatively associated with HbA1c (r = -0.17, p = 0.021), after controlling age, BMI and physical exercise in the partial correlation analysis; the similar results were confirmed in the multiple linear regression. No significant correlations between job stress and HbA1c were found for men. Effort and ERI are positively associated with HbA1c, and reward is inversely related to HbA1c among Chinese women. The association is not accounted for by age, BMI, and physical exercise. More efforts should be made to improve the job stress status of Chinese working women for the purpose of DM prevention.\n[Hb Matera (HBB: c.167 T > A): A Second Case Detected in a Pregnant Chinese Woman by the Capillary Electrophoresis Method.](https://www.ncbi.nlm.nih.gov/pubmed/26911301)\nLi, You-qiong; Ye, Li-Hua; Mo, Yun\n2016-01-01\nHb Matera (HBB: c.167 T > A) is an unstable \u03b2-globin gene variant with an ATG > AAG substitution at codon 55. Its coelution with Hb A2 on high performance liquid chromatography (HPLC) makes it difficult to discriminate between Hb Matera and Hb E (HBB: c.79 G > A) that also coelutes with Hb A2 in this method. However, we found that capillary electrophoresis (CE) was able to detect Hb Matera and discriminate it from Hb E, based on the quantification of the peaks and on hematological parameters.\n[Associations between gestational diabetes mellitus and elevated HbA1c early postpartum in a multi-ethnic population.](https://www.ncbi.nlm.nih.gov/pubmed/27771271)\nWaage, Christin; Jenum, Anne Karen; Mdala, Ibrahimu; Berg, Jens Petter; Richardsen, K\u00e5re; Birkeland, K\u00e5re\n2017-04-01\nTo investigate the prevalence of elevated HbA 1c 14 weeks postpartum in different ethnic groups and in women with and without gestational diabetes mellitus (GDM) in the index pregnancy and to explore demographic and biological factors from early pregnancy associated with elevated HbA 1c (HbA 1c \u22655.7% (\u226539mmol/mol)) postpartum. From a cohort study in Oslo, Norway, we included 570 pregnant women, examined in gestational week 15, 28, and 14 weeks postpartum. The association between elevated HbA 1c and demographic and biological factors were assessed by logistic regression analyses. The prevalence of elevated HbA 1c postpartum was 23% in the total population, 15% among Western Europeans and 28% among women with ethnic minority background (p<0.01). In ethnic minorities elevated HbA 1c was found in 39% of women with recent GDM diagnosed by the World Health Organization 2013 criteria and in 21% of women without GDM (p<0.01), compared to 22% and 13% in Western Europeans (p=0.11). We found independent associations between elevated HbA 1c and ethnic minority background (OR 2.0, 95% CI 1.27, 3.18), and GDM (OR 2.04, 95% CI 1.35, 3.10) (p<0.01). The prevalence of elevated HbA 1c postpartum was 23%, and significantly higher among women with ethnic minority background irrespective of GDM. Copyright \u00a9 2016 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.\n[Molecular characterization of HbEREBP2, a jasmonateresponsive ...](https://www.ajol.info/index.php/ajb/article/view/95746) [African Journals Online (AJOL)](http://www.ajol.info/index.php)\nTranscription factors of AP2/ERF superfamily are generally involved in defense responses of plants to biotic and abiotic stresses. Although, defense proteins are present in abundance in laticifers of rubber tree, little is known about their transcriptional regulation. In this study, a full length cDNA, referred to as HbEREBP2 was ...\n[Identifying the independent effect of HbA1c variability on adverse health outcomes in patients with Type 2 diabetes.](https://www.ncbi.nlm.nih.gov/pubmed/27279250)\nPrentice, J C; Pizer, S D; Conlin, P R\n2016-12-01\nTo characterize the relationship between HbA 1c variability and adverse health outcomes among US military veterans with Type 2 diabetes. This retrospective cohort study used Veterans Affairs and Medicare claims for veterans with Type 2 diabetes taking metformin who initiated a second diabetes medication (n = 50 861). The main exposure of interest was HbA 1c variability during a 3-year baseline period. HbA 1c variability, categorized into quartiles, was defined as standard deviation, coefficient of variation and adjusted standard deviation, which accounted for the number and mean number of days between HbA 1c tests. Cox proportional hazard models predicted mortality, hospitalization for ambulatory care-sensitive conditions, and myocardial infarction or stroke and were controlled for mean HbA 1c levels and the direction of change in HbA 1c levels during the baseline period. Over a mean 3.3 years of follow-up, all HbA 1c variability measures significantly predicted each outcome. Using the adjusted standard deviation measure for HbA 1c variability, the hazard ratios for the third and fourth quartile predicting mortality were 1.14 (95% CI 1.04, 1.25) and 1.42 (95% CI 1.28, 1.58), for myocardial infarction and stroke they were 1.25 (95% CI 1.10, 1.41) and 1.23 (95% CI 1.07, 1.42) and for ambulatory-care sensitive condition hospitalization they were 1.10 (95% CI 1.03, 1.18) and 1.11 (95% CI 1.03, 1.20). Higher baseline HbA 1c levels independently predicted the likelihood of each outcome. In veterans with Type 2 diabetes, greater HbA 1c variability was associated with an increased risk of adverse long-term outcomes, independently of HbA 1c levels and direction of change. Limiting HbA 1c fluctuations over time may reduce complications. \u00a9 2016 Diabetes UK.\n[HbA1c values calculated from blood glucose levels using truncated Fourier series and implementation in standard SQL database language.](https://www.ncbi.nlm.nih.gov/pubmed/18690368)\nTemsch, W; Luger, A; Riedl, M\n2008-01-01\nThis article presents a mathematical model to calculate HbA1c values based on self-measured blood glucose and past HbA1c levels, thereby enabling patients to monitor diabetes therapy between scheduled checkups. This method could help physicians to make treatment decisions if implemented in a system where glucose data are transferred to a remote server. The method, however, cannot replace HbA1c measurements; past HbA1c values are needed to gauge the method. The mathematical model of HbA1c formation was developed based on biochemical principles. Unlike an existing HbA1c formula, the new model respects the decreasing contribution of older glucose levels to current HbA1c values. About 12 standard SQL statements embedded in a php program were used to perform Fourier transform. Regression analysis was used to gauge results with previous HbA1c values. The method can be readily implemented in any SQL database. The predicted HbA1c values thus obtained were in accordance with measured values. They also matched the results of the HbA1c formula in the elevated range. By contrast, the formula was too \"optimistic\" in the range of better glycemic control. Individual analysis of two subjects improved the accuracy of values and reflected the bias introduced by different glucometers and individual measurement habits.\n[Polar bear hemoglobin and human Hb A0: same 2,3-diphosphoglycerate binding site but asymmetry of the binding?](https://www.ncbi.nlm.nih.gov/pubmed/12484631)\nPomponi, Massimo; Bertonati, Claudia; Patamia, Maria; Marta, Maurizio; Derocher, Andrew E; Lydersen, Christian; Kovacs, Kit M; Wiig, Oystein; B\u00e5rdgard, Astrid J\n2002-11-01\nPolar bear (Ursus maritimus) hemoglobin (Hb) shows a low response to 2,3-diphosphoglycerate (2,3-DPG), compared to human Hb A0, even though these proteins have the same 2,3-DPG-binding site. In addition, polar bear Hb shows a high response to chloride and an alkaline Bohr effect (deltalog P50/deltapH) that is significantly greater than that of human Hb A0. The difference in sequence Pro (Hb A0)-->Gly (polar bear Hb) at position A2 in the A helix seems to be critical for reduced binding of 2,3-DPG. Our results also show that the A2 position may influence not only the flexibility of the A helix, but that differences in flexibility of the first turn of the A helix may affect the unloading of oxygen for the intrinsic ligand affinities of the alpha and beta chains. However, preferential binding to either chain can only take place if there is appreciable asymmetric binding of the phosphoric effector. Regarding this point, 31P NMR data suggest a loss of symmetry of the 2,3-DPG-binding site in the deoxyHb-2,3-DPG complex.\n[Effect of the systemic inflammatory response, as provoked by elective orthopaedic surgery, on HbA1c.](https://www.ncbi.nlm.nih.gov/pubmed/27856516)\nChadburn, Andrew J; Garman, Elizabeth; Abbas, Raad; Modupe, Anu; Ford, Clare; Thomas, Osmond L; Chugh, Sanjiv; Deshpande, Shreeram; Gama, Rousseau\n2017-07-01\nBackground In acutely ill patients with new onset hyperglycaemia, plasma glucose cannot reliably distinguish between stress hyperglycaemia and undiagnosed diabetes mellitus. We, therefore, investigated the diagnostic reliability of glycated haemoglobin (HbA1c) in acute illness by prospectively evaluating the effect of the systemic inflammatory response, as provoked by elective orthopaedic surgery, on HbA 1c . Methods HbA 1c and serum C-reactive protein concentrations were compared before and two days after elective knee or hip surgery in 30 patients without diabetes. C-reactive protein was used to assess the systemic inflammatory response. Results The mean (standard deviation) serum C-reactive protein increased following surgery (4.8 [7.5] vs. 179.7 [61.9] mg/L; P<0.0001). HbA 1c was similar before and after surgery (39.2 [5.4] vs. 38.1 [5.1] mmol/moL, respectively; P = 0.4363). Conclusions HbA 1c is unaffected within two days of a systemic inflammatory response as provoked by elective orthopaedic surgery. This suggests that HbA 1c may be able to differentiate newly presenting type 2 diabetes mellitus from stress hyperglycaemia in acutely ill patients with new onset hyperglycaemia.\n[Hb taradale [beta82(EF6)Lys-->Arg]: a novel mutation at a 2,3-diphosphoglycerate binding site.](https://www.ncbi.nlm.nih.gov/pubmed/16370489)\nBrennan, Stephen O; Sheen, Campbell; Chan, Tim; George, Peter M\n2005-01-01\nHb Taradale [beta82(EF6)Lys-->Arg] was initially detected as a split Hb A0 peak on Hb A1c, monitoring. Red cell parameters, hemoglobin (Hb) electrophoresis and stability tests were normal. Mass spectrometry (ms) clearly identified a variant beta chain with a mass increase of 28 Da and peptide mapping located the mutation site to peptide betaT-9. DNA sequencing confirmed the presence of a novel beta82(EF6)Lys-->Arg mutation. This conservative substitution at a 2,3-diphosphoglycerate (2,3-DPG) binding site did not, however, appear to affect the P50 for oxygen binding.\n[Alternate site testing for HbA1c using the Primus CLC330 GHb analyzer.](https://www.ncbi.nlm.nih.gov/pubmed/9096987)\nPhillipov, G; Charles, P; Beng, C; Phillips, P J\n1997-04-01\nTo determine whether the Primus high-pressure liquid chromatography (HPLC) is suited to alternate site testing (AST) for HbA1c in a hospital diabetes outpatient clinic. Patients were attending the clinic for routine management of their diabetes. A number of diabetic patients with uremia (n = 11) were also investigated. HbA1c levels were measured in the outpatient setting by the Primus HPLC and in a more limited study the DCA-2000 instrument using the new 6-min assay cartridge. HbA1c measurements were also performed with Pierce affinity minicolumns and a Bio-Rad Variant HPLC. The Primus HPLC assay had low imprecision of 2.3, 1.6, and 1.0% for HbA1c levels of 4.7, 7.3, and 11.1%, respectively, and was not prone to interference by carbamylated hemoglobin as found for the ion-exchange Variant HPLC method. Method comparison studies showed that the bias and proportional error between the Pierce affinity minicolumn procedure (standardized with respect to an external quality control program) and the Primus HPLC (Y) was -0.4 and 1.2% respectively (n = 32). Similarly the bias and proportional error between the Primus and DCA-2000 methods was 0.7 and -2.5%. The Primus was shown to give falsely elevated HbA1c concentrations if the time between sequential injections was > 28 min. The Primus HPLC has a decided advantage over specialty AST instruments, like the DCA-2000, in not only meeting AST requirements but also allowing rapid automated batch processing of all laboratory HbA1c samples.", "language": null, "image": null, "pagetype": null, "links": ["#", "//worldwidescience.org/index.html", "//worldwidescience.org/about.html", "//worldwidescience.org/news.html", "//worldwidescience.org/wws", "//worldwidescience.org/contact.html", "//worldwidescience.org/sitemap.html", "//worldwidescience.org/help.html", "#", "#", "#", "#", "#", "#", "https://www.openaire.eu/search/publication?articleId=doajarticles::cd2d869696f88a55899ab58f2ce979f2", "https://www.openaire.eu/search/advanced/publications", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-31942009000200011", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/9805071", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=doajarticles::71daec30452063189f5b50ff40cbc04d", "https://www.openaire.eu/search/advanced/publications", "http://www.revistabiomedica.org/index.php/biomedica/article/view/2011", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892004000400005", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200001&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892002001000005", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892006000300006", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2005000100002&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2016000200002&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2012000200003&lng=es&nrm=iso", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2010000300001&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://revistabionatura.com/2017.02.01.7.html", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200002&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2014000100003&lng=es&nrm=iso", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/21941089", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=od______1404::4f4db4f9056e1f4cbb5edb2cfbec944e", "https://www.openaire.eu/search/advanced/publications", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891998001000001&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891998001000006", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www2c.cdc.gov/podcasts/player.asp?f=8630175", "http://www2c.cdc.gov/podcasts/search.asp", "https://www.openaire.eu/search/publication?articleId=od______3040::cc271e44d67bb301b8673ae704eb1321", "https://www.openaire.eu/search/advanced/publications", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000300001&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892007000300011", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od______3272::e04c2a8ca070b76a97f8c299cefc6434", "https://www.openaire.eu/search/advanced/publications", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2008000200004&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od______1472::a09ac4cf255ae73a6b4363b1bbc0a6ad", "https://www.openaire.eu/search/advanced/publications", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891998001000001", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=doajarticles::4639710bd8874709386dd27339826e1d", "https://www.openaire.eu/search/advanced/publications", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102009000600013", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27776238", "https://www.science.gov/", "http://revistamedicina.net/ojsanm/index.php/Revistamedicina/article/view/903", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2004000200001&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od______1404::6574285bd1662fef225103ab5f2fa6f1", "https://www.openaire.eu/search/advanced/publications", "http://www.sciencedirect.com/science/article/pii/S0716864017300160", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1135-57271999000400003", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od______1404::05502ca26081377cb9ac9b967d7e66d8", "https://www.openaire.eu/search/advanced/publications", "http://www.revistas.usach.cl/ojs/index.php/historiasocial/article/view/319", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::61ee14b25b56c72855596bb426219d56", "https://www.openaire.eu/search/advanced/publications", "http://estudiosamericanos.revistas.csic.es/index.php/estudiosamericanos/article/view/372/378", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://asclepio.revistas.csic.es/index.php/asclepio/article/view/71/74", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::9c7220297c636745e06628ec37f2b47e", "https://www.openaire.eu/search/advanced/publications", "https://www.openaire.eu/search/publication?articleId=od______1326::8ba7ba7cedd44552d4d60ca52f50c9aa", "https://www.openaire.eu/search/advanced/publications", "http://www.romanischestudien.de/index.php/rst/article/view/127", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od______1325::4966a7cc814137a440382bdf643c90d0", "https://www.openaire.eu/search/advanced/publications", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2016000200003&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://www.sciencedirect.com/science/article/pii/S0716864014700689", "https://doaj.org/search#.V6PA8bgrK70", "http://riiad.org/index.php/riiad/article/view/riiad.2017.2.05", "https://doaj.org/search#.V6PA8bgrK70", "https://www2c.cdc.gov/podcasts/player.asp?f=8630647", "http://www2c.cdc.gov/podcasts/search.asp", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1135-57271997000200003", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2010000200006&lng=es&nrm=iso", "https://doaj.org/search#.V6PA8bgrK70", "http://www.revistabiomedica.org/index.php/biomedica/article/view/1320", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-70542011000100021", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=doajarticles::d1c5d56abb3c55f6f0d140a1ec694442", "https://www.openaire.eu/search/advanced/publications", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802010000300002&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od______1404::4dfcdb9afa501d98d59e07e37c0dec1f", "https://www.openaire.eu/search/advanced/publications", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891997001200001", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891997001200001&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-40142011000200004", "https://doaj.org/search#.V6PA8bgrK70", "http://www.redalyc.org/articulo.oa?id=17023106004", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.openaire.eu/search/publication?articleId=od______1325::3699ed70c8821c924c79160abcf4fcaf", "https://www.openaire.eu/search/advanced/publications", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-77042009000200013&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-05822012000200008", "https://doaj.org/search#.V6PA8bgrK70", "http://www.redalyc.org/articulo.oa?id=17020115007", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=doajarticles::136a986051855d4bcd529e7bf176cfb3", "https://www.openaire.eu/search/advanced/publications", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75152009000200004", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2017000100001&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=doajarticles::6b66ddb6469e571415699a6d6ab5c90f", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/28407371", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=od______1404::024354d31010002918ddb339dc0408a6", "https://www.openaire.eu/search/advanced/publications", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::9f9342f04c4ecfc6206eb357ddd593ea", "https://www.openaire.eu/search/advanced/publications", "https://www.openaire.eu/search/publication?articleId=doajarticles::665616b0e79abcde2883f393f494e02c", "https://www.openaire.eu/search/advanced/publications", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2017000100003&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/8629117", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=od_______296::4dfda7f2f3e4339756541268672e7022", "https://www.openaire.eu/search/advanced/publications", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802011000500015&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://edusol.cug.co.cu/index.php/EduSol/editor/submission/262", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2004000200002&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://www.redalyc.org/articulo.oa?id=129517775004", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0465-546X2007000400010", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200004&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27664335", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/26036869", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28698850", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=doajarticles::10bf287ae0007ca1c04dfbe102687a3b", "https://www.openaire.eu/search/advanced/publications", "http://www.revistabiomedica.org/index.php/biomedica/article/view/44", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od_______617::72f63e3faddc26d37afb5bec15e160d2", "https://www.openaire.eu/search/advanced/publications", "http://www.mjhid.org/index.php/mjhid/article/view/2050", "https://doaj.org/search#.V6PA8bgrK70", "http://dx.doi.org/10.1155/2011/248527", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1726-46342015000300021&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://dx.doi.org/10.1016/j.jmmm.2012.08.029", "http://inis.iaea.org/search/", "http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=22155474", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832008000100006&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::1ea3de1bdf059dfdef615fb2bb624b84", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/29398808", "https://www.science.gov/", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-40142011000200007", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412012000300014", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=doajarticles::6f322a77ce0bd5fd88c95f861a1a0782", "https://www.openaire.eu/search/advanced/publications", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0036-36341998000100006", "https://doaj.org/search#.V6PA8bgrK70", "https://revistas.unal.edu.co/index.php/achsc/article/view/28085", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1726-46342013000200018&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.redalyc.org/articulo.oa?id=17033372012", "https://doaj.org/search#.V6PA8bgrK70", "http://www.sciencedirect.com/science/article/pii/S2352396415301432", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=doajarticles::0d49daa6f3bda39c5d5eb8a5dc3c809d", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/28107170", "https://www.science.gov/", "http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342009000900012", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892013001000002&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://revistas.uexternado.edu.co/index.php?journal=emerca&page=article&op=view&path%5B%5D=2625", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27368113", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=doajarticles::9f083d9cb2b9e06dbceeb1cf2c0fabe3", "https://www.openaire.eu/search/advanced/publications", "http://revistas.unicartagena.edu.co/index.php/palobra/article/view/73", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2005000100003&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "https://revistas.unal.edu.co/index.php/actabiol/article/view/11338", "https://doaj.org/search#.V6PA8bgrK70", "http://www.revistabiomedica.org/index.php/biomedica/article/view/1056", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75152015000100015&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=45076028", "http://inis.iaea.org/search/", "https://www.openaire.eu/search/publication?articleId=od_______623::6cb0e6090b3a2b34b24cec7568c14ca8", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/28497611", "https://www.science.gov/", "http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0213-91112005000600006", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802010000600014&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2007000300004&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2014;volume=57;issue=4;spage=626;epage=628;aulast=Parab", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27408410", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=issn07193092::9380935891261c89d8ba9bef474961c5", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/28900367", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/10471280", "https://www.science.gov/", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-44782014000100006&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://pure.au.dk/ws/files/36381690/Dietary_determinants_for_Hb_acrylamide_and_Hb_glycidamide_adducts_in_Danish_non_smoking_women.pdf", "http://forskningsbasen.deff.dk/?lang=eng", "https://www.ncbi.nlm.nih.gov/pubmed/29075078", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=od______3056::82b64147f5ee52a084b87646ddedd8d4", "https://www.openaire.eu/search/advanced/publications", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::75a9e32286355fccc441602108255ca3", "https://www.openaire.eu/search/advanced/publications", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200005&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://revistamedicina.net/ojsanm/index.php/Revistamedicina/article/view/92", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/29457528", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=od______1326::8fd162326a4cf806bef07884700a3945", "https://www.openaire.eu/search/advanced/publications", "http://www.redalyc.org/articulo.oa?id=17015304012", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=doajarticles::0f1a7e9d964b5b4dd7e2026d0f5f7623", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/27408407", "https://www.science.gov/", "http://www.redalyc.org/articulo.oa?id=83743886006", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28699687", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.ncbi.nlm.nih.gov/pubmed/25869492", "https://www.science.gov/", "https://revistas.unal.edu.co/index.php/revfacmed/article/view/22140", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/25825563", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/26485748", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28244614", "https://www.science.gov/", "http://www.sciencedirect.com/science/article/pii/S0716864010706088", "https://doaj.org/search#.V6PA8bgrK70", "http://200.169.97.104/seer/index.php/RBGN/article/view/720/779", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200003&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::69504224a67a1db5cf7f4eafc85160f1", "https://www.openaire.eu/search/advanced/publications", "https://www.openaire.eu/search/publication?articleId=od_______935::d513a40dc09e50440853f4ad3258003a", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/24746101", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27535451", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/26956449", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/24074341", "https://www.science.gov/", "http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342007000300011&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342006000100007&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.dovepress.com/hydroxyurea-decreases-hospitalizations-in-pediatric-patients-with-hb-s-peer-reviewed-article-JBM", "https://doaj.org/search#.V6PA8bgrK70", "http://www.revista-socampar.com/images/articulos/ArticulosSeparadosNum6/Articulo%20especial.pdf", "https://doaj.org/search#.V6PA8bgrK70", "http://www.tse.go.cr/revista/art/18/pena_barrios.pdf", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1726-46342012000200017", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.openaire.eu/search/publication?articleId=od______3056::d4191acb1173d7dbea934cb8c961809f", "https://www.openaire.eu/search/advanced/publications", "https://www.openaire.eu/search/publication?articleId=od______3056::90581237738de503aa4b6681ae4c01e3", "https://www.openaire.eu/search/advanced/publications", "http://www.sciencedirect.com/science/article/pii/S1575181316301450", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-21862013000100003&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://estudiosamericanos.revistas.csic.es/index.php/estudiosamericanos/article/view/106", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::f118b21a924c80aa9ffde3c6916975f2", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/28361593", "https://www.science.gov/", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=30013890", "http://inis.iaea.org/search/", "http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342010000300007", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28791912", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/26974561", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28792665", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27254408", "https://www.science.gov/", "http://dx.doi.org/10.1016/j.msec.2016.03.102", "http://inis.iaea.org/search/", "http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=22579736", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "https://www.ncbi.nlm.nih.gov/pubmed/28472705", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::b02a57661d19008e458fea569a4b230a", "https://www.openaire.eu/search/advanced/publications", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892008000800004", "https://doaj.org/search#.V6PA8bgrK70", "http://www.ijem.in/article.asp?issn=2230-8210;year=2012;volume=16;issue=4;spage=528;epage=531;aulast=Unnikrishnan", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27005335", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://tools.cdc.gov/medialibrary/index.aspx#/media/id/303181", "http://www2c.cdc.gov/podcasts/search.asp", "https://www.ncbi.nlm.nih.gov/pubmed/25884994", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27105433", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75152001000100011", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75151996000100006", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36341997000400006", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1135-57272002000400008", "https://doaj.org/search#.V6PA8bgrK70", "http://investiga.uned.ac.cr/revistas/index.php/espiga/article/view/1800", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od______1106::2d0994ebc04aca806f25b6ad7129d7d2", "https://www.openaire.eu/search/advanced/publications", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2017000100002&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/25522142", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/25490067", "https://www.science.gov/", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842002000100010", "https://doaj.org/search#.V6PA8bgrK70", "http://www.periodico.ebras.bio.br/ojs/index.php/ebras/article/view/ebrasilis.v10i1.641", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27191339", "https://www.science.gov/", "http://rii.cujae.edu.cu/index.php/revistaind/article/view/224", "https://doaj.org/search#.V6PA8bgrK70", "http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=1204359", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "https://www.ncbi.nlm.nih.gov/pubmed/27670359", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/25976777", "https://www.science.gov/", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412009000200005", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.ncbi.nlm.nih.gov/pubmed/29279598", "https://www.science.gov/", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-40142011000200008", "https://doaj.org/search#.V6PA8bgrK70", "http://revistas.uo.edu.cu/index.php/stgo/article/view/140", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=doajarticles::a9d6493ca919442f461e731f2a8a6c9c", "https://www.openaire.eu/search/advanced/publications", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-37862014000300281&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27997764", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5579747", "https://www.science.gov/", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892008000900002", "https://doaj.org/search#.V6PA8bgrK70", "http://www.redalyc.org/articulo.oa?id=181517990006", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od______3056::5d7a8a9d35638166a4e7ccabd8678667", "https://www.openaire.eu/search/advanced/publications", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842001000300004", "https://doaj.org/search#.V6PA8bgrK70", "http://periodicos.uem.br/ojs/index.php/EspacoAcademico/article/view/10587", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802010000300002", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/26118199", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3279321", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2004000100001&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/25897478", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/22646534", "https://www.science.gov/", "http://asclepio.revistas.csic.es/index.php/asclepio/article/view/62/64", "https://doaj.org/search#.V6PA8bgrK70", "http://dx.doi.org/10.1186/1471-2407-12-205", "http://inis.iaea.org/search/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3414754", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/29124865", "https://www.science.gov/", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-62762003000100008", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27184351", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1727-81202014000100010&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.elcriterio.com/revista/ajoica/contenidos_4/341ndez.pdf", "https://doaj.org/search#.V6PA8bgrK70", "http://www.biomedcentral.com/1471-2407/12/205", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2011000200003&lng=es&nrm=iso", "https://doaj.org/search#.V6PA8bgrK70", "https://ntrs.nasa.gov/search.jsp?R=19830048737&hterms=hb&qs=N%3D0%26Ntk%3DAll%26Ntx%3Dmode%2Bmatchall%26Ntt%3Dhb", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2013000300004&lng=es&nrm=iso", "https://doaj.org/search#.V6PA8bgrK70", "http://asclepio.revistas.csic.es/index.php/asclepio/article/view/546/568", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/29573459", "https://www.science.gov/", "http://dx.doi.org/10.1016/j.bbrc.2008.08.062", "http://inis.iaea.org/search/", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::1ea120f5c5649aaca65d523215f29803", "https://www.openaire.eu/search/advanced/publications", "https://www.openaire.eu/search/publication?articleId=od______3056::c178bdb2747b8762099be70feeaa7237", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/29484903", "https://www.science.gov/", "http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=988640", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832011000300003&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28413893", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28589542", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://dx.doi.org/10.1016/j.tsf.2005.07.044", "http://inis.iaea.org/search/", "http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=20810878", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "https://www.ncbi.nlm.nih.gov/pubmed/26372398", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4604587", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4762213", "https://www.science.gov/", "http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342009000900010", "https://doaj.org/search#.V6PA8bgrK70", "http://www.redalyc.org/articulo.oa?id=17043728001", "https://doaj.org/search#.V6PA8bgrK70", "http://babel.revues.org/876", "https://doaj.org/search#.V6PA8bgrK70", "http://www.mdpi.com/1996-1944/8/3/1187", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28224676", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/29533098", "https://www.science.gov/", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802011000500015", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/29274275", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/26519868", "https://www.science.gov/", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46651991000100005", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842003000400013", "https://doaj.org/search#.V6PA8bgrK70", "http://www.forskningsdatabasen.dk/en/catalog/233181859", "http://forskningsbasen.deff.dk/?lang=eng", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-21002010000600013", "https://doaj.org/search#.V6PA8bgrK70", "http://periodicos.ufpb.br/ojs2/index.php/pgc/article/view/27377", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28092674", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://www.forskningsdatabasen.dk/en/catalog/2115115", "http://forskningsbasen.deff.dk/?lang=eng", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4886677", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27552675", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28817231", "https://www.science.gov/", "http://revistas.unimagdalena.edu.co/index.php/clioamerica/article/view/342", "https://doaj.org/search#.V6PA8bgrK70", "http://www.forskningsdatabasen.dk/en/catalog/194464157", "http://forskningsbasen.deff.dk/?lang=eng", "https://www.ncbi.nlm.nih.gov/pubmed/28498080", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4822872", "https://www.science.gov/", "http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/5100.pdf&manuscript_id=5100", "https://doaj.org/search#.V6PA8bgrK70", "http://www.redalyc.org/articulo.oa?id=80125017008", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27086429", "https://www.science.gov/", "http://www.forskningsdatabasen.dk/en/catalog/2262879396", "http://forskningsbasen.deff.dk/?lang=eng", "https://www.openaire.eu/search/publication?articleId=od______1106::9226084bf3884fcadfc72593ce73fd24", "https://www.openaire.eu/search/advanced/publications", "https://www.openaire.eu/search/publication?articleId=od_______935::69e2b78c0813ba798e7f18af9d21bb8d", "https://www.openaire.eu/search/advanced/publications", "https://www.openaire.eu/search/publication?articleId=doajarticles::3941e408f16fd779b922d875bd01b15f", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/29191924", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::079e97a5d510c0250481d9007f374dfc", "https://www.openaire.eu/search/advanced/publications", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2000000400004&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/1288", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od_______908::b5af65e02d9cf002bdf116019402dcb0", "https://www.openaire.eu/search/advanced/publications", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412012000200004", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/26100115", "https://www.science.gov/", "http://e-journal.unair.ac.id/index.php/MKG/article/view/879", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86821974000200007", "https://doaj.org/search#.V6PA8bgrK70", "https://hal.archives-ouvertes.fr/inserm-00659373/document", "http://forskningsbasen.deff.dk/?lang=eng", "http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0718-560X2015000500005&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842003000300007", "https://doaj.org/search#.V6PA8bgrK70", "http://ukrbiochemjournal.org/wp-content/uploads/2015/06/Korotkevych_4_14.pdf", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27679433", "https://www.science.gov/", "https://www2c.cdc.gov/podcasts/player.asp?f=8636392", "http://www2c.cdc.gov/podcasts/search.asp", "https://www.openaire.eu/search/publication?articleId=doajarticles::3fce4732c2a56c9ba98c537539d5200b", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/26344325", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/18588431", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27768851", "https://www.science.gov/", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892006000900001", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od______1106::f4d741f2ddd69717da31854495ecc2ce", "https://www.openaire.eu/search/advanced/publications", "https://www.openaire.eu/search/publication?articleId=od______2347::862e193bff7f2aed1ec83096ecbe1486", "https://www.openaire.eu/search/advanced/publications", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312014000200012&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/24060751", "https://www.science.gov/", "http://estudiosamericanos.revistas.csic.es/index.php/estudiosamericanos/article/view/106/111", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=11525338", "http://inis.iaea.org/search/", "http://dx.doi.org/10.1155/2016/2698362", "https://doaj.org/search#.V6PA8bgrK70", "https://cdsweb.cern.ch/record/938513", "http://cdsweb.cern.ch/collection/Multimedia%20%26%20Outreach?ln=en", "https://cdsweb.cern.ch/record/944771", "http://cdsweb.cern.ch/collection/Multimedia%20%26%20Outreach?ln=en", "https://www.ajol.info/index.php/aam/article/view/8356", "http://www.ajol.info/index.php", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4346585", "https://www.science.gov/", "http://www.forskningsdatabasen.dk/en/catalog/232208163", "http://forskningsbasen.deff.dk/?lang=eng", "https://www.ncbi.nlm.nih.gov/pubmed/27117568", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28614537", "https://www.science.gov/", "https://www.narcis.nl/publication/RecordID/oai%3Apure.rug.nl%3Apublications%2F760f75fa-4e77-4bbf-8276-fc423008490a/uquery/HBA1C/id/6/Language/EN", "http://www.narcis.nl", "https://www.ncbi.nlm.nih.gov/pubmed/28395541", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/29115167", "https://www.science.gov/", "http://www.revistas.unal.edu.co/index.php/lthc/article/view/37135", "https://doaj.org/search#.V6PA8bgrK70", "http://biblios.pitt.edu/ojs/index.php/biblios/article/view/51", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::ece01fbd6d31d8575f7f4ae84e6b72a6", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/23634648", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3285435", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/25113778", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/25676138", "https://www.science.gov/", "http://files.eric.ed.gov/fulltext/ED572962.pdf", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://www.journalagent.com/z4/download_fulltext.asp?pdir=tjh&plng=eng&un=TJH-42243", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/10852312", "https://www.science.gov/", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=19047070", "http://inis.iaea.org/search/", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572009000400007", "https://doaj.org/search#.V6PA8bgrK70", "http://europepmc.org/articles/PMC4169520?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "http://www.pagepressjournals.org/index.php/thal/article/view/1832", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2001000200002&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75152014000100003&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://tools.cdc.gov/medialibrary/index.aspx#/media/id/303180", "http://www2c.cdc.gov/podcasts/search.asp", "https://www.ncbi.nlm.nih.gov/pubmed/26385729", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75071999000300005", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/26328752", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27692850", "https://www.science.gov/", "http://dx.doi.org/10.1016/j.bbrc.2010.09.130", "http://inis.iaea.org/search/", "http://scielo.sld.cu/scielo.php?script=sci_pdf&pid=S1025-028X2014000300002&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "https://ntrs.nasa.gov/search.jsp?R=19850060859&hterms=hb&qs=N%3D0%26Ntk%3DAll%26Ntx%3Dmode%2Bmatchall%26Ntt%3Dhb", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28128321", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/25432160", "https://www.science.gov/", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892010000500005", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ajol.info/index.php/ejas/article/download/144689/134351", "http://www.ajol.info/index.php", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-11042016000400009&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/29219637", "https://www.science.gov/", "http://revistanuestramerica.cl/ojs/index.php/nuestramerica/article/view/83", "https://doaj.org/search#.V6PA8bgrK70", "http://www.lenus.ie/hse/handle/10147/238825", "http://www.lenus.ie/hse/", "https://www.ncbi.nlm.nih.gov/pubmed/28049107", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28065181", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::2c7550e41cc1b600c078d86db0fb4ab3", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/26372199", "https://www.science.gov/", "https://medlineplus.gov/labtests/hemoglobina1chba1ctest.html", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3836095", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28361589", "https://www.science.gov/", "http://www.forskningsdatabasen.dk/en/catalog/266213608", "http://forskningsbasen.deff.dk/?lang=eng", "https://www.ncbi.nlm.nih.gov/pubmed/27659279", "https://www.science.gov/", "http://rii.cujae.edu.cu/index.php/revistaind/article/view/225", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892004000100006", "https://doaj.org/search#.V6PA8bgrK70", "http://ukrbiochemjournal.org/2017/12/changes-in-prohb-egf-expression-after-functional-activation-of-the-immune-system-cells.html", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27117572", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=od_______623::95730adb527958be28a6c0f4c800bce7", "https://www.openaire.eu/search/advanced/publications", "https://revistas.unal.edu.co/index.php/revfacmed/article/view/27236", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28026908", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://ocean.kisti.re.kr/downfile/volume/kosss/OJOOBS/2007/v24n1/OJOOBS_2007_v24n1_39.pdf", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/1920879", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/29881441", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27043025", "https://www.science.gov/", "http://www.sciencedirect.com/science/article/pii/S2352551716300245", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28945175", "https://www.science.gov/", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=30026502", "http://inis.iaea.org/search/", "http://adsabs.harvard.edu/abs/2018E%26ES..125a2165P", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4183551", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/24513588", "https://www.science.gov/", "http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36341998000100006", "https://doaj.org/search#.V6PA8bgrK70", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=19047111", "http://inis.iaea.org/search/", "https://revistas.unal.edu.co/index.php/actabiol/article/view/27394", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/26757782", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28973588", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192015000200020&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://revistas.utadeo.edu.co/index.php/TyE/article/view/945/984", "https://doaj.org/search#.V6PA8bgrK70", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=17060275", "http://inis.iaea.org/search/", "https://www.ncbi.nlm.nih.gov/pubmed/27810987", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75152003000200006", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.ncbi.nlm.nih.gov/pubmed/27246670", "https://www.science.gov/", "http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=22202894", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "https://www.ncbi.nlm.nih.gov/pubmed/25349480", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=rcubrevistes::9dfff61308824eba56d96a517f753a50", "https://www.openaire.eu/search/advanced/publications", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::ba3b6519697861405c1331692741b042", "https://www.openaire.eu/search/advanced/publications", "https://www.openaire.eu/search/publication?articleId=revistmanabi::7fbb7e71699112f7661a712545458c8b", "https://www.openaire.eu/search/advanced/publications", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75152009000100006", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28407666", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28121795", "https://www.science.gov/", "http://www.biomedcentral.com/1756-0500/4/298", "https://doaj.org/search#.V6PA8bgrK70", "https://eric.ed.gov/?q=outsourcing&pg=3&id=ED547796", "https://www.science.gov/", "http://www.forskningsdatabasen.dk/en/catalog/190371253", "http://forskningsbasen.deff.dk/?lang=eng", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4167218", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5037378", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1727-81202007000200003", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27535164", "https://www.science.gov/", "http://informesdelaconstruccion.revistas.csic.es/index.php/informesdelaconstruccion/article/view/1688/1882", "https://doaj.org/search#.V6PA8bgrK70", "http://rii.cujae.edu.cu/index.php/revistaind/article/view/80", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2005000100001&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://europepmc.org/articles/PMC4546239?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3816136", "https://www.science.gov/", "http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-37-349.pdf", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412005000400002", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/25220229", "https://www.science.gov/", "http://redc.revistas.csic.es/index.php/redc/article/view/160/214", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/25503669", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28768465", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/29464999", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/24244560", "https://www.science.gov/", "http://europepmc.org/articles/PMC3820602?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/24069532", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/26016900", "https://www.science.gov/", "http://www.mjhid.org/index.php/mjhid/article/view/1403", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27440936", "https://www.science.gov/", "http://www.lenus.ie/hse/handle/10147/220231", "http://www.lenus.ie/hse/", "https://www.osti.gov/servlets/purl/9562-YkLSaJ/webviewable/", "http://inis.iaea.org/search/", "https://www.ncbi.nlm.nih.gov/pubmed/28412484", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28817663", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::e53e6396d7036924ac4edb136005a9b2", "https://www.openaire.eu/search/advanced/publications", "http://rii.cujae.edu.cu/index.php/revistaind/article/view/267", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.osti.gov/servlets/purl/812197-SDjaLW/native/", "http://inis.iaea.org/search/", "http://dx.doi.org/10.1155/2013/543973", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/29124870", "https://www.science.gov/", "http://www.dovepress.com/significance-of-hba1c-and-its-measurement-in-the-diagnosis-of-diabetes-peer-reviewed-article-DMSO", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/9140718", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5421591", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27650096", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28332377", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/29626415", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27431094", "https://www.science.gov/", "http://revistadeindias.revistas.csic.es/index.php/revistadeindias/article/view/811/880", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28105519", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/29187944", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28601670", "https://www.science.gov/", "http://dx.doi.org/10.1155/2017/1261972", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342003000900019", "https://doaj.org/search#.V6PA8bgrK70", "http://www.redalyc.org/articulo.oa?id=62913391004", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/26663794", "https://www.science.gov/", "http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-36-37.pdf", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/29493331", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.ncbi.nlm.nih.gov/pubmed/20675575", "https://www.science.gov/", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892006000500007", "https://doaj.org/search#.V6PA8bgrK70", "http://www.iaea.org/inis/collection/NCLCollectionStore/_Public/23/026/23026483.pdf?r=1", "http://inis.iaea.org/search/", "https://www.ncbi.nlm.nih.gov/pubmed/18441530", "https://www.science.gov/", "http://www.redalyc.org/articulo.oa?id=73138582007", "https://doaj.org/search#.V6PA8bgrK70", "http://dx.doi.org/10.1155/2015/761740", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/24036080", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28387422", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/29662324", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2000000400001&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ifch.unicamp.br/ojs/index.php/proa/article/view/2326", "https://doaj.org/search#.V6PA8bgrK70", "http://www.narcis.nl/publication/RecordID/oai%3Atudelft.nl%3Auuid%3A2bdc7c7d-b1a2-45d3-8584-41c89d679935/uquery/LED/id/7/Language/EN", "http://www.narcis.nl", "https://www.ncbi.nlm.nih.gov/pubmed/28733374", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27797673", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27250692", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3714498", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/29156870", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/29251012", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28039017", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4997021", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5505423", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/22084702", "https://www.science.gov/", "http://adsabs.harvard.edu/abs/1996SPIE.2927..119K", "https://www.science.gov/", "http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=22242225", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "http://dx.doi.org/10.1016/j.bbrc.2013.11.019", "http://inis.iaea.org/search/", "https://www.ncbi.nlm.nih.gov/pubmed/29398805", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28668900", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75152009000300004", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802005000400008", "https://doaj.org/search#.V6PA8bgrK70", "http://www.biomedcentral.com/1471-2296/6/28", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21251997000200008", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/26331290", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3961526", "https://www.science.gov/", "http://www.anfamed.edu.uy/index.php/rev/article/view/123", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od______1106::9e316d1d40664e1f75d27ff2273fde6d", "https://www.openaire.eu/search/advanced/publications", "https://www.openaire.eu/search/publication?articleId=od______1106::1f22a06ee30018481e8bc9557c0923e8", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/29442911", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5428399", "https://www.science.gov/", "http://www.forskningsdatabasen.dk/en/catalog/2398248268", "http://forskningsbasen.deff.dk/?lang=eng", "http://www.forskningsdatabasen.dk/en/catalog/99481224", "http://forskningsbasen.deff.dk/?lang=eng", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.ncbi.nlm.nih.gov/pubmed/28338881", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27032675", "https://www.science.gov/", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2010000500012", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/25458507", "https://www.science.gov/", "http://revistaperifrasis.uniandes.edu.co/index.php?option=com_content&view=article&id=112:de-alimento-a-poesia-la-identidad-cubana-en-paradiso-de-jose-lezama-lima-maria-adelaida-escobar-trujillo-mcgill-university&catid=37:volumen-1-numero-1&Itemid=65", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2014000200006&lng=es&nrm=iso", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/22699293", "https://www.science.gov/", "http://www.mdpi.com/1422-0067/17/3/247", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802010000600014", "https://doaj.org/search#.V6PA8bgrK70", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=10458629", "http://inis.iaea.org/search/", "https://www.ncbi.nlm.nih.gov/pubmed/21626311", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/26911301", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27771271", "https://www.science.gov/", "https://www.ajol.info/index.php/ajb/article/view/95746", "http://www.ajol.info/index.php", "https://www.ncbi.nlm.nih.gov/pubmed/27279250", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/18690368", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/12484631", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27856516", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/16370489", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/9096987", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "http://worldwidescience.org/disclaimer.html", null, "http://www.science.gov", "http://worldwidescience.org"]}